Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGRP,Agouti-related protein,42754,0.207396100166097,0.00501877522309751,0.197559300728826,0.217232899603368,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42679,-0.134861465924442,0.00319910179503107,-0.141131705442703,-0.128591226406181,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LDLR,Low-density lipoprotein receptor,42644,0.24384247343439,0.0048363975449663,0.234363134246256,0.253321812622524,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFGE8,Lactadherin,42611,0.211529229648164,0.0040980284875918,0.203497093812484,0.219561365483844,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PON3,Serum paraoxonase/lactonase 3,42676,-0.117241844980154,0.00275711961075515,-0.122645799417234,-0.111837890543074,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRAP1,Proline-rich acidic protein 1,40527,0.160462131532556,0.0040235467830857,0.152575979837708,0.168348283227404,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS8,Prostasin,42568,0.169482900387765,0.00407941591000448,0.161487245204156,0.177478555571374,0
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPY,Pro-neuropeptide Y,42721,0.246452954086725,0.00627844130961717,0.234147209119875,0.258758699053574,1.11253692926801e-308
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCG,Pro-glucagon,42346,0.481739075078288,0.0123472251571825,0.45753851377021,0.505939636386365,1.11253710798762e-308
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASGR1,Asialoglycoprotein receptor 1,42495,0.11291713507105,0.00298243181440093,0.107071568714824,0.118762701427275,5.44353311921123e-298
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42611,-0.118392742039244,0.00325513813729756,-0.124772812788347,-0.112012671290141,2.52060091975484e-276
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS4,Galectin-4,42618,0.201172548971268,0.00557993529923767,0.190235875784762,0.212109222157774,9.06090914713498e-272
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42495,0.120551115994712,0.00335202389290595,0.113981149164616,0.127121082824808,2.19009799418084e-270
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOM,Apolipoprotein M,42663,-0.0991148380048364,0.00278375548101883,-0.104570998747633,-0.0936586772620395,1.94032525898958e-265
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPR37,Prosaposin receptor GPR37,42357,0.231417864963089,0.00676772171433597,0.21815313040299,0.244682599523187,1.36907113322767e-245
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD4,T-cell surface glycoprotein CD4,42570,0.10124759597243,0.00306868667352928,0.0952329700923121,0.107262221852547,1.38909614851255e-229
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGSF9,Protein turtle homolog A,40511,0.266580150681631,0.00822418728990702,0.250460743593414,0.282699557769849,1.7222936133409e-220
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADIPOQ,Adiponectin,40539,-0.221520797830279,0.00686023191932733,-0.234966852392161,-0.208074743268398,6.37132792056593e-219
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPL,Lipoprotein lipase,42636,-0.148299210333862,0.00463381710056602,-0.157381491850972,-0.139216928816753,1.17086712273031e-216
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOF,Apolipoprotein F,40532,-0.0759684606324466,0.00237346538267141,-0.0806204527824826,-0.0713164684824107,2.73383461281924e-215
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RTN4R,Reticulon-4 receptor,42721,0.108858722562131,0.00341826642262305,0.10215892037379,0.115558524750473,1.12946769869686e-214
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42585,0.169790272160572,0.0054205350834345,0.159166023397041,0.180414520924104,6.42652898751379e-208
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLTP,Phospholipid transfer protein,42752,-0.111208590418612,0.00356436299426526,-0.118194741887372,-0.104222438949852,1.92553718593751e-206
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PYY,Peptide YY,40116,0.316072951305907,0.0101949332910635,0.296090882055423,0.336055020556392,2.44737104439845e-202
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42721,0.10035535096557,0.00326053159064009,0.093964709047915,0.106745992883224,3.98236482098288e-201
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GDF15,Growth/differentiation factor 15,42794,0.1417219937,0.0046231510205352,0.132660617699751,0.150783369700249,1.29723556723641e-199
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFASC,Neurofascin,42754,0.0883961691658103,0.00289491497211919,0.0827221358204567,0.094070202511164,4.2028234682064e-198
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42587,0.210143966445388,0.00694574737733756,0.196530301585807,0.22375763130497,1.45708449116629e-194
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MVK,Mevalonate kinase,42370,0.240039203167547,0.00794890986907882,0.224459339824152,0.255619066510941,9.33829600612959e-194
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42705,0.139641103908983,0.00469298661950461,0.130442850134754,0.148839357683212,1.66568728753796e-188
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42587,0.0991278616715437,0.00335067793962581,0.0925605329098771,0.10569519043321,2.19169255416998e-186
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBP5,Retinol-binding protein 5,42587,0.164777280758042,0.00557126771539276,0.153857596035872,0.175696965480212,2.74944613907616e-186
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMPRSS15,Enteropeptidase,42587,0.267280953431409,0.00911859560926054,0.249408506037258,0.285153400825559,4.17883658172586e-183
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN1,CCN family member 1,42569,0.213986716289654,0.00735240374038039,0.199576004958508,0.228397427620799,1.26898918386005e-180
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42679,0.107147548828868,0.00368688350629601,0.099921257156528,0.114373840501208,3.67519202001815e-180
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOS3,"Nitric oxide synthase, endothelial",42311,0.158078825591473,0.00547179165543616,0.147354113946818,0.168803537236127,5.63965561648791e-178
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,42408,0.138283533916748,0.00478996408227708,0.128895204315485,0.147671863518011,8.96330248633541e-178
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42692,0.0698733579601174,0.00242808570718413,0.0651143099740365,0.0746324059461983,8.53220697225904e-177
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACY1,Aminoacylase-1,42636,0.174053185164911,0.0060506107101186,0.162193988173079,0.185912382156744,1.20511180270354e-176
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGSF8,Immunoglobulin superfamily member 8,42636,0.0874545777359419,0.00307148609005639,0.0814344649994314,0.0934746904724525,3.30979041518424e-173
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CES1,Liver carboxylesterase 1,42661,0.230097720597343,0.00810392940606831,0.214214018961449,0.245981422233237,2.75561598404081e-172
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UPB1,Beta-ureidopropionase,40511,0.254360455326406,0.00900364003741446,0.236713320853074,0.272007589799738,9.9051143068402e-170
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HGF,Hepatocyte growth factor,42754,0.0981275083735479,0.0034854152194234,0.0912960945434781,0.104958922203618,1.54396848943596e-169
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42443,0.1354551717553,0.00483069475982487,0.125987010026043,0.144923333484556,4.0174752256754e-168
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42754,0.114870800942092,0.00416873303816006,0.106700084187298,0.123041517696886,1.10860304254553e-162
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NHLRC3,NHL repeat-containing protein 3,40013,0.0889900975592993,0.00324350760454129,0.0826328226543984,0.0953473724642003,2.84952741684865e-160
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGF,Placenta growth factor,42754,0.0726203058650697,0.0026701198585702,0.0673868709422722,0.0778537407878673,1.21013370760585e-158
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MUC13,Mucin-13,42311,0.142262593050695,0.00523796816896596,0.131996175439521,0.152529010661868,4.37153546394368e-158
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSD,Cathepsin D,41747,0.114547690623775,0.00421866799241381,0.106279101358644,0.122816279888906,8.13703062208808e-158
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS9,Galectin-9,42620,0.0877738678022664,0.00324056769579678,0.0814223551185047,0.0941253804860281,2.34764329956562e-157
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTSL2,ADAMTS-like protein 2,40527,0.0931141810911922,0.00343034721990246,0.0863907005401834,0.099837661642201,2.95906674784056e-157
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACE2,Angiotensin-converting enzyme 2,42357,0.145389059607178,0.00540681662893738,0.13479169901446,0.155986420199895,4.28125883887142e-155
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42357,0.218385563251775,0.00818254750795324,0.202347770136187,0.234423356367364,7.07458243352276e-153
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FURIN,Furin,42679,0.0866469944196162,0.00327253353897308,0.0802328286832289,0.0930611601560034,1.22127672731543e-150
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42679,0.0931389833156851,0.0035275378131956,0.0862250092018217,0.100052957429548,7.7962111980698e-150
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42587,0.213468277253554,0.0081053617562707,0.197581768211263,0.229354786295845,4.41100635088435e-149
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42495,0.154711089818769,0.00588657974417063,0.143173393520195,0.166248786117343,1.83860912218066e-148
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,42370,0.146195109487706,0.00558994545776837,0.13523881639048,0.157151402584932,4.95077962184496e-147
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL16,C-C motif chemokine 16,42794,0.137277640648924,0.00525158673293798,0.126984530652366,0.147570750645483,5.28086429465831e-147
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42495,0.101324376522475,0.00390811291465084,0.0936644752097592,0.10898427783519,1.26493812287483e-144
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40511,0.193711076803672,0.00747191783217657,0.179066117852606,0.208356035754738,5.26534455100267e-144
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42346,0.166944387559121,0.00648934398125928,0.154225273355853,0.179663501762389,1.93848553695784e-142
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGRN,Agrin,42676,0.0941597250469944,0.00366436135663636,0.0869775767879871,0.101341873306002,3.3298333259875e-142
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF21,Fibroblast growth factor 21,42689,0.300104159985311,0.0117693889010242,0.277036157739304,0.323172162231319,4.12117676647668e-140
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTH,Parathyroid hormone,40182,0.209861944924514,0.00826197638302212,0.19366847121379,0.226055418635237,2.30637181562162e-138
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OCLN,Occludin,40482,0.11517926384494,0.00454215379984912,0.106276642397235,0.124081885292644,5.14240779137364e-138
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARB2,Lysosome membrane protein 2,42302,0.0887379324865743,0.00352317473448074,0.0818325100069921,0.0956433549661566,9.67931065329222e-137
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42754,0.101337848283498,0.00403799368977555,0.0934233806515383,0.109252315915458,6.76418850736597e-136
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MXRA8,Matrix remodeling-associated protein 8,40283,-0.0793270823939326,0.00315398364416957,-0.0855088903365049,-0.0731452744513602,8.3603996144233e-136
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFNA4,Ephrin-A4,42475,0.0858378853262149,0.00342139152523748,0.0791319579367495,0.0925438127156804,9.36112737632519e-136
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST3,Cystatin-C,42659,0.0763239293860845,0.00304457051901733,0.0703565711688105,0.0822912876033584,1.36498225040684e-135
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AREG,Amphiregulin,42587,0.107139525490196,0.00430156359527453,0.0987084608434579,0.115570590136934,6.77867527958954e-134
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42587,0.203708345417657,0.00819951766291038,0.187637290798352,0.219779400036961,3.05136943090722e-133
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42711,0.0888217624684877,0.00357894122953467,0.0818070376585997,0.0958364872783757,5.33176071277074e-133
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL15,C-C motif chemokine 15,42794,0.112056358551731,0.00451768016021411,0.103201705437711,0.120911011665751,7.13012371886649e-133
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MENT,Protein MENT,40283,-0.0582498266738126,0.00234774912288071,-0.0628514149546588,-0.0536482383929664,2.65953070976371e-132
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRIP2,Cysteine-rich protein 2,42495,0.091018812265433,0.00368366105843428,0.0837988365909018,0.0982387879399642,7.88915291294008e-132
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMBP,Protein AMBP,42706,0.0518583793880231,0.0021099052650471,0.0477229650685308,0.0559937937075154,1.54321189504348e-130
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPM,Carboxypeptidase M,42655,0.0833340821517161,0.00339243072713679,0.076684917926528,0.0899832463769042,2.18952435509413e-130
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFR2,Fibroblast growth factor receptor 2,42679,0.055268899463438,0.0022543723711061,0.05085032961607,0.0596874693108059,6.7606314666854e-130
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHI3L1,Chitinase-3-like protein 1,42416,0.204015973239126,0.00832802415166377,0.187693045901865,0.220338900576387,1.19214364587881e-129
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL18R1,Interleukin-18 receptor 1,42754,0.081254192748388,0.00332570374106386,0.0747358134159028,0.0877725720808731,4.70549034005849e-129
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL23,C-C motif chemokine 23,42676,0.102995554924233,0.00423638515813484,0.0946922400142892,0.111298869834178,8.07850657620469e-128
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCLY,Selenocysteine lyase,42674,0.114287032923318,0.0047049268134253,0.105065376369005,0.123508689477632,1.3258502320602e-127
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPY30,Protein dpy-30 homolog,42651,0.14722607038477,0.00606312352935358,0.135342348267237,0.159109792502303,1.6413920691371e-127
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOD,Apolipoprotein D,40033,-0.106723034002486,0.00439742629809344,-0.115341989546749,-0.0981040784582227,9.57032040258584e-127
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL27,C-C motif chemokine 27,42636,0.143694148544322,0.00595101875223495,0.132030151789941,0.155358145298702,3.90525437197076e-126
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPC2,NPC intracellular cholesterol transporter 2,40367,0.0838114265281275,0.00346375060030017,0.0770224753515391,0.0906003777047158,4.0915369293895e-126
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP1,"Fatty acid-binding protein, liver",42618,0.22997373213384,0.00954333509121674,0.211268795355055,0.248678668912625,1.20504094735595e-125
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42611,0.0784934960691082,0.00326186238212948,0.0721002458001344,0.084886746338082,2.64255448142241e-125
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL13,C-X-C motif chemokine 13,42711,0.151617687059296,0.00631419715187482,0.139241860641622,0.163993513476971,8.36994343269591e-125
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIGR,Polymeric immunoglobulin receptor,42464,0.0867302295998914,0.0036115906088566,0.0796515120065324,0.0938089471932503,8.86315938598775e-125
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42638,0.0772412076109584,0.00321787441631694,0.0709341737549772,0.0835482414669396,1.04834812419115e-124
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OXT,Oxytocin-neurophysin 1,42711,0.333469497078118,0.0139413675294498,0.306144416720397,0.36079457743584,7.08709839976056e-124
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGSF3,Immunoglobulin superfamily member 3,42587,0.0872994366779955,0.00365579264440861,0.0801340830949546,0.0944647902610364,1.85851968351176e-123
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCS1,Neuronal calcium sensor 1,42721,0.069343110805073,0.00291638558807089,0.063626995052454,0.0750592265576919,1.84495143825297e-122
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTRK3,NT-3 growth factor receptor,42711,-0.0520158755930015,0.00219961536322191,-0.0563271217049165,-0.0477046294810866,3.53999018616358e-121
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40277,0.111397468642611,0.00471259914732145,0.102160774313861,0.120634162971361,1.45672559177863e-120
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF23,Fibroblast growth factor 23,42711,0.129215802287639,0.00549983779407606,0.11843612021125,0.139995484364028,1.1440592905998e-119
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40171,0.0938548457858864,0.00398753661798887,0.0860392740146283,0.101670417557145,1.51117710063767e-119
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42370,0.109113583868196,0.00465558624551636,0.0999886348269843,0.118238532909408,4.79338705075249e-119
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTA1,Glutathione S-transferase A1,42611,0.194779524273943,0.00832541602328123,0.178461708868312,0.211097339679574,1.10411294855443e-118
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42618,0.094783558589756,0.00406269264404353,0.0868206810074307,0.102746436172081,4.80823725949798e-118
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40283,0.117793322620983,0.00503972398575571,0.107915463608902,0.127671181633064,5.56852170340553e-118
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MME,Neprilysin,42587,0.191187621522741,0.0082060004521878,0.175103860636452,0.207271382409029,9.91847295470817e-118
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,40483,0.177569748083353,0.00761724740388112,0.162639943171746,0.19249955299496,1.9596340143998e-117
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLA,Alpha-galactosidase A,40267,0.0875611154635715,0.00378119535608396,0.080149972565647,0.0949722583614961,6.82418765266999e-116
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42794,0.119794074174799,0.00518547326685953,0.109630546571754,0.129957601777843,7.43632123146384e-116
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INHBC,Inhibin beta C chain,42611,0.0953301555843476,0.00413748008258125,0.0872206946224883,0.103439616546207,3.10525285901648e-115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSO,Cathepsin O,42754,0.0713210312346298,0.00310640106682955,0.0652324851436439,0.0774095773256157,1.78569489776694e-114
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,40462,0.198845134102018,0.00865661318132016,0.18187817226663,0.215812095937405,3.77521306488948e-114
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C9,Complement component C9,40532,-0.123724826936359,0.00539166706882086,-0.134292494391248,-0.11315715948147,6.02413913387376e-114
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42357,0.128604459052593,0.00561856524564701,0.117592071171125,0.139616846934061,9.74767732375241e-114
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL6A3,Collagen alpha-3(VI) chain,42794,0.0878653185434124,0.00384800430471085,0.0803232301061792,0.0954074069806457,2.80755925469788e-113
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REN,Renin,42636,0.197849237204723,0.0086779632155405,0.180840429302264,0.214858045107182,6.40888895869576e-113
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFF3,Trefoil factor 3,42613,0.0995060579642011,0.00436674900236627,0.0909472299195632,0.108064886008839,8.38004891790738e-113
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42611,0.0709182542152633,0.00311720320721515,0.0648085359291216,0.0770279725014049,1.87416959997036e-112
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLUL1,Clusterin-like protein 1,42621,-0.102886963498967,0.0045470432521341,-0.11179916827315,-0.0939747587247838,2.78220710481866e-111
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42611,0.104247369683622,0.00462157656618122,0.0951890796139065,0.113305659753337,1.30042651073425e-110
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCG2,Secretogranin-2,42636,0.0780510977855363,0.00346095244324104,0.0712676309967839,0.0848345645742888,1.42999308584553e-110
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,42477,0.33963298510511,0.0151719868302639,0.309895890917793,0.369370079292427,5.57721169276807e-109
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42733,0.0712015920660038,0.00318153545952951,0.064965782565326,0.0774374015666816,5.81732101674583e-109
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42591,0.0991553450250862,0.0044342209677431,0.0904642719283097,0.107846418121863,9.04264011441407e-109
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOC1,Apolipoprotein C-I,40516,-0.0838358489415764,0.00374686672990555,-0.0911797077321913,-0.0764919901509615,1.52639928741786e-108
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KYNU,Kynureninase,42754,0.0998760785856326,0.00449525076594344,0.0910653870843835,0.108686770086882,1.87690659230205e-107
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM20A,Pseudokinase FAM20A,40511,0.0637096073976124,0.00286794573301899,0.0580884337608952,0.0693307810343297,4.75099883355471e-107
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42562,0.158085022972456,0.00714139957670012,0.144087879802124,0.172082166142789,1.15048333217221e-106
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUOM,Fucose mutarotase,40283,0.142677370610801,0.00643637403931137,0.130062077493751,0.155292663727851,1.43567737502383e-106
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOA1,Apolipoprotein A-I,40539,-0.0619086228136436,0.00280684719013216,-0.0674100433063027,-0.0564072023209846,1.35227419940594e-105
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,40451,0.127058249501709,0.00577409309444571,0.115741027036595,0.138375471966822,4.17163349615637e-105
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42638,0.0801698577481495,0.00365375831865761,0.0730084914435805,0.0873312240527184,7.11713109827812e-105
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF1,Macrophage colony-stimulating factor 1,42676,0.0618219574060955,0.00282741024745452,0.0562802333210847,0.0673636814911064,3.56181282232338e-104
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHA1,Ephrin type-A receptor 1,42658,0.0730055676179581,0.00334629385162663,0.0664468316687699,0.0795643035671463,9.95780822369757e-104
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42611,0.0845341851926208,0.00388308015936369,0.076923348080268,0.0921450223049737,2.71959216959944e-103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXNB2,Plexin-B2,42743,0.0532500927208947,0.00245042395808243,0.0484472617630531,0.0580529236787362,5.93465651473911e-103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42547,0.0620165073300862,0.00285604871095075,0.0564186518566227,0.0676143628035497,8.9675041413255e-103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NECTIN2,Nectin-2,42613,0.0692459632647391,0.00320354187448505,0.0629670211907484,0.0755249053387298,6.9647453018151e-102
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42346,0.178792523782466,0.00827223508615388,0.162578943013605,0.195006104551328,7.83933481202246e-102
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAMDC4,Apical endosomal glycoprotein,40451,0.120928629017753,0.00558861767203373,0.109974938380567,0.131882319654939,9.11322311832499e-102
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRELD1,Protein disulfide isomerase CRELD1,40283,0.0833258471012482,0.00385176299045053,0.0757763916399652,0.0908753025625312,1.08939574609596e-101
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMP1,Metalloproteinase inhibitor 1,42501,0.0640923057831773,0.00296935180688723,0.0582723762416783,0.0699122353246763,1.37134984508761e-101
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD5,T-cell surface glycoprotein CD5,42706,0.0785610543449771,0.0036537509127929,0.0713997025559031,0.0857224061340512,7.32702853477912e-101
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA3F,Semaphorin-3F,42636,0.05911107743733,0.00275315611155589,0.0537148914586805,0.0645072634159796,1.43036586208172e-100
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",42357,0.201135126751326,0.00938162607332724,0.182747139647605,0.219523113855047,2.95376151539799e-100
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL3,C-C motif chemokine 3,42594,0.124622382178339,0.00581746908768028,0.113220142766485,0.136024621590192,3.94083419558751e-100
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42250,0.119616684253238,0.00559075452707176,0.108658805380177,0.130574563126299,7.56205980732669e-100
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42594,0.0841819576786571,0.00394858540293766,0.0764427302888993,0.0919211850684149,3.29777290161087e-99
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPT2,Angiopoietin-2,42721,0.0814418509554291,0.00383442223438299,0.0739263833760384,0.0889573185348197,1.65495030824927e-98
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASET2,Ribonuclease T2,42749,0.0595987524505537,0.00280621267547651,0.0540985756066197,0.0650989292944876,1.69493874996417e-98
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42676,0.0648515707130439,0.00305838379861646,0.0588571384677557,0.0708460029583322,3.45266041340486e-98
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFRA1,GDNF family receptor alpha-1,42689,0.0637786985587763,0.00301099006435321,0.057877158032644,0.0696802390849086,5.47011190726013e-98
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPPC,C-type natriuretic peptide,42594,0.107405045779645,0.00507789303152987,0.0974523754378461,0.117357716121443,1.04877342279895e-97
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE4,Ribonuclease 4,40169,0.0631194806078158,0.00298050477011184,0.0572776912583966,0.068961269957235,1.36112115981138e-97
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42770,-0.257453352838848,0.0121909681407797,-0.281347650394777,-0.23355905528292,1.97481660016137e-97
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GZMA,Granzyme A,42754,0.0758527678023965,0.0036036777641929,0.0687895593845784,0.0829159762202146,8.2469508135585e-97
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40483,0.0898344060495018,0.00426152382729215,0.0814818193480092,0.0981869927509944,8.71295343669152e-97
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPY,Pancreatic prohormone,42600,0.220794414302957,0.0104957561819921,0.200222732186253,0.241366096419662,1.10039980421089e-96
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM3B,Protein FAM3B,42587,0.0752569905090082,0.00358515939540206,0.0682300780940202,0.0822839029239963,2.78003614756339e-96
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHBG,Sex hormone-binding globulin,40532,-0.108200804569629,0.00514936855770755,-0.118293566942736,-0.0981080421965223,3.39648653817016e-96
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42594,0.110117476431206,0.00525820100718226,0.0998114024571283,0.120423550405283,7.55263182277944e-96
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE6,Ribonuclease K6,40468,0.0729787557813891,0.00347983800050783,0.0661582733003938,0.0797992382623845,7.90313607343166e-96
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGAV,Integrin alpha-V,42721,-0.0347782535625075,0.0016634213381897,-0.0380385593853593,-0.0315179477396557,1.47007976688681e-95
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGA11,Integrin alpha-11,42594,-0.0719553858927447,0.0034427610467466,-0.0787031975443681,-0.0652075742411214,1.75615754773263e-95
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL12A_IL12B,Interleukin-12,42587,0.173967105931989,0.00832359635237651,0.157652857081331,0.190281354782647,1.75981851632519e-95
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42721,0.0728514726250747,0.00348934458042071,0.0660123572474501,0.0796905880026993,2.66878931185059e-95
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42706,0.139871616060375,0.00672461256708438,0.12669137542889,0.153051856691861,1.30688881467301e-94
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HAO1,Hydroxyacid oxidase 1,42721,0.262637324575759,0.0126621819085508,0.237819448035,0.287455201116519,4.20291182915905e-94
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD72,B-cell differentiation antigen CD72,40283,0.0937151847181661,0.0045265942740288,0.0848430599410697,0.102587309495263,1.87195992697686e-93
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42794,0.0827782286054722,0.00401122259141053,0.0749162323263075,0.0906402248846368,3.42373783764466e-93
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFA,Protransforming growth factor alpha,42594,0.0991667188525886,0.00480974295843524,0.0897396226540556,0.108593815051122,5.23270574926274e-93
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,42346,0.123289999326047,0.00600078338785978,0.111528463885842,0.135051534766252,2.35667988521491e-92
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UMOD,Uromodulin,42764,-0.115100967612705,0.00561188835649305,-0.126100268791431,-0.104101666433978,4.32369778720625e-92
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42587,0.12321389551677,0.00602237523160409,0.111410040062826,0.135017750970714,1.24047001037372e-91
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F9,Coagulation factor IX,42663,0.0371068414845648,0.00183239805748886,0.0335153412918866,0.0406983416772429,7.61991200464997e-90
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HLA_E,,42594,0.0632122168436297,0.00312898015966615,0.057079415730684,0.0693450179565753,1.99960982970213e-89
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL12B,Interleukin-12 subunit beta,42754,0.116332536134141,0.00576503480468157,0.105033067916965,0.127632004351317,3.04448233935329e-89
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,42346,0.0771773496248577,0.0038239323330255,0.0696824422521277,0.0846722569975876,3.10053608975965e-89
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42611,0.061594096979889,0.00305393823054889,0.0556083780480132,0.0675798159117649,3.84112543622848e-89
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SULT2A1,Bile salt sulfotransferase,42594,0.114627710001582,0.00568561691774876,0.103483900842794,0.12577151916037,4.48844370183812e-89
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD27,CD27 antigen,42679,0.0907894314927283,0.00450379914754421,0.0819619851635417,0.0996168778219149,4.63437212650041e-89
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELE,E-selectin,42794,0.103674312701052,0.00515553495328074,0.0935694641926222,0.113779161209483,1.18293006330104e-88
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FSTL3,Follistatin-related protein 3,42574,0.0692929431048069,0.00344702550862569,0.0625367731079006,0.0760491131017133,1.42511115158973e-88
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40116,0.114139125774118,0.0056976584970087,0.102971715119981,0.125306536428255,1.06442228606082e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42636,0.0710602643843016,0.00355589586174918,0.0640907084952732,0.07802982027333,1.41778829512967e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM3C,Protein FAM3C,42613,0.0631361777305772,0.00316830479261152,0.0569263003370586,0.0693460551240958,4.25852994444727e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42555,0.066272656986354,0.00332634139804432,0.0597530278461871,0.0727922861265209,4.6450831398908e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XCL1,Lymphotactin,42721,0.11346714518254,0.0057007677044074,0.102293640481901,0.124640649883178,6.5793188895011e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL10,C-X-C motif chemokine 10,42676,0.136839074262085,0.00687663910919899,0.123360861608055,0.150317286916115,7.27670064302366e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTA3,Glutathione S-transferase A3,42346,0.154350372099812,0.00776076756657684,0.139139267669321,0.169561476530303,9.5827265839813e-87
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGR3,Anterior gradient protein 3,42326,0.120859494746521,0.00608531258819308,0.108932282073663,0.13278670741938,1.64444520425211e-86
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH2,Cadherin-2,42636,0.07165489129213,0.00361300507199154,0.0645734013510266,0.0787363812332335,2.66339800218547e-86
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42594,-0.079344311411597,0.00400227866449694,-0.087188777594011,-0.071499845229183,3.11790261749625e-86
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COLEC12,Collectin-12,42618,0.0565225801374569,0.00285195650398868,0.0509327453896391,0.0621124148852748,3.47709336381002e-86
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELN,Elastin,40511,0.0740679954792199,0.00374017188239736,0.066737258589721,0.0813987323687187,7.84221274614632e-86
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42587,0.173466157966001,0.00877823399190011,0.156260819341877,0.190671496590126,1.06918127346109e-85
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADM,Pro-adrenomedullin,42721,0.0538731702412209,0.00272655967983732,0.0485291132687398,0.0592172272137021,1.08707054040193e-85
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGR2,Anterior gradient protein 2 homolog,42215,0.203146404376429,0.0103110741425778,0.182936699056977,0.223356109695882,3.60397586235526e-85
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,40451,0.104216389678007,0.00529201749931098,0.0938440353793573,0.114588743976656,6.5783021994099e-85
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC39A5,Zinc transporter ZIP5,42594,0.107325011600674,0.00545909020345338,0.0966251948019054,0.118024828399443,7.43643163819617e-85
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42689,0.0843224765237687,0.00429091888473589,0.0759122755096864,0.0927326775378511,8.58556412366565e-85
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHISA5,Protein shisa-5,40527,0.0557207738667428,0.00284038076007049,0.0501536275770046,0.0612879201564809,2.7279491312187e-84
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEG1,Protein HEG homolog 1,40283,0.0540739930271031,0.00275688446380539,0.0486704994780446,0.0594774865761617,3.10597480615028e-84
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42663,-0.0600382710129706,0.00306561867343639,-0.066046883612906,-0.0540296584130353,3.10699200487806e-84
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42587,0.0874710215543989,0.00447068117347277,0.0787084864543923,0.0962335566544056,4.52428318851799e-84
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42618,0.0544903110337853,0.00278864014396346,0.0490245763516169,0.0599560457159537,7.29416324799543e-84
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL18BP,Interleukin-18-binding protein,42689,0.0642681713107145,0.00329285520936744,0.0578141751003543,0.0707221675210746,1.10713434633993e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300E,CMRF35-like molecule 2,42677,0.0857806954450307,0.00439672139826117,0.0771631215044388,0.0943982693856226,1.27530448506829e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KITLG,Kit ligand,42636,-0.0743885119490295,0.00382409383135423,-0.0818837358584838,-0.0668932880395752,3.83676475802594e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOMO1,Nodal modulator 1,42611,0.0456073690457889,0.00234664795434891,0.0410079390552651,0.0502067990363128,5.36941701867258e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL7,Angiopoietin-related protein 7,42721,0.0717329450528869,0.00369569202417284,0.0644893886855081,0.0789765014202656,8.48072751424528e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41948,0.0864209890069251,0.00445242047598376,0.077694244873997,0.0951477331398533,9.89040993954809e-83
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KHK,Ketohexokinase,40223,0.124020617911837,0.00639156456305933,0.111493151368241,0.136548084455433,1.68736885234471e-82
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42683,0.0607346861388335,0.00313609735586721,0.0545879353213338,0.0668814369563333,1.9466310477841e-82
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUCB2,Nucleobindin-2,42683,0.0723419370600411,0.003747686980973,0.064996470577334,0.0796874035427481,6.41711651878562e-82
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL17,C-X-C motif chemokine 17,42754,0.0795447601274227,0.00412538904834965,0.0714589975926574,0.0876305226621881,9.46391414161139e-82
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL2,Angiopoietin-related protein 2,42640,0.0786169558860143,0.00408336785436782,0.0706135548914534,0.0866203568805752,1.66048192206617e-81
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40199,0.0876510713521874,0.00454736974613744,0.078738226649758,0.0965639160546168,1.89755494687129e-81
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42636,-0.0528752651900346,0.00275992667081596,-0.0582847214648339,-0.0474658089152353,9.81441587651047e-81
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD302,CD302 antigen,42587,0.0625831607206438,0.00326679753149316,0.0561802375589172,0.0689860838823704,1.00646085329654e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42689,0.0801026517268969,0.00418432840984811,0.0719013680435946,0.0883039354101992,1.28013680306811e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGLN1,Egl nine homolog 1,42594,0.107626458854278,0.00562361336447059,0.0966041766599154,0.11864874104864,1.43455205148654e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG4,Regenerating islet-derived protein 4,42638,0.102315505188741,0.00536884333324271,0.0917925722555851,0.112838438121896,6.44821061900056e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42587,0.153742055181487,0.00806739757557387,0.137929955933362,0.169554154429612,6.51488803435556e-80
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PALM2,Paralemmin-2,40483,0.0733647630481464,0.00385331870099952,0.0658122583941873,0.0809172677021054,1.41245056248045e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL9,C-X-C motif chemokine 9,42676,0.131211359937932,0.00691085633392543,0.117666081523438,0.144756638352426,2.39519389023421e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42636,0.0671150084605399,0.00353519808066644,0.0601860202224336,0.0740439966986461,2.47866343450419e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LSP1,Lymphocyte-specific protein 1,42594,0.0765832310332958,0.00403476326764395,0.0686750950287136,0.0844913670378779,2.68641909379293e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B2M,Beta-2-microglobulin,40539,0.0609957215477207,0.00321008168605665,0.0547039614430497,0.0672874816523918,2.81557501876465e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINF1,Pigment epithelium-derived factor,40351,0.0516650619776768,0.00272219168222599,0.0463295662805139,0.0570005576748397,4.43351651391088e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42587,0.201135262109556,0.0106162305190793,0.180327450292161,0.221943073926952,5.12694757462723e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,42346,0.156682175338049,0.00827144142634676,0.14047015014241,0.172894200533689,5.70527911870802e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THBS2,Thrombospondin-2,42611,0.0748047121525499,0.00395132237720433,0.0670601202932294,0.0825493040118704,6.6700815236338e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD80,T-lymphocyte activation antigen CD80,40511,0.0675940689440641,0.00356691638508966,0.0606029128292883,0.0745852250588398,7.26346416249893e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300LG,CMRF35-like molecule 9,42611,-0.0739241842375709,0.00390757593743791,-0.0815830330749492,-0.0662653354001925,8.54386121319952e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40449,0.0567712133879332,0.00299786438973961,0.0508953991840436,0.0626470275918228,9.37893738254209e-79
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42590,0.0965599870637467,0.00510706351413694,0.0865501425760383,0.106569831551455,1.05118559988356e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42611,0.0706427360306281,0.00373987763307221,0.0633125758698066,0.0779728961914497,1.46272676752707e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL16,Pro-interleukin-16,42754,0.0789527160396168,0.00419790057700701,0.0707248309086831,0.0871806011705505,6.39149216234753e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42580,0.0392263701869104,0.00208818064513998,0.035133536122436,0.0433192042513847,9.98690533669987e-78
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F11R,Junctional adhesion molecule A,42611,0.105769601581979,0.00563119553556368,0.0947324583322738,0.116806744831683,1.03355072405591e-77
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS2,Trypsin-2,42689,0.106675606349874,0.00568698409453319,0.0955291175245892,0.117822095175159,1.61215618765874e-77
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STC1,Stanniocalcin-1,42711,0.0858766986590789,0.0045918801585503,0.0768766135483204,0.0948767837698375,4.47739330720345e-77
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BMPER,BMP-binding endothelial regulator protein,40283,0.0444643945456217,0.00237752487456281,0.0398044457914786,0.0491243432997648,7.21997535834789e-77
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALCA,Calcitonin,42476,0.119746695866027,0.00642425369880443,0.10715515861637,0.132338233115684,1.44477964458061e-76
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4A,C-type lectin domain family 4 member A,42594,-0.0665807551788976,0.00357698733735179,-0.0735916503601071,-0.0595698599976881,2.28082888578595e-76
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42746,0.071866594492813,0.00386877667247884,0.0642837922147545,0.0794493967708715,4.4089749604237e-76
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42636,0.0708136750444816,0.00382054209949841,0.0633254125294647,0.0783019375594985,9.45288814267196e-76
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42746,0.0761873283506332,0.00411641988775054,0.0681191453706421,0.0842555113306242,1.5105001570561e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGBL1,Integrin beta-like protein 1,40527,0.0736639685980376,0.00397682883805307,0.0658693840754536,0.0814585531206216,1.73425240307295e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42495,0.0853123381700744,0.00461389876913943,0.0762690965825612,0.0943555797575877,2.17106864253136e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42594,0.120567995602883,0.00652999693646584,0.10776920160741,0.133366789598356,3.45464867941097e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42594,0.130431910001092,0.00706457437038767,0.116585344235133,0.144278475767052,3.51136269354195e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HJV,Hemojuvelin,40482,0.0830492970248884,0.00450367526260945,0.0742220935101739,0.0918765005396029,7.79157045874086e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42594,0.0661640164097315,0.00359263480655175,0.0591224521888901,0.073205580630573,8.08488250071831e-75
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGXT,Serine--pyruvate aminotransferase,42636,0.141312936927327,0.00768172036623129,0.126256765009514,0.156369108845141,1.16333151001123e-74
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE1,Ribonuclease pancreatic,40532,0.0497850536325156,0.00271285662670103,0.0444678546441815,0.0551022526208496,3.7835847320091e-74
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42676,0.052892631455869,0.00288583090276789,0.047236402886444,0.0585488600252941,3.8959014826147e-74
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP12,Macrophage metalloelastase,42592,0.104472755237872,0.0057108310743757,0.0932795263320957,0.115665984143648,7.33437252656097e-74
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GOLM2,Protein GOLM2,42711,0.0427064009726124,0.0023459912430114,0.0381082581363101,0.0473045438089148,3.58310502290218e-73
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEPH,Hephaestin,40511,0.0493107609381916,0.00271129791696725,0.0439966170209358,0.0546249048554474,7.08779035905418e-73
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BPIFB1,BPI fold-containing family B member 1,42573,-0.115607822960208,0.00636990059713012,-0.128092828130583,-0.103122817789832,9.71448141860842e-73
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CKAP4,Cytoskeleton-associated protein 4,42713,0.0535499860744313,0.00295268241687299,0.0477627285373602,0.0593372436115023,1.199710613506e-72
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42594,0.0698614263664809,0.0038640315454856,0.0622879245373291,0.0774349281956327,3.30109320710589e-72
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCAM,Cell surface glycoprotein MUC18,42689,-0.061670746259583,0.00342533886293805,-0.0683844104309416,-0.0549570820882244,1.23973902671485e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSTB,Cystatin-B,42437,0.0780396836148118,0.00433714124170502,0.06953888678107,0.0865404804485537,1.5583304374856e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPL,N-acetylneuraminate lyase,40511,0.083782450223262,0.00465610631821903,0.0746564818395528,0.0929084186069713,2.13311094927809e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42570,0.19174642118742,0.0106841093240886,0.170805566912206,0.212687275462634,3.46350305024189e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42754,0.0876791966848025,0.00488868594322956,0.0780973722360725,0.0972610211335324,4.1505777989854e-71
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42636,0.0503146070443777,0.00282062111156873,0.0447861896657029,0.0558430244230524,2.30906241252085e-70
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB6A,Ras-related protein Rab-6A,42594,-0.0832718240915394,0.00467540525380976,-0.0924356183890065,-0.0741080297940722,3.75561439981327e-70
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL21,C-C motif chemokine 21,42676,0.076776306301102,0.00431202064665643,0.0683247458336554,0.0852278667685486,4.08323885790059e-70
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DKK4,Dickkopf-related protein 4,42477,0.0839260358777421,0.00472415945504155,0.0746666833458607,0.0931853884096236,8.40949470219743e-70
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNF,Tumor necrosis factor,42339,0.0697851026775585,0.00393531870246134,0.0620718780207343,0.0774983273343827,1.50217905688198e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40511,0.13383994433044,0.0075504292166423,0.119041103065821,0.148638785595059,2.27409561984876e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42711,0.093252741070624,0.00526876914470347,0.0829259535470052,0.103579528594243,2.57221167933868e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEL1L,Protein sel-1 homolog 1,40223,0.0592208953309372,0.00334448153123927,0.0526657115297082,0.0657760791321662,3.34241766707632e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40116,0.122439816359648,0.00692514114552144,0.108866539714426,0.13601309300487,5.3994836093296e-69
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNCG,Gamma-synuclein,42495,0.12346284870175,0.00700761552420195,0.109727922274314,0.137197775129186,1.07142600919695e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFI,Complement factor I,40539,0.0352267468616199,0.00200081916443511,0.0313051412993271,0.0391483524239127,1.79156736865045e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL20,C-C motif chemokine 20,42754,0.164346285106847,0.00934902229281444,0.146022201412931,0.182670368800764,2.04484412564244e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLAT,Tissue-type plasminogen activator,42760,0.0903971378396564,0.00514573295890144,0.0803115012402096,0.100482774439103,2.49483925959327e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40223,0.102720084111744,0.00584310955091261,0.0912675893919554,0.114172578831533,2.99319674347304e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ULBP2,UL16-binding protein 2,42495,0.0714923345186926,0.00407514867492231,0.0635050431158449,0.0794796259215404,3.89572766913793e-68
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IDUA,Alpha-L-iduronidase,42721,0.0824126182909372,0.00471544265672695,0.0731703506837524,0.091654885898122,1.18222702812274e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,42476,0.130743723475891,0.00748148453690747,0.116080013783553,0.14540743316823,1.25207125028909e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42679,0.0502302644427201,0.00287521383515524,0.0445948453258158,0.0558656835596243,1.34176765883727e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42346,0.0907712317893744,0.00521302625196476,0.0805537003355235,0.100988763243225,3.75721033577921e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHA2,Ephrin type-A receptor 2,42125,0.0600358845224941,0.00345155752443368,0.0532708317746041,0.0668009372703842,5.30703963567653e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300C,CMRF35-like molecule 6,42711,0.0637212157966374,0.00366508659536899,0.0565376460697142,0.0709047855235606,5.6295110689472e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HYAL1,Hyaluronidase-1,42544,0.0411315280705672,0.00236602425652652,0.0364941205277752,0.0457689356133592,5.92293644313767e-67
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IMMT,MICOS complex subunit MIC60,40451,0.0801681298933022,0.0046295010646897,0.0710943078065103,0.089241951980094,2.53326128769771e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VEGFA,Vascular endothelial growth factor A,42716,0.102958416744865,0.00596195960198691,0.0912729759249709,0.11464385756476,4.09990063295853e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGFR,Epidermal growth factor receptor,42794,-0.0287421169204815,0.00166522470365279,-0.032005957339641,-0.0254782765013221,4.7334303321249e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EZR,Ezrin,42711,0.0419032956422137,0.00242914470032068,0.0371421720295852,0.0466644192548422,5.66017796647687e-66
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PXN,Paxillin,42311,0.0895407934446381,0.00520966664546988,0.0793298468195171,0.0997517400697591,1.71697937680927e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL18,Interleukin-18,42566,0.0813345157557128,0.00473677923407288,0.07205042845693,0.0906186030544957,2.20175300702852e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPO,Erythropoietin,42594,0.129378825333696,0.00753724152024932,0.114605831954008,0.144151818713385,2.41056369743615e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAXX,Protein PAXX,40283,0.0800280050871678,0.00466033261995583,0.0708937531520544,0.0891622570222812,2.98435774325653e-65
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRPB1,Signal-regulatory protein beta-1,42600,0.0841371915393763,0.00492760186899572,0.0744790918761446,0.0937952912026079,1.10476057037055e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPB1,Carboxypeptidase B,42794,0.105678437611053,0.00619286673965799,0.0935404188013229,0.117816456420782,1.28066430199572e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42676,0.0482302368694652,0.00282765011505465,0.0426880426439581,0.0537724310949723,1.48141084257659e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42676,0.0488871257970217,0.00286712823488962,0.043267554456638,0.0545066971374053,1.63109262854883e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4D,C-type lectin domain family 4 member D,42594,0.108013938637855,0.00634538141134531,0.0955769910716177,0.120450886204091,2.65044302782795e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42689,0.0741730424604076,0.00436243848537204,0.0656226630290784,0.0827234218917368,3.65003797157553e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAYN,Layilin,42476,0.0656079132592957,0.00385940408179796,0.0580434812589717,0.0731723452596197,3.94263563592136e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SORD,Sorbitol dehydrogenase,42658,0.115390038014036,0.00680098899891952,0.102060099576154,0.128719976451919,6.67869049361782e-64
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GUSB,Beta-glucuronidase,42711,0.104491960309429,0.00617936843080109,0.0923803981850592,0.116603522433799,1.71002287781776e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42595,0.055938713321895,0.00330976948193651,0.0494515651372995,0.0624258615064906,2.0020945161151e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G15,Phospholipase A2 group XV,42679,0.0458303455266661,0.00271275195214196,0.0405133517004679,0.0511473393528643,2.21627189605083e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSS,Cathepsin S,39872,0.042005999394926,0.00248348953572128,0.0371383599049123,0.0468736388849397,2.35813746681633e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD83,CD83 antigen,42594,0.0608000844753012,0.00360172045640241,0.0537407123807524,0.0678594565698499,2.8019274792858e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA6,Carbonic anhydrase 6,42581,-0.107593868573768,0.00637719345610758,-0.120093167747739,-0.0950945693997972,3.26735340777305e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA14,Carbonic anhydrase 14,42721,-0.0619444115228005,0.00367217735716304,-0.06914187914284,-0.0547469439027609,3.38655169537232e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH1,Cadherin-1,42188,0.0685969379884918,0.00406748808074116,0.0606246613502391,0.0765692146267444,3.83531576922734e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEP1A,Meprin A subunit alpha,40449,0.125018974134565,0.00742958321910006,0.110456991025129,0.139580957244001,9.00227541203817e-63
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42611,0.0738077339761023,0.00439393243694423,0.0651956263996916,0.082419841552513,1.10806029006774e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HNMT,Histamine N-methyltransferase,42439,0.0820135087756849,0.00488722527897817,0.0724345472288877,0.0915924703224821,1.48116383748355e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LBR,Delta(14)-sterol reductase LBR,42711,0.113383812652209,0.00676815333577615,0.100118232114088,0.126649393190331,2.30623890380036e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPA2,Carboxypeptidase A2,42670,0.112556228245108,0.00673468209782371,0.0993562513333731,0.125756205156842,4.44504182747351e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTGR1,Prostaglandin reductase 1,40511,0.143493581125951,0.00859508671846047,0.126647211157769,0.160339951094134,7.8269825636149e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,40511,0.114477368403388,0.00685979493599636,0.101032170328835,0.127922566477941,8.72962998297564e-62
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC6A,C-type lectin domain family 6 member A,42346,0.0811598921107191,0.00487244888110332,0.0716098923037566,0.0907098919176816,1.15347761865804e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIP,Gastric inhibitory polypeptide,40223,0.100090855157458,0.00601118146642245,0.0883089394832699,0.111872770831646,1.67825086136626e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUOX,"Sulfite oxidase, mitochondrial",40482,0.106018690207557,0.00636890461530452,0.0935356371615599,0.118501743253554,1.7364514856223e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFBR2,TGF-beta receptor type-2,42679,0.0609217369849809,0.00366524924205178,0.0537378484705594,0.0681056254994023,1.98878030207784e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100P,Protein S100-P,42357,0.092687038692815,0.00558292080768619,0.0817445139097501,0.10362956347588,2.83133943047125e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL7,C-C motif chemokine 7,42594,0.099934721284509,0.00602394938872176,0.0881277804826144,0.111741662086404,3.37647488974532e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSZ,Cathepsin Z,42648,0.0543967577314403,0.00329047822085195,0.0479474204185705,0.0608460950443101,8.63691563572177e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40449,0.0514852937573105,0.00311167840399119,0.0453864040854877,0.0575841834291332,8.93676597117441e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD274,Programmed cell death 1 ligand 1,42495,0.0590086614444599,0.00357083964210946,0.0520098157459253,0.0660075071429944,9.73749921153929e-61
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42594,0.0976718332991094,0.00592376292802638,0.0860612579601777,0.109282408638041,1.75797850695895e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL6,C-X-C motif chemokine 6,42754,0.128391313655465,0.00779811925325656,0.113106999919082,0.143675627391848,2.54254275694508e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSR1,Macrophage scavenger receptor types I and II,42711,0.0773820470078556,0.00470191875115438,0.0681662862555931,0.0865978077601182,2.85282418472838e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSC2,Desmocollin-2,42488,0.0594155209270691,0.0036171786323409,0.0523258508076809,0.0665051910464572,4.86460823566402e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPIND1,Heparin cofactor 2,40516,0.0472699809950527,0.00287806781692474,0.0416289680738802,0.0529109939162252,6.31577580714255e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,42370,0.065090322595526,0.0039702799098056,0.057308573972307,0.0728720712187449,8.19118099676977e-60
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMOT,Angiomotin,40283,0.0651931095925869,0.00398157871165512,0.0573892153177429,0.072997003867431,1.47007376278629e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSME1,Proteasome activator complex subunit 1,42480,0.0618018534514068,0.00378192951592509,0.0543892716001936,0.06921443530262,1.90298855111319e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP5,Fatty acid-binding protein 5,42678,0.112306448279158,0.00688037445511365,0.0988209143471353,0.125791982211181,2.51832658066542e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42721,0.0580231598545603,0.00355836180502826,0.0510487707167049,0.0649975489924157,3.27310733145409e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42587,0.0565005177416518,0.00347598460652565,0.0496875879128615,0.0633134475704421,7.58022918032662e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MLN,Promotilin,42594,0.146947137029788,0.00904281682735429,0.129223216048173,0.164671058011402,8.12571542304008e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFF2,Trefoil factor 2,42654,0.0968739231401819,0.00596174420517267,0.0851889044980435,0.10855894178232,8.19572817792357e-59
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SRP14,Signal recognition particle 14 kDa protein,42587,0.0981264184910646,0.00604380055228621,0.0862805694085837,0.109972267573546,1.0215276139927e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSL,Cathepsin L1,42636,0.0411878799169206,0.00253818357259991,0.0362130401146247,0.0461627197192164,1.16610629787372e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSG2,Desmoglein-2,42611,-0.0450090211091686,0.00277465758700054,-0.0504473499796897,-0.0395706922386476,1.28306859254521e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42676,0.0652932828330954,0.0040266148470676,0.0574011177328429,0.0731854479333479,1.40439411535654e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,40482,0.066980758386736,0.00412757445581053,0.0588907124533473,0.0750708043201246,1.47626421925603e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABL1,Tyrosine-protein kinase ABL1,42587,0.110367666776226,0.00681067816536524,0.0970187375721098,0.123716595980342,1.67015210289294e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42721,0.0680480337299017,0.00420170921486925,0.059812683668758,0.0762833837910454,1.92753928817342e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42587,0.0458836525262767,0.00283560892081875,0.040325859041472,0.0514414460110815,2.44308553800142e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCOF1,Treacle protein,40511,0.0535205007219771,0.00330577382834296,0.0470411840184249,0.0599998174255293,2.67497555649069e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,40451,0.109963445856789,0.00679990161436405,0.096635638692635,0.123291253020942,3.62667400120063e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42587,0.0656156704125124,0.00406382114947684,0.0576505809595378,0.073580759865487,4.25992438720784e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,42311,0.0473022745976305,0.00293822991246574,0.0415433439691977,0.0530612052260634,9.27791445065795e-58
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELOA,Elongin-A,42587,0.0879498068235761,0.00546701945164156,0.0772344486983586,0.0986651649487936,1.08584516858536e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALDH1A1,Retinal dehydrogenase 1,42611,0.0876692497098008,0.0054608620521102,0.0769659600876648,0.0983725393319368,1.83349664533375e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MET,Hepatocyte growth factor receptor,42654,-0.0326213077437022,0.00203293993057608,-0.0366058700076313,-0.028636745479773,2.06391777781223e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,40223,-0.0995924210307555,0.00621993061410633,-0.111783485034404,-0.0874013570271071,4.63601619680436e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42587,-0.0321204094372906,0.00201343053081175,-0.0360667332776816,-0.0281740855968995,9.03436692897649e-57
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42587,0.057501304423216,0.0036089048876308,0.0504278508434596,0.0645747580029724,1.23500134920738e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42587,0.070820697909698,0.00444963841360058,0.0620994066190409,0.0795419892003551,1.6154527387807e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADA2,Adenosine deaminase 2,42572,0.0722598547521448,0.00454487424691746,0.0633519012281866,0.0811678082761031,2.10681139836746e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42620,0.0799271930035927,0.00503238907620347,0.0700637104142339,0.0897906755929515,2.72262168635255e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LMNB2,Lamin-B2,40483,0.0467555022816774,0.00294460830787943,0.0409840699982338,0.0525269345651211,3.62294083754381e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MDK,Midkine,42638,0.0826655296605287,0.00521196970508726,0.0724500690385576,0.0928809902824997,3.8256763771165e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENO3,Beta-enolase,40223,0.0958261814627522,0.00604364663710275,0.0839806340540308,0.107671728871474,5.32586645911235e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,42240,0.0653710943719989,0.00413258001167588,0.0572712375491142,0.0734709511948836,7.66009759217042e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL22,C-C motif chemokine 22,42509,0.0857501212831963,0.00542550123932356,0.0751161388541222,0.0963841037122705,9.22462357548931e-56
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM1,Intercellular adhesion molecule 1,42595,0.0471368040055771,0.00298405932613626,0.04128804772635,0.0529855602848041,1.0503497756902e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADH1B,All-trans-retinol dehydrogenase,40283,0.120780261609114,0.00764482238120173,0.105796409741959,0.135764113476269,1.2761908654417e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRD1,Natural killer cells antigen CD94,42754,0.0758220497663272,0.00480928376261113,0.0663958535916094,0.085248245941045,1.66400899247973e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH2D1A,SH2 domain-containing protein 1A,42594,0.0926414299512717,0.00588218608930565,0.0811123452162326,0.104170514686311,2.17156374471858e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,40449,0.096102942854394,0.00609867727432256,0.0841495353967218,0.108056350312066,2.3596058329714e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIPC2,PDZ domain-containing protein GIPC2,40483,0.0501272474515343,0.00318183070189217,0.0438908592758256,0.0563636356272429,2.49177545901424e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTNB,Dystrobrevin beta,40430,0.0689772946206992,0.00439059656516454,0.0603717253529767,0.0775828638884217,4.94830313478262e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42660,0.0849276085086311,0.00541651872850744,0.0743112318007565,0.0955439852165057,6.39993832888429e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP7,Matrilysin,42333,0.0811166257808479,0.00517638112984391,0.0709709187663539,0.091262332795342,7.54122653460688e-55
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERMAP,Erythroid membrane-associated protein,40199,0.072021663145199,0.00459754250262726,0.0630104798400496,0.0810328464503485,1.01745474048671e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFNA1,Ephrin-A1,42590,0.0484081620529635,0.00309738574275052,0.0423372859971725,0.0544790381087545,1.40683333391281e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40199,0.110070003498373,0.00703637295290126,0.0962787125106863,0.123861294486059,1.43245372900327e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD59,CD59 glycoprotein,42130,0.0400681117795492,0.00256362447299362,0.0350434078124817,0.0450928157466167,1.44564966671347e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOP2B,DNA topoisomerase 2-beta,40199,0.127041900700787,0.00816224681095935,0.111043896951307,0.143039904450267,4.76622609678358e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD160,CD160 antigen,42754,0.0779759169009892,0.00501922015369226,0.0681382453997524,0.0878135884022261,5.82062869350451e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD2AP,CD2-associated protein,42636,0.100843073306701,0.00649788726739155,0.0881072142626134,0.113578932350788,7.51805872741038e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGA5,Integrin alpha-5,42611,0.0396229915440386,0.00255369738586103,0.034617744667751,0.0446282384203262,7.93934496091142e-54
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC1,Sialoadhesin,42676,0.0686003289261838,0.00442687031543549,0.0599236631079302,0.0772769947444374,1.06572911434224e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42594,0.0434455282898841,0.00280450430419303,0.0379486998536658,0.0489423567261025,1.15797655895374e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42676,0.0639275553133754,0.00413021401990282,0.0558323358343659,0.0720227747923849,1.4100794427333e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHCHD6,MICOS complex subunit MIC25,40451,0.0458173216471144,0.00297016312912651,0.0399958019140265,0.0516388413802024,3.83029880967464e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PENK,Proenkephalin-A,40283,0.0518982331273671,0.00337471839606828,0.0452837850710733,0.0585126811836609,7.99020293362655e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4M,C-type lectin domain family 4 member M,40504,-0.0780670955973503,0.00507698348307524,-0.0880179832241778,-0.0681162079705228,8.02296954473394e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PON1,Serum paraoxonase/arylesterase 1,40532,-0.0433044438757245,0.00281732126461095,-0.0488263935543619,-0.037782494197087,8.74321111401421e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN4,CCN family member 4,42721,0.0628074245385153,0.00409090941248473,0.0547892420900452,0.0708256069869854,9.42390679351369e-53
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BST2,Bone marrow stromal antigen 2,42711,0.0801625655402795,0.00522726356581479,0.0699171289512825,0.0904080021292765,1.2283881349101e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,42357,0.0662957458710889,0.00432991553929211,0.0578091114140764,0.0747823803281015,1.82465099358962e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFF1,Trefoil factor 1,42556,0.129769492656161,0.00848207820677055,0.113144619370891,0.146394365941431,2.14874236503783e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTSS1,Protein MTSS 1,40449,0.175399232124117,0.0114560168161699,0.152945439164424,0.19785302508381,2.1854595238513e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG1B,Lithostathine-1-beta,42794,0.0916901377282366,0.00600083020352906,0.0799285105293197,0.103451764927154,2.84137344797403e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEP,Leptin,42636,0.103683953517465,0.00678603954791439,0.0903833160035525,0.116984591031377,2.89925435649485e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OGN,Mimecan,42611,0.0692288812014645,0.00453238966631677,0.0603453974554836,0.0781123649474453,3.12042762971797e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17RB,Interleukin-17 receptor B,42416,-0.0831423241891975,0.00544493222224582,-0.0938143913447993,-0.0724702570335957,3.39333714437821e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42689,0.0674411792203245,0.00442901304167087,0.0587603136586496,0.0761220447819994,6.3070008915119e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42495,0.112862827530449,0.00742257760012595,0.098314575434202,0.127411079626696,8.87569061075774e-52
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLL1,Delta-like protein 1,42679,0.0489015325518517,0.00322126868372893,0.042587845931743,0.0552152191719604,1.26481388373011e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42654,0.0804072331305861,0.00529709759287474,0.0700249218485516,0.0907895444126205,1.29283058539659e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42566,0.0598582894996429,0.00395823180520554,0.0521001551614401,0.0676164238378458,3.0527111311366e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40283,0.0466796721584751,0.00308589201586952,0.0406313238073708,0.0527280205095793,3.48975444064025e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42611,0.0600372684614853,0.00397482932784358,0.0522466029789119,0.0678279339440587,3.9876763234191e-51
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THY1,Thy-1 membrane glycoprotein,42711,0.0460285200981488,0.00308179915117169,0.0399881937618523,0.0520688464344453,4.84386888736233e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD48,CD48 antigen,42654,0.0474902229515683,0.00318028527518761,0.0412568638122005,0.053723582090936,5.07569517991341e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN3,Contactin-3,42611,0.0474750277805135,0.00318375189414122,0.0412348740679968,0.0537151814930303,6.94124304102058e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIAE,Sialate O-acetylesterase,42646,0.0697494063953411,0.00467836265384734,0.0605798155938004,0.0789189971968819,7.20854267702233e-50
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDCP1,CUB domain-containing protein 1,42495,0.0824435916019631,0.00555156274775768,0.0715625286163581,0.0933246545875682,1.71905729646372e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LATS1,Serine/threonine-protein kinase LATS1,40199,0.128178512013973,0.00866560530963694,0.111193925607085,0.145163098420862,4.89922715462143e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PVR,Poliovirus receptor,42711,0.055432076965125,0.00375507990891812,0.0480721203436455,0.0627920335866045,6.19977531363859e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTDH,Protein LYRIC,40199,0.142340712738877,0.00963480304294391,0.123456498774707,0.161224926703047,6.37106167420715e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42638,0.0526651172036582,0.00357281983042377,0.0456623903360276,0.0596678440712887,8.51031210754827e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,40482,0.0802935949091664,0.00544462074131251,0.0696221382561939,0.0909650515621389,9.09089616617492e-49
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,40223,0.0491282299729085,0.00333563647247529,0.0425903824868569,0.0556660774589601,1.22780335286143e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RLN2,Prorelaxin H2,40257,0.0756922254671882,0.00514624425804714,0.0656055867214158,0.0857788642129605,1.63675280753076e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,42351,0.0827408937403126,0.00562989596050267,0.0717062976577274,0.0937754898228979,1.63984030697118e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,40449,0.0673423348629227,0.00458503029373233,0.0583556754872074,0.0763289942386381,2.17375182143124e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL11,C-X-C motif chemokine 11,42711,0.119543470328633,0.00815248430823788,0.103564601084487,0.13552233957278,2.59627114958718e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPP1,Tripeptidyl-peptidase 1,42545,0.0676973283772659,0.00461832024825224,0.0586454206906915,0.0767492360638403,2.82130519802656e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,40483,0.048627178212402,0.00331552179695559,0.0421287554903691,0.055125600934435,2.93277464585718e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42794,0.0438708690111852,0.00299407364081244,0.0380024846751928,0.0497392533471776,3.02384406451601e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFH,Complement factor H,39956,0.0346405111200469,0.00236373769795518,0.0300075852320548,0.0392734370080391,3.64042116158626e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB8,Serpin B8,42754,0.0863638004094903,0.00590175641324687,0.0747963578395264,0.0979312429794541,3.99101208704264e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40223,0.145645582371065,0.00995734660770582,0.126129183019962,0.165161981722168,5.31720206216873e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH17,Protocadherin-17,42636,0.0557458708444561,0.0038208294288217,0.0482570451639656,0.0632346965249466,7.54715416987783e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSME2,Proteasome activator complex subunit 2,42441,0.0538407733878346,0.00369333460586374,0.0466018375603416,0.0610797092153275,9.10597524285052e-48
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42794,-0.0508440893233434,0.00349124491237242,-0.0576869293515933,-0.0440012492950935,1.09813437321529e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLI1,Friend leukemia integration 1 transcription factor,42346,0.163546449504993,0.0112358538506353,0.141524175957748,0.185568723052238,1.25872312273646e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFC1,Cryptic protein,42346,0.0707358591378482,0.0048627706124563,0.0612048287374339,0.0802668895382626,1.44005722772336e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42587,0.125130521773912,0.0086293447109655,0.108217006140419,0.142044037407404,2.73982995353542e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPA1,Carboxypeptidase A1,42794,0.0926343717078303,0.00639370052187421,0.0801027186849569,0.105166024730704,3.22343588422629e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUMB,Protein numb homolog,40199,0.122330159117825,0.00844361728847515,0.105780669232414,0.138879649003237,3.91966367932631e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCXR,L-xylulose reductase,42679,0.0775842373833005,0.00536647116728924,0.0670659538954136,0.0881025208711874,5.07090615630476e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRP,Gastrin-releasing peptide,40223,0.083353606961123,0.00576191057821715,0.0720602622278174,0.0946469516944286,5.32162351390214e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPB6,Heat shock protein beta-6,42721,0.0583111604342001,0.00403620980011829,0.0504001892259683,0.066222131642432,5.85326141226085e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POF1B,Protein POF1B,40199,0.0695253430725038,0.00481170337219824,0.0600944044629952,0.0789562816820124,6.80490594840077e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42346,0.100309623161085,0.00694833619190666,0.0866908842249484,0.113928362097223,6.95790962358289e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTYMK,Thymidylate kinase,40511,0.100575832972426,0.00697219060256608,0.0869103393913967,0.114241326553456,9.31503214685864e-47
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,40199,0.0786930359951928,0.00547537169038569,0.0679613074820369,0.0894247645083487,2.03362497305203e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,40169,0.0726856515694193,0.00505775790409387,0.0627724460773953,0.0825988570614433,2.06981544656745e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAT2,Linker for activation of T-cells family member 2,42587,0.180698881178573,0.0125954615387658,0.156011776562592,0.205385985794554,2.47513726000133e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42651,0.0849798026139072,0.00595272817364903,0.0733124553935551,0.0966471498342593,6.70088457277016e-46
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39983,0.0723472492381773,0.00507619440080926,0.0623979082125911,0.0822965902637634,1.12618014807687e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA7A,Semaphorin-7A,42760,0.0415199117433509,0.00291886532918893,0.0357989356981406,0.0472408877885612,1.36949927498582e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT8,"Keratin, type II cytoskeletal 8",40136,0.11907658764926,0.00837044863889629,0.102670508317023,0.135482666981497,1.61117105124239e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42569,0.0370072797090698,0.00260967416450356,0.0318923183466428,0.0421222410714968,2.56498096591413e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BECN1,Beclin-1,40223,0.0872159123712388,0.0061488934966094,0.0751640811178844,0.0992677436245933,2.87503055391873e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS1,Galectin-1,42636,0.0509166549552734,0.00359399287095388,0.0438724289282038,0.057960880982343,3.0949713074953e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAFA5,Chemokine-like protein TAFA-5,42587,0.0560451284760206,0.00395666598164873,0.0482900631519891,0.0638001938000521,3.21049941856544e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWC2,Brorin,42456,0.0596445548742381,0.00421074495902773,0.0513914947545437,0.0678976149939324,3.22917757641328e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42587,-0.0363107941762222,0.00256505782199968,-0.0413383075073415,-0.0312832808451028,3.63207646932582e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42778,0.0415029407073181,0.00293367201581998,0.035752943556311,0.0472529378583253,4.06840967947738e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42681,0.0395553906516574,0.00279734113427645,0.0340726020284756,0.0450381792748393,4.49494358762232e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXLNA,Alpha-taxilin,42495,0.126165186651822,0.00893985663166637,0.108643067653756,0.143687305649888,6.68925058468327e-45
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300A,CMRF35-like molecule 8,40283,0.0453237361645888,0.00321762861878128,0.0390171840717775,0.0516302882574001,1.12199303690154e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,40511,0.0387841807775993,0.0027538125492832,0.0333867081810043,0.0441816533741944,1.1375037339088e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL3,Angiopoietin-related protein 3,42652,-0.0513966338744053,0.00365870560183668,-0.0585676968540052,-0.0442255708948054,1.6393930386837e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,42475,0.0383353740434648,0.00273166686684211,0.0329813069844542,0.0436894411024753,2.01281901357246e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMSB10,Thymosin beta-10,42611,0.106094299952957,0.00756136247243397,0.0912740295069863,0.120914570398927,2.07118503203962e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42587,0.0636880034927356,0.00453928899447375,0.0547909970635671,0.0725850099219042,2.09460875292698e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDHR2,Cadherin-related family member 2,42587,0.100945707579491,0.00722311924296018,0.0867883938632887,0.115103021295693,4.49360866932367e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEPTIN8,Septin-8,40470,0.046712912089114,0.00334116608945573,0.0401642265537807,0.0532615976244472,4.74337865864121e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL11,Eotaxin,42754,0.0524421834044619,0.00375413655859061,0.0450840757496243,0.0598002910592995,4.85323634895612e-44
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F7,Coagulation factor VII,42671,0.0440689454396774,0.00317361303809052,0.0378486638850199,0.0502892269943348,1.53490065864133e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBS,Cystathionine beta-synthase,40223,0.0734467236944303,0.00528791352244554,0.063082413190437,0.0838110341984235,1.70221527401505e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GHR,Growth hormone receptor,40283,0.0405935470731375,0.00292301211991218,0.0348644433181097,0.0463226508281654,1.74106378494427e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANG,Angiogenin,42618,0.0476815239777795,0.00343655714510345,0.0409458719733768,0.0544171759821823,1.79671669833917e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS3BP,Galectin-3-binding protein,40539,0.0437364425598402,0.00315144082573515,0.0375596185413993,0.0499132665782811,1.94239293933148e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,40290,0.0631107529568539,0.00454855714562225,0.0541955809514343,0.0720259249622735,2.07064006621391e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSB,Cathepsin B,42659,-0.0761386397048289,0.00551174501809111,-0.0869416599402875,-0.0653356194693704,4.135124880744e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YTHDF3,YTH domain-containing family protein 3,42370,0.119528173789844,0.00865457648228284,0.10256520388457,0.136491143695119,4.36693541145909e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,42311,0.0722525990546763,0.00523300154634656,0.0619959160238371,0.0825092820855156,4.61886769682541e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL3A1,Collagen alpha-1(III) chain,40527,0.0331793572609269,0.00240381219291235,0.0284678853628187,0.0378908291590351,5.45595740144503e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUS,RNA-binding protein FUS,42336,0.0562298405942322,0.00407797569934789,0.0482370082235103,0.064222672964954,5.93543535113677e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42545,0.0400405595261417,0.00290526919044902,0.0343462319128616,0.0457348871394217,6.42805439625031e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,40451,0.0980807074042051,0.00711381066171834,0.0841376385072371,0.112023776301173,6.77083278559856e-43
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG1A,Lithostathine-1-alpha,42575,0.0736663553803792,0.005359165830771,0.0631623903520681,0.0841703204086904,1.05154046189326e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RETN,Resistin,42598,0.0609697169962398,0.00444606130540655,0.0522554368376429,0.0696839971548366,1.63835772248018e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBKS,Ribokinase,42317,0.0695502122000448,0.00507440865762622,0.0596043712310974,0.0794960531689922,1.83036245432328e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42636,0.081886203588759,0.00597981625481834,0.070165763729315,0.093606643448203,2.12940287530479e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',40483,0.0608149067577332,0.00444392461685811,0.0521048145086913,0.0695249990067751,2.71462252477665e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42721,0.112969152259348,0.00828279699173014,0.0967348701555572,0.129203434363139,4.45396802162044e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,40483,0.0890266283043501,0.00652631108128008,0.0762350585850412,0.101818198023659,4.90397581497708e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,42346,0.0876732423398627,0.00643371864771843,0.0750631537903346,0.100283330889391,5.32381223714499e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN5,CCN family member 5,42611,0.0538659274551948,0.00395408172291013,0.046115927278291,0.0616159276320987,5.56892597459382e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FETUB,Fetuin-B,42663,0.0447782453608221,0.00329103147685438,0.0383278236661875,0.0512286670554567,6.96245131227371e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBP1,Guanylate-binding protein 1,40466,0.0917390158677085,0.00674705940789911,0.0785147794282263,0.104963252307191,8.91634607475845e-42
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAST,Gastrin,40483,0.203385651285049,0.0149816892687274,0.174021540318343,0.232749762251755,1.18538901134593e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD209,CD209 antigen,42668,-0.0540703448079745,0.00398650863465106,-0.0618839017318905,-0.0462567878840584,1.23923250247223e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,42475,0.122998076010431,0.00907607191328896,0.105208975060385,0.140787176960478,1.45816541237844e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNAP29,Synaptosomal-associated protein 29,42679,0.125813370649491,0.0093123655241966,0.107561134222066,0.144065607076917,2.52271681011961e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42681,0.0415451962390324,0.003078237989305,0.0355118497799946,0.0475785426980702,3.0401490587736e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARA5,Scavenger receptor class A member 5,42711,0.0425934880178964,0.0031586817154345,0.0364024718556448,0.048784504180148,3.55751836765553e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARF6,ADP-ribosylation factor 6,40449,0.148549341783861,0.0110125959550765,0.126964653711911,0.170134029855811,3.786197837932e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AP3S2,AP-3 complex subunit sigma-2,40483,0.0659021013748642,0.00488576976878967,0.0563259926280365,0.075478210121692,3.80109682447954e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40223,0.0513675115647658,0.00381476909079822,0.0438905641468013,0.0588444589827303,5.2645357526901e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AFM,Afamin,40539,0.0276046264777024,0.00205032120518483,0.0235859969155402,0.0316232560398647,5.28759225215379e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAG1,Dystroglycan,42676,0.0630760403656988,0.00469359464354962,0.0538765948643415,0.072275485867056,6.57126426952601e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD207,C-type lectin domain family 4 member K,42365,0.0546749054259233,0.00407484874021151,0.0466882018951087,0.0626616089567378,8.8275762069408e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTN,Pleiotrophin,42357,0.0682667083504209,0.00508812107268013,0.0582939910479679,0.078239425652874,8.92217964652912e-41
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EEF1D,Elongation factor 1-delta,40511,0.125933753823219,0.00938876592346333,0.107531772613231,0.144335735033207,1.03442395536559e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42611,0.0319192655109184,0.00238266322254337,0.0272492455947334,0.0365892854271034,1.15712608877261e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C19orf12,Protein C19orf12,42311,0.0872266949154885,0.0065114613558712,0.074464230657981,0.0999891591729961,1.18231408795591e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40449,0.144153964046821,0.0107554626769994,0.123073257199902,0.165234670893739,1.19179120947191e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,40532,0.0561951731114758,0.00419992666489086,0.0479633168482898,0.0644270293746619,1.60448577294418e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCN1,Ficolin-1,40515,0.0769137240289964,0.00574947571884257,0.065644751620065,0.0881826964379279,1.66061789622364e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42357,0.0673431588108325,0.00504379796493573,0.0574573147995585,0.0772290028221066,2.12057816365256e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YES1,Tyrosine-protein kinase Yes,42587,0.154346821263919,0.0115829173546297,0.131644303248845,0.177049339278994,2.97255465411439e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL25,C-C motif chemokine 25,42754,0.0653320135243902,0.00491172235883182,0.0557050377010798,0.0749589893477006,4.06021397324425e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCD5,Programmed cell death protein 5,42711,0.0779450174870572,0.00587814772883277,0.0664238479385449,0.0894661870355694,6.99382876018022e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAT,Linker for activation of T-cells family member 1,42754,0.101957514507211,0.00769367511718117,0.086877911277536,0.117037117736886,7.75746912163322e-40
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42711,0.090310515723441,0.00682764941640008,0.0769283228672968,0.103692708579585,1.07869742078074e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NIT2,Omega-amidase NIT2,40462,0.0993290007701701,0.00750963434062258,0.0846101174625498,0.11404788407779,1.21146983329001e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL6,Interleukin-6,42587,0.104269587529114,0.00789529575175238,0.0887948078556797,0.119744367202549,1.42138417889599e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FMNL1,Formin-like protein 1,42311,0.0836211182423129,0.00633292385386619,0.0712085874887352,0.0960336489958907,1.48350980093556e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD63,CD63 antigen,42475,0.0688115415842099,0.00521443044085178,0.0585912579201405,0.0790318252482794,1.63194608543206e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD28,T-cell-specific surface glycoprotein CD28,42346,0.051458038221636,0.0039025413958852,0.043809057085701,0.059107019357571,1.88515295046008e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40223,0.113909583812105,0.00864066530195092,0.0969738798202814,0.130845287803929,2.1824977380998e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42495,0.0586738209371908,0.00445474562729219,0.0499425195076981,0.0674051223666834,2.27015667653217e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42754,-0.0344189894683367,0.00261457743888252,-0.0395435612485465,-0.029294417688127,2.45529944135924e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL14,C-C motif chemokine 14,42618,0.0544508212842476,0.00413776040667149,0.0463408108871715,0.0625608316813238,2.62796586633687e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JAM2,Junctional adhesion molecule B,42711,0.0382188050910672,0.00291391457881333,0.0325075325165931,0.0439300776655414,4.61924715836144e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42495,0.0316714424961012,0.0024173583572654,0.026933420115861,0.0364094648763414,5.61304272863531e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40482,0.0652489233329721,0.00498273788687094,0.0554827570747051,0.0750150895912392,6.75210056699358e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OGFR,Opioid growth factor receptor,42587,0.0435054474967875,0.00333015782483568,0.0369783381601096,0.0500325568334654,9.11348774865086e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42587,0.0450709103313008,0.0034515950904827,0.0383057839539547,0.0518360367086469,9.86199320534522e-39
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42668,-0.0408695005424697,0.00313053717735812,-0.0470053534100916,-0.0347336476748478,1.02050142750134e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDC1,Syndecan-1,42636,0.0544986615992797,0.00417782370339218,0.046310127140631,0.0626871960579284,1.16863528532724e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP20,Centrosomal protein 20,42346,0.0999516225829181,0.00766283027151054,0.0849324752507575,0.114970769915079,1.1987725314593e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40199,0.0606050621727909,0.00464365314173033,0.0515035020149994,0.0697066223305823,1.21095746453693e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCD1,Programmed cell death protein 1,42689,0.0601670100369413,0.00462021321292522,0.0511113921396079,0.0692226279342747,1.55423751256825e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THOP1,Thimet oligopeptidase,42571,0.0411708030841816,0.00316291103394032,0.0349714974576586,0.0473701087107047,1.6835258061321e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRC1,Macrophage mannose receptor 1,40532,0.0393167827218689,0.00301972293773919,0.0333981257639001,0.0452354396798377,1.77674681288482e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSM,Oncostatin-M,42534,0.0933080353961609,0.00717135019450351,0.079252189014934,0.107363881777388,1.81074064203914e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GUCA2A,Guanylin,42563,0.0484907783218425,0.00373275111109175,0.0411745861441026,0.0558069704995823,2.35971637955708e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COCH,Cochlin,40511,0.0626042069252057,0.0048267253860716,0.0531438251685054,0.072064588681906,3.3724764438957e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLAMF8,SLAM family member 8,42346,0.0737670015561632,0.00569215918237418,0.0626103695587098,0.0849236335536166,3.5594603554863e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,40116,0.0482559813936126,0.00372123763729036,0.0409623556245235,0.0555496071627017,3.5662689907311e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,40451,0.10515190991386,0.00812703300106138,0.0892229252317802,0.121080894595941,5.08923478278826e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42754,0.129453969065615,0.0100143463346817,0.109825850249638,0.149082087881591,5.32398839581855e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RTBDN,Retbindin,42587,0.0395971921591379,0.00306448013975766,0.0335908110852129,0.0456035732330629,5.75100500307836e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSNL1,Visinin-like protein 1,40483,0.0510135437667871,0.0039516760171362,0.0432682587732002,0.0587588287603741,7.38430698310876e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42760,0.0441718350948118,0.00342426642860859,0.037460272894739,0.0508833972948847,7.54632667906264e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP3,"Fatty acid-binding protein, heart",40511,0.0698462631511132,0.00541289537000359,0.0592369882259061,0.0804555380763202,7.92741957896505e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42679,0.0435457610239785,0.00337820785199799,0.0369244736340624,0.0501670484138945,8.54409744222829e-38
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMN,Protein amnionless,42370,0.06194008047445,0.00481667752582183,0.0524993925238392,0.0713807684250607,1.28041479192253e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YAP1,Transcriptional coactivator YAP1,40483,0.038093919094747,0.00296580035598549,0.0322809503970154,0.0439068877924785,1.69194572446403e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,P4HB,Protein disulfide-isomerase,42563,0.0501779138879241,0.00391227455693862,0.0425098557563244,0.0578459720195238,1.95482358545845e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42611,-0.0691607176604161,0.00539351682583862,-0.0797320106390598,-0.0585894246817724,2.02295776429758e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40511,0.102614622938158,0.00799982099603326,0.0869349737859327,0.118294272090383,2.10510214404637e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS3,Galectin-3,42669,0.0393457930975683,0.00306949367218802,0.0333295855000798,0.0453620006950569,2.14050415507577e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PI3,Elafin,42446,0.0747324111508882,0.00583085661965483,0.0633039321763648,0.0861608901254117,2.20357925250069e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDT,D-dopachrome decarboxylase,40527,0.05476327895035,0.004273062660748,0.0463880761352839,0.0631384817654161,2.42470815902922e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLF4,Krueppel-like factor 4,40136,0.0530424875560147,0.00414041676615305,0.0449272706943547,0.0611577044176747,2.63966648835191e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD46,Membrane cofactor protein,42580,0.0379798133809024,0.00296859335008384,0.032161370414738,0.0437982563470667,2.93187621398823e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL5A1,Collagen alpha-1(V) chain,40283,0.0546398404129747,0.00427280394534717,0.0462651446800942,0.0630145361458552,3.50963081254003e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TALDO1,Transaldolase,40499,0.0578578688760631,0.00452559153301688,0.04898770947135,0.0667280282807761,3.61432970765517e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SRPK2,SRSF protein kinase 2,42594,0.108566111314222,0.0085065412644431,0.0918932904359132,0.12523893219253,4.35601175109009e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT5,ADP-sugar pyrophosphatase,42611,0.0658629224600877,0.0051611420163231,0.0557470841080944,0.0759787608120809,4.4287165972471e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42737,0.0556128500601621,0.00437496968073304,0.0470379094859253,0.0641877906343988,8.27294637534895e-37
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSAP,Prosaposin,40440,0.0378944401132845,0.00298399153447671,0.0320458167057101,0.0437430635208588,1.06609739621852e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42654,0.110414615936488,0.00870450445738839,0.0933537872000072,0.12747544467297,1.16425039393935e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42611,0.0586603225188405,0.00462568919739471,0.0495939716919469,0.0677266733457341,1.21626479277886e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADA,Adenosine deaminase,42754,0.0450039191368402,0.00355257568163179,0.0380408708008419,0.0519669674728386,1.43373971171053e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHMP6,Charged multivesicular body protein 6,40511,0.0728670519712597,0.00575815880719996,0.0615810607091478,0.0841530432333716,1.86299489933878e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42370,0.0769467506577542,0.00610017949935694,0.0649903988390146,0.0889031024764937,2.86958652716415e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRN,Progranulin,42552,0.0317337339325922,0.00251647987902123,0.0268014333697106,0.0366660344954738,2.9782435823654e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40449,0.0402746409884572,0.00319420685954377,0.0340139955437514,0.046535286433163,3.32279165829871e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GDNF,Glial cell line-derived neurotrophic factor,42311,0.0493755616814587,0.00391816312053716,0.0416959619652059,0.0570551613977116,3.34835509379979e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40223,0.0889204605427916,0.0070533297190163,0.0750959342935197,0.102744986792064,3.43640717850452e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,QDPR,Dihydropteridine reductase,42581,0.0548559940110027,0.00435577605787382,0.04631867293757,0.0633933150844354,3.65934684703185e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42794,0.0406270263021352,0.00323015113139336,0.0342959300846042,0.0469581225196662,4.46115637393211e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNCA,Alpha-synuclein,40283,0.149476105404767,0.0118774941558095,0.12619621685938,0.172755993950153,4.51309647367867e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPL14,60S ribosomal protein L14,40223,0.051931134217718,0.00412824087444582,0.0438397821038042,0.0600224863316318,4.83865809896573e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42636,0.0559598958512453,0.00445505220756718,0.0472279935244136,0.064691798178077,5.50872433824695e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40449,0.0669693642640334,0.00533747420335291,0.0565079148254617,0.0774308137026051,7.17136171650892e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40483,0.106058007151822,0.00845352130319744,0.0894891053975548,0.122626908906089,7.24915564733818e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINH1,Serpin H1,40302,0.166650546249015,0.0132883623903808,0.140605355963869,0.192695736534161,7.77624694390921e-36
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP53I3,Quinone oxidoreductase PIG3,40058,0.0685979840942094,0.00548795565449776,0.0578415910113938,0.079354377177025,1.31595148445451e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP1,Interstitial collagenase,42136,0.116982883615177,0.00937627692949724,0.0986053808333625,0.135360386396992,1.60578087947684e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42794,0.0415328428182614,0.00333210722619426,0.0350019126549206,0.0480637729816022,1.82281498165586e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SARG,Specifically androgen-regulated gene protein,40456,0.139222072582608,0.0111701919287036,0.117328496402349,0.161115648762867,2.01595810473136e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OMD,Osteomodulin,42676,-0.0540112598968146,0.00434144956440437,-0.0625205010430471,-0.045502018750582,2.45143418018715e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42495,0.0731562450028027,0.00589051366853401,0.061610838212476,0.0847016517931294,3.21752469974531e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,42346,0.0630532207543029,0.00508229357055823,0.0530919253560087,0.073014516152597,3.79137974811709e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NADK,NAD kinase,42636,0.0696134050757138,0.00561542470751248,0.0586071726489893,0.0806196375024383,4.2286433351024e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHB4,Ephrin type-B receptor 4,42794,0.0336071945473621,0.00271190271825051,0.0282918652195911,0.0389225238751332,4.43860044839009e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ROBO1,Roundabout homolog 1,42638,0.0311807417731836,0.00251938932690721,0.0262427386924455,0.0361187448539217,5.44453507230039e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RSPO3,R-spondin-3,42721,0.0377439795358875,0.0030499083136584,0.0317661592411171,0.043721799830658,5.48797214531063e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL19,Interleukin-19,42261,0.0920429431816831,0.00743981579779868,0.0774609042179977,0.106624982145368,5.83738886520717e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40283,0.027632796070043,0.00223356402794652,0.0232550105752679,0.0320105815648182,6.32544727894733e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPK9,Mitogen-activated protein kinase 9,42594,0.0532466895708313,0.00430963861049672,0.0447997978942577,0.0616935812474049,7.06465567365251e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGR,Tyrosine-protein kinase Fgr,42311,0.0724293259314166,0.0058676994630519,0.0609286349838349,0.0839300168789984,8.21550326884482e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TDRKH,Tudor and KH domain-containing protein,42311,0.106755796963365,0.00865259709136973,0.0897967066642804,0.12371488726245,8.814161103705e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42587,0.0673388428394071,0.00546110720269699,0.056635072722121,0.0780426129566932,9.56328964633194e-35
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NELL1,Protein kinase C-binding protein NELL1,42679,-0.0553108577802145,0.00448943754425379,-0.0641101553669519,-0.046511560193477,1.08328829366835e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,42238,0.0249537104747334,0.00202937049548173,0.0209761443035893,0.0289312766458776,1.47339490398269e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42587,0.121609510866369,0.00992079942448884,0.102164743994371,0.141054277738367,2.3245819263289e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALB2,Calretinin,42311,0.0403177826463078,0.00328927620050049,0.0338708012933268,0.0467647639992887,2.36517827692548e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOLR1,Folate receptor alpha,42600,0.0381531590595068,0.0031139159908887,0.0320498837173649,0.0442564344016486,2.48690283166365e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",40223,0.0811920094933486,0.00663933096498373,0.0681789208019805,0.0942050981847168,3.62297828943415e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INSL5,Insulin-like peptide INSL5,40449,0.124308519775222,0.0101825058286584,0.104350808351052,0.144266231199393,4.62191491517389e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMG3,Proteasome assembly chaperone 3,42594,0.063879095095506,0.00523607992309607,0.0536163784462377,0.0741418117447743,4.72251021854141e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VCAM1,Vascular cell adhesion protein 1,42663,0.0350099850436917,0.00287153291091126,0.0293817805383056,0.0406381895490777,5.17470362114734e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40223,0.0574271632546164,0.00470744883872891,0.0482005635307078,0.0666537629785251,5.19648441766463e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLO1,Lactoylglutathione lyase,42357,0.0726365668165811,0.00596191547339774,0.0609512124887215,0.0843219211444406,5.80302564003047e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40408,0.13664313336426,0.0112119484423651,0.114667714417224,0.158618552311295,5.95535521682485e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,42370,0.0862263228216746,0.00708722392099264,0.072335363936529,0.10011728170682,7.12627112955555e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTN1,Dynactin subunit 1,42721,0.0803217026003496,0.00660611842724866,0.0673737104829422,0.093269694717757,7.74480061300715e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM3D,Protein FAM3D,40449,0.107832260316978,0.00886503210501608,0.0904567973911466,0.12520772324281,7.89968390377205e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42636,0.0469858168174734,0.0038655409357584,0.0394093565833869,0.0545622770515599,8.11438552981264e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WDR46,WD repeat-containing protein 46,40451,0.0450408448558362,0.00370584232822472,0.0377773938925157,0.0523042958191566,8.88813245617215e-34
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FYB1,FYN-binding protein 1,42590,0.113768942761839,0.00938047185758606,0.09538321792097,0.132154667602707,1.12307318530621e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPON2,Spondin-2,42562,0.0446731661045393,0.00368573471787995,0.0374491260574946,0.051897206151584,1.23376017246427e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42721,0.0492779296558926,0.0040698980359374,0.0413009295054553,0.0572549298063299,1.43050153733109e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42746,0.0652157961677616,0.0053864048786543,0.0546584426055992,0.0757731497299241,1.43673849316348e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40465,0.100224614720641,0.00827778689798048,0.0840001524005993,0.116449077040683,1.55316225225126e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP85,Centrosomal protein of 85 kDa,42346,0.0793545482037974,0.00655952223357346,0.0664978846259934,0.0922112117816013,1.63780276484482e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH3,Cadherin-3,42711,0.0465290082018717,0.00384674334658925,0.0389893912425567,0.0540686251611866,1.65787600159247e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,40302,0.0706498237611924,0.00583956765163064,0.0592042711639964,0.0820953763583885,1.74679038943716e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42711,0.0644462700212311,0.00533350125798603,0.0539926075555785,0.0748999324868837,1.92468209409129e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTRB1,Chymotrypsinogen B,42611,0.0718017240558247,0.00594369213951942,0.0601520874623666,0.0834513606492827,2.00061289741359e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFAP5,Microfibrillar-associated protein 5,42794,0.0509822701006828,0.00422071209415548,0.0427096743961381,0.0592548658052276,2.02024723261863e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAMR1,Inactive serine protease PAMR1,42611,0.0330050738174964,0.00273774349832564,0.0276390965607782,0.0383710510742147,2.6936697765201e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42594,0.0472711705849604,0.00392327309906562,0.0395815553107917,0.054960785859129,2.91946069469423e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1R2,Interleukin-1 receptor type 2,42600,0.0246127518012548,0.00204467528975706,0.0206051882333309,0.0286203153691786,3.34767780605489e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAL,Galanin peptides,42676,-0.0795264749387135,0.00660671438679935,-0.0924756351368402,-0.0665773147405868,3.351001625732e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40483,0.0795921528998867,0.00661913733716998,0.0666186437190336,0.0925656620807399,4.20493852329568e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTBS,Di-N-acetylchitobiase,40383,0.0332976473577034,0.00277052686634464,0.0278674146996679,0.0387278800157389,4.53753122090114e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R9B,Neurabin-2,42754,0.11493747661372,0.00957322192542314,0.0961739616398902,0.133700991587549,4.85105645334774e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOST,Sclerostin,42613,0.0479999201235396,0.00399828236812682,0.040163286682011,0.0558365535650682,4.92970977914146e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42611,0.0749451518667363,0.00624530230595703,0.0627043593470605,0.0871859443864121,5.22689753071882e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BSG,Basigin,42746,0.0267230113046722,0.00223114098855007,0.0223499749671141,0.0310960476422304,6.84968295938791e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40449,0.17054105315094,0.0142416878464286,0.14262734497194,0.198454761329941,7.62477611024934e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLSCR3,Phospholipid scramblase 3,40457,0.0713747618770562,0.00596287717671695,0.059687522610691,0.0830620011434214,8.08255477951028e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNMBP,Dynamin-binding protein,42495,0.0732343079795947,0.0061299197919292,0.0612196651874135,0.0852489507717759,9.89419199333959e-33
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42517,0.0512056408987016,0.0042868321304091,0.0428034499230998,0.0596078318743034,1.01451988197687e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLIN1,Perilipin-1,42311,0.0427318984528885,0.00357810868310306,0.0357188054340065,0.0497449914717705,1.04860456614917e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD244,Natural killer cell receptor 2B4,42754,0.0335363423289101,0.00280877993433017,0.028031133657623,0.0390415510001973,1.07008279743514e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6AP2,Renin receptor,42346,0.0494669173410783,0.00414799058877033,0.0413368557870884,0.0575969788950681,1.28335769068871e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSN,Gelsolin,40488,-0.023931027161714,0.00200817528166991,-0.0278670507137871,-0.019995003609641,1.51573818101016e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA2,Annexin A2,40054,0.0891812600777554,0.0074912400320648,0.0744984296149084,0.103864090540602,1.77979318221928e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42192,0.104654960392483,0.00880265847981943,0.0874017497720366,0.121908171012929,1.98754589652437e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,40223,0.0885590563218226,0.00744617054312282,0.0739645620573018,0.103153550586343,2.02492084697548e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCAM2,Neural cell adhesion molecule 2,42611,-0.0330866733229097,0.00278812482078092,-0.0385513979716403,-0.0276219486741791,2.54856274629381e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA9,Serpin A9,42538,0.087292416837704,0.0073680736517842,0.0728509924802069,0.101733841195201,3.21968783374298e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARF1,Scavenger receptor class F member 1,42794,0.0508029388824933,0.00429077851026926,0.0423930130023656,0.059212864762621,3.48755386703585e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACAN,Aggrecan core protein,42488,-0.0338111421786443,0.00285789010295924,-0.0394126067804444,-0.0282096775768442,3.92079834560809e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SORT1,Sortilin,42613,0.044810712675538,0.0037895648416228,0.0373831655859573,0.0522382597651187,4.1957560987024e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,42346,0.0364717895395107,0.00308419766913772,0.0304267621080008,0.0425168169710206,4.19668936371871e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAB2,Stabilin-2,40527,0.034107792317422,0.00288588809946778,0.0284514516424652,0.0397641329923789,4.81130244127134e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK11,Kallikrein-11,42543,0.0396671866981,0.00335938304999382,0.0330827959201121,0.0462515774760879,5.1286736161179e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POSTN,Periostin,40527,-0.0469019068615947,0.00397457776135505,-0.0546920792738506,-0.0391117344493388,5.96848075033584e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RASSF2,Ras association domain-containing protein 2,42346,0.0687926074404918,0.00583406990016305,0.0573578304361722,0.0802273844448114,6.24977353901088e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42618,0.0355679407207902,0.00301775772949184,0.0296531355709862,0.0414827458705942,6.60316603154864e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFRP4,Secreted frizzled-related protein 4,40283,0.0491065356042766,0.00416494470480222,0.0409432439828642,0.0572698272256889,6.77746423725439e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDN1,Endothelin-1,40223,0.0370508741589567,0.00314349051633732,0.0308896327469355,0.0432121155709778,7.11152151713228e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42760,0.023295019464675,0.00198033745677879,0.0194135580493886,0.0271764808799615,8.62317424668161e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYH9,Myosin-9,40527,0.138509984706025,0.0117691636182759,0.115442424014204,0.161577545397845,8.64366981302849e-32
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,40283,0.0465614626811336,0.00396033046424223,0.0387992149712188,0.0543237103910484,1.00307552722553e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42587,0.0384831192649864,0.00327702778287332,0.0320601448105546,0.0449060937194181,1.0931652752195e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40511,0.0763816853586028,0.00650586309327123,0.0636301936957912,0.0891331770214144,1.20634321426694e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40199,0.0406489523244802,0.00346264706782456,0.0338621640715441,0.0474357405774163,1.23751150169854e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MARCO,Macrophage receptor MARCO,42636,0.0316341268798915,0.00269627931280952,0.0263494194267849,0.0369188343329982,1.23865980462934e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42721,0.0411540235177831,0.00351263239777293,0.0342692640181482,0.0480387830174181,1.49892220946087e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42754,0.0659571700926829,0.00563036086771996,0.0549216627919518,0.076992677393414,1.52326449627624e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGFL7,Epidermal growth factor-like protein 7,42346,0.0478000320810689,0.00409405622920784,0.0397756818718216,0.0558243822903163,2.42852207258042e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42618,0.0627242418227096,0.00537733925318628,0.0521846568864645,0.0732638267589547,2.73790870117219e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BACH1,Transcription regulator protein BACH1,42594,0.0869851327580745,0.00746095632158912,0.0723616583677598,0.101608607148389,2.93207057839563e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C2,Complement C2,42663,0.0274132159874321,0.00235181810651936,0.0228036524986541,0.03202277947621,3.01427053856363e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP43,Centrosomal protein 43,42255,0.0826911450156144,0.0070960471579195,0.0687828925860922,0.0965993974451366,3.15672974292399e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,42311,0.0724202755575565,0.00621778338427906,0.0602334201243695,0.0846071309907435,3.37342290525347e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42594,0.0582674786629466,0.00500465499984771,0.0484583548632451,0.0680766024626481,3.53326837446024e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFPI,Tissue factor pathway inhibitor,42618,-0.0369021345857629,0.00317470170356763,-0.0431245499247555,-0.0306797192467703,4.39394803312303e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC27,Cell division cycle protein 27 homolog,42346,0.0717749619488213,0.00617816546181981,0.0596657576436544,0.0838841662539881,4.75960024916696e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASAH2,Neutral ceramidase,42495,0.0636141565711732,0.0054823638397982,0.0528687234451688,0.0743595896971777,5.5820786951818e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASAH1,Acid ceramidase,40418,0.0547041388518061,0.00471361524648872,0.0454654529686883,0.063942824734924,5.80014516753518e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC7A,C-type lectin domain family 7 member A,42754,0.0722938328600144,0.00624801650412911,0.0600477205119213,0.0845399452081074,8.09585131157803e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL4,C-C motif chemokine 4,42642,0.0812618250703132,0.00702599767004082,0.0674908696370332,0.0950327805035932,8.58133649108281e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42711,0.0552424911772199,0.00477768099948957,0.0458782364182203,0.0646067459362194,8.89513786106513e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AP3B1,AP-3 complex subunit beta-1,40449,0.0910904466441348,0.00787537314044256,0.0756547152888674,0.106526177999402,9.0914998429064e-31
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNAPIN,SNARE-associated protein Snapin,40482,0.0684329667564472,0.00592506323924139,0.0568198428075341,0.0800460907053604,1.10111021834732e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTSS2,Protein MTSS 2,40451,0.117221487473044,0.0101512342361482,0.0973250683701936,0.137117906575895,1.13098132265527e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,40527,0.0277013781310022,0.00240052014464184,0.0229963586475042,0.0324063976145002,1.23337884155676e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42794,0.0776255942320176,0.00676614013303184,0.0643639595712751,0.09088722889276,2.49589037086549e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40483,0.0815471187474288,0.00711204044085541,0.0676075194833522,0.0954867180115054,2.87247603873978e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYN,Tyrosine-protein kinase Lyn,42587,0.0983764126886849,0.0085924185544435,0.0815352723219756,0.115217553055394,3.27939672280263e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS8,Galectin-8,42711,0.0697979505272848,0.00611979427843627,0.0578031537415497,0.0817927473130199,5.39622250171971e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBLIF,Cobalamin binding intrinsic factor,42613,0.0949314224378005,0.00832763401159613,0.0786092597750721,0.111253585100529,5.77168502587e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40482,0.114047550656345,0.0100088778547779,0.0944301500609799,0.133664951251709,6.47777136205472e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMB1,Laminin subunit beta-1,40223,0.0357549166250945,0.00313771552735194,0.0296049941914847,0.0419048390587043,6.49285959176126e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPAN8,Tetraspanin-8,40449,0.120680152190277,0.0105969989161811,0.0999100343145618,0.141450270065992,6.98083315171393e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42566,0.0353784510556697,0.00311155572854517,0.0292798018277211,0.0414771002836182,8.08298821578058e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TTR,Transthyretin,40424,0.0295844692485862,0.00260384149937074,0.0244809399098195,0.0346879985873528,9.41105997693651e-30
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,42370,0.0421000494435428,0.00371481199885833,0.0348190179257805,0.0493810809613051,1.23481520469859e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,42346,0.0836415645327258,0.00738969409505521,0.0691577641064176,0.098125364959034,1.4530043422524e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NECTIN4,Nectin-4,42679,0.0401411213494346,0.00354800716725088,0.0331870273016229,0.0470952153972464,1.52505474586998e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD7,T-cell antigen CD7,40166,0.0523301206342349,0.00462444720385253,0.0432662041146839,0.0613940371537859,1.59390210900157e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TARBP2,RISC-loading complex subunit TARBP2,42311,0.0903580696126778,0.00799148885786103,0.0746947514512702,0.106021387774085,1.66312349798763e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NGRN,Neugrin,40483,0.0269682563675127,0.002390055791941,0.0222837470153083,0.031652765719717,2.27284796198751e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,40383,0.0692843193998839,0.00614849772319956,0.0572332638624127,0.081335374937355,2.69964153776867e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42357,0.109179699567394,0.00969489305790587,0.090177709173899,0.12818168996089,2.76459079138637e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DBI,Acyl-CoA-binding protein,42562,0.0879513168414024,0.00781078316864445,0.0726421818308593,0.103260451851946,2.79293081074471e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FEN1,Flap endonuclease 1,42346,0.073514320529457,0.00654716448470627,0.0606818781394327,0.0863467629194813,4.01168790433458e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLIN3,Perilipin-3,42636,0.0485011329147335,0.00432642359312532,0.0400213426722079,0.0569809231572592,4.87465656129893e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40116,0.0850198735384852,0.0075811021967593,0.070160913232837,0.0998788338441334,4.97432781485135e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPR,Nucleoprotein TPR,40116,0.0560207429066644,0.00500960386958641,0.0462019193222751,0.0658395664910538,7.11235027858606e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLA2,Src-like-adapter 2,40482,0.119185234601514,0.0106793931926968,0.0982536239438285,0.1401168452592,9.01894351117124e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42794,0.0750511830861116,0.00672845893660846,0.061863403570359,0.0882389626018642,9.09518585710737e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GORASP2,Golgi reassembly-stacking protein 2,40449,0.0540494635125041,0.00484525663423572,0.0445527605094021,0.0635461665156061,9.56254227067753e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAG4,BAG family molecular chaperone regulator 4,40199,0.056353889929982,0.00505216684260136,0.0464516429184833,0.0662561369414806,9.71607466274269e-29
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40451,0.0819215540664375,0.00735863211911547,0.0674986351129711,0.0963444730199038,1.22657009885106e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DKK1,Dickkopf-related protein 1,42711,0.0667754295436835,0.00600527782712687,0.0550050850025148,0.0785457740848522,1.34227761625346e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRLF1,Cytokine receptor-like factor 1,42676,0.0287466190711171,0.00258530222218338,0.0236794267156377,0.0338138114265965,1.34637653554205e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,40283,0.0434353336077956,0.00390576738634901,0.0357800295305515,0.0510906376850396,1.40682527077539e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42495,0.12202305004205,0.0110087641657276,0.100445872277224,0.143600227806876,1.99410364342345e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEFTY2,Left-right determination factor 2,42689,0.0567110662028702,0.00511857800876235,0.0466786533056959,0.0667434791000444,2.09238887793948e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA4,Kallistatin,40342,0.0275701320836765,0.00248811060524763,0.0226934352973911,0.0324468288699618,2.18793542235396e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BPIFA2,BPI fold-containing family A member 2,39838,-0.129551299755341,0.0116920789073412,-0.15246777441373,-0.106634825096952,2.23529798619932e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CES2,Cocaine esterase,42587,0.0623182957269786,0.00563092986756374,0.0512816731865537,0.0733549182674036,2.40288011192752e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLK1,Protein delta homolog 1,42794,0.0624675763277849,0.00564999960989675,0.0513935770923872,0.0735415755631825,2.69986642561603e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYDGF,Myeloid-derived growth factor,40511,0.111818726653646,0.0101098547510988,0.0920034113414926,0.1316340419658,2.72618986236597e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42636,0.0714960118074638,0.00648112263620689,0.0587930114404983,0.0841990121744293,3.56046991747018e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM24,Transcription intermediary factor 1-alpha,40287,0.0738574431514433,0.00669623865551702,0.0607328153866299,0.0869820709162566,3.84761008580354e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD248,Endosialin,40527,-0.0463988774902497,0.00420770363918536,-0.054645976623053,-0.0381517783574464,3.92980984922099e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,40449,0.0338826966538291,0.00307495533875765,0.0278557841898642,0.0399096091177941,4.31040909037538e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42587,0.0862887205591797,0.00785293394196295,0.0708969700329323,0.101680471085427,5.74077568671253e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42674,-0.0273647040515414,0.00249050144973836,-0.0322460868930286,-0.0224833212100542,5.75958778790171e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42565,0.0488329943092108,0.00444910144473058,0.0401127554775389,0.0575532331408828,6.56344339635436e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,40483,0.121133525788779,0.011034909563873,0.099505103043588,0.14276194853397,6.79807423616257e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH17,Cadherin-17,42636,0.078446959435465,0.00715756548312461,0.0644181310885408,0.0924757877823892,7.80309009144266e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SWAP70,Switch-associated protein 70,40449,0.0403651298561609,0.00368450249188909,0.0331435049720583,0.0475867547402636,8.64860334613242e-28
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42495,0.105926779012346,0.00968904974535705,0.0869362415114466,0.124917316513246,1.05573715865919e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPON1,Spondin-1,42638,0.0381414521341111,0.00348909410767268,0.0313028276830726,0.0449800765851496,1.0643679610875e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YOD1,Ubiquitin thioesterase OTU1,40116,0.0714286896180207,0.00653772594591357,0.0586147467640301,0.0842426324720113,1.20845615405601e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,40283,0.0745953577674243,0.00683220504050368,0.0612042358880371,0.0879864796468116,1.30377564908415e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JAM3,Junctional adhesion molecule C,40283,0.0572256073282055,0.00524468721438208,0.0469460203880166,0.0675051942683944,1.40762898423987e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40449,0.0854086142935127,0.00782814226675491,0.0700654554506731,0.100751773136352,1.41170614874052e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40449,0.0242279523022348,0.00222817257019798,0.0198607340646467,0.0285951705398228,2.11033007420785e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFAP4,Microfibril-associated glycoprotein 4,40283,0.0366383755164646,0.00337400906288507,0.0300253177532098,0.0432514332797193,2.48002562764722e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42771,-0.0690131542510928,0.00636332620757396,-0.0814852736179377,-0.0565410348842478,2.71176568596271e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42679,0.106050142977999,0.00978050106157312,0.0868803608973157,0.125219925058682,2.78918255060241e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AXIN1,Axin-1,42594,0.104847279141153,0.00967470046886269,0.0858848662221824,0.123809692060124,2.97347058246216e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",40527,0.0459400563298867,0.00423790477141961,0.0376337629779043,0.0542463496818692,3.01704805300658e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL8,Interleukin-8,42494,0.0774707775587429,0.00715242849555244,0.0634520177074601,0.0914895374100257,3.17475317145959e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42357,0.0646253574109381,0.00596940775368207,0.0529253182137212,0.0763253966081549,3.37140891902132e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMP3,Metalloproteinase inhibitor 3,42676,0.144594037568411,0.0133589740521247,0.118410448426247,0.170777626710575,3.43699437911988e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RARRES1,Retinoic acid receptor responder protein 1,42346,0.0367137350092577,0.00339594357485905,0.030057685602534,0.0433697844159815,3.96752124627783e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSE,Cathepsin E,40283,0.0573572522096318,0.00530627034747807,0.0469569623285747,0.0677575420906888,4.24275057324527e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CES3,Carboxylesterase 3,42587,0.0781027656032393,0.00722933709395112,0.0639332648990951,0.0922722663073835,4.28082765237917e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42658,0.0775422892199949,0.00717765246867204,0.0634740903813977,0.0916104880585921,4.28857182370533e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,40483,0.0362887280961008,0.00336042100036959,0.0297023029353764,0.0428751532568252,4.72401069508116e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40511,0.0677172706996909,0.00627190419762842,0.0554243384723392,0.0800102029270426,4.82021995705802e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OTUD7B,OTU domain-containing protein 7B,40482,0.0688233765424087,0.00637581186366165,0.0563267852896318,0.0813199677951855,4.9543103221442e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNAP23,Synaptosomal-associated protein 23,42636,0.0957610140869324,0.00888193652503937,0.0783524184978553,0.11316960967601,5.42502499252776e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC16A1,Monocarboxylate transporter 1,42311,0.0636916031140848,0.00590786755333349,0.0521121827095512,0.0752710235186185,5.50255729458793e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40511,0.0328318294273665,0.00304517621606267,0.0268632840438837,0.0388003748108494,5.68595726384951e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERBIN,Erbin,42587,0.112505300415065,0.010440208648362,0.0920424914642759,0.132968109365855,5.75493876770901e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42562,0.0745970790616814,0.00692651098477276,0.0610211175315268,0.088173040591836,6.16609090779939e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42594,0.116400903848323,0.0108105356419275,0.0952122539901452,0.137589553706501,6.32598120250057e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAP18,Chromatin complexes subunit BAP18,40483,0.075149777826727,0.00698307638915579,0.0614629481039817,0.0888366075494724,7.04669242636694e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,40223,0.0354283621978898,0.00329230579716275,0.0289754428354508,0.0418812815603288,7.15325505205395e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PQBP1,Polyglutamine-binding protein 1,42346,0.0629810308648363,0.00585643764530923,0.0515024130800302,0.0744596486496424,7.32622131041454e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCR,Breakpoint cluster region protein,42594,0.100108490819169,0.00931255627165515,0.0818558805267249,0.118361101111613,7.63774951385527e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,40283,0.0924924007376499,0.0086016529657904,0.0756331609247007,0.109351640550599,7.78979538258614e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFX1,Transcriptional repressor NF-X1,40116,0.0752624576339859,0.00700659031770625,0.0615295406112816,0.0889953746566901,8.82446721586477e-27
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPO,Myeloperoxidase,42611,0.0511623242868625,0.00477148086928489,0.0418102217830641,0.0605144267906609,1.02371632141502e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAA80,N-alpha-acetyltransferase 80,40182,0.133259841528159,0.0124228394076033,0.108911076289257,0.157608606767062,1.03066275091405e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42357,-0.0236729539516945,0.00220795824133185,-0.0280005521047049,-0.0193453557986841,1.0383264780111e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALCAM,CD166 antigen,42794,0.0216629272880702,0.00202206016391746,0.017699689366792,0.0256261652093484,1.12642020134398e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN3,CCN family member 3,42779,0.0390891209700751,0.00365080129466427,0.0319335504325332,0.0462446915076171,1.20534848235294e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,42346,0.0724913964636535,0.00677393473718087,0.059214484378779,0.085768308548528,1.2884081411384e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAPG,Macrophage-capping protein,42461,0.0642827530619741,0.00601086800043093,0.0525014517811294,0.0760640543428187,1.38704195850984e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STK11,Serine/threonine-protein kinase STK11,42357,0.0794381907343073,0.00744375684086172,0.0648484273262183,0.0940279541423962,1.76988663142752e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40283,0.0463110827754541,0.0043383599173924,0.037807897337365,0.0548142682135432,1.7953728914196e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNM3,Dynamin-3,40482,0.0604008016369629,0.00565872897367606,0.0493096928485578,0.071491910425368,1.80280642919976e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40449,0.0703873132701339,0.00660100430633144,0.0574493448297242,0.0833252817105435,2.02422617637977e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDLIM7,PDZ and LIM domain protein 7,42676,0.134996254237208,0.012668613608469,0.110165771564609,0.159826736909808,2.08309816529863e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42594,0.105105445894439,0.00986346284987485,0.0857730587086847,0.124437833080194,2.08443412395528e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCF2,Neutrophil cytosol factor 2,42578,0.09048044945748,0.00849682243747816,0.0738266774800228,0.107134221434937,2.25366625956324e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NBN,Nibrin,42370,0.0584360594101434,0.00548868657711307,0.0476782337190018,0.069193885101285,2.31347590218641e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH15,Cadherin-15,42692,0.0680479928080923,0.00639834968344349,0.0555072274285431,0.0805887581876416,2.59661032253355e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCRG1,Scrapie-responsive protein 1,40511,0.0313890734383545,0.00295046097002534,0.0256061699371048,0.0371719769396042,2.62047925139568e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RFC4,Replication factor C subunit 4,40451,0.0232058797424823,0.00218132592925024,0.0189304809211518,0.0274812785638128,2.6320757660683e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOXO1,Forkhead box protein O1,42594,0.0922044717040448,0.00867354462509941,0.07520432423885,0.10920461916924,2.73448022337457e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCK2,Cytoplasmic protein NCK2,42676,0.113702992575424,0.0107204616898672,0.0926908876632842,0.134715097487564,3.53742788625549e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNLR1,Interferon lambda receptor 1,42594,0.0395251573310817,0.00373110401979917,0.0322121934522753,0.0468381212098881,4.05511763197305e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42587,0.0272799062519418,0.00257743746281672,0.022228128824821,0.0323316836790625,4.47558601080156e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40199,0.0479021472836277,0.00452963668343925,0.0390240593840868,0.0567802351831686,5.17169215110945e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,40483,0.0978605522546965,0.00925485102879133,0.0797210442382655,0.116000060271127,5.20568041393235e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAX1BP1,Tax1-binding protein 1,40483,0.0688051579385781,0.00650866820477397,0.0560481682572211,0.0815621476199351,5.35413280819857e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATG16L1,Autophagy-related protein 16-1,40449,0.0919861398537779,0.00870336690121736,0.0749275407273919,0.109044738980164,5.48930901199918e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42611,0.0585782937532649,0.00554706174382007,0.0477060527353776,0.0694505347711523,5.75925573822365e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS22,Brain-specific serine protease 4,40199,0.0399781816707938,0.00378508301743878,0.0325594189566138,0.0473969443849738,5.94719930694085e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELP,P-selectin,42689,0.0605466048944398,0.00573753434023524,0.0493010375875787,0.0717921722013009,6.22671726199712e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHRDL1,Chordin-like protein 1,42654,0.0350627987796409,0.00332751628187219,0.0285408668671714,0.0415847306921104,7.33696012263842e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD6,T-cell differentiation antigen CD6,42746,0.0569522924582452,0.00541267290917019,0.0463434535562716,0.0675611313602188,8.5979844929996e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42711,0.0700434019989668,0.00666358940572172,0.0569827667637522,0.0831040372341814,9.62493760554557e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HYOU1,Hypoxia up-regulated protein 1,42794,0.0249513029889071,0.00237433373111313,0.0202976088759253,0.0296049971018888,9.87831311753882e-26
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZBP1,Z-DNA-binding protein 1,40199,0.0434934700657198,0.00414092140392416,0.0353772641140285,0.0516096760174112,1.10285088697437e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TJAP1,Tight junction-associated protein 1,42679,0.0882924639914177,0.00842739839805159,0.0717747631312366,0.104810164851599,1.38391085292848e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFC,Platelet-derived growth factor C,42346,0.0307037379714301,0.00293471762319067,0.0249516914299764,0.0364557845128838,1.62165178761522e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42587,0.0737001606403606,0.0070468090485513,0.0598884149052001,0.0875119063755212,1.67680234468401e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPE,Carboxypeptidase E,42588,-0.0414630203106355,0.0039649209389148,-0.0492342653509085,-0.0336917752703625,1.69783684236542e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC1B,C-type lectin domain family 1 member B,42711,0.101823935057087,0.00974557527584142,0.0827226075164375,0.120925262597736,1.86638989650908e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EBI3_IL27,Interleukin-27,42689,0.0331027936089597,0.00316876454877706,0.0268920150933567,0.0393135721245627,1.89914386048092e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPI,Glucose-6-phosphate isomerase,40532,0.0506851627449563,0.00485038582509245,0.0411784065277751,0.0601919189621375,1.917492759941e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42594,0.0760229243370698,0.0072897215262751,0.0617350701455706,0.090310778528569,2.2911115984131e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42737,0.0334356675437177,0.00320763485015799,0.027148703237408,0.0397226318500273,2.40835865151705e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGALS7_LGALS7B,Galectin-7,42524,0.0463685710036969,0.00444982887147004,0.0376469064156156,0.0550902355917782,2.50595340761356e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRLB,Fc receptor-like B,42346,0.069699480897655,0.00669948445407114,0.0565684913676756,0.0828304704276345,2.98805779716345e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,METAP2,Methionine aminopeptidase 2,42689,0.0606276236370958,0.00583039452115888,0.0492000503756244,0.0720551968985672,3.13513781006361e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNXB,Tenascin-X,42611,-0.0275318252150415,0.00265209565792038,-0.0327299327045654,-0.0223337177255175,3.76136243961059e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VAMP5,Vesicle-associated membrane protein 5,42357,0.0594222434828813,0.00572604174049718,0.0481992016715068,0.0706452852942558,3.92180147556998e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC14A,C-type lectin domain family 14 member A,42611,0.035541163067742,0.00342745427318505,0.0288233526922993,0.0422589734431846,4.24329609415344e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLIT2,Slit homolog 2 protein,42311,0.0559165017189241,0.00540129258404706,0.0453299682541919,0.0665030351836564,5.09302683494535e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40209,0.0851298336910042,0.00822381980072067,0.0690111468815917,0.101248520500417,5.35660787943016e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DHPS,Deoxyhypusine synthase,40451,0.0432590436852373,0.00418035950763481,0.0350655390502731,0.0514525483202015,5.52027926125164e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLAMF6,SLAM family member 6,42346,0.041348126006514,0.00399723560314998,0.03351354422434,0.0491827077886879,5.5441257751554e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX8,Syntaxin-8,42594,0.0505161439151721,0.00489683332182005,0.0409183506044048,0.0601139372259394,7.38370199340322e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40283,0.0615393453452886,0.00596867237797224,0.049840747484463,0.0732379432061142,8.18506309066671e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42495,0.0562732442682833,0.00546637377875602,0.0455591516619215,0.0669873368746451,9.24618004054424e-25
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EHBP1,EH domain-binding protein 1,40511,0.0786615569153553,0.00764831690211739,0.0636708557872052,0.0936522580435054,1.05956637398779e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,42370,-0.0418829958177053,0.00407427520759243,-0.0498685752245864,-0.0338974164108241,1.07653678962528e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARSA,Arylsulfatase A,42611,0.0469035369517642,0.00456544744682201,0.0379552599559931,0.0558518139475354,1.14393890551392e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPT,Dermatopontin,42794,0.0267238238419822,0.00260165628212814,0.0216245775290111,0.0318230701549534,1.16132747915592e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LGMN,Legumain,42676,0.0376552894128915,0.00366883460249099,0.0304643735920091,0.0448462052337738,1.26700941210458e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WNT9A,Protein Wnt-9a,42370,0.0313172978483086,0.00305192994835313,0.0253355151495365,0.0372990805470807,1.30066953281453e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40449,0.054166923615823,0.00528827617129805,0.0438019023200789,0.0645319449115672,1.63258327774425e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,40449,0.059487909432879,0.00581591091158062,0.0480887240461809,0.070887094819577,1.89100128201647e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RALY,RNA-binding protein Raly,40451,0.0501292081229935,0.00490295934101218,0.0405194078146096,0.0597390084313774,1.97393347255721e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42711,0.0331641735352426,0.00324556296243805,0.0268028701288641,0.0395254769416212,2.01416260217734e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IKBKG,NF-kappa-B essential modulator,42594,0.0950235502897455,0.00930205954592095,0.0767915135797404,0.113255586999751,2.08038633557007e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRELP,Prolargin,42618,0.0255988057722557,0.00250850680841341,0.0206821324277654,0.030515479116746,2.31597371951587e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42458,0.0363828170878817,0.00356569838393769,0.0293940482553638,0.0433715859203996,2.35124049065033e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40482,0.0505769553847999,0.0049554951199306,0.0408641849497359,0.0602897258198639,2.37182944545556e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40223,0.0516124611302233,0.00505897741708067,0.0416968653927452,0.0615280568677014,2.48683817290085e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNRD2,Protein ZNRD2,40449,0.0734470868192376,0.00720009201250637,0.0593349064747252,0.0875592671637501,2.50754059096269e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGN,Secretagogin,42370,0.0473698516171936,0.00464945583901638,0.0382569181727215,0.0564827850616657,2.75270795997046e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN5,Contactin-5,42640,-0.0397532075742402,0.00391357488032934,-0.0474238143396857,-0.0320826008087947,3.74006672247028e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42611,0.0590061811178472,0.00580935024047317,0.0476198546465198,0.0703925075891746,3.76721993634495e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CIT,Citron Rho-interacting kinase,40182,0.047563101799814,0.00468821316721483,0.0383742039920729,0.0567519996075551,4.44094568679141e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL5,C-C motif chemokine 5,42689,0.103464892304541,0.0102118297957583,0.0834497059048544,0.123480078704227,4.86322960175403e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP8,Neutrophil collagenase,42681,0.0759366397927227,0.00750031147768879,0.0612360292964526,0.0906372502889927,5.24317299386288e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL19,C-C motif chemokine 19,42711,0.136159749003315,0.0134560745315787,0.109785842921421,0.16253365508521,5.54903304182795e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLMAP,Sarcolemmal membrane-associated protein,40449,0.0862696581666178,0.00852245779607706,0.0695656408863068,0.102973675446929,5.55382484695508e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA5,Plasma serine protease inhibitor,40387,0.0329334026801743,0.00325554482109492,0.0265525348308282,0.0393142705295203,5.94116959650534e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCAN,Brevican core protein,42495,-0.0359798886613273,0.00355854971674174,-0.0429546461061412,-0.0290051312165135,6.03691877471382e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCHE,Cholinesterase,40346,0.0290906053806586,0.00288075426689727,0.0234443270175399,0.0347368837437772,7.12151103689164e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL2,Fc receptor-like protein 2,42681,0.0546352149049622,0.00541406369794682,0.0440236500569864,0.065246779752938,7.33249788313924e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX4,Syntaxin-4,42587,0.061507595337943,0.0060989866348514,0.0495535815336343,0.0734616091422518,7.83819478197289e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DFFA,DNA fragmentation factor subunit alpha,42754,0.0689156662031594,0.00684339748703938,0.0555026071285622,0.0823287252777565,9.05256627224809e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40302,0.11635029146152,0.0115501078234066,0.093712080127643,0.138988502795397,9.14906334335271e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM5,Tripartite motif-containing protein 5,42594,0.0878405786628738,0.00872514856107491,0.070739287483167,0.104941869842581,9.33997058211716e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40451,0.0498278401578674,0.0049478264655768,0.0401301002853368,0.0595255800303979,9.38869467121088e-24
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42594,0.10655818647085,0.0105950800227601,0.0857918296262398,0.127324543315459,1.03506672960156e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHRDL2,Chordin-like protein 2,42636,0.0488627216417034,0.00486111441920628,0.0393349373800591,0.0583905059033477,1.09420797880977e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRCAM,Neuronal cell adhesion molecule,42636,0.0299867372840765,0.00299406561789945,0.0241183686729936,0.0358551058951594,1.57726151717984e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42495,0.0737108090575481,0.00736203576908257,0.0592812189501463,0.08814039916495,1.6304428195122e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42611,-0.046136469811204,0.0046082546683181,-0.0551686489611074,-0.0371042906613005,1.6373364191946e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEXIM1,Protein HEXIM1,42594,0.0825198375715061,0.00824849913310082,0.0663527792706285,0.0986868958723837,1.76528293854683e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A4,Protein S100-A4,42679,0.0583279503365384,0.00583512312400577,0.0468911090134871,0.0697647916595897,1.91450820007229e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LY6D,Lymphocyte antigen 6D,42548,0.0420540261303853,0.00421013091582875,0.033802169535361,0.0503058827254097,2.06229153813007e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEMIP2,Cell surface hyaluronidase,40199,0.0355819899315663,0.00356184849047319,0.0286007668902388,0.0425632129728937,2.12571242989662e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42370,0.073281222516906,0.00733914320661254,0.0588965018319455,0.0876659432018666,2.14739317182199e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESYT2,Extended synaptotagmin-2,40483,0.0845428538149487,0.00847592936250933,0.0679300322644304,0.101155675365467,2.46242770861104e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42587,0.139831331902807,0.0140318511469803,0.112328903654725,0.167333760150888,2.6069493562803e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLB1,Beta-galactosidase,42495,0.04225789183321,0.00424048610040526,0.0339465390764156,0.0505692445900043,2.60871462638758e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,42311,0.0679855391725787,0.00682666078912412,0.0546052840258955,0.081365794319262,2.7913414737278e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NSFL1C,NSFL1 cofactor p47,42711,0.0660402055839588,0.00663987588173809,0.0530260488557522,0.0790543623121655,3.154758766539e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBP7,Retinoid-binding protein 7,40449,0.0618418991369021,0.00621653046041973,0.0496574994344794,0.0740262988393248,3.20894933249768e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA10,Annexin A10,42311,0.0881542161546504,0.00888138293030818,0.0707467056112464,0.105561726698054,3.88203831627758e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,40449,0.040924470658458,0.00412382827519088,0.0328417672390838,0.0490071740778321,4.07721716432633e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGL1,Fibrinogen-like protein 1,40532,0.0674735173812984,0.00680906749980374,0.0541277450816831,0.0808192896809138,4.70300026898933e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOLR2,Folate receptor beta,42711,0.0301254446701262,0.00304179270902464,0.0241635309604379,0.0360873583798145,4.79896883261823e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LONP1,"Lon protease homolog, mitochondrial",40223,0.0886631445623893,0.00894959976346426,0.0711219290259993,0.106204360098779,4.8464133887406e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C3,Complement C3,39989,0.0483231734328083,0.00488015497449965,0.038758069682789,0.0578882771828276,5.1152456344366e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42579,0.0249003647154652,0.00251656200223068,0.0199679031910931,0.0298328262398374,5.2697258844575e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNPEP,Aspartyl aminopeptidase,40483,0.058405370510415,0.00590599327872075,0.0468296236841223,0.0699811173367077,5.75049187164018e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAB2,Disabled homolog 2,42721,0.110290140893792,0.0111658685694471,0.088405038497676,0.132175243289908,6.23517965103787e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CKB,Creatine kinase B-type,40527,-0.0614459059509543,0.00622160854893435,-0.0736402587068657,-0.049251553195043,6.53207444100688e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42721,0.0620668243641553,0.00628818856692128,0.0497419747729896,0.074391673955321,6.6861826621617e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST7,Cystatin-F,42642,0.0952693580756866,0.00965518042485366,0.0763452044429734,0.1141935117084,6.90897340156405e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,42370,0.0687796472586784,0.00697061574806777,0.0551172403924656,0.0824420541248913,6.94072699200749e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40482,0.0786762630041011,0.00797832626889611,0.0630387435170648,0.0943137824911375,7.57924262909311e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IDS,Iduronate 2-sulfatase,42754,-0.0088549837453652,0.000898573137789229,-0.0106161870954321,-0.00709378039529831,7.82057513148061e-23
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GM2A,Ganglioside GM2 activator,40269,0.0415905223385966,0.00423000102939892,0.0332997203209747,0.0498813243562184,1.01268157501305e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42594,0.111661699172397,0.0113647007504776,0.0893868857014611,0.133936512643333,1.04526939836539e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGAL,Integrin alpha-L,40199,0.0453644119175616,0.00461747186587046,0.0363141670604555,0.0544146567746677,1.09452712119854e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42565,0.0263450587444911,0.00268667767638215,0.0210791704987821,0.0316109469902001,1.26691725931843e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40483,0.0865333863646677,0.00883276058856637,0.0692211756110776,0.103845597118258,1.42848553006505e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASS1,Argininosuccinate synthase,40116,0.078526217892475,0.00803179546418119,0.0627838987826799,0.0942685370022701,1.74900175523281e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LY9,T-lymphocyte surface antigen Ly-9,42443,0.0308143623814131,0.00315526560981744,0.0246300417861709,0.0369986829766553,1.87544289107313e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATXN2L,Ataxin-2-like protein,40482,0.0485033162678603,0.00497701135610952,0.0387483740098857,0.058258258525835,2.36255649030055e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAT2,Signal transducer and activator of transcription 2,40199,0.0764399058201309,0.00784748469205808,0.0610588358236971,0.0918209758165647,2.48828988389192e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIGYF2,GRB10-interacting GYF protein 2,40482,0.075496983793556,0.00775314023925382,0.0603008289246185,0.0906931386624935,2.5511696516579e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGMB,RGM domain family member B,42711,0.028490464716875,0.00292690568821261,0.0227537295679783,0.0342271998657717,2.55654000243336e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,40199,0.0893632437095002,0.00918609722820261,0.0713584931422231,0.107367994276777,2.813361562544e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DGKA,Diacylglycerol kinase alpha,40199,0.0549168969525837,0.00564681303300212,0.0438491434078996,0.0659846504972679,2.89135341762727e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GZMH,Granzyme H,42357,0.0778667867903635,0.00801495737313259,0.0621574703390237,0.0935761032417034,3.08517183952328e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CETN2,Centrin-2,42311,0.0669837913245172,0.00689736090831557,0.0534649639442187,0.0805026187048157,3.19953706151896e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FSTL1,Follistatin-related protein 1,40223,0.0227757830731241,0.00234459502078334,0.0181803768323887,0.0273711893138594,3.22072814085467e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNLIP,Pancreatic triacylglycerol lipase,40532,0.0656850300994932,0.00676287500265687,0.0524297950942858,0.0789402651047007,3.25237723006211e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL6,Fc receptor-like protein 6,42594,0.0698884950556392,0.00720048294622307,0.055775548481042,0.0840014416302364,3.36100150607539e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DOK2,Docking protein 2,42636,0.119544178120914,0.012338637741984,0.095360448146625,0.143727908095203,3.98207225848225e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNG,Interferon gamma,42370,0.112328760894491,0.0116108615038288,0.0895714723469868,0.135086049441996,4.58406752978769e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17C,Interleukin-17C,42370,0.0742873873763392,0.00768248906974839,0.0592297087996324,0.089345065953046,4.80043100488126e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42587,0.0376406773122244,0.00389471448692611,0.0300070369178492,0.0452743177065996,5.03260630362264e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42346,0.0767126091085998,0.0079425723639729,0.0611451672752129,0.0922800509419867,5.35766688329691e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATOX1,Copper transport protein ATOX1,42679,0.0688897077111234,0.00713350309075066,0.0549080416532521,0.0828713737689947,5.39812899099767e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BOLA1,BolA-like protein 1,40136,0.0541820113473814,0.00561012705324574,0.0431861623230198,0.0651778603717431,5.56936851321164e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F2R,Proteinase-activated receptor 1,42654,0.0554777777948035,0.00574679786651918,0.0442140539764259,0.0667415016131811,5.58714958454728e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42295,0.0569487523754488,0.0058998878206833,0.0453849722469095,0.068512532503988,5.67620222431419e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,40223,0.0740059726304987,0.00767549733276054,0.0589619978582881,0.0890499474027094,6.49390555379611e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42476,0.0939015522305586,0.00977440475886282,0.0747437189031875,0.11305938555793,8.80207761617522e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40173,0.0272973846698041,0.00284081054881986,0.0217293959941172,0.032865373345491,8.92163837628105e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL2L15,Bcl-2-like protein 15,40199,0.0559568399974475,0.00582998089474113,0.0445300774437549,0.0673836025511401,9.90345750560338e-22
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLAMF1,Signaling lymphocytic activation molecule,42370,0.0597291601360689,0.00623072497024848,0.0475169391943819,0.0719413810777559,1.07531790144665e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GOLGA3,Golgin subfamily A member 3,40482,0.0774315773119054,0.00807660042224936,0.0616014404842967,0.0932617141395142,1.0951394513356e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCAN,Neurocan core protein,42711,-0.0373873003096841,0.00390603347398809,-0.0450431259187007,-0.0297314747006674,1.23175113837046e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD300LF,CMRF35-like molecule 1,42721,0.0598877319086301,0.00626291796744825,0.0476124126924315,0.0721630511248287,1.34805452030524e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCN2,Transcobalamin-2,42771,0.0303625972964234,0.00317680441168547,0.0241360606495199,0.036589133943327,1.40920186948902e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPPK1,Epiplakin,40223,0.0716595971558212,0.00750040131756595,0.0569588105733919,0.0863603837382505,1.51037770533503e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL16,C-X-C motif chemokine 16,42778,0.0234238704130977,0.00245606654267691,0.0186099799894509,0.0282377608367444,1.71412123290705e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SYTL4,Synaptotagmin-like protein 4,40511,0.0725351914263691,0.00760685245661495,0.0576257606114038,0.0874446222413344,1.79582265451293e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USO1,General vesicular transport factor p115,42587,0.087771649956927,0.00922240035938747,0.0696957452525276,0.105847554661326,2.07856209221996e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,40182,0.0633908906036676,0.00666210623120196,0.0503331623905118,0.0764486188168235,2.19339814060647e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40483,0.0391551126479513,0.00411856457460148,0.0310827260817324,0.0472274992141702,2.35907954063525e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40511,0.0297924128460594,0.00313751037235906,0.0236428925162356,0.0359419331758831,2.62912534235906e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ISM1,Isthmin-1,42594,0.0374225343162373,0.00394532350444606,0.029689700247523,0.0451553683849515,2.81863800985582e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,40451,0.111099194477864,0.0117163738849227,0.0881351016634151,0.134063287292312,2.98307770054331e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42636,0.0765206611910791,0.00807643895221855,0.0606908408447308,0.0923504815374275,3.12041025863646e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STIP1,Stress-induced-phosphoprotein 1,42586,0.0626351677368795,0.00661846417694298,0.0496629779500713,0.0756073575236878,3.46160778889258e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP2,Microtubule-associated protein 2,40483,0.0453761674495724,0.00479388900469117,0.0359801450003777,0.0547721898987671,3.50317158832465e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MATN2,Matrilin-2,42638,0.0287649390289345,0.00304629689345365,0.0227941971177654,0.0347356809401036,4.2272318418112e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NT5E,5'-nucleotidase,42679,0.0547585940248044,0.00581213360464414,0.0433668121597019,0.0661503758899069,5.16338303221834e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTGES2,Prostaglandin E synthase 2,40102,0.0530740474564213,0.00563180608406686,0.0420357075316503,0.0641123873811924,5.21937266817836e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMOX2,Heme oxygenase 2,42311,0.0441868955492135,0.00469254454154655,0.0349895082477823,0.0533842828506448,5.43716893027611e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TREH,Trehalase,40527,0.0721294709262174,0.00766373554080856,0.0571085492662326,0.0871503925862021,5.81661904356718e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42674,0.0700429415170095,0.00744800361137851,0.0554448544387076,0.0846410285953114,6.073797037887e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT5,"Keratin, type II cytoskeletal 5",42311,0.049650470260842,0.0052812152467936,0.0392992883771266,0.0600016521445575,6.26923150673861e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42495,0.0553441413219772,0.00588770986859956,0.0438042299795221,0.0668840526644324,6.33884548465179e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42754,0.0334881949449211,0.00356335044108801,0.0265040280803886,0.0404723618094536,6.44087346392106e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42346,0.0421543099280839,0.00448587430691839,0.0333619962865238,0.0509466235696439,6.52090120398089e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COMMD1,COMM domain-containing protein 1,40223,0.0585600022625857,0.00623027101293467,0.0463486710772337,0.0707713334479376,6.57751048933783e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40223,0.0249472681444214,0.00265532383543512,0.0197428334269685,0.0301517028618742,6.83551398682642e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,40283,0.0689292262203658,0.00733841320058187,0.0545459363472254,0.0833125160935063,6.97558362897808e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40451,0.0333503604567501,0.00355332270304392,0.026385847958784,0.0403148729547162,7.44886995942447e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HPSE,Heparanase,40408,0.0906482485981332,0.00965832966542726,0.0717179224538958,0.109578574742371,7.46674015794964e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,40182,0.0671581164882716,0.00716944877949595,0.0531059968804596,0.0812102360960837,8.89577448689726e-21
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LY96,Lymphocyte antigen 96,42495,0.034320359127714,0.00367100570118569,0.02712518795339,0.0415155303020379,1.02378265273538e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40449,0.112996425649617,0.0120988048413573,0.0892827681605564,0.136710083138677,1.14984554788774e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42370,0.0413396998621692,0.00442850516949662,0.0326598297299558,0.0500195699943825,1.17050093431997e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40302,0.0440775122803625,0.00472131740273225,0.0348237301710072,0.0533312943897177,1.19220578052409e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLSTN3,Calsyntenin-3,40483,0.0296067160372766,0.00317228400576769,0.0233890393859719,0.0358243926885812,1.22183020656419e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD164,Sialomucin core protein 24,42611,0.0261866109029235,0.00280833783884772,0.0206822687387819,0.031690953067065,1.28596658818401e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGLC2,Immunoglobulin lambda constant 2,40519,0.0244425600058465,0.00262093179942505,0.0193055336789734,0.0295795863327196,1.30423495598676e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL17,C-C motif chemokine 17,42604,0.0877201531386022,0.0094177288340573,0.0692614046238499,0.106178901653355,1.41535506151354e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40223,0.0731881765401059,0.0078676734378862,0.0577675366018489,0.0886088164783628,1.63215507159296e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42586,0.0181349334451807,0.0019505347889332,0.0143118852588716,0.0219579816314898,1.65871401333991e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42370,0.0506807149623633,0.00545241637291328,0.0399939788714533,0.0613674510532734,1.69904029048384e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSCAM,Down syndrome cell adhesion molecule,40482,0.0347953817328655,0.00374339177352863,0.0274583338567494,0.0421324296089816,1.73942060456594e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAGK,N-acetyl-D-glucosamine kinase,40209,0.0533486877191818,0.00574840052438899,0.0420818226913794,0.0646155527469842,2.00002862613544e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42611,0.0359711765667409,0.00387846762568964,0.0283693800203892,0.0435729731130926,2.05202239033619e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40223,0.0504955981866822,0.00544807615508142,0.0398173689227227,0.0611738274506418,2.23785745035052e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,40116,0.0592050250837405,0.00638767777956273,0.0466851766357975,0.0717248735316834,2.23925404171302e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMP4,Metalloproteinase inhibitor 4,42611,-0.0392609262144553,0.00423842686504425,-0.047568242869942,-0.0309536095589686,2.28394179308725e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42370,0.0411183944056485,0.00444781886370198,0.0324006694327926,0.0498361193785044,2.71881697805883e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42636,0.0695373513842722,0.00752422229315106,0.0547898756896961,0.0842848270788483,2.78324614562742e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OPLAH,5-oxoprolinase,40223,0.0645822316529604,0.00698640687928302,0.0508888741695657,0.0782755891363551,2.81073448969415e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40199,0.033648851610059,0.00364139503882534,0.0265117173339614,0.0407859858861567,2.90011244583214e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BID,BH3-interacting domain death agonist,42594,0.0635507798873415,0.00687986240045797,0.0500662495824439,0.0770353101922391,2.90549281737578e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDA,Cytidine deaminase,40494,0.0448189840700644,0.00485096418585734,0.035311094265784,0.0543268738743448,2.92674100330537e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,40223,0.0498345739959974,0.00539586883438291,0.0392586710806069,0.0604104769113879,3.03544238883074e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,40511,0.0463063996813579,0.00501692398133399,0.0364732286779432,0.0561395706847725,3.18513863820485e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNL1,Interferon lambda-1,42311,0.0434900251936803,0.0047163070266227,0.0342460634214998,0.0527339869658608,3.38076097152708e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCBP2,Poly(rC)-binding protein 2,40482,0.0684723482971669,0.00742428823880562,0.0539207433491079,0.0830239532452259,3.40902765269829e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH3BP1,SH3 domain-binding protein 1,40449,0.0455731339055465,0.00494698823865925,0.0358770369577744,0.0552692308533186,3.75695184598078e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42594,-0.0569047456390556,0.00618494470580435,-0.0690272372624321,-0.044782254015679,4.08198278130094e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,40451,0.0641753766895049,0.00697763237418116,0.0504992172361098,0.0778515361428999,4.31540785438515e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIMAP8,GTPase IMAP family member 8,40080,0.0501913501698572,0.00545945392607598,0.0394908204747483,0.0608918798649661,4.49509637324224e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGFLAM,Pikachurin,40449,0.0295023652132072,0.00321199125272211,0.0232068623578718,0.0357978680685425,4.83111864696242e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42674,0.0329078111216995,0.00358631512094507,0.0258786334846471,0.0399369887587518,5.1185822273363e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSF,Cathepsin F,42679,0.0373365459657483,0.00407260105025013,0.029354247907258,0.0453188440242386,5.52034087740479e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WASHC3,WASH complex subunit 3,40483,0.070704864253951,0.00771496635348961,0.0555835302011113,0.0858261983067906,5.82898288361886e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARSB,Arylsulfatase B,42587,0.0517094177024179,0.00564411262781853,0.0406469569518936,0.0627718784529422,5.84394240012523e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VEGFB,Vascular endothelial growth factor B,40199,0.0280892758878252,0.00306664363704044,0.0220786543592259,0.0340998974164244,6.12953878585715e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40116,0.0354194646522783,0.00386976241659548,0.0278347303157512,0.0430041989888054,6.52916819407835e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,40449,0.0598189497500554,0.00654166791766947,0.0469972806314232,0.0726406188686875,7.03083939350594e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRSF1,G-rich sequence factor 1,40014,0.0763881702070958,0.00835641026914708,0.0600096060795675,0.0927667343346241,7.27503065692372e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDHR5,Cadherin-related family member 5,42636,0.0362876839453553,0.00398486227869954,0.0284773538791042,0.0440980140116064,9.70402846492111e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42611,0.0910555864616973,0.0100001361527088,0.0714553196023881,0.110655853321006,9.79107083728634e-20
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",40481,0.037454075935805,0.00411365340606092,0.0293913152599256,0.0455168366116844,1.00907357481719e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,42370,0.0560129837683743,0.00615673506245095,0.0439457830459705,0.0680801844907782,1.05208854125336e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TADA3,Transcriptional adapter 3,40451,0.0371445783670911,0.00408467024925509,0.0291386246785511,0.0451505320556311,1.1179517929001e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM4,Intercellular adhesion molecule 4,42594,-0.0492700470189847,0.0054216977617633,-0.0598965746320407,-0.0386435194059286,1.15313566902397e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOS1,"Nitric oxide synthase, brain",42311,0.0507565149956991,0.00558791050435069,0.0398042104071717,0.0617088195842264,1.20263205219653e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OLFM4,Olfactomedin-4,39870,0.116374942178442,0.0128194158089185,0.0912488871929614,0.141500997163922,1.30015620821995e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,40449,0.049344996123478,0.00544363109086791,0.0386754791853769,0.0600145130615791,1.45556900663061e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTK7,Inactive tyrosine-protein kinase 7,42311,0.0356444141368256,0.00393481348872301,0.0279321796989285,0.0433566485747227,1.50437223355386e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPHOSPH8,M-phase phosphoprotein 8,42357,0.0702435598532206,0.00775845355415981,0.0550369908870674,0.0854501288193738,1.57260955103284e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AAMDC,Mth938 domain-containing protein,40223,0.0496598728433188,0.00548627961342883,0.0389067648009983,0.0604129808856393,1.64452781880013e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAP3,Cytosol aminopeptidase,42370,0.0449648227706445,0.00497240044488151,0.0352189178986767,0.0547107276426122,1.73682614183901e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHAD,Chondroadherin,40283,-0.0486898735062065,0.00539429979947339,-0.0592627011131744,-0.0381170458992387,2.07083276038897e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42307,0.072456225005222,0.00803262215854298,0.0567122855744777,0.0882001644359662,2.13459154887766e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40482,0.0623048395269377,0.00690717591179434,0.0487667747398208,0.0758429043140546,2.17809277236154e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CMIP,C-Maf-inducing protein,40451,0.0770903974055916,0.00854642620951382,0.0603394020349445,0.0938413927762387,2.18125387618549e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,A1BG,Alpha-1B-glycoprotein,40539,0.0158440205289596,0.00175683963499535,0.0124006148443687,0.0192874262135505,2.2128091596857e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GMPR2,GMP reductase 2,40283,0.0628070058255686,0.00696503367381141,0.0491555398248982,0.0764584718262389,2.24069002447064e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LIFR,Leukemia inhibitory factor receptor,42594,0.0223691181976675,0.00248213981263044,0.0175041241649119,0.0272341122304232,2.29341175426401e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,40183,0.0779670305972292,0.00864941602037531,0.0610141751972936,0.0949198859971648,2.31259017873555e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EREG,Proepiregulin,42476,0.0741344426173246,0.00824052299525999,0.0579830175466151,0.0902858676880342,2.64686228754378e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42737,0.0321483973161848,0.00357508029629973,0.0251412399354373,0.0391555546969323,2.73707466582859e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42602,0.0322514218021768,0.00358875222157531,0.0252174674478892,0.0392853761564644,2.88152467678501e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1RL2,Interleukin-1 receptor-like 2,42370,0.0355999719310112,0.00396243207775778,0.0278336050586059,0.0433663388034164,2.95199968601687e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42611,0.0277003914191705,0.00308559883922586,0.0216526176942878,0.0337481651440531,3.13933153325335e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GET3,ATPase GET3,40511,0.0501159360628854,0.00558442482286986,0.0391704634100605,0.0610614087157103,3.30226612309523e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40449,0.134935446626829,0.015038061947892,0.105460845208961,0.164410048044697,3.34407226895027e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AP2B1,AP-2 complex subunit beta,40182,0.0447323946125504,0.00499031301006145,0.0349513811128299,0.0545134081122708,3.64219161178411e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YJU2,Splicing factor YJU2,40451,0.0300392785947004,0.00335228790893099,0.0234687942931956,0.0366097628962051,3.72919462710591e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNIP1,TNFAIP3-interacting protein 1,40483,0.0819149801432767,0.00914328146608133,0.0639941484697573,0.0998358118167961,3.78836001187094e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40482,0.0771040855778097,0.0086250841401634,0.0601989206630895,0.09400925049253,4.51544563807858e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHB6,Ephrin type-B receptor 6,42476,0.0308490438531458,0.0034519445564013,0.0240832325225993,0.0376148551836924,4.53184461147728e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VAMP8,Vesicle-associated membrane protein 8,40199,0.081226904863277,0.0090923636133866,0.0634058721810393,0.0990479375455147,4.7824876992254e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42476,0.101532062401767,0.0113695620245551,0.0792477208336394,0.123816403969895,4.80667149624718e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42495,0.0713209523857364,0.00799461556834461,0.0556515058717809,0.0869903988996918,5.21236262270389e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KAZN,Kazrin,40449,0.0959591662191527,0.0107583363155596,0.074872827040656,0.117045505397649,5.40555511156901e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APLP1,Amyloid-like protein 1,42636,-0.0473638746702863,0.00531605541828323,-0.0577833432901215,-0.0369444060504512,5.77326741994352e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ING1,Inhibitor of growth protein 1,42292,0.0431220931487774,0.00484012133741442,0.0336354553274452,0.0526087309701097,5.80644632567355e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,40223,0.0941262056233165,0.010562998615506,0.0734227283369247,0.114829682909708,5.85467593101327e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42794,-0.026560063383788,0.0029831927228756,-0.0324071211206242,-0.0207130056469518,6.10327847838786e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42620,0.0517675104135404,0.00581925246467143,0.0403617755827844,0.0631732452442964,6.5273563855123e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LARP1,La-related protein 1,40451,0.0563054768926203,0.00632771573249771,0.0439031540569248,0.0687077997283159,6.54057802614563e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAMBP,STAM-binding protein,42476,0.0575034856493875,0.00646748312576645,0.0448272187228852,0.0701797525758897,6.81867109401606e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RABEP1,Rab GTPase-binding effector protein 1,40283,0.071776776587301,0.00808073626047204,0.0559385335167758,0.0876150196578262,7.54699335366253e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH9,Protocadherin-9,40449,0.0316892999550604,0.00356849360190164,0.0246950524953332,0.0386835474147876,7.67733983820258e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGB1A1,Uteroglobin,42646,0.0509455029514597,0.00574767497268266,0.0396800600050017,0.0622109458979178,8.70452585816792e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,42357,0.0844449591228334,0.00952751575058962,0.0657710282516777,0.103118889993989,8.75805051681578e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNGR2,Interferon gamma receptor 2,42495,0.047417380813016,0.00535050246746256,0.0369303959767893,0.0579043656492426,8.82890805804232e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH3GLB2,Endophilin-B2,40483,0.0609410546068525,0.00687856807221776,0.0474590611853057,0.0744230480283993,9.23372619330347e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCN2,CCN family member 2,42624,0.0501739858994153,0.00566740571261889,0.0390658707026822,0.0612821010961483,9.56862073492328e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42495,0.0276464074200861,0.0031228858408729,0.0215255511719753,0.033767263668197,9.59981189259351e-19
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TLR3,Toll-like receptor 3,42754,0.0555270001377708,0.00627648250894644,0.0432250944202358,0.0678289058553058,1.01046907344551e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,40451,0.0799605858353505,0.00904572216288125,0.0622309703961033,0.0976902012745978,1.10319806582508e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,40482,0.0611533104974722,0.00692160946825595,0.0475869559396905,0.0747196650552539,1.14750267996873e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASC3,Protein CASC3,40182,0.038207364116883,0.00433090005260826,0.0297188000137708,0.0466959282199952,1.29372783099222e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPP4,Dipeptidyl peptidase 4,42441,-0.0255896565944546,0.00290535039340841,-0.0312841433655351,-0.0198951698233741,1.43367614360091e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRTAC1,Cartilage acidic protein 1,42794,-0.0271078599257798,0.00307826151251234,-0.0331412524903039,-0.0210744673612556,1.449106350627e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42346,0.0588293301147983,0.00668854291546376,0.0457197860004893,0.0719388742291073,1.59912392536384e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP10,Caspase-10,42311,0.06450696218299,0.00734078818793942,0.0501190173346288,0.0788949070313513,1.71799415115994e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPL,Periplakin,40199,0.0303541718771131,0.00345382347630618,0.023584677863553,0.0371236658906733,1.7395387181451e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42594,0.0708560454952394,0.00806783604480984,0.0550430868474121,0.0866690041430666,1.79029422575393e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PKD2,Polycystin-2,40116,0.0528883438298134,0.00602415625482886,0.0410809975703489,0.064695690089278,1.88865326597236e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42495,0.0328781449941056,0.00374995300419939,0.0255282371058748,0.0402280528823364,2.04425009389363e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TREML2,Trem-like transcript 2 protein,42611,0.03129014581343,0.00357343548571693,0.0242862122614248,0.0382940793654352,2.25625378654254e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OGA,Protein O-GlcNAcase,40449,0.063341174589484,0.00723299545684563,0.0491645034940666,0.0775178456849014,2.28621141997212e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IMPACT,Protein IMPACT,40483,0.0506069499700007,0.00578089078686116,0.0392764040277528,0.0619374959122485,2.34803312769926e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNST,Consortin,42636,0.0973908660973276,0.0111394564588386,0.0755575314380039,0.119224200756651,2.53950972260679e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLNK,B-cell linker protein,40199,0.0369243175680434,0.00422614250997008,0.028641078248502,0.0452075568875847,2.73746057637432e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL32,Interleukin-32,42594,-0.0397096157520727,0.00454656581286326,-0.0486208847452847,-0.0307983467588607,2.74720440081363e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFDC1,WAP four-disulfide core domain protein 1,40229,0.051036947473607,0.00585000825242916,0.0395709312988458,0.0625029636483681,3.0638520237242e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGBP1,Immunoglobulin-binding protein 1,40482,0.0548439554300886,0.00629312666073815,0.0425094271750418,0.0671784836851354,3.31594247042255e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA9,Carbonic anhydrase 9,42721,0.0433308288559481,0.00498703205422798,0.0335562460296613,0.053105411682235,4.08299362651113e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,40283,0.0484224064082041,0.00557279393299622,0.0374997302995315,0.0593450825168767,4.16685147797899e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40189,0.0315962761125632,0.00363877842974877,0.0244642703902556,0.0387282818348708,4.39076489700998e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42587,0.0353634174372002,0.00407859574945753,0.0273693697682635,0.043357465106137,4.79286696231679e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40483,0.034123768528999,0.00393505151954168,0.0264110675506973,0.0418364695073007,4.83640884084714e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX15,Sorting nexin-15,40283,0.0486444293619036,0.00561625817253094,0.037636563343743,0.0596522953800643,5.30710112256378e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRAP,BRCA1-associated protein,40342,0.0973908103248676,0.0112598452302082,0.0753215136736595,0.119460106976076,5.88610372670095e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEC31A,Protein transport protein Sec31A,40223,0.06843643302931,0.00791282473098602,0.0529272965565774,0.0839455695020426,5.92467862127771e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM13A,Protein FAM13A,40449,0.0600831304770846,0.00695228495513234,0.0464566519650252,0.073709608989144,6.25784062593461e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXNA4,Plexin-A4,42594,0.0724674779726595,0.00839251723786437,0.0560181441864454,0.0889168117588737,6.54298199840149e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YWHAQ,14-3-3 protein theta,40283,0.0656243531437478,0.00760224188135046,0.0507239590563009,0.0805247472311947,6.83758387086443e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40302,0.0341443833615415,0.003959420057133,0.0263839200495608,0.0419048466735222,7.36961127236408e-18
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,42346,0.0500650117513642,0.00583098712026518,0.0386362769956445,0.061493746507084,1.00065540913701e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42689,-0.0391680325819377,0.00456944999492346,-0.0481241545719877,-0.0302119105918877,1.12940426796007e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42521,0.0511058602948817,0.00596623730460928,0.0394120351778475,0.0627996854119159,1.18968199058109e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,42357,0.0336265520772381,0.00392706745313763,0.0259294998690884,0.0413236042853879,1.2232998724827e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SBSN,Suprabasin,40511,-0.031008419477402,0.0036213799568633,-0.0381063241928541,-0.02391051476195,1.24602376779242e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTA,Lymphotoxin-alpha,42594,0.0358813587110099,0.00419491964790251,0.027659316201121,0.0441034012208988,1.32230767247873e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRR3,Small proline-rich protein 3,40483,0.0620428278029494,0.0072548819921176,0.047823259098399,0.0762623965074999,1.36704885518361e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A12,Protein S100-A12,42434,0.066246454905072,0.00774939487268738,0.0510576409546047,0.0814352688555392,1.38139257771195e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLMP,CXADR-like membrane protein,42721,0.0193140710014122,0.00225965321246913,0.0148851507049727,0.0237429912978517,1.39314385237792e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40482,0.0701433773645734,0.00820502578768887,0.0540615268207032,0.0862252279084435,1.40333525364457e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSC22D1,TSC22 domain family protein 1,40482,0.0574904736028452,0.0067289820357719,0.0443016688127323,0.0706792783929582,1.46654762620403e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C7,Complement component C7,40251,0.0291367195556727,0.0034129761062974,0.0224472863873298,0.0358261527240156,1.55699342437706e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFB,Platelet-derived growth factor subunit B,42676,0.0748944220132309,0.00877868156319141,0.0576882061493758,0.0921006378770861,1.59886207066029e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42706,0.0258415355437896,0.00303458032140065,0.0198937581138443,0.0317893129737349,1.82951397528413e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,42346,0.0548607461067637,0.00644255934189301,0.0422333297966534,0.067488162416874,1.83955991656106e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBPL,FK506-binding protein-like,40449,0.0515134116770626,0.00605041305988651,0.039654602079685,0.0633722212744401,1.89293203096473e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACYP1,Acylphosphatase-1,40250,0.0577365343802773,0.00678428472010205,0.0444393363288773,0.0710337324316773,1.95806223274959e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEFL,Neurofilament light polypeptide,42262,0.0404929240765241,0.00476691596757437,0.0311497687800783,0.0498360793729698,2.19987084326681e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP9,Matrix metalloproteinase-9,42594,0.0524513248988178,0.0061796135584061,0.0403392823243418,0.0645633674732937,2.32534969498414e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42711,0.0203236310788489,0.00239616528797553,0.0156271471144169,0.025020115043281,2.44715144194886e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFHR4,Complement factor H-related protein 4,40509,-0.0655123920521307,0.00772316183656618,-0.0806497892518004,-0.050374994852461,2.47592379601087e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK10,Kallikrein-10,42636,0.0354210382941625,0.00417704925317794,0.0272340217579337,0.0436080548303912,2.4867338601926e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42794,0.0239556400086759,0.00282527611667573,0.0184180988199915,0.0294931811973604,2.50254923334382e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40449,0.0312350865244395,0.00368285260057077,0.0240166954273208,0.0384534776215582,2.50654179723555e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRKL,Crk-like protein,42636,0.0907970972309321,0.0107407811054435,0.0697451662642628,0.111849028197601,3.11603635687876e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42613,0.0283300305093711,0.00335216903673793,0.0217597791973648,0.0349002818213775,3.17655246758701e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40527,-0.023729260519251,0.00280895859271825,-0.0292348193609787,-0.0182237016775232,3.33282439721335e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,42190,0.105080053517165,0.0124420333014019,0.0806936682464173,0.129466438787913,3.34466362613239e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRK1,NKG2-D type II integral membrane protein,40483,0.04266546400249,0.00505608027094363,0.0327555466714405,0.0525753813335395,3.607540531998e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40511,0.0786066431422482,0.00931563989644491,0.0603479889452162,0.0968652973392803,3.61603485366356e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MBL2,Mannose-binding protein C,40379,-0.0951637499294678,0.0112801553867989,-0.117272854487594,-0.073054645371342,3.67517330110724e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALB1,Calbindin,42587,0.0396385344817325,0.00470215418933104,0.0304223122706437,0.0488547566928214,3.81140498827576e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A11,Protein S100-A11,42531,0.0394721691869551,0.00469281394711479,0.0302742538506101,0.0486700845233001,4.4680546981288e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40030,0.029145812596634,0.00346405481385033,0.0223562651614873,0.0359353600317806,4.46866935845138e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,42311,0.0575514757592809,0.00685158274015309,0.0441223735885808,0.0709805779299809,4.93171735133312e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBXN1,UBX domain-containing protein 1,40283,0.0594495957935535,0.00707716260540685,0.0455783570869561,0.0733208345001509,4.9999773652546e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AZI2,5-azacytidine-induced protein 2,40482,0.0476518108327282,0.0056816204385323,0.0365158347732049,0.0587877868922515,5.57879441326983e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB27B,Ras-related protein Rab-27B,40511,0.0712394582165296,0.00850081875219684,0.0545778534622238,0.0879010629708354,5.90220545056251e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUB1,NEDD8 ultimate buster 1,42594,0.0712804661646727,0.00850792960657144,0.0546049241357927,0.0879560081935527,5.90913918133049e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADD1,Alpha-adducin,40283,0.0616316195517347,0.00736451456630664,0.0471971710017737,0.0760660681016958,6.52273632339423e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40527,0.0320119427982934,0.0038258650070413,0.0245132473844925,0.0395106382120944,6.58890050178208e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASGR2,Asialoglycoprotein receptor 2,40532,0.0233570288406189,0.00279660576690685,0.0178756815374814,0.0288383761437563,7.49635908644038e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42587,0.0186751245423438,0.00223862619748413,0.0142874171952749,0.0230628318894127,7.99841047231565e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JUN,Transcription factor AP-1,42370,0.041123393732288,0.00492985213820806,0.0314608835414002,0.0507859039231758,8.04544852637178e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,42346,0.0450378038652982,0.00539913714506302,0.0344554950609747,0.0556201126696217,8.04969847202622e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HS1BP3,HCLS1-binding protein 3,40223,0.0762225439783993,0.0091359719477536,0.0583160389608023,0.0941290489959964,8.09682886301427e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42676,0.0243491529838613,0.00292253531003558,0.0186209837761916,0.0300773221915311,8.7468439946386e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL15,Interleukin-15,42594,0.0284192048294243,0.00341276125026264,0.0217301927789095,0.0351082168799391,9.06477629330103e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC3B,Tetranectin,40269,-0.018136399470983,0.00217847346292358,-0.0224062074583132,-0.0138665914836528,9.40151906945162e-17
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAX,Protein max,42311,0.0893547649537084,0.0107534732349835,0.0682779574131407,0.110431572494276,1.0558984710086e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDC,Nuclear migration protein nudC,42754,0.0528205915876047,0.00635923005348106,0.0403565006827818,0.0652846824924276,1.08183127217755e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42611,0.0303493431045258,0.00365797631418836,0.0231797095287167,0.037518976680335,1.17129484745018e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDIA3,Protein disulfide-isomerase A3,40283,0.02129438599782,0.00256750162676502,0.0162620828093605,0.0263266891862794,1.22339896623945e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40511,0.0344428664067317,0.00415357567842496,0.0263018580770188,0.0425838747364446,1.23586202650313e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH2B3,SH2B adapter protein 3,42346,0.0829272622604795,0.0100076710232841,0.0633122270548428,0.102542297466116,1.27995440484866e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,40449,0.0771703178697739,0.00933003318788795,0.0588834528215135,0.0954571829180342,1.47561514373875e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,40302,0.0451635336222404,0.00546025684830801,0.0344614301995567,0.0558656370449241,1.47587354860063e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CMC1,COX assembly mitochondrial protein homolog,40511,0.0772171780921706,0.00933827271802008,0.0589141635648513,0.09552019261949,1.50305792626664e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNLY,Granulysin,42611,0.0454598631631666,0.00550707462190362,0.0346659969042355,0.0562537294220977,1.6626100193108e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42679,0.0512913247523427,0.00621778051342151,0.0391044749460366,0.0634781745586489,1.74228413303928e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PARK7,Parkinson disease protein 7,42611,0.0438093360183414,0.00531147241628917,0.0333988500824146,0.0542198219542681,1.75877967305506e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GMPR,GMP reductase 1,42754,0.0417884565304534,0.00506877985219675,0.0318536480201478,0.0517232650407591,1.81323252753212e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MIA,Melanoma-derived growth regulatory protein,42679,0.0319386509205589,0.00387848307467559,0.0243368240941948,0.0395404777469231,1.96246401026568e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42594,0.0805212134806537,0.00978187466084829,0.0613487391453911,0.0996936878159163,2.01571489517051e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42292,0.0396329343950578,0.00482829393975237,0.0301694782731431,0.0490963905169725,2.4484204625553e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42569,0.0645109912563277,0.00786026305428609,0.049104875669927,0.0799171068427284,2.46927569952351e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL18,C-C motif chemokine 18,42477,0.0588399229464512,0.00717453168852241,0.0447778408369472,0.0729020050559551,2.59681559037963e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",40267,0.0720370946921325,0.00878164419387249,0.0548250720721425,0.0892491173121226,2.60062029915789e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A14,Protein S100-A14,40482,0.0465798622688222,0.0056821479924141,0.0354428522036906,0.0577168723339539,2.71767504970282e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOD1,Superoxide dismutase [Cu-Zn],42365,0.0404487090899664,0.00493583665665077,0.0307744692429309,0.0501229489370019,2.73818896461302e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42638,-0.0288593111037719,0.00352372108026525,-0.0357658044210918,-0.021952817786452,2.84622472589908e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THBD,Thrombomodulin,42636,0.0254774839016261,0.00311337360906777,0.0193752716278533,0.0315796961753989,3.01004143127821e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,40532,0.0187743345042851,0.00229664088251478,0.0142729183745561,0.0232757506340141,3.28143579243997e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP6,Gastrotropin,42334,0.0495621839288377,0.00607118361995099,0.0376626640337338,0.0614617038239416,3.54902753953748e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD14,Monocyte differentiation antigen CD14,42416,0.0351116452349007,0.00430222015021129,0.0266792937404866,0.0435439967293148,3.61283188240174e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40302,0.031533591904858,0.00386339702996848,0.0239613337261198,0.0391058500835962,3.64649478978529e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,L1CAM,Neural cell adhesion molecule L1,42679,-0.0245996987587941,0.00301490743777286,-0.0305089173368289,-0.0186904801807593,3.66461552052822e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GH1,Somatotropin,42613,-0.144084577964376,0.0176653602052235,-0.178708683966614,-0.109460471962138,3.75848032148064e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42594,0.0356201382081441,0.00436985588502575,0.0270552206734936,0.0441850557427946,3.91700172245715e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,42346,0.0438339768279658,0.00537934966946161,0.0332904514758211,0.0543775021801106,4.0135335359942e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CETN3,Centrin-3,40449,0.063760496961965,0.00782614646552777,0.0484212498895306,0.0790997440343995,4.1207935858e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STC2,Stanniocalcin-2,42591,0.0208468081175372,0.0025594167465695,0.0158303512942609,0.0258632649408134,4.12171405164285e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,40116,0.0559609682756016,0.00687966315294302,0.0424768284958333,0.06944510805537,4.59339097463315e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,42346,0.0425582676767417,0.00523335383855769,0.0323008941531686,0.0528156412003147,4.59425572013023e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,40511,0.0239187754120238,0.0029407479354273,0.0181549094585863,0.0296826413654613,4.60303423478777e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42635,0.0315020928797782,0.00387460612625486,0.0239078648723187,0.0390963208872378,4.65117307461641e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOXJ3,Forkhead box protein J3,40199,0.0367757336546502,0.00452250631713958,0.0279116212730566,0.0456398460362438,4.68666132772677e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NIT1,Deaminated glutathione amidase,40223,0.0398790206402163,0.00490429949764028,0.0302665936248414,0.0494914476555913,4.69618913839648e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DRAXIN,Draxin,42495,0.0366549445928457,0.00451146169629847,0.0278124796681007,0.0454974095175907,4.87217012301746e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42611,0.063594531099133,0.00782914281250907,0.0482494111866153,0.0789396510116508,4.95131693299056e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MINK1,Misshapen-like kinase 1,40483,0.077655078983554,0.00956007920069227,0.0589173237501972,0.0963928342169109,5.02718692526377e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42594,0.0510278121110608,0.00628651420661384,0.0387062442660977,0.063349379956024,5.19165703371866e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,40449,0.0643547181861167,0.00793463881409434,0.0488028261104918,0.0799066102617416,5.55901345057792e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42587,0.0730590759657507,0.00901482030301528,0.0553900281718407,0.0907281237596606,5.7609283776069e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WIF1,Wnt inhibitory factor 1,42721,-0.0287508046763668,0.00354857062944047,-0.0357060031100701,-0.0217956062426634,5.8631599513993e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42594,0.0860107524190339,0.0106338205991135,0.0651684640447714,0.106853040793296,6.56125038037083e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALPI,Intestinal-type alkaline phosphatase,40199,0.105277030397559,0.0130153369546318,0.0797669699664808,0.130787090828637,6.66394308252286e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP53,Cellular tumor antigen p53,42346,0.0358185571242458,0.00443199733023143,0.0271318423569922,0.0445052718914994,6.93551244240909e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLGN,Calmegin,40182,0.0389104228591996,0.00481713862158505,0.0294688311608929,0.0483520145575063,7.30197029938832e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOXO3,Forkhead box protein O3,42346,0.0787454335107807,0.00977171979698739,0.0595928627086854,0.097898004312876,8.38634197682942e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATXN3,Ataxin-3,40483,0.0517828645685961,0.00642523897871181,0.039189396170321,0.0643763329668713,8.44640964760609e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLAMF7,SLAM family member 7,42594,0.0492597220405045,0.00611907458149227,0.0372663358607796,0.0612531082202293,8.95940848757463e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DYNLT1,Dynein light chain Tctex-type 1,40182,0.0669293133952541,0.00832526780631954,0.0506117884948678,0.0832468382956404,9.96153034167609e-16
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP25,Rho GTPase-activating protein 25,42346,0.0490324140284775,0.00611520153560888,0.0370466190186841,0.0610182090382709,1.16405060049538e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42495,0.0765254905894042,0.00956646139240991,0.0577752262602808,0.0952757549185277,1.35370988484736e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TLR1,Toll-like receptor 1,40199,0.0222261095730012,0.00277962972479213,0.0167780353124086,0.0276741838335937,1.41310909735101e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RRAS,Ras-related protein R-Ras,40182,0.107013304372702,0.0133838815050868,0.0807808966227318,0.133245712122672,1.41769410989947e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MITD1,MIT domain-containing protein 1,42495,0.0783726913871671,0.00980863544881749,0.0591477659074848,0.0975976168668494,1.45789280068947e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40449,0.0847537146338244,0.0106101860474155,0.06395774998089,0.105549679286759,1.50549040589556e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD22,B-cell receptor CD22,42754,0.0358020633045259,0.00448342075090489,0.0270145586327523,0.0445895679762995,1.51245718091348e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42594,0.0821125056440987,0.0102859572584458,0.061952029417545,0.102272981870652,1.54422524339299e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAX,Apoptosis regulator BAX,42292,0.0728208458688682,0.00913840818000488,0.0549095658360587,0.0907321259016778,1.7361337420255e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA12,Carbonic anhydrase 12,42587,0.0271812172861304,0.00341361132834478,0.0204905390825746,0.0338718954896862,1.81973938698732e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AIF1,Allograft inflammatory factor 1,42346,0.0427261495417107,0.00536584522172658,0.0322090929071266,0.0532432061762948,1.82209484411495e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LY75,Lymphocyte antigen 75,42594,0.031880327687378,0.00400444248006559,0.0240316204264495,0.0397290349483066,1.83966813558619e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42711,0.0376719613445593,0.00473300393497948,0.0283952736319995,0.0469486490571191,1.86557560561986e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPD52L2,Tumor protein D54,40283,0.0882995541053164,0.0110912759051924,0.0665606533311392,0.110038454879494,1.87035967169878e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSV,Cathepsin L2,42677,-0.0342577461747389,0.00430690922223565,-0.0426992882503208,-0.025816204099157,1.94689060257138e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBCA,Tubulin-specific chaperone A,40283,0.0696727515808435,0.00877255505894102,0.0524785436653191,0.0868669594963679,2.17932881114942e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGER,Advanced glycosylation end product-specific receptor,42587,0.0343862925590889,0.0043312647530251,0.0258970136431597,0.0428755714750181,2.19811598027106e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP3R1,Calcineurin subunit B type 1,42495,0.0326299163122222,0.00411128227350186,0.0245718030561585,0.0406880295682858,2.242238932407e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA5,Annexin A5,42261,0.0251195402948682,0.00316492777312652,0.0189162818595403,0.0313227987301962,2.24227843955806e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX9,Sorting nexin-9,42636,0.05461448666251,0.00688896740073437,0.0411121105570706,0.0681168627679493,2.40531727982159e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT16,U8 snoRNA-decapping enzyme,40429,0.0709485728324245,0.00894876835025588,0.053408986865923,0.088488158798926,2.43165271939992e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PREB,Prolactin regulatory element-binding protein,42370,0.0240476531487613,0.00303441567594859,0.018100198423902,0.0299951078736205,2.46458815183564e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40449,0.0890284755091514,0.0112362911132922,0.0670053449270988,0.111051606091204,2.53070356936713e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CILP,Cartilage intermediate layer protein 1,40527,0.0451871840744495,0.00571087177590834,0.0339938753936692,0.0563804927552299,2.75754930431306e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,40223,0.0356724609126965,0.00451404125394689,0.0268249400549606,0.0445199817704324,2.9923715563139e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,40135,0.034905475200108,0.00441752644993712,0.0262471233582312,0.0435638270419847,3.01774867997849e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTSL4,ADAMTS-like protein 4,40223,0.0194001417408759,0.00246125095057408,0.0145760898777507,0.0242241936040011,3.51865640447537e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APRT,Adenine phosphoribosyltransferase,42480,0.0383067593555848,0.00486123197773625,0.0287787446792218,0.0478347740319478,3.52607178987867e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TEK,Angiopoietin-1 receptor,42679,0.0177908477901471,0.00225948185129994,0.0133622633615992,0.0222194322186949,3.70017267652359e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42676,0.0842395819828309,0.010701293484906,0.0632650467524152,0.105214117213247,3.75826945873659e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ST13,Hsc70-interacting protein,40283,0.0458653661289286,0.00584154805904947,0.0344159319331916,0.0573148003246656,4.48680882617086e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SYAP1,Synapse-associated protein 1,40283,0.0465340791229245,0.00593178784128568,0.0349077749540045,0.0581603832918444,4.73200676292772e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,40223,0.0474127076214472,0.00604638801379661,0.0355617871144059,0.0592636281284886,4.86247899019498e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINE2,Glia-derived nexin,40511,0.0520159289773341,0.00663634655142622,0.0390086897365388,0.0650231682181295,4.98625475550001e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,40527,0.0238439837935906,0.0030436162085836,0.0178784960247668,0.0298094715624145,5.14362554034079e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40449,0.0719339406544153,0.00918230175822235,0.0539366292082995,0.0899312521005311,5.15154234955915e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42679,-0.0193504862336279,0.00247163048398222,-0.0241948819822331,-0.0145060904850228,5.28160330113182e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MASP1,Mannan-binding lectin serine protease 1,42476,0.0188285529214678,0.00240505052974835,0.014114653883161,0.0235424519597745,5.29916064408438e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40283,0.0681187826755683,0.00873224976481545,0.05100357313653,0.0852339922146066,6.70184707714199e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RILP,Rab-interacting lysosomal protein,42674,0.0475934864461792,0.00610718329172387,0.0356234071944004,0.0595635656979579,7.01926270975927e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPO,Lactoperoxidase,42134,0.0486857685207608,0.00624984298218952,0.0364360762756694,0.0609354607658523,7.21478864893e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17A,Interleukin-17A,42347,0.0345894863532197,0.00444495408547584,0.0258773763456871,0.0433015963607524,7.68548093263998e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAG3,Lymphocyte activation gene 3 protein,42587,0.032941450081395,0.00423402486215629,0.0246427613515687,0.0412401388112214,7.7709450875698e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBCC,Tubulin-specific chaperone C,42495,0.0639181643961947,0.00821626034993429,0.0478142941103235,0.080022034682066,7.8178056640081e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHGB,Secretogranin-1,42664,0.0343961583566404,0.00442228859038364,0.0257284727194885,0.0430638439937924,7.90750035326185e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42722,0.0227716802099195,0.00292888193077657,0.0170310716255975,0.0285122887942416,8.09629624675894e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42636,0.0924608363719961,0.0118941320065362,0.0691483376391853,0.115773335104807,8.17796350619394e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1R1,Interleukin-1 receptor type 1,42590,0.0188377509572773,0.00242497367338264,0.0140848025574473,0.0235906993571073,8.53609583784927e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42582,0.0546410675275143,0.00703509870429024,0.0408522740671054,0.0684298609879232,8.62452382134426e-15
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,40199,0.0455594871497314,0.00588571347306361,0.0340234887425267,0.0570954855569361,1.07538351295013e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLRX,Glutaredoxin-1,42546,0.0446774065687419,0.00577391506331327,0.0333605330446479,0.055994280092836,1.08392165901191e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42721,0.0424964604509878,0.00549769670405982,0.0317209749110305,0.053271945990945,1.15232323217092e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CR2,Complement receptor type 2,42689,0.0381632726812207,0.00493979531952481,0.028481273854952,0.0478452715074893,1.19086489407854e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,40483,0.0420137217611212,0.00543793099958316,0.0313553770019382,0.0526720665203042,1.20325360379206e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MERTK,Tyrosine-protein kinase Mer,42754,0.020301709326586,0.00263080534131886,0.015145330857601,0.0254580877955709,1.27481158136348e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RWDD1,RWD domain-containing protein 1,42711,0.0497415124475799,0.00644642684158075,0.0371065158380816,0.0623765090570782,1.28288420797896e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BOLA2_BOLA2B,BolA-like protein 2,40223,0.0431747563881875,0.00560202405349652,0.0321947892433343,0.0541547235330407,1.39875070751351e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40482,0.0462993884835188,0.00600877759000442,0.0345221844071101,0.0580765925599274,1.41473200282002e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40449,0.0367831616127774,0.00477382180313774,0.0274264708786274,0.0461398523469273,1.41629195018125e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEPR,Leptin receptor,42636,-0.0247093358547255,0.00321159629282771,-0.0310040645886678,-0.0184146071207832,1.52766039108207e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DBNL,Drebrin-like protein,42676,0.0723258756595901,0.00941230523220675,0.0538777574044649,0.0907739939147154,1.64585714627458e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRAP2,GRB2-related adapter protein 2,42636,0.100258830677967,0.0130494413498522,0.0746819256322568,0.125835735723678,1.66142136129482e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,40451,0.0409819751571122,0.00534216109682855,0.0305113394073282,0.0514526109068962,1.84125744307675e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42654,-0.0685593225320889,0.00896262166351832,-0.0861260609925849,-0.050992584071593,2.15480896033762e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42594,0.0682863790334792,0.00892746792256592,0.05078854190525,0.0857842161617084,2.16299713463667e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHACTR2,Phosphatase and actin regulator 2,40482,0.089473549294637,0.011698254748648,0.066544969987287,0.112402128601987,2.19934084830445e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,40329,0.0442396700227552,0.0057914634883719,0.0328884015855463,0.0555909384599641,2.37276464485216e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42587,0.030890131284802,0.00404535555900286,0.0229612343891564,0.0388190281804476,2.39320333868928e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VEGFC,Vascular endothelial growth factor C,42679,0.0434752897629183,0.00570012943377993,0.0323030360727097,0.054647543453127,2.56197393246861e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APP,Amyloid-beta precursor protein,42592,0.0520075541845838,0.00681998233587672,0.0386403888062654,0.0653747195629022,2.58909473921885e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MB,Myoglobin,42794,0.0417313228980369,0.00547371192951302,0.0310028475161914,0.0524597982798824,2.62294660916279e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MIF,Macrophage migration inhibitory factor,42586,0.052773804782805,0.00693961127151894,0.0391721666906279,0.0663754428749822,3.04510690900587e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNGR1,Interferon gamma receptor 1,42676,0.0171694574124436,0.00225979398042732,0.0127402612108061,0.0215986536140811,3.21036180472202e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNN,Tenascin-N,40527,0.0345854884416633,0.00456294568817814,0.0256421148928341,0.0435288619904924,3.73528850492585e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIT1,ARF GTPase-activating protein GIT1,40199,0.0758307551329517,0.0100115833116852,0.0562080518420487,0.0954534584238547,3.89999023168933e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,40449,0.0385900878477445,0.00509634446454003,0.028601252697246,0.0485789229982429,3.95923833368091e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NID1,Nidogen-1,42652,0.0298663989010391,0.00394722245864117,0.0221298428821024,0.0376029549199758,4.08480184351851e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DXO,Decapping and exoribonuclease protein,40483,0.0356531586311752,0.00471720802421173,0.0264074309037202,0.0448988863586302,4.40625473782176e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,40511,0.0255721881561382,0.00338595228739327,0.0189357216728474,0.032208654639429,4.60060242046295e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB6,Serpin B6,42679,0.0448018086819404,0.00593445646746505,0.0331702740057089,0.0564333433581719,4.6516957584467e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42495,0.0456688746563884,0.00605212065822357,0.0338067181662702,0.0575310311465067,4.78221235288359e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGCC,Regulator of cell cycle RGCC,40482,0.058705598498584,0.00778259308488964,0.0434517160522003,0.0739594809449677,4.93806511054623e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPK1,Thiamin pyrophosphokinase 1,40511,0.0213609285370044,0.00283414126888277,0.0158060116499942,0.0269158454240146,5.17592973268376e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40199,0.0272175227947678,0.00361249292963498,0.0201370366526832,0.0342980089368523,5.29558420419835e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40482,0.0512162680180854,0.00680504157824382,0.0378783865247275,0.0645541495114433,5.62012528517123e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA3G,Semaphorin-3G,40283,0.0350045730050072,0.00465365760499793,0.0258834040992112,0.0441257419108031,5.81370682347277e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,42346,0.044988459915703,0.00598359178483265,0.033260620017431,0.056716299813975,5.89313082898553e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCRIB,Protein scribble homolog,40223,0.0706568082206442,0.00939635554500738,0.0522399513524298,0.0890736650888587,5.92106921502231e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRY2,Protein sprouty homolog 2,42370,0.0708870904704186,0.00943325476286747,0.0523979111351983,0.0893762698056388,6.07662550098269e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB44,Ras-related protein Rab-44,40451,0.0326892074068858,0.00435143320016268,0.0241603983345669,0.0412180164792046,6.25027451145475e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITPA,Inosine triphosphate pyrophosphatase,40116,0.0521227514064538,0.00694559514447731,0.0385093849232782,0.0657361178896293,6.64935074163697e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEO1,RNA polymerase-associated protein LEO1,40482,0.0252638493333958,0.00337267333572872,0.0186534095953675,0.0318742890714241,7.35912923240074e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42636,0.0524644592874038,0.0070068071117845,0.0387311173483062,0.0661978012265014,7.44853918314045e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TWF2,Twinfilin-2,40527,0.063996908610757,0.00855353660184422,0.0472319768711423,0.0807618403503717,7.86588172246027e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDIA4,Protein disulfide-isomerase A4,40527,0.0461505175778123,0.00617677365306109,0.0340440412178125,0.058256993937812,8.5037435511302e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40223,0.070704097678937,0.00946532048339251,0.0521520695314877,0.0892561258263863,8.63821404564945e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AZU1,Azurocidin,42216,0.0586950005931322,0.00786138255039301,0.0432866907943619,0.0741033103919025,8.77597460711622e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFRP1,Secreted frizzled-related protein 1,42457,0.0339151056482843,0.00454493845024179,0.0250070262858104,0.0428231850107582,9.04041785443927e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XG,Glycoprotein Xg,42734,0.0265135027627477,0.00355333264309479,0.0195489707822819,0.0334780347432135,9.06917123131817e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IST1,IST1 homolog,40375,0.076127556866908,0.0102062972672618,0.0561232142230749,0.096131899510741,9.37224251102785e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHSG,Alpha-2-HS-glycoprotein,40532,0.0209930823243992,0.00281543774858881,0.0154748243371651,0.0265113403116332,9.53871058860381e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF2,Fibroblast growth factor 2,42594,0.0523589213367775,0.00702575013537041,0.0385884510714515,0.0661293916021034,9.72474953230405e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40449,0.0316076221639048,0.00424074640513865,0.023295759209833,0.0399194851179765,9.7697713802932e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECI2,Enoyl-CoA delta isomerase 2,40116,0.0475078201354942,0.00637626166686873,0.0350103472684315,0.0600052930025569,9.98346358614091e-14
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAMDC2,MAM domain-containing protein 2,40511,0.028209390568493,0.00378702758724969,0.0207868164974836,0.0356319646395024,1.00927650683206e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGA4,Pepsin A-4,40532,0.0624006107734698,0.00838529090545149,0.0459654405987849,0.0788357809481547,1.06605716266479e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UROD,Uroporphyrinogen decarboxylase,40283,0.0530865924118517,0.0071374863231973,0.0390971192183849,0.0670760656053184,1.10004802622217e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPP,Lipoma-preferred partner,40116,0.0505648026529896,0.00679918727415269,0.0372383955956503,0.0638912097103289,1.10811477559236e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,40116,0.0301289405216489,0.00405181538423531,0.0221873823685477,0.0380704986747501,1.11630150155237e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42676,0.0837265952523288,0.0112640020720021,0.0616491511912047,0.105804039313453,1.12459742604159e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4G,C-type lectin domain family 4 member G,42594,0.0252746948028238,0.00340264026190979,0.0186055198894806,0.031943869716167,1.16945349971993e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,40116,0.0282364451749283,0.003806120418398,0.0207764491548683,0.0356964411949884,1.27059093482852e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXNB3,Plexin-B3,42597,0.0357129590059023,0.00481690951897302,0.0262718163487152,0.0451541016630894,1.298147142961e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42582,0.0206511785736766,0.00278745096604867,0.0151877746802212,0.026114582467132,1.35254254507979e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMA4,Laminin subunit alpha-4,42676,0.0252663282402797,0.00341301629647349,0.0185768162991916,0.0319558401813677,1.41101550422711e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYBB1,Beta-crystallin B1,40511,0.0487746397657941,0.00659505466719969,0.0358483326180827,0.0617009469135055,1.50673008679045e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACTA2,"Actin, aortic smooth muscle",42357,0.0336337291043706,0.0045486365226268,0.0247184015200221,0.0425490566887191,1.50808942084123e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,40451,0.0263317559705728,0.00356132400899644,0.0193515609129398,0.0333119510282058,1.52804867718757e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42611,0.0902393082629084,0.0122164354890419,0.0662950947043862,0.114183521821431,1.59384027347782e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FDX1,"Adrenodoxin, mitochondrial",40116,0.0474211166182566,0.00642561199726555,0.0348269171036161,0.0600153161328971,1.69771043894356e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL1,Fc receptor-like protein 1,42636,0.0357161414709998,0.00484769223592187,0.0262146646885929,0.0452176182534067,1.83772705121238e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAG6,Large proline-rich protein BAG6,42357,0.0270259545843737,0.00367187250146049,0.0198290844815111,0.0342228246872362,1.94432725462439e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40980,-0.0240285197324998,0.00326754713391115,-0.0304329121149656,-0.0176241273500339,2.05578667057828e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40116,0.021677710947152,0.00294788891293197,0.0158998486778053,0.0274555732164987,2.06694745741893e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CIAPIN1,Anamorsin,42679,0.0467757659493771,0.0063637050714839,0.0343029040092686,0.0592486278894855,2.08990398240952e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACYBP,Calcyclin-binding protein,40267,0.077580233422073,0.0105551236882847,0.0568921909930349,0.0982682758511111,2.12161917845467e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICA1,Islet cell autoantigen 1,42370,0.0592484022256598,0.00806561395497621,0.0434397988739065,0.0750570055774132,2.16552846515029e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN1,Contactin-1,42794,-0.0210399276362978,0.00287037472774991,-0.0266658621026876,-0.0154139931699079,2.43086143609579e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDHD2,Phospholipase DDHD2,40482,0.0495955762452574,0.00676969224400726,0.0363269794470032,0.0628641730435117,2.53063330528841e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40302,0.0372697836769856,0.00508872209623078,0.0272958883683732,0.0472436789855979,2.5735610855856e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DMD,Dystrophin,40223,0.0390707673947017,0.00533656448647818,0.0286111010012044,0.0495304337881989,2.62616988859095e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRAF2,TNF receptor-associated factor 2,42594,0.0520837624257413,0.00711898326488785,0.0381305552265611,0.0660369696249215,2.69632421990849e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42676,0.0156265285369359,0.00213834489761618,0.0114353725376082,0.0198176845362636,2.86888896880433e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL1,Angiopoietin-related protein 1,42439,0.0218492260339231,0.00299776116298881,0.015973614154465,0.0277248379133812,3.31146073284346e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL22,Interleukin-22,40451,0.0529748942062848,0.00726735539231278,0.0387308776373517,0.0672189107752178,3.32115872157836e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFB,Complement factor B,40344,0.0244171383731153,0.00335378029804696,0.0178437289889433,0.0309905477572874,3.55020121970084e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSC,Dipeptidyl peptidase 1,42616,0.0329728644033444,0.00454153511393592,0.02407145558003,0.0418742732266588,4.07512667089763e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSPN,Persephin,42594,0.0693010672747592,0.00957437153147958,0.0505352990730592,0.0880668354764592,4.79487138563624e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASEH2A,Ribonuclease H2 subunit A,40482,0.0358992048860491,0.00495902289587471,0.0261795200101347,0.0456188897619635,4.80766063326647e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCAM1,Neural cell adhesion molecule 1,42689,-0.0225518406168891,0.00311734398229268,-0.0286618348221828,-0.0164418464115955,4.9312818371482e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LACTB2,Endoribonuclease LACTB2,42636,0.0483358070480584,0.00669207268875795,0.0352193445780928,0.0614522695180239,5.3650169896939e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GDF2,Growth/differentiation factor 2,42636,-0.0266962280565098,0.00369723064327432,-0.0339428001173275,-0.0194496559956921,5.45396647468644e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGH,Gamma-glutamyl hydrolase,42437,0.0254320226299685,0.00352376618340968,0.0185254409104855,0.0323386043494515,5.59246050108877e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSR,"Glutathione reductase, mitochondrial",40490,0.0168498365767607,0.00233502160240812,0.0122731942360408,0.0214264789174806,5.69122241609078e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL5,Fc receptor-like protein 5,42611,0.0437754841616776,0.00607006652194793,0.0318781537786596,0.0556728145446955,5.82190487380816e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD36,Platelet glycoprotein 4,40199,0.0334477907061683,0.00463767128708197,0.0243579549834877,0.042537626428849,5.86728566175573e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OPHN1,Oligophrenin-1,40483,0.0795220714668999,0.0110282293443781,0.0579067419519189,0.101137400981881,5.91911392759647e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40302,0.0491232605657253,0.00681339077326479,0.0357690146501263,0.0624775064813243,5.96693401073518e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL5,C-X-C motif chemokine 5,42605,0.0838976614032767,0.0116426187957619,0.0610781285635834,0.10671719424297,6.06617356581898e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCTN3,Tectonic-3,40511,0.0223198807870278,0.003102605492607,0.0162387740215181,0.0284009875525375,6.69359874399511e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPART,Spartin,40283,0.057045396496562,0.0079326433932264,0.0414974154458382,0.0725933775472857,6.8349592808806e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCN2,Ficolin-2,42597,0.0303210843328017,0.00422558195490405,0.0220389437011898,0.0386032249644137,7.57747845812242e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",40449,0.065141856937861,0.00908736857152302,0.0473306145376759,0.0829530993380461,8.06328072012234e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,40457,0.0281401335710775,0.00392827167920712,0.0204407210798315,0.0358395460623235,8.3556167425386e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD101,Immunoglobulin superfamily member 2,40449,0.0323536308231945,0.00452147467462821,0.0234915404609232,0.0412157211854658,8.85196448912816e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,40511,0.0445765214522323,0.00623041144434246,0.0323649150213211,0.0567881278831435,8.90580750035862e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STK24,Serine/threonine-protein kinase 24,42311,0.0451317159135162,0.00631550317440623,0.03275332969168,0.0575101021353524,9.39425476177502e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42794,-0.0182857434138487,0.00255983721256041,-0.0233030243504671,-0.0132684624772303,9.57339820853358e-13
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH7,Protocadherin-7,40449,0.0268487804044522,0.00376273182038484,0.0194738260364979,0.0342237347724065,1.02401022285288e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40482,0.0289119607769321,0.00405193424701021,0.0209701696527921,0.0368537519010721,1.02458001653415e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFD,Complement factor D,40539,0.0155028835839303,0.0021736404670203,0.0112425482685705,0.0197632188992901,1.04771854794743e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPAG1,Sperm-associated antigen 1,40482,0.0423144855898358,0.00593474805500978,0.0306823794020167,0.053946591777655,1.06534966143893e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCT5,T-complex protein 1 subunit epsilon,42346,0.0337343842171577,0.0047321758388214,0.0244593195730677,0.0430094488612476,1.06589491821592e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42587,0.0402718958524804,0.00565176941878536,0.0291944277916611,0.0513493639132997,1.08977129660408e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATRN,"Attractin, Isoform 2",40539,0.0123472818115867,0.0017334133662969,0.00894979161364476,0.0157447720095286,1.11911856903147e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40511,0.0715750363878812,0.0100495043952473,0.0518780077731965,0.0912720650025659,1.12623759394289e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATG4A,Cysteine protease ATG4A,42346,0.0431281028206678,0.00606241820955027,0.0312457631299493,0.0550104425113863,1.18553523791559e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIF1C,Kinesin-like protein KIF1C,40116,0.0264929216501537,0.00372576106865077,0.0191904299555982,0.0337954133447092,1.2263598959278e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HPCAL1,Hippocalcin-like protein 1,42754,0.0528488632220241,0.00744136014135029,0.0382637973449775,0.0674339290990706,1.29051012243863e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TYMP,Thymidine phosphorylase,42563,0.047439774726707,0.0066958638013328,0.0343158816760947,0.0605636677773193,1.46072602690189e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHMP1A,Charged multivesicular body protein 1a,42495,0.0573015019746244,0.00809134737557596,0.0414424611184955,0.0731605428307533,1.49416935318867e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,40482,0.030164811351647,0.00426283846684304,0.0218096479566347,0.0385199747466594,1.5690923813797e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB1,Integrin beta-1,42638,-0.0155903191490921,0.00220457742202293,-0.019911290896257,-0.0112693474019271,1.60500262419024e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,42357,0.0797300704480465,0.0112894952814478,0.0576026596964088,0.101857481199684,1.71964563258373e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX7,Syntaxin-7,40199,0.0366149170104002,0.00518527056130218,0.0264517867102479,0.0467780473105525,1.74858185203651e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TST,Thiosulfate sulfurtransferase,42277,0.0540834899960509,0.00766485189142638,0.0390603802888552,0.0691065997032466,1.79943333590373e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTN6,Dynactin subunit 6,42311,0.0519090733266146,0.00737875811286499,0.0374467074253992,0.06637143922783,2.09248561220843e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBCB,Tubulin-folding cofactor B,42495,0.071703164206078,0.0102039607386101,0.0517034011584022,0.0917029272537539,2.21308769642926e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42636,0.0482934405127874,0.00687338640971512,0.0348216031497458,0.061765277875829,2.22534938918014e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD69,Early activation antigen CD69,42585,0.0631555493140325,0.00900046471278594,0.045514638476972,0.0807964601510929,2.37717908002442e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALPP,"Alkaline phosphatase, placental type",42587,0.0728788750451181,0.0103947430697451,0.0525051786284177,0.0932525714618184,2.47733243807957e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYO9B,Unconventional myosin-IXb,42370,0.0475064904454345,0.00677708774017957,0.0342233984746825,0.0607895824161864,2.50158569028086e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,40511,0.0771792176224735,0.0110204649133509,0.0555791063923057,0.0987793288526412,2.64241265396349e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,40199,0.0653048991498376,0.00932890846117782,0.0470202385659291,0.0835895597337461,2.70339912723002e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERP29,Endoplasmic reticulum resident protein 29,40283,0.0856040336465737,0.0122558861786437,0.0615824967364321,0.109625570556715,3.01749700335742e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PON2,Serum paraoxonase/arylesterase 2,42357,0.0251735763434597,0.0036142480165328,0.0180896502310554,0.032257502455864,3.43775831578078e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,40116,0.0496949393809962,0.007136322803094,0.035707746686932,0.0636821320750605,3.50587281553848e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFA,Platelet-derived growth factor subunit A,42794,0.0512964352367204,0.00737205481838858,0.0368472077926788,0.0657456626807621,3.60350795669987e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,40482,0.0669229437987413,0.00962118008462911,0.0480654308328683,0.0857804567646144,3.69966890226796e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,42357,0.0388219117801072,0.00558520382462081,0.0278749122838505,0.049768911276364,3.80200917597879e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPEP1,Dipeptidase 1,42476,-0.0357105794578915,0.00513888313189853,-0.0457827903964126,-0.0256383685193704,3.84787440601722e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSNAX,Translin-associated protein X,40116,0.0283952305509538,0.00408648392734149,0.0203857220533645,0.0364047390485431,3.90015853952926e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42636,0.059267939992473,0.00853215432861586,0.0425449175083859,0.0759909624765601,3.91903961515925e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE10,Inactive ribonuclease-like protein 10,40223,0.0355586642919006,0.00513272061993633,0.0254985318768254,0.0456187967069758,4.51123132127826e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP1,Caspase-1,42311,0.0493373516985531,0.00712583711997742,0.0353707109433974,0.0633039924537088,4.60391500079224e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTPP1,dCTP pyrophosphatase 1,42636,0.0226091119441531,0.00326856878021735,0.0162027171349271,0.0290155067533791,4.81734496329821e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGCT,Gamma-glutamylcyclotransferase,40500,0.0340593464831905,0.00492707913046761,0.024402271387474,0.0437164215789071,5.01168724202528e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTF1,Cardiotrophin-1,42357,0.0597500633604117,0.00866378051247191,0.0427690535559668,0.0767310731648567,5.57193946871652e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42657,0.072735319756175,0.0105522007496644,0.0520530062868328,0.0934176332255172,5.70984281153236e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PKD1,Polycystin-1,40511,0.0191723119728408,0.00278345325091279,0.0137167436010518,0.0246278803446299,5.9599155671442e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACHE,Acetylcholinesterase,40283,0.0238120863559599,0.00345905505484607,0.0170323384484616,0.0305918342634582,6.13438645348551e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDHB,Succinate dehydrogenase,40449,0.0473822387535146,0.00688462676885687,0.0338883702865552,0.0608761072204741,6.20125827713088e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RHOC,Rho-related GTP-binding protein RhoC,42443,0.0812305097533328,0.0118085679295016,0.0580857166115096,0.104375302895156,6.30038147964683e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOBR,Apolipoprotein B receptor,40223,-0.0304142387532764,0.00442112746972179,-0.0390796485939311,-0.0217488289126217,6.34072720332061e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL2,C-C motif chemokine 2,42475,0.0375998861303248,0.00546739467670105,0.0268837925639908,0.0483159796966589,6.38105832323831e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1RL,Complement C1r subcomponent-like protein,40519,0.0141012857339852,0.00205260519424266,0.0100781795532696,0.0181243919147008,6.75934580735954e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42711,0.0405946477954296,0.00591376892416935,0.0290036607040577,0.0521856348868016,6.96695667216176e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42658,0.0362011067763194,0.00527873844416877,0.0258547794257487,0.0465474341268902,7.29243834960103e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK4,Kallikrein-4,42721,0.044870734305959,0.00654862520081379,0.032035428912364,0.0577060396995541,7.60118087489368e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC5A,C-type lectin domain family 5 member A,42603,0.0213145443161319,0.00311213932515449,0.0152147512388291,0.0274143373934347,7.76957178863224e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42587,0.0321931556940154,0.00470106922710635,0.022979060008887,0.0414072513791439,7.81285093154418e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB1,Leukocyte elastase inhibitor,42569,0.0621363432926896,0.00909437757028288,0.0443113632549351,0.079961323330444,8.71247051524849e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MILR1,Allergin-1,42370,0.0362294063989068,0.00530542227328227,0.0258307787432735,0.04662803405454,8.94130087761063e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VNN2,Vascular non-inflammatory molecule 2,42587,0.0320542725549587,0.00469659876542871,0.0228489389747185,0.041259606135199,9.17104684168356e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40511,0.0371107620934072,0.00544082849754105,0.0264467382382267,0.0477747859485876,9.51545962553442e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NACC1,Nucleus accumbens-associated protein 1,40451,0.0389527836789064,0.00571280080110112,0.0277556941087482,0.0501498732490646,9.66983188834907e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42495,0.0203620558430285,0.00298765565098239,0.014506250767103,0.0262178609189539,9.80550486523375e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFT20,Intraflagellar transport protein 20 homolog,40182,0.0303062392791762,0.00444653230629053,0.0215910359588468,0.0390214425995056,9.87176076512037e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,40483,-0.0260773764760314,0.00382684754499193,-0.0335779976642156,-0.0185767552878472,9.95297773288769e-12
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINI2,Serpin I2,40449,0.0395851013625891,0.00581108388723386,0.0281953769436107,0.0509748257815675,1.01159590371686e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GYS1,"Glycogen [starch] synthase, muscle",42357,0.0647998657621435,0.00952182792374404,0.0461370830316052,0.0834626484926818,1.05130128280072e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BMP6,Bone morphogenetic protein 6,42342,0.0285120812166121,0.00419003875976329,0.020299605247476,0.0367245571857481,1.05625510426713e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42594,0.0569367922578451,0.00837266169359733,0.0405263753383944,0.0733472091772959,1.08810459337537e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLYR1,Putative oxidoreductase GLYR1,40451,0.0414700763507836,0.0061065159274566,0.0295013051329687,0.0534388475685985,1.16870602541409e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PALM,Paralemmin-1,40384,0.0221688708695842,0.003272804310086,0.0157541744218156,0.0285835673173528,1.318594738174e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPPB,Natriuretic peptides B,42357,0.0990897232120932,0.0146461121334624,0.0703833434305069,0.127796102993679,1.38373129750075e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPI,Mannose-6-phosphate isomerase,42587,0.0586864354390878,0.00867800686428494,0.0416775419850893,0.0756953288930863,1.41097701923344e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40449,0.0555460612339511,0.00821439020262599,0.0394458564368041,0.071646266031098,1.42795574018365e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,40199,0.0211603256821975,0.00312927922965013,0.0150269383920833,0.0272937129723118,1.42950603451816e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40511,0.0509082428557519,0.00752913388771623,0.0361511404358281,0.0656653452756757,1.43291524700457e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL10,Interleukin-10,42370,0.0591524664448097,0.00875271570028034,0.0419971436722603,0.0763077892173592,1.45609257500733e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40223,0.0291583875392184,0.00431482761624298,0.0207013254113822,0.0376154496670546,1.47249969264355e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,40532,0.019130312950341,0.00283176514692394,0.0135800532623701,0.0246805726383119,1.49194173818717e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42613,0.0789582754807946,0.0116987093952731,0.0560288050660594,0.10188774589553,1.54645767380053e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QA,Complement C1q subcomponent subunit A,42701,0.0153139332942504,0.00226946376376401,0.010865784317273,0.0197620822712279,1.56200757277692e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNPY4,Protein canopy homolog 4,42587,0.0512790403785009,0.00760082126882683,0.0363814306916003,0.0661766500654015,1.57662333726438e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40451,0.057212243908433,0.00848505693981019,0.0405815323064051,0.073842955510461,1.63071622659963e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLG4,Disks large homolog 4,40483,0.0487480802094814,0.00723295626333407,0.0345714859333466,0.0629246744856162,1.66425027104352e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,40199,0.0633246852339829,0.00942692183779786,0.0448479184318991,0.0818014520360667,1.94082661012674e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42607,0.0154298077789096,0.0022995720034378,0.0109226466521715,0.0199369689056477,2.02630115634422e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42658,-0.0450414336451818,0.00671569296683107,-0.0582041918601707,-0.0318786754301929,2.06747690210106e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF19,Fibroblast growth factor 19,42676,0.0535764084921168,0.00798956199338218,0.0379168669850878,0.0692359499991459,2.08284497087539e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40199,0.0376709101770615,0.00561989431099354,0.0266559173275142,0.0486859030266089,2.13973305274747e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB33A,Ras-related protein Rab-33A,40116,0.0454676574806739,0.00678656245075996,0.0321659950771844,0.0587693198841634,2.19182383300388e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,40302,0.0470224532878172,0.00702188039855754,0.0332595677066444,0.0607853388689899,2.23679010362079e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACRBP,Acrosin-binding protein,40451,0.0271875822916824,0.0040603108217397,0.0192293730810726,0.0351457915022922,2.24493968366077e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERI1,3'-5' exoribonuclease 1,40302,0.0239234994773296,0.0035732495697699,0.0169199303205806,0.0309270686340786,2.25815036308926e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPXM1,Probable carboxypeptidase X1,42679,0.0478274405742375,0.00715013252818313,0.0338131808189986,0.0618417003294764,2.33515242766642e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLTA,Clathrin light chain A,42357,0.032927937618612,0.0049247058472781,0.023275514157947,0.0425803610792771,2.38158716757518e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TTF2,Transcription termination factor 2,40182,0.033872976617245,0.00506706306539609,0.0239415330090686,0.0438044202254213,2.42226653595992e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIL1,Nucleotide exchange factor SIL1,40223,0.0214581692338303,0.00321229323076907,0.0151620745015229,0.0277542639661377,2.50417133806581e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40483,0.0669970902238311,0.0100312118599401,0.0473359149783485,0.0866582654693137,2.52114109245102e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42679,0.0491380189665237,0.00737215410058611,0.0346885969293749,0.0635874410036725,2.74292255309277e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAT,Catalase,40361,0.0375228094507949,0.00562986958475825,0.0264882650646687,0.048557353836921,2.77222424313095e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNASE3,Eosinophil cationic protein,42578,0.0755085836136941,0.0113382050705716,0.0532857016753737,0.0977314655520146,2.85178577041813e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REEP4,Receptor expression-enhancing protein 4,40482,0.0426151498729703,0.0064033387437014,0.0300646059353156,0.0551656938106251,2.96127716623518e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HRG,Histidine-rich glycoprotein,40479,0.0212845174854637,0.00319947391999189,0.0150135486022796,0.0275554863686479,3.01472524547508e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40482,0.0455694030726123,0.00685721292544074,0.0321292657387485,0.0590095404064762,3.16167804934144e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP2,Caspase-2,42594,0.0457311692056417,0.00690387969753084,0.0321995649984813,0.0592627734128021,3.62997105308484e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPAN1,Tetraspanin-1,42357,0.046513991586951,0.00702393578418538,0.0327470774499476,0.0602809057239543,3.67602380352639e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPTLC1,Serine palmitoyltransferase 1,40483,0.0265790428281688,0.00401326381963798,0.0187130457416784,0.0344450399146592,3.68465232097909e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAVS,Mitochondrial antiviral-signaling protein,42346,0.0618081733541182,0.00933592686677152,0.0435097566952461,0.0801065900129904,3.71971505802289e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LUZP2,Leucine zipper protein 2,40451,0.031556421219269,0.00477115128139194,0.0222049647077408,0.0409078777307972,3.9100457230669e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMPRSS11D,Transmembrane protease serine 11D,40470,0.0280927438038008,0.00424818281294563,0.0197663054904274,0.0364191821171743,3.93936535595415e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COMT,Catechol O-methyltransferase,42214,0.0566377852001673,0.00857139382111202,0.0398378533107877,0.0734377170895469,4.0534133128129e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPBP,Platelet basic protein,40471,0.0574462542985895,0.008696696014632,0.0404007301099108,0.0744917784872682,4.13929461208557e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42667,0.075159121986672,0.0113968197822042,0.0528213552135519,0.0974968887597921,4.41874529461923e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CIRBP,Cold-inducible RNA-binding protein,40449,0.0647710260743663,0.00982145899090718,0.0455209664521883,0.0840210856965444,4.44760213095052e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RCOR1,REST corepressor 1,42357,0.0302060759297445,0.00458236637416628,0.0212246378363786,0.0391875140231104,4.51068260246878e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42587,-0.0281520273282746,0.00427629016348834,-0.0365335560487117,-0.0197704986078374,4.77320329403978e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40283,0.0705492709864735,0.0107336161389937,0.0495113833540458,0.0915871586189013,5.16140345299639e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INHBB,Inhibin beta B chain,40283,0.0372659316960467,0.00567406278607185,0.0261447686353458,0.0483870947567475,5.33595998506161e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMOTL2,Angiomotin-like protein 2,40404,0.0328451608830551,0.00500249722145743,0.0230402663289985,0.0426500554371116,5.40582196737267e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40451,0.0361249621866241,0.00550215944717747,0.0253407296701562,0.0469091947030919,5.41048289169017e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBM17,Splicing factor 45,40482,0.0517145982277418,0.00788995963545635,0.0362502773422473,0.0671789191132362,5.82684838656132e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAGED1,Melanoma-associated antigen D1,42346,0.032653495153889,0.00498505945048788,0.0228827786309327,0.0424242116768452,5.95691859747325e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSNK2A1,Casein kinase II subunit alpha,40482,-0.0304007598470388,0.00464149912664891,-0.0394980981352707,-0.021303421558807,6.01290131047406e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASPN,Asporin,40511,-0.019096101305479,0.00291644093373572,-0.024812325535601,-0.013379877075357,6.09421503278009e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PF4,Platelet factor 4,40463,0.0663704816735652,0.0101382005408129,0.0464996086135719,0.0862413547335586,6.14294264424563e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD276,CD276 antigen,42618,0.0247911519061162,0.00378980310861401,0.0173631378132327,0.0322191659989997,6.30951856606785e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL13,C-C motif chemokine 13,42734,0.046399680693632,0.00709783977104203,0.0324879147423896,0.0603114466448743,6.49468342491431e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM2,Intercellular adhesion molecule 2,42794,0.0218695345188624,0.00334565842253588,0.0153120440106921,0.0284270250270327,6.51380441225922e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPR15L,Protein GPR15L,40449,0.0412407410004405,0.00631306260820796,0.0288671382883529,0.0536143437125281,6.74232679601972e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA4D,Semaphorin-4D,42711,0.0200498160766817,0.00307006983354226,0.0140324792029389,0.0260671529504246,6.77874318487116e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,40223,0.0617833849048382,0.00946559422270699,0.0432308202283325,0.0803359495813439,6.99728785432597e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAS2,Growth arrest-specific protein 2,40302,0.0356834192396345,0.0054732422079601,0.0249558645120327,0.0464109739672363,7.35458237145659e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA3,Carbonic anhydrase 3,42770,0.040008354882107,0.0061467325199704,0.027960759142965,0.052055950621249,7.83719645364671e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42587,-0.0178412137031514,0.00274184877342389,-0.0232152372990622,-0.0124671901072406,7.93930967009754e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC1A,C-type lectin domain family 1 member A,42357,0.0236449283521712,0.00363416965034224,0.0165219558375004,0.030767900866842,7.98220504928437e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEXN,Nexilin,40532,0.0464684617737468,0.00714492444847167,0.0324644098547424,0.0604725136927513,8.16626723404522e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD226,CD226 antigen,40199,0.028566460941818,0.00439246708497228,0.0199572254552724,0.0371756964283637,8.18676222349006e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNAS,Neuroendocrine secretory protein 55,40482,0.0578205073649124,0.00889767409549242,0.0403810661377472,0.0752599485920775,8.46057069612186e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LIF,Leukemia inhibitory factor,42311,0.0344437573764598,0.0053040164699519,0.024047885095354,0.0448396296575655,8.66566647335426e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA2,Carbonic anhydrase 2,42573,0.0463055526684146,0.0071414123327637,0.0323083844961977,0.0603027208406314,9.24044248025413e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40199,0.0245290734219078,0.00378334784182651,0.0171137116519278,0.0319444351918877,9.34989492652992e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,42459,0.0198778532519883,0.00306786571094359,0.0138648364585389,0.0258908700454378,9.53563441870883e-11
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIFBP,KIF-binding protein,42587,0.0542255054859337,0.0083880829007295,0.0377848630005039,0.0706661479713635,1.05095547941649e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,40482,0.0567181384819279,0.00878052300394596,0.0395083133941938,0.073927963569662,1.09339625043756e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,40116,0.0458485810780653,0.00709881467716338,0.031934904310825,0.0597622578453055,1.10148364256618e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSPB1,Heat shock protein beta-1,42448,0.0449307602137908,0.00696518912984253,0.0312789895192994,0.0585825309082822,1.15156597907843e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPARC,SPARC,42679,0.0463673797176516,0.00719102658352674,0.0322729676139391,0.060461791821364,1.17235979304843e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCDC134,Coiled-coil domain-containing protein 134,40451,0.0325748671270191,0.00505139771722658,0.022674127601255,0.0424756066527832,1.17446191516864e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FDX2,"Ferredoxin-2, mitochondrial",40116,0.0377061095411711,0.00585932825142953,0.0262218261683692,0.049190392913973,1.28452244864878e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42587,0.0762887500710318,0.0118585681573067,0.0530459564827108,0.0995315436593528,1.29178054061218e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,42370,0.0217037601692299,0.0033737532575666,0.0150912037843994,0.0283163165540605,1.2933174614916e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,40332,0.0379980823754751,0.00590925250767041,0.0264159474604411,0.0495802172905091,1.32592011253078e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHA4,Ephrin type-A receptor 4,40283,0.0194694412921766,0.00303352865847582,0.0135237251215639,0.0254151574627892,1.43631263790073e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSLN,Mesothelin,42553,0.0393843036651618,0.00615282820005815,0.0273247603930478,0.0514438469372758,1.59511924466166e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42760,0.0302211513777504,0.0047241481225423,0.0209618210575675,0.0394804816979333,1.6348390550606e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACE,Angiotensin-converting enzyme,40532,0.0177006556360594,0.00279158944901772,0.0122291403159847,0.0231721709561342,2.37404658605575e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,40511,0.046018680109756,0.00726338051214523,0.0317824543059513,0.0602549059135606,2.45218646776892e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRUNE2,Protein prune homolog 2,40302,0.0197998861362521,0.00312755510381662,0.0136698781327715,0.0259298941397326,2.5332183814849e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD2,T-cell surface antigen CD2,40116,0.0252490525771969,0.00399929755880258,0.0174104293619438,0.03308767579245,2.83617284768746e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXN,Thioredoxin,40384,0.0291211493087967,0.00462253805946227,0.0200609747122507,0.0381813239053428,3.09183686254384e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,40449,0.0738086823030283,0.0117239929296193,0.0508296561609745,0.0967877084450821,3.17767010694058e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL1A1,Collagen alpha-1(I) chain,42794,-0.0162819132258197,0.00258739067570784,-0.0213531989502071,-0.0112106275014324,3.21367269389605e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL1,Growth-regulated alpha protein,42607,0.0619153388483592,0.00984804336071019,0.0426131738613672,0.0812175038353512,3.33539120178687e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC39A14,Zinc transporter ZIP14,42311,0.0223810494334128,0.00356145243318901,0.0154006026643624,0.0293614962024633,3.39869555584584e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42346,0.0390763411526773,0.00622082009801785,0.0268835337605623,0.0512691485447923,3.45792786106312e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,42311,0.0406340396728808,0.00647047578901731,0.0279519071264069,0.0533161722193548,3.4944761240664e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMED8,Protein TMED8,40449,0.0662910801462226,0.0105572537535471,0.0455988627892703,0.0869832975031748,3.52864014155271e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA7,Thyroxine-binding globulin,40539,0.0120107662880127,0.00191505019338216,0.00825726790898372,0.0157642646670418,3.69936548204823e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40283,0.0458452501958615,0.00732122649451101,0.03149564626662,0.0601948541251031,3.94225938725867e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MESD,LRP chaperone MESD,42611,0.0772547210195296,0.0123391128381908,0.0530700598566756,0.101439382182384,3.94268708156345e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX5,Sorting nexin-5,40223,0.0188621261409835,0.00301249243768621,0.0129576409631185,0.0247666113188485,3.9597224947443e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42656,0.059902460396485,0.00957103011831813,0.0411432413645815,0.0786616794283886,3.99905205191817e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,QSOX1,Sulfhydryl oxidase 1,40342,0.0281714082480051,0.00450075164587207,0.0193499350220958,0.0369928814739143,4.00999112007351e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40482,0.0278533918555846,0.004450276968991,0.0191308489963623,0.036575934714807,4.02019978819664e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP7,Caspase-7,40483,0.0540125613377134,0.00863281015611315,0.0370922534317316,0.0709328692436951,4.07550267331927e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DENR,Density-regulated protein,40199,0.0369687978005571,0.00591022974240433,0.0253847475054446,0.0485528480956696,4.12133373868785e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,42311,0.0325590089272535,0.00520878092974224,0.0223497983049587,0.0427682195495483,4.2102683700399e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDLIM5,PDZ and LIM domain protein 5,40482,0.0751801817520135,0.0120594144778099,0.051543729375506,0.098816634128521,4.70457650016228e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAFB2,Scaffold attachment factor B2,40482,0.0177635278972159,0.0028507575389997,0.0121760431207765,0.0233510126736553,4.79489170365269e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCRL3,Fc receptor-like protein 3,42370,0.0361724083183085,0.00581564235667855,0.0247737492992186,0.0475710673373985,5.12687120392814e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42679,0.053252720873711,0.00856927633590039,0.0364569392553462,0.0700485024920757,5.30451850966071e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESM1,Endothelial cell-specific molecule 1,42618,-0.0220193628564956,0.0035448638323966,-0.028967295967993,-0.0150714297449983,5.3987623086196e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDGF,Hepatoma-derived growth factor,42700,0.0593551872415985,0.00956065211319325,0.0406163090997397,0.0780940653834572,5.51365267113181e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA3,Annexin A3,42681,0.0441971002145817,0.00713131812341596,0.0302197166926864,0.058174483736477,5.89977288008356e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40283,0.0384781775461705,0.00621983576396674,0.0262872994487957,0.0506690556435453,6.37378005506562e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COMP,Cartilage oligomeric matrix protein,42511,-0.0214764132224356,0.00347485227806781,-0.0282871236874485,-0.0146657027574227,6.57524853424277e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OTUD6B,Deubiquitinase OTUD6B,40449,0.0373939885593935,0.00605601829419988,0.0255241927027617,0.0492637844160253,6.85818860422198e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THTPA,Thiamine-triphosphatase,40436,0.0560947332576379,0.00909278336190096,0.038272877868312,0.0739165886469638,7.10196057443041e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42587,0.0356321223448818,0.0057768031012218,0.0243095882664871,0.0469546564232765,7.10870569637622e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C7orf50,Uncharacterized protein C7orf50,40483,0.0145361634389699,0.00235693529697311,0.00991657025690258,0.0191557566210371,7.1796349421932e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FIS1,Mitochondrial fission 1 protein,42624,0.0477405570061496,0.00774981170643948,0.0325509260615282,0.062930187950771,7.47173681248538e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JPT2,Jupiter microtubule associated homolog 2,40449,0.0553854629434308,0.0089943272118297,0.0377565816082445,0.073014344278617,7.62671407020961e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRISP2,Cysteine-rich secretory protein 2,42721,-0.0376085173802491,0.00611868651501552,-0.0496011429496795,-0.0256158918108187,8.14359646966581e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELOB,Elongin-B,40116,0.0255533786643578,0.00415786713732582,0.0174039590751992,0.0337027982535164,8.23418606330354e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42689,0.0175569241484977,0.00285735667774286,0.0119565050601216,0.0231573432368737,8.24909067436893e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPARCL1,SPARC-like protein 1,42644,-0.0175297607480219,0.00285476290144488,-0.0231250960348539,-0.0119344254611899,8.45612457941815e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AK2,"Adenylate kinase 2, mitochondrial",40483,0.0669045544423344,0.0109001388924004,0.0455402822132296,0.0882688266714391,8.63963132346078e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPT1,Angiopoietin-1,42554,0.0529342719396414,0.00863316048425842,0.0360132773904949,0.0698552664887879,8.95042290057675e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBC1D23,TBC1 domain family member 23,42587,0.0563289103456414,0.00919349168982929,0.038309666633576,0.0743481540577068,9.20370342297701e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NID2,Nidogen-2,42611,0.0465600847119645,0.00760344188817309,0.0316573386111452,0.0614628308127837,9.40654072796967e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,0.0176486987915004,0.00288215064506427,0.0119996835271745,0.0232977140558264,9.47002665914028e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42587,0.021670611402824,0.00354233374966686,0.0147276372534769,0.028613585552171,9.76361864920523e-10
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL15A1,Collagen alpha-1(XV) chain,40527,0.017723500653983,0.00290126078145728,0.0120370295223268,0.0234099717856393,1.03613871898391e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNMA1,Paraneoplastic antigen Ma1,40223,0.0352507919049027,0.00577489402038023,0.0239319996249574,0.0465695841848479,1.06827001898472e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42357,0.0211411010906431,0.0034684817445765,0.0143428768712731,0.027939325310013,1.12352523224245e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDF1,Endothelial differentiation-related factor 1,40482,0.0422525767800317,0.00693854985602879,0.0286530190622153,0.0558521344978481,1.16918926533798e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40511,0.0561382751728712,0.00923968088159431,0.0380285006449463,0.074248049700796,1.27353318340303e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17D,Interleukin-17D,42370,0.0215510573216079,0.00354870968659716,0.0145955863358775,0.0285065283073384,1.29054666041085e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42558,0.0219309533069505,0.00362009951011448,0.0148355582671261,0.0290263483467749,1.41431714779251e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPK13,Mitogen-activated protein kinase 13,40080,0.0263051750284611,0.00434686337003328,0.0177853228231959,0.0348250272337264,1.48199674241596e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS27,Serine protease 27,42603,0.0251126633501366,0.00416124436627982,0.0169566243922281,0.033268702308045,1.63262598653932e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL8,C-C motif chemokine 8,42706,0.0375035070467022,0.00621645120759072,0.0253192626798244,0.04968775141358,1.65205497658582e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX6,Syntaxin-6,42346,0.0411347548842447,0.00682590039619646,0.0277559901076997,0.0545135196607898,1.72267401826436e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MGLL,Monoglyceride lipase,42654,0.0531315092051788,0.00882344740839196,0.0358375522847305,0.070425466125627,1.77168789167358e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,40302,0.0428714861340757,0.00711874766561468,0.0289187407094709,0.0568242315586805,1.77358067270925e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA1,Annexin A1,40235,0.0260206601411534,0.0043222952034796,0.0175489615423334,0.0344923587399734,1.79847935355954e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSDE1,Cold shock domain-containing protein E1,40116,0.0727103173433861,0.0120793186141023,0.0490348528597455,0.0963857818270266,1.80682856154895e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,42311,0.0322895625933315,0.00536890377287505,0.0217665111984964,0.0428126139881666,1.85606580598793e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPOCK1,Testican-1,42495,-0.0159259957523974,0.0026520090753729,-0.0211239335401283,-0.0107280579646665,1.96009919048424e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BGN,Biglycan,42328,-0.0745167223815866,0.012413784582673,-0.0988477401636256,-0.0501857045995476,1.99130201272754e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42311,0.0392536422832504,0.00655166713119599,0.0264123747061063,0.0520949098603946,2.13496809966449e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHGA,Chromogranin-A,40527,0.060788393570509,0.0101450532486315,0.0409040892031912,0.0806726979378269,2.13674543673189e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XRCC4,DNA repair protein XRCC4,42311,0.0227477681215468,0.00379704688779122,0.015305556221476,0.0301899800216176,2.14135458410981e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX2,Sorting nexin-2,40451,0.0510141096577853,0.00851667502408334,0.0343214266105819,0.0677067927049886,2.1637439222732e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB10,Ras-related protein Rab-10,40511,0.0331403742752624,0.00553365213533867,0.0222944160899986,0.0439863324605262,2.17709818937612e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42346,0.0478131663197977,0.00798812676510432,0.0321564378601933,0.0634698947794022,2.21302084868778e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,40182,0.0426156775640628,0.00711937684835883,0.0286616989412795,0.0565696561868461,2.21956312398311e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLVRB,Flavin reductase,42611,0.0404674093397276,0.006767533465857,0.0272030437466479,0.0537317749328073,2.29315402551127e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM5,Intercellular adhesion molecule 5,42636,0.0282471608594817,0.00473595197176931,0.0189646949948138,0.0375296267241495,2.51684465578825e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPP7,Dipeptidyl peptidase 2,42551,0.0370344403061833,0.00621613219324699,0.0248508212074192,0.0492180594049474,2.62097460231044e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42679,-0.0275241054563078,0.00462311351000413,-0.0365854079359159,-0.0184628029766997,2.6884884611957e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEPTIN9,Septin-9,42587,0.0174574026920257,0.00293299790420223,0.0117087267997894,0.0232060785842621,2.71394775781426e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,40451,0.0253439353623998,0.00425787666491573,0.016998497099165,0.0336893736256346,2.72368652229576e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GMFG,Glia maturation factor gamma,40511,0.0439502873833614,0.00738972720281079,0.0294664220658522,0.0584341527008705,2.80341929100166e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ORM1,Alpha-1-acid glycoprotein 1,40483,0.0123721167797383,0.0020823729811644,0.0082906657366561,0.0164535678228205,2.91017002899963e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42583,0.0201665372854998,0.00339541792487643,0.013511518152742,0.0268215564182576,2.93270302388139e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKG1,cGMP-dependent protein kinase 1,40283,0.0763017569925895,0.0128916772436985,0.0510340695949405,0.101569444390238,3.34133675730512e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST5,Cystatin-D,42357,0.0347211864159653,0.00586717036298489,0.023221532504515,0.0462208403274157,3.34236628167644e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX16,Syntaxin-16,42346,0.0352160785178114,0.00596999385824758,0.0235148905556462,0.0469172664799767,3.75047824144127e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL2,Apoptosis regulator Bcl-2,40449,0.0350530615573403,0.00594229829240955,0.0234061569042175,0.046699966210463,3.76446828972745e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPE,Ribulose-phosphate 3-epimerase,40302,0.0427597760706247,0.0072516621600595,0.0285465182369081,0.0569730339043413,3.81989839762935e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GHRL,Appetite-regulating hormone,42636,0.0514783996874434,0.00875789756319585,0.0343129204635795,0.0686438789113072,4.25250991628031e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,42370,0.0397936235037035,0.0067703454831474,0.0265237463567346,0.0530635006506724,4.2623366474152e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLITRK1,SLIT and NTRK-like protein 1,40199,-0.0200426299449005,0.00341088962417404,-0.0267279736082816,-0.0133572862815194,4.32295740008078e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42590,0.0502142482009689,0.00856058587400219,0.0334354998879246,0.0669929965140132,4.57660134615332e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBP4,Guanylate-binding protein 4,42311,0.0298570546103963,0.00509324362688406,0.0198742971017035,0.039839812119089,4.680664003775e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CR1,Complement receptor type 1,40509,0.0219887571427448,0.00375861437370361,0.0146218729702857,0.0293556413152039,5.04491429262754e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42676,0.034637872338956,0.00593001305170058,0.0230150467576229,0.0462606979202891,5.3049168009198e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMEM106A,Transmembrane protein 106A,40451,0.0423538738032971,0.00725373452566075,0.028136554133002,0.0565711934735922,5.39965327420394e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INSR,Insulin receptor,40199,0.0105185895271811,0.00180486662078656,0.00698105095043942,0.0140561281039227,5.77028299671013e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRTN3,Myeloblastin,42276,0.0292626000627206,0.00502817668429514,0.0194073737615021,0.0391178263639391,6.03260914308882e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42346,0.0506106348954119,0.00870120858703402,0.0335562660648252,0.0676650037259986,6.14876721755338e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC51B,Organic solute transporter subunit beta,40116,0.0465427590359292,0.00800121750208799,0.0308603727318367,0.0622251453400216,6.16096708973981e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,42346,-0.0230257931337115,0.00396199587848629,-0.0307913050555446,-0.0152602812118784,6.32882245158913e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40482,0.0645477630253647,0.0111170298798345,0.042758384460889,0.0863371415898404,6.56266741773569e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40451,0.0331781771841734,0.00572168703147498,0.0219636706024824,0.0443926837658643,6.86400115396562e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40482,0.0594468845799037,0.0102624272826102,0.0393325271059877,0.0795612420538196,7.11248580898651e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUSD2,Sushi domain-containing protein 2,42611,-0.0171942442576503,0.00297299646018028,-0.0230213173196037,-0.011367171195697,7.48048305008616e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLB1,"Phospholipase B1, membrane-associated",40483,-0.0360694051690355,0.00623597372787338,-0.0482919136756673,-0.0238468966624037,7.48432773465571e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRG3,Proteoglycan 3,40527,-0.0298627357159057,0.00516367458458588,-0.0399835379016941,-0.0197419335301174,7.52147383786479e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHCY,Adenosylhomocysteinase,42636,0.039988538899197,0.00691685657262231,0.0264315000168573,0.0535455777815367,7.576452670671e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC12A,C-type lectin domain family 12 member A,40199,0.0124442302411908,0.00215265605227131,0.00822502437873906,0.0166634361036426,7.63340039509705e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40199,0.0186500685456036,0.00322864215558906,0.012321929920649,0.0249782071705582,7.83636096577889e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGAM,Integrin alpha-M,42611,-0.0188110541466864,0.00325829405741715,-0.025197310499224,-0.0124247977941488,7.94622985906895e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN4B,Sodium channel subunit beta-4,40223,0.0263559047201816,0.00456759188335796,0.0174034246288,0.0353083848115632,8.13106758198547e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C8B,Complement component C8 beta chain,40539,-0.0181727772104815,0.00315035226401482,-0.0243474676479505,-0.0119980867730124,8.20750574703012e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40482,0.0548065619006548,0.00950191866092536,0.0361828013252411,0.0734303224760685,8.23501278818189e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42594,0.0895817607342122,0.0155361561408892,0.0591308946980694,0.120032626770355,8.29561242868095e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40451,0.0227628171152208,0.00395233806449227,0.015016234508816,0.0305093997216257,8.66593136293507e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMOX1,Heme oxygenase 1,42500,-0.0287146118533763,0.00498872981135856,-0.038492522283639,-0.0189367014231135,8.80841416105259e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42594,0.0480804943508261,0.00835749385496649,0.0316998063950918,0.0644611823065604,8.9600391082688e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40223,0.0289505317125822,0.00504061373967913,0.0190709287828111,0.0388301346423533,9.5216982717061e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F12,Coagulation factor XII,40539,0.0246515912999173,0.00429782880871611,0.0162278468348337,0.0330753357650008,9.9519194407035e-09
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAPK2,Death-associated protein kinase 2,40199,0.0321602804740383,0.00561813048110162,0.0211487447310791,0.0431718162169974,1.06530446044178e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42636,0.0289369212163459,0.00507002148737009,0.0189996791011005,0.0388741633315913,1.17099554118693e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMIGO2,Amphoterin-induced protein 2,42587,0.0138163251503278,0.0024215238801252,0.00907013834528245,0.0185625119553732,1.18365783694537e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCRN1,Secernin-1,42594,0.0323748264020995,0.00567874134094269,0.0212444933738518,0.0435051594303471,1.21578444030297e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,40483,0.0226005355919642,0.00396473593841998,0.014829653152661,0.0303714180312673,1.22530963815186e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,40451,0.0554781112393682,0.00973721766195132,0.0363931646219436,0.0745630578567927,1.24603728713931e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42721,0.0199163688559602,0.00349911166417789,0.0130581099941715,0.0267746277177489,1.28289924103495e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,42292,0.025226800477315,0.00443326373129611,0.0165376035639747,0.0339159973906554,1.29499159844855e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42346,0.0257062484719577,0.00452003472064527,0.016846980419493,0.0345655165244224,1.31904351401071e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEDD9,Enhancer of filamentation 1,40199,0.0196742507957351,0.00346086877959966,0.0128909479877198,0.0264575536037505,1.34320031186475e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42587,0.012438096801107,0.00219060294761566,0.00814451502378034,0.0167316785784337,1.39163672403801e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KEL,Kell blood group glycoprotein,42311,0.0212420568140141,0.00374117129271983,0.0139093610802833,0.028574752547745,1.39237493520986e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSMB,Beta-microseminoprotein,42559,0.0424301380802682,0.00747292948326071,0.0277831962930772,0.0570770798674592,1.39240790311026e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFBR1,TGF-beta receptor type-1,40199,0.0127201712863669,0.00224724908765989,0.00831556307455353,0.0171247794981803,1.54861934582475e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40483,0.0275094796797428,0.0048660930212393,0.0179719373581138,0.0370470220013718,1.61215895918092e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATXN10,Ataxin-10,42311,0.0420776637132538,0.0074480162951613,0.0274795517747377,0.05667577565177,1.64249525576175e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42698,0.0378832056562494,0.00674182231108268,0.0246692339265273,0.0510971773859714,1.95711480893283e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GTPBP2,GTP-binding protein 2,40182,0.046865055276548,0.00834918482494974,0.0305006530196465,0.0632294575334495,2.03517476844902e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CREG1,Protein CREG1,42445,0.0222226426674199,0.00396100361723243,0.0144590755776444,0.0299862097571955,2.05954742098928e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK6,Kallikrein-6,42656,0.0183047894092375,0.00327076208802956,0.0118940957166996,0.0247154831017755,2.23004876291295e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTN2,Dynactin subunit 2,42587,0.0539757914599706,0.00964521750869274,0.0350711651429328,0.0728804177770083,2.23503427899111e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CERT,Ceramide transfer protein,42311,0.0351424568701016,0.00628492032479256,0.0228240130335082,0.047460900706695,2.29544289567969e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40451,0.0290129463108407,0.00519342873707504,0.0188338259861736,0.0391920666355078,2.37109747959159e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PROC,Vitamin K-dependent protein C,42663,0.0144387070395275,0.00258529842640532,0.00937152212377303,0.0195058919552819,2.38321927314445e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,40182,0.0351724061556853,0.00630733350270983,0.022810032490374,0.0475347798209965,2.51305269871987e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,40199,0.023316943653197,0.00418198610889907,0.0151202508797548,0.0315136364266391,2.52542339431626e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42495,0.0337443460786711,0.00605383165353173,0.0218788360377489,0.0456098561195933,2.5372960538069e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,42311,0.0418826009651096,0.00751871395007658,0.0271459216229595,0.0566192803072597,2.59086305895169e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP45,Rho GTPase-activating protein 45,40283,0.0475093477206032,0.00853549795338714,0.0307797717319644,0.064238923709242,2.66574192120651e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42636,0.0166216584538044,0.00298701929158682,0.0107671006422942,0.0224762162653145,2.67732028215739e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CENPF,Centromere protein F,40302,0.0315251746057235,0.00566854912976467,0.0204148183113848,0.0426355309000623,2.73778780566065e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMPRSS5,Transmembrane protease serine 5,42438,-0.021800144695904,0.00392319877989683,-0.0294896143045018,-0.0141106750873062,2.80185936348169e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40199,0.0459507961859578,0.00826862190243353,0.0297442972571881,0.0621572951147275,2.80437640718527e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,40428,0.0398107696046972,0.00716534209919063,0.0257666990902836,0.0538548401191108,2.82284921353084e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EGF,Pro-epidermal growth factor,42597,0.0586911473879611,0.0105653093241422,0.0379831411126423,0.0793991536632799,2.82769190895288e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INSL4,Early placenta insulin-like peptide,40451,0.0280720439371422,0.0050605417469209,0.0181533821131772,0.0379907057611072,2.96768682499069e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TF,Serotransferrin,40539,0.0122364983415302,0.00220971664122413,0.00790545372473093,0.0165675429583295,3.13493759702663e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HLA_DRA,,42549,0.021071301446609,0.00380560959309492,0.013612306644143,0.0285302962490751,3.13673005933604e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,40302,0.0423859168292595,0.00765897341202052,0.0273743289416993,0.0573975047168197,3.19833491530681e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRGN,Neurogranin,40532,0.0520822849900026,0.00941367102322706,0.0336314897844775,0.0705330801955276,3.22480965565905e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSNK1D,Casein kinase I isoform delta,40199,0.0360970582141178,0.00652606256709574,0.0233059755826102,0.0488881408456255,3.25286567325632e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBP2,Guanylate-binding protein 2,42370,0.0344379933854961,0.00625808074160856,0.0221721551319433,0.0467038316390488,3.80434155021143e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,42346,0.0418980405962193,0.00761789144919511,0.0269669733557969,0.0568291078366418,3.86987337647073e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTF3,Neurotrophin-3,42594,0.0203206457853832,0.00369572512914496,0.013077024532259,0.0275642670385073,3.90225658248319e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHNAK2,Protein AHNAK2,40223,0.0172558150400597,0.00313793131845351,0.0111054696558908,0.0234061604242286,3.90230313900369e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42654,0.0428535870784561,0.00779615715528257,0.0275731190541023,0.05813405510281,3.93878296314763e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,40166,0.0320264300668488,0.00582695856345386,0.0206055912824792,0.0434472688512183,3.96622816284198e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A13,Protein S100-A13,40199,0.0203144639988467,0.00369812601219572,0.0130661370149431,0.0275627909827503,4.03545045767453e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,40116,0.039259341632072,0.00714976703006593,0.0252457982531428,0.0532728850110012,4.08617230801727e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PEPD,Xaa-Pro dipeptidase,40532,-0.0150528641554673,0.00274951437901146,-0.0204419123383298,-0.00966381597260484,4.47498440410899e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RANBP1,Ran-specific GTPase-activating protein,40223,0.0297165190362087,0.00543269585953134,0.0190684351515273,0.0403646029208901,4.60015021909713e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42311,0.0273061330044972,0.00499315910878523,0.0175195411512781,0.0370927248577163,4.61626438454157e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40223,0.0367224983943242,0.00672217305749409,0.0235470392016358,0.0498979575870126,4.78615742760211e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFRC,Transferrin receptor protein 1,42673,0.0212950985161467,0.00390732009397182,0.013636751131962,0.0289534459003315,5.12402055263764e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42794,0.0132552107068893,0.00243316755942641,0.00848620229041355,0.0180242191233651,5.19075030558616e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP3,Caspase-3,42794,0.0485635011965463,0.00891912265188018,0.0310820207988612,0.0660449815942315,5.27417932910223e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMPD3,AMP deaminase 3,40483,0.0399753673149929,0.00734141234594791,0.025586199116935,0.0543645355130508,5.28347454776334e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,40182,0.0404319505943404,0.00742978487550728,0.0258695722383462,0.0549943289503347,5.38551719808814e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42582,0.0191166170095582,0.00351479428461186,0.0122276202117189,0.0260056138073974,5.455161286133e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42676,0.0659044295975728,0.0121309852748471,0.0421276984588725,0.089681160736273,5.6460044565901e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIF22,Kinesin-like protein KIF22,40116,0.0703367564189576,0.0129459658233482,0.0449626634051951,0.0957108494327201,5.65715772114781e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40482,0.0451965896853805,0.00832943370877956,0.0288708996161726,0.0615222797545885,5.87789187269948e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRADD,Death domain-containing protein CRADD,42476,0.0416196183941296,0.00767350665704814,0.0265795453463152,0.056659691441944,5.93643681194468e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIMAP7,GTPase IMAP family member 7,40283,-0.0179636702714517,0.0033127212063735,-0.0244566038359437,-0.0114707367069596,5.99598495444539e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FXN,"Frataxin, mitochondrial",42721,0.0406841530366299,0.00752131790191077,0.0259423699488848,0.055425936124375,6.43912731963569e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40080,0.0367106320112401,0.00678728178382875,0.0234075597149357,0.0500137043075444,6.48135096532978e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PZP,Pregnancy zone protein,40539,0.0285764881108469,0.00528652339202809,0.0182149022624718,0.0389380739592219,6.59238477018114e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL2L1,Bcl-2-like protein 1,40483,0.0552441815002978,0.010240462650946,0.0351728747044436,0.0753154882961521,7.00259358488882e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DGCR6,Protein DGCR6,40136,0.0248616175511155,0.00461060796482888,0.0158248259400509,0.0338984091621801,7.10227623100273e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RCC1,Regulator of chromosome condensation,40451,0.0293931909237451,0.0054533504335906,0.0187046240739075,0.0400817577735827,7.19067661446686e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TK1,"Thymidine kinase, cytosolic",40302,0.0254164633812338,0.00472447908006501,0.0161564843843064,0.0346764423781612,7.6108682920848e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABHD14B,Protein ABHD14B,42460,0.0314427353723199,0.0058544006385463,0.0199681101207691,0.0429173606238706,7.97164872699503e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BOC,Brother of CDO,42357,-0.0130244006475079,0.00242633897728036,-0.0177800250429774,-0.00826877625203845,8.09999744782311e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",40511,0.0399567706643421,0.00744365539899158,0.0253672060823186,0.0545463352463656,8.12341443208562e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FBLN2,Fibulin-2,40527,0.0181646505011961,0.00338591643904174,0.0115282542806743,0.0248010467217179,8.26495354369956e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STK4,Serine/threonine-protein kinase 4,42636,0.0472833140881886,0.00882417472664791,0.0299879316239587,0.0645786965524185,8.53550587009079e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA11,Annexin A11,42570,0.0365382880122831,0.00684295038633847,0.0231261052550597,0.0499504707695065,9.47004041451991e-08
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,40116,0.0303114935438436,0.00569346154951314,0.0191523089067979,0.0414706781808894,1.03572392103638e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK8,Kallikrein-8,42154,0.0204600608336847,0.00384876341477565,0.0129164845407244,0.028003637126645,1.07827959407978e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPME1,Protein phosphatase methylesterase 1,42587,0.0325808388491136,0.00614617286116,0.02053434004124,0.0446273376569872,1.17001145820131e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,42346,0.0411976459599314,0.00778375094653137,0.0259414941047299,0.0564537978151329,1.22410159593685e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL2A1,Collagen alpha-1(II) chain,40223,0.0443329501881727,0.00838181883715724,0.0279045852673445,0.0607613151090008,1.25217474917073e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PMVK,Phosphomevalonate kinase,42303,0.0587309013495927,0.0111071878861961,0.0369608130926483,0.080500989606537,1.25889457000423e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBC1D17,TBC1 domain family member 17,42311,0.024726811874781,0.00467656806355311,0.0155607384702169,0.0338928852793451,1.26069595817465e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F10,Coagulation factor X,40532,0.0155682780601667,0.00294512745686936,0.00979582824470277,0.0213407278756307,1.27262867180695e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELENOP,Selenoprotein P,40539,-0.0126197404497526,0.00238859707490409,-0.0173013907165646,-0.00793809018294057,1.2920813021526e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENAH,Protein enabled homolog,42370,0.0256700426911602,0.0048605771785259,0.0161433114212494,0.0351967739610709,1.30329050267817e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1B,Interleukin-1 beta,42293,0.0309074086945566,0.00585693388899527,0.0194278182721258,0.0423869991169873,1.33364892934237e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,40283,0.0470948477996283,0.00893136651798706,0.0295893694243737,0.064600326174883,1.36756657022903e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LMNB1,Lamin-B1,40434,0.0326549536326666,0.00620709526159625,0.020489046919938,0.0448208603453953,1.45982252622311e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,40136,0.0538890760163396,0.0102591639422129,0.0337811146896023,0.073997037343077,1.52638615705577e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40302,0.0495650527040871,0.00943895745381082,0.0310646960946178,0.0680654093135563,1.5397417320676e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40199,0.0271704509087006,0.00518567017614784,0.0170065373634508,0.0373343644539503,1.63966609286794e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DOK1,Docking protein 1,40483,0.0735037456166882,0.0140329573041463,0.0459991493005614,0.101008341932815,1.65304268710194e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GZMB,Granzyme B,42594,0.0357726787016109,0.00683590762405445,0.0223742997584642,0.0491710576447576,1.69247547458932e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCTD,Deoxycytidylate deaminase,40283,0.0508970666244165,0.00974876758413953,0.031789482159503,0.07000465108933,1.81305061911194e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42619,0.0315008072680703,0.00603986093833889,0.0196626798289261,0.0433389347072145,1.86062071932363e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTNAP2,Contactin-associated protein-like 2,42594,0.0224665446919879,0.00431098965266151,0.0140170049727713,0.0309160844112044,1.9014390228977e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD58,Lymphocyte function-associated antigen 3,42600,-0.00953589762168349,0.00183333046517614,-0.0131292253334287,-0.00594256990993826,2.00699493761164e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,40182,0.0260748915094706,0.005024416869933,0.0162270344444019,0.0359227485745393,2.14465300515162e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VNN1,Pantetheinase,40532,0.0391786482919616,0.00755761448858383,0.0243657238943373,0.0539915726895859,2.20919044242574e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40283,0.0203320497932886,0.00392758626968932,0.0126339807046975,0.0280301188818797,2.29762818311021e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40283,0.0473023346959265,0.00915528320125938,0.0293579796214581,0.0652466897703949,2.4244056633766e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42794,0.00849849003821291,0.0016462951871172,0.0052717514714632,0.0117252286049626,2.47517644216565e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPSAB1,Tryptase alpha/beta-1,42741,0.027820791864237,0.00540400184337229,0.0172289482512273,0.0384126354772467,2.66705502041206e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STXBP1,Syntaxin-binding protein 1,40482,0.0408881754035596,0.00794195876528986,0.0253219362235915,0.0564544145835278,2.67176434641728e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40482,0.0386532936179652,0.00752342286626759,0.0239073848000807,0.0533992024358497,2.82724203310724e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF3,Granulocyte colony-stimulating factor,42370,0.0258113652274751,0.00503538406494036,0.015942012460192,0.0356807179947582,3.00158756983235e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VASP,Vasodilator-stimulated phosphoprotein,40532,0.0383196031681323,0.00747574451527967,0.0236671439181842,0.0529720624180805,3.0106525781857e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40482,0.0156735545322381,0.00305994748175541,0.00967605746799755,0.0216710515964787,3.07031996820554e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42587,0.0489994954290454,0.00957705436743151,0.0302284688688796,0.0677705219892112,3.1582489852992e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42495,0.0325518369667115,0.00636383963974168,0.0200787112728178,0.0450249626606052,3.17895429698344e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40482,0.0251114167941523,0.0049121735498916,0.0154835566363648,0.0347392769519398,3.23850744356939e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,40451,0.0153086648517604,0.00299606806002955,0.00943637145410247,0.0211809582494183,3.28158278066032e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSBP1,Heat shock factor-binding protein 1,40223,0.0500486161782824,0.00981130784227958,0.0308184528074145,0.0692787795491504,3.43269648554577e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYZL2,Lysozyme-like protein 2,40080,0.0190450429924515,0.00374272434031463,0.0117093032854348,0.0263807826994682,3.66828800216545e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SATB1,DNA-binding protein SATB1,40482,0.0154292867503842,0.0030412710560223,0.00946839548058052,0.0213901780201879,3.97186221886343e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PADI2,Protein-arginine deiminase type-2,42370,0.0290522419592334,0.00574369276313568,0.0177946041434875,0.0403098797749794,4.29122061191214e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEK7,Serine/threonine-protein kinase Nek7,40302,0.039957739894026,0.00791348492842098,0.0244473094343209,0.0554681703537311,4.50411469386454e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLG,Plasminogen,40285,0.0111667166824854,0.00222389913792471,0.00680787437215298,0.0155255589928179,5.21388147271347e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPQ,Carboxypeptidase Q,40516,0.0185769957878125,0.00370014613156458,0.011324709369946,0.0258292822056791,5.22911429327626e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOL1,Apolipoprotein L1,40532,-0.0302663481931204,0.00604570188559342,-0.0421159238888835,-0.0184167724973573,5.63322155514575e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42618,-0.0196081125272565,0.00392100812715118,-0.0272932884564728,-0.0119229365980402,5.78188525013142e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40449,0.052873924194151,0.0105744873222473,0.0321479290425462,0.0735999193457557,5.81517715537635e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NXPH1,Neurexophilin-1,42311,0.0200705827511499,0.00401563685610615,0.0121999345131818,0.0279412309891179,5.86426136849564e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G4A,Cytosolic phospholipase A2,42676,0.0444078461458552,0.00891615799127675,0.0269321764829528,0.0618835158087577,6.4170938314479e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42587,-0.0340193162305041,0.00683467148513649,-0.0474152723413716,-0.0206233601196365,6.52242839873697e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALCB,Calcitonin gene-related peptide 2,40483,0.0211864067590965,0.00425689214326013,0.0128428981583066,0.0295299153598863,6.55417092145204e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LBP,Lipopolysaccharide-binding protein,42689,0.0301404297762923,0.00605913901629823,0.0182645173043478,0.0420163422482369,6.62640172577243e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD5L,CD5 antigen-like,40479,0.0246216709853745,0.00495373589148768,0.0149123486380586,0.0343309933326903,6.78226905582878e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST6,Cystatin-M,42332,0.0259627913735032,0.00522826874558071,0.0157153846321651,0.0362101981148414,6.92602917379758e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNDP1,Beta-Ala-His dipeptidase,42689,-0.0235958290184209,0.00475621827698747,-0.0329180168413163,-0.0142736411955254,7.09676252241562e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GASK1A,Golgi-associated kinase 1A,40116,0.0222280561212745,0.00448411863937905,0.0134391835880915,0.0310169286544574,7.26417920110288e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PARD3,Partitioning defective 3 homolog,40302,0.0382142497579283,0.00771789246538387,0.0230871805257759,0.0533413189900806,7.47707083117634e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYM,Ketimine reductase mu-crystallin,40136,0.0389432634909152,0.00787892699505191,0.0235005665806135,0.054385960401217,7.81854488691733e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MICALL2,MICAL-like protein 2,40182,0.0351285525540445,0.00712621009157321,0.021161180774561,0.049095924333528,8.36506436124375e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BMP10,Bone morphogenetic protein 10,40283,-0.0147510854768448,0.00299340128160119,-0.0206181519887831,-0.00888401896490647,8.43336179440965e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM172A,Cotranscriptional regulator FAM172A,40223,0.0310449619198096,0.00630539163228692,0.0186863943205272,0.0434035295190919,8.62157022284483e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UNC79,Protein unc-79 homolog,40080,0.0284181874884567,0.00577283015957272,0.0171034403756942,0.0397329346012193,8.6589070223524e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42679,0.0119055683516065,0.00242623839243191,0.00715014110243993,0.016660995600773,9.35571087692315e-07
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYAR,Cell growth-regulating nucleolar protein,42346,0.0274768402534519,0.00561759151390362,0.0164663608862008,0.038487319620703,1.01401711898614e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42613,0.0239424630405931,0.00490643988537538,0.0143258408652574,0.0335590852159289,1.07411636738106e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF5,Fibroblast growth factor 5,42370,0.0166250388412963,0.00340767168048347,0.00994600234754874,0.023304075335044,1.08030958258755e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOA2,Apolipoprotein A-II,40532,-0.0248936521398767,0.00511150452280704,-0.0349122010045785,-0.0148751032751749,1.13035468053822e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTD,Biotinidase,40539,0.0103772445584727,0.00213257545669309,0.00619739666335421,0.0145570924535911,1.15375394019819e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP5,Rho GTPase-activating protein 5,40080,0.0403757072135318,0.0083012316527012,0.0241052931742374,0.0566461212528261,1.16752756459716e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEPACAM2,HEPACAM family member 2,40483,-0.0211672379656822,0.00437338518009253,-0.0297390729186636,-0.0125954030127008,1.31550436030348e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDK1,Cyclin-dependent kinase 1,40080,0.0185510336049082,0.00383556133532983,0.0110333333876617,0.0260687338221546,1.33895510081151e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42346,0.0289480891137301,0.00599056016574774,0.0172065911888646,0.0406895870385957,1.3649908002644e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MKI67,Proliferation marker protein Ki-67,40199,0.0194158182631467,0.00402766085089191,0.0115216029953986,0.0273100335308949,1.4502790782606e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA12,Serpin A12,42249,0.0514176440472843,0.0106724771872329,0.0304995887603078,0.0723356993342608,1.46796370580311e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",42311,0.0139529953542452,0.00289665364805791,0.00827555420405173,0.0196304365044388,1.47409279043635e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUSD1,Sushi domain-containing protein 1,42357,0.0244947907786008,0.00508989509803547,0.0145185963864513,0.0344709851707503,1.50757357413793e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,40182,0.0312305442401858,0.00649304013593892,0.0185041855737455,0.043956902906626,1.53050388657146e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40283,0.0216591814998369,0.00450664457785718,0.0128261581272369,0.030492204872437,1.55957364052217e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPM1F,Protein phosphatase 1F,40511,0.0258949197275501,0.0053907155465259,0.0153291172563593,0.0364607221987409,1.57825877152371e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PROK1,Prokineticin-1,42594,0.0273268622913653,0.00569294159591552,0.0161686967633709,0.0384850278193597,1.6027424744815e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEP1B,Meprin A subunit beta,42636,-0.0585042515850527,0.0121895269262694,-0.0823957243605407,-0.0346127788095648,1.60732746788338e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRK5,G protein-coupled receptor kinase 5,42357,0.0251732338013519,0.00525306816099624,0.0148772202057993,0.0354692473969045,1.66846116854502e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMTN,Smoothelin,40460,0.0456847784808717,0.00954126613098731,0.0269838968641365,0.0643856600976068,1.70489216512273e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD55,Complement decay-accelerating factor,42201,0.0134337461083114,0.00281448544940644,0.00791735462747478,0.018950137589148,1.83410219096172e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,40199,0.0182783620822972,0.00384747038042524,0.0107373201366637,0.0258194040279307,2.05227878278015e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMS,Spermine synthase,40136,0.0314663395727829,0.00662599082522129,0.0184793975553492,0.0444532815902166,2.07096401943818e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42346,0.0244024823258197,0.00514295834749639,0.0143222839647268,0.0344826806869126,2.10872890356515e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RILPL2,RILP-like protein 2,40511,0.0474766533848155,0.0100178936612765,0.0278415818087136,0.0671117249609175,2.17192354269438e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40302,0.0358114227115672,0.00760494900993109,0.0209057226521023,0.0507171227710321,2.51994298987581e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRND,Prion-like protein doppel,40483,0.0255895528554091,0.00543469291982879,0.0149375547325447,0.0362415509782736,2.52448834812659e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH1,Protocadherin-1,42721,0.010518951327086,0.00223798756908345,0.00613249569168248,0.0149054069624896,2.62491423198727e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DBN1,Drebrin,40199,0.0243543366027804,0.00518368398675035,0.0141943159887497,0.0345143572168111,2.65554939776088e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PMS1,PMS1 protein homolog 1,40182,0.0253573924027516,0.00540345096788342,0.0147666285057001,0.0359481562998031,2.72726304040619e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KDR,Vascular endothelial growth factor receptor 2,42679,0.0119036420051815,0.002540942606262,0.00692339449690798,0.016883889513455,2.83060647588907e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VASN,Vasorin,42449,-0.0133102917922105,0.0028441870161803,-0.0188848983439239,-0.00773568524049714,2.89964310112835e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42649,0.0103491027917502,0.00221176038150684,0.00601405244399676,0.0146841531395036,2.90909235425707e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42346,0.0320843332475194,0.00685740625194078,0.0186438169937155,0.0455248495013234,2.9145509886811e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYL4,Myosin light chain 4,40223,0.0253334227434281,0.0054200113215525,0.0147102005531852,0.035956644933671,2.98810981720138e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,40428,0.0201000705033877,0.00430077855492345,0.0116705445357377,0.0285295964710376,2.99422564598364e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA1,Carbonic anhydrase 1,42362,0.0290215135843568,0.00621024899380383,0.0168494255565013,0.0411936016122123,2.99533035011966e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL3,C-X-C motif chemokine 3,42620,0.0447719092126061,0.00959385789817246,0.0259679477321881,0.0635758706930241,3.0899447881113e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42664,0.0569307320847001,0.0122066339427881,0.0330057295568353,0.0808557346125648,3.13227889055836e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBA,Lysosomal acid glucosylceramidase,40182,0.0268622099119459,0.00576074086169152,0.0155711578230305,0.0381532620008613,3.15337974567809e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAEP,Glycodelin,42495,0.0431616853219766,0.0092847363295698,0.0249636021160198,0.0613597685279334,3.37291620415026e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDK2,Protein sidekick-2,40283,0.0195549117919003,0.00420776498874917,0.0113076924139519,0.0278021311698487,3.40119039897531e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP8,Caspase-8,42674,0.0292820971342876,0.0063031872859659,0.0169278500537945,0.0416363442147808,3.42294468674647e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,40483,0.0340826734005529,0.0073378485085398,0.0197004903238149,0.0484648564772909,3.442888829042e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SF3B4,Splicing factor 3B subunit 4,42587,0.0348040408587578,0.00749556692119116,0.0201127296932231,0.0494953520242924,3.46174379946514e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD40LG,CD40 ligand,42754,0.0370073913538728,0.00797702751646584,0.0213724174215997,0.0526423652861458,3.52954006643684e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFAP,Glial fibrillary acidic protein,42326,-0.0234709854715209,0.00506131509397133,-0.0333911630557047,-0.0135508078873371,3.56343733704585e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",40182,0.0185630907198118,0.00402002053522107,0.0106838504707785,0.0264423309688451,3.92494196531226e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PKN3,Serine/threonine-protein kinase N3,40302,0.0357606786049584,0.00776751253890822,0.0205363540286983,0.0509850031812185,4.19297429486221e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDH12,Protocadherin-12,40482,0.0123327566371435,0.002679265025877,0.00708139718642458,0.0175841160878624,4.20916815029262e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CST1,Cystatin-SN,39042,0.0527026625734701,0.0114540095473449,0.030252803860674,0.0751525212862662,4.2522817506921e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42618,0.140969055429525,0.0306515966286568,0.0808919260373575,0.201046184821692,4.28244786096676e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRTN,Neurturin,42370,0.0233141202419186,0.005074719406159,0.013367670205847,0.0332605702779903,4.38505308356068e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42439,-0.0283016804364337,0.00616702845611833,-0.0403890562104256,-0.0162143046624417,4.49051476364984e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FADD,FAS-associated death domain protein,42636,0.0356615961823768,0.00777689178382834,0.0204188882860733,0.0509043040786804,4.56802749202881e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,40223,0.015968986505883,0.00348233227584691,0.00914361524522307,0.022794357766543,4.574135441583e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMCN2,Hemicentin-2,40269,0.0279243361701978,0.00609051307478521,0.0159869305436188,0.0398617417967768,4.59199686097519e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40223,0.0159154480331827,0.00348040596572615,0.00909385234035941,0.0227370437260059,4.8632461407649e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40451,0.0508859850143997,0.0111437803348971,0.0290441755580013,0.072727794470798,5.01644325046844e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFIC,Nuclear factor 1 C-type,40482,0.0225037840720285,0.00493061236933683,0.0128397838281283,0.0321677843159287,5.0695062910103e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42594,0.0561205601691594,0.0122991352605136,0.0320142550585527,0.0802268652797661,5.0883452794826e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42346,0.0396704835653333,0.00869924333589559,0.022619966626978,0.0567210005036887,5.15608494100022e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42698,0.0194157200765156,0.00425777252596089,0.0110704859256323,0.027760954227399,5.1587320761813e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40223,0.0360676337279283,0.00792390508875635,0.0205367797539659,0.0515984877018907,5.37706618865825e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COPB2,Coatomer subunit beta',40116,0.0204514419630619,0.00449847616415952,0.0116344286813093,0.0292684552448146,5.51831043658928e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VGF,Neurosecretory protein VGF,40482,0.0148540405279843,0.00327437101770264,0.00843627333328717,0.0212718077226815,5.77975336825541e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C2orf69,UPF0565 protein C2orf69,40182,0.0286196443417878,0.0063292160617432,0.0162143808607711,0.0410249078228044,6.19488150263224e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLPS,Colipase,42590,0.0339005399798448,0.0075076222938293,0.0191856002839394,0.0486154796757502,6.37117675658319e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX3,Syntaxin-3,40483,0.0181869333914564,0.00402833111452401,0.0102914044069894,0.0260824623759235,6.40315405361846e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL4A1,Collagen alpha-1(IV) chain,42636,0.0185946931993123,0.00411928568760633,0.0105208932516039,0.0266684931470207,6.41391449624252e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40527,0.0294613525050414,0.00654340302889156,0.016636282568414,0.0422864224416689,6.78447339170602e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,40451,0.0196081179246528,0.00436122057335925,0.0110601256008686,0.0281561102484369,6.99305085809425e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,42346,0.021658632219731,0.00481870409448736,0.0122139721945358,0.0311032922449262,7.02628808956469e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42594,0.0548412660147512,0.012276962238272,0.0307784200277381,0.0789041120017643,7.99711125682268e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,40116,0.0211891643261649,0.00474609621816869,0.0118868157385542,0.0304915129137755,8.10434004865559e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICAM3,Intercellular adhesion molecule 3,42794,0.012398326935501,0.00277785884647131,0.00695372359641719,0.0178429302745847,8.13680730962168e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42587,0.0243069013359048,0.00544923579807816,0.0136263991716716,0.034987403500138,8.23933427262397e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL34,Interleukin-34,42292,0.016836751753188,0.00377501617654132,0.00943772004716705,0.024235783459209,8.26235921886722e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40451,0.0174446279645227,0.00391261540273018,0.00977590177517151,0.0251133541538738,8.33109616401543e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,42370,0.0266513097593573,0.0059824764196445,0.0149256559768541,0.0383769635418606,8.4625401283723e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP10,Stromelysin-2,42608,0.0269810479582933,0.00606545963162542,0.0150927470803075,0.0388693488362792,8.72447281102187e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40255,-0.0223868816658617,0.00504106503454435,-0.0322673691335686,-0.0125063941981548,9.04512199147422e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LCN15,Lipocalin-15,40482,0.028855438429576,0.00650337057790063,0.0161088320968907,0.0416020447622612,9.20866367277133e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX1,Peroxiredoxin-1,42261,-0.0408174158138865,0.00921171582726558,-0.058872378835327,-0.0227624527924459,9.45460004544826e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AK1,Adenylate kinase isoenzyme 1,42636,0.028783939634941,0.00649905900850828,0.0160457839782647,0.0415220952916172,9.54452916938844e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40223,0.0317778078705766,0.00718158033504045,0.0177019104138973,0.0458537053272558,9.74108156205141e-06
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITM2A,Integral membrane protein 2A,42594,0.0281006476181608,0.00636077174751456,0.0156335349930322,0.0405677602432893,1.00490632315722e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PMM2,Phosphomannomutase 2,40116,0.0274758565277369,0.00622775651367594,0.0152694537609321,0.0396822592945418,1.03478575514027e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD84,SLAM family member 5,42594,0.0142281119199673,0.00322580132991604,0.00790554131333185,0.0205506825266027,1.03829940984149e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40511,0.0129684082889766,0.00294939721875752,0.00718758974021185,0.0187492268377413,1.10774882220594e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42754,-0.0127583328686778,0.00290269233238871,-0.0184476098401596,-0.0070690558971959,1.11437971907634e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,42357,0.0282176562671625,0.00644746174933176,0.0155806312384722,0.0408546812958527,1.21499992050615e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17RA,Interleukin-17 receptor A,42611,0.0198372307068833,0.0045344073005796,0.0109497923977473,0.0287246690160193,1.22448066270731e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42689,0.0308592617155401,0.00705422896678995,0.0170329729406318,0.0446855504904484,1.22581356705588e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40482,-0.0121246413412202,0.00278312614595436,-0.0175795685872907,-0.00666971409514966,1.33336337565526e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUSD4,Sushi domain-containing protein 4,40451,0.0190037691623635,0.00436425555931085,0.0104498282661142,0.0275577100586128,1.34603721669233e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42311,0.0495345936371082,0.0113909364756589,0.0272083581448168,0.0718608291293996,1.38044799998113e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42346,0.0439648676964392,0.0101132927933902,0.0241428138213943,0.063786921571484,1.38900110293581e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42172,0.0299457557680251,0.0068998287104822,0.01642209149548,0.0434694200405703,1.43513821118886e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB9,Serpin B9,42495,0.0146510599744159,0.00337736480511466,0.00803142495639114,0.0212706949924406,1.4483491336733e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RSPO1,R-spondin-1,42495,0.0151629143762353,0.0034960739028904,0.00831060952657015,0.0220152192259005,1.45420805286263e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL33,Interleukin-33,42370,0.0172869180145117,0.00399790611212441,0.00945102203474788,0.0251228139942756,1.54356287728125e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBC1D5,TBC1 domain family member 5,42594,0.0347475558683888,0.00805094258423343,0.0189677084032913,0.0505274033334864,1.60050041869206e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,40223,0.0327025166039238,0.00758312537733649,0.0178395908643443,0.0475654423435033,1.62794541632429e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CABP2,Calcium-binding protein 2,40182,0.0289307437221111,0.00670865354705359,0.0157817827698861,0.0420797046743361,1.62863363562575e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNX18,Sorting nexin-18,40449,0.0196280452251133,0.00455617008754029,0.0106979518535344,0.0285581385966923,1.66124808367584e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NME3,Nucleoside diphosphate kinase 3,42638,-0.0106568953838901,0.00247512422551088,-0.0155081388658915,-0.00580565190188882,1.67713620072898e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCDHB15,Protocadherin beta-15,40451,0.0180172695038162,0.0041887798212688,0.00980726105412938,0.0262272779535031,1.71218118381505e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCD6,Programmed cell death protein 6,42636,-0.0312272674174432,0.00727889047492772,-0.0454938927483015,-0.0169606420865849,1.79829991558624e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RP2,Protein XRP2,42587,0.0185505784477516,0.00432412008041036,0.0100753030901473,0.0270258538053559,1.79907173640026e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STXBP3,Syntaxin-binding protein 3,42346,0.0191674302809061,0.00447249459613996,0.0104013408724718,0.0279335196893405,1.8352368369375e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40302,0.0465178637029588,0.0109095859266041,0.0251350752868148,0.0679006521191027,2.02510350045427e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD99L2,CD99 antigen-like protein 2,42611,0.0106355129262293,0.00249529566883345,0.0057447334153157,0.0155262924371428,2.03783563945927e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFHR2,Complement factor H-related protein 2,40451,0.0255395999499577,0.00600326343308993,0.0137732036211014,0.0373059962788139,2.11413161193228e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42495,0.0227865076023968,0.00536136447572854,0.0122782332299689,0.0332947819748247,2.1510064589456e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOE,Apolipoprotein E,40539,0.0320182525563553,0.00754194649452699,0.0172360374270824,0.0468004676856282,2.19983371173752e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRL,Prolactin,42711,0.032728399664054,0.00771460634172674,0.0176077712342696,0.0478490280938384,2.22620946195981e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL14,C-X-C motif chemokine 14,42370,0.0246948619360973,0.00582222458601084,0.013283301747516,0.0361064221246785,2.23564574765119e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",40116,0.0172049083552221,0.00405708215388972,0.00925302733359828,0.025156789376846,2.24648912009362e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFCAB2,Dynein regulatory complex protein 8,40302,0.0153782221755763,0.00362645518304769,0.00827037001680283,0.0224860743343498,2.24761999351383e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CGN,Cingulin,40182,0.0181414930644574,0.00428559027238901,0.00974173613057497,0.0265412499983399,2.32327041651296e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP6,Platelet glycoprotein VI,42590,0.037774521163173,0.00893463277079212,0.0202626409324205,0.0552864013939256,2.37472407594293e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40080,0.0254960454230059,0.00604438149171012,0.0136490576992541,0.0373430331467578,2.48320446298919e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42587,0.0236518920912896,0.00562907184924826,0.012618911266763,0.0346848729158162,2.66588443760132e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,40527,-0.0223018468151498,0.00532639882332227,-0.0327415885088615,-0.0118621051214382,2.8475194419463e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCN1,Transcobalamin-1,40337,0.0148718809851244,0.00355832494648142,0.00789756409002082,0.021846197880228,2.94431695518452e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LCP1,Plastin-2,40527,0.0207810400407173,0.00497324099780317,0.0110334876850231,0.0305285923964115,2.95546983651818e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40421,0.0130720900760043,0.00313341573953157,0.00693059522652243,0.0192135849254862,3.0443177528545e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP170,Centrosomal protein of 170 kDa,40223,0.0333091372715868,0.00799346158597239,0.0176419525630809,0.0489763219800927,3.10923355172127e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40283,0.0269498643086076,0.00648310762186016,0.0142429733697617,0.0396567552474535,3.24968475913083e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1S,Complement C1s subcomponent,40539,0.00896151469467811,0.00215633383868791,0.0047351003708498,0.0131879290185064,3.26382984105303e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMG4,Proteasome assembly chaperone 4,40199,0.0246141923642579,0.00592271846369362,0.0130056641754184,0.0362227205530974,3.26469229495474e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBP1,Retinol-binding protein 1,40182,0.0294240619423464,0.00710685240937095,0.0154946312199793,0.0433534926647135,3.49537091873771e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42754,0.0152292886651591,0.00368243336925339,0.00801171926142246,0.0224468580688958,3.56069844283536e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFNB2,Ephrin-B2,40182,0.0234383793581841,0.00567416419959214,0.0123170175269835,0.0345597411893847,3.64307854748106e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BIN2,Bridging integrator 2,42611,0.0382269102914765,0.00927431981806869,0.0200492434480619,0.0564045771348912,3.78180144793024e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UROS,Uroporphyrinogen-III synthase,40182,0.0290714350750314,0.0070526141459634,0.0152483113489431,0.0428945588011196,3.7822608058431e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40511,0.0318767349144952,0.00773853135713831,0.0167092134545041,0.0470442563744863,3.82856542704172e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMARCA2,Probable global transcription activator SNF2L2,42311,0.0306074172139182,0.00749386277481522,0.0159194461752803,0.045295388252556,4.44665094912266e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,40223,0.0169248455397331,0.00415563456720285,0.00877980178801556,0.0250698892914507,4.67868323391733e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RABEPK,Rab9 effector protein with kelch motifs,42346,0.0241884054874044,0.00594133750181759,0.0125433839838419,0.0358334269909669,4.70441695667387e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDIA5,Protein disulfide-isomerase A5,40080,0.0259455876986511,0.00637841656533594,0.0134438912305927,0.0384472841667096,4.78108779957441e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,40483,0.0228004189263787,0.00561470159102182,0.011795603807976,0.0338052340447815,4.92261930074642e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRH,Corticoliberin,42322,-0.0360540959653416,0.00888192523641186,-0.0534626694287089,-0.0186455225019744,4.95126292218048e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CORO1A,Coronin-1A,42353,0.0372920474924887,0.009191447719259,0.0192768099627411,0.0553072850222364,4.99394919415538e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42711,0.0118331566157994,0.00293504432462103,0.00608046973954215,0.0175858434920566,5.56836191496845e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42594,0.0239849807285773,0.00594929178549339,0.0123243688290103,0.0356455926281443,5.57123083987568e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FBN2,Fibrillin-2,40182,0.0254357932498614,0.00633267161730916,0.0130237568799354,0.0378478296197874,5.94374684844319e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DGKZ,Diacylglycerol kinase zeta,42370,0.0143981445253592,0.00359239641320462,0.00735704755547814,0.0214392414952402,6.15852325344028e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DYNLT3,Dynein light chain Tctex-type 3,40451,0.0180410332803089,0.00450556863857552,0.00921011874870091,0.026871947811917,6.26369597549851e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,40482,0.0520480689453373,0.0130038828446569,0.0265604585698098,0.0775356793208647,6.30768148648653e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFRAL,GDNF family receptor alpha-like,40109,-0.0261344404170908,0.00653198744622478,-0.0389371358116914,-0.0133317450224902,6.34935411474719e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PADI4,Protein-arginine deiminase type-4,42292,0.0296671097748109,0.0074170637626226,0.0151296648000706,0.0442045547495512,6.37320783740207e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKD2,Serine/threonine-protein kinase D2,40116,0.0189361650985858,0.00474276571335063,0.00964034430041851,0.028231985896753,6.57689708874789e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNU13,NHP2-like protein 1,40116,0.0262743992021399,0.00658165782442596,0.013374349866265,0.0391744485380148,6.59292622319107e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRK1,Protein BRICK1,42311,0.0184885235048018,0.00463773823928987,0.00939855655579363,0.0275784904538099,6.74073729594302e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTSH,Pro-cathepsin H,42332,0.0307392501809311,0.00771239937353141,0.0156229474088095,0.0458555529530527,6.76473117469704e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LXN,Latexin,42461,-0.027733042497616,0.00698080959587824,-0.0414154293055373,-0.0140506556896946,7.14218390723354e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42357,0.0127368799801853,0.00321723141785188,0.00643110640119563,0.019042653559175,7.56737027511186e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDZD2,PDZ domain-containing protein 2,40116,0.0247555854618258,0.00626370420881791,0.0124787252125427,0.037032445711109,7.79147019674416e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40482,0.0132464975221776,0.00337567902577479,0.00663016663165904,0.0198628284126962,8.75714223389047e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EHD3,EH domain-containing protein 3,40223,0.0474936266495251,0.0121418190659303,0.0236956612803018,0.0712915920187485,9.22464573177395e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTT2B,Glutathione S-transferase theta-2B,40483,0.0969771375969656,0.0248854556936289,0.048201644437453,0.145752630756478,9.79783564949048e-05
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40449,0.0175414589951947,0.00451019804751736,0.00870147082206072,0.0263814471683288,0.000101117024110234
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,40483,0.019009374964306,0.00488834378697645,0.00942822114183213,0.0285905287867798,0.000101354000578408
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42689,-0.0150084533908587,0.00386484023878367,-0.0225835402588747,-0.00743336652284271,0.000103526442836201
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMBS,Porphobilinogen deaminase,42721,0.0172591149952053,0.0044492507407991,0.00853858354323909,0.0259796464471716,0.000105337698363072
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX5,Syntaxin-5,40199,0.0165516830947998,0.0042705265276855,0.00818145110053622,0.0249219150890634,0.000106894381378192
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42644,0.0196923491095189,0.00508339195943635,0.00972890086902366,0.0296557973500142,0.000107632671954566
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRIM26,Tripartite motif-containing protein 26,40080,0.0226544039110102,0.00585238163300959,0.0111837359103114,0.034125071911709,0.000109035617910608
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40199,0.023542610907804,0.00608390040953707,0.0116181661051114,0.0354670557104967,0.00010961732512145
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL2RG,Cytokine receptor common subunit gamma,40451,0.0146797621994754,0.00380752096289368,0.0072170211122038,0.022142503286747,0.000116152727198781
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPA4,Carboxypeptidase A4,40060,0.0177761551207858,0.00461168771831606,0.00873724719288632,0.0268150630486853,0.000116592445323063
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42346,0.0320622607203045,0.00833050110831456,0.0157344785480079,0.048390042892601,0.000119269318845757
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGT,Angiotensinogen,40532,0.00956118466965461,0.00248635682914939,0.00468792528452181,0.0144344440547874,0.000120984886391213
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40136,0.0129553269298904,0.00337733744163545,0.00633574554428495,0.0195749083154959,0.00012577780165632
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,40136,0.0296741516055597,0.00774724793717688,0.014489545648693,0.0448587575624263,0.000128710763091012
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THBS4,Thrombospondin-4,42652,0.0180906217020692,0.00472419780208494,0.00883119400998275,0.0273500493941557,0.0001290631221904
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,40527,-0.013160575525444,0.00343663623296524,-0.0198963825420558,-0.00642476850883211,0.000129099102717879
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42292,0.0190795017466204,0.00499044135191025,0.00929823669687626,0.0288607667963644,0.000132335922918944
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42676,-0.0165566524530034,0.00436953235512745,-0.0251209358690532,-0.00799236903695359,0.000151843647363595
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40116,0.0176048818320061,0.00464729999016874,0.00849617385127538,0.0267135898127368,0.000152559573731769
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,40451,0.0131554681975477,0.00348017051313732,0.00633433399179859,0.0199766024032969,0.000157561217420573
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PER3,Period circadian protein homolog 3,40199,0.0483514337998867,0.0127919874152172,0.0232791384660611,0.0734237291337123,0.000157769434250474
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYGD,Gamma-crystallin D,40483,0.0380549012835559,0.0100937861048359,0.0182710805180775,0.0578387220490343,0.000163993419718485
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK13,Kallikrein-13,42381,0.0179310806950986,0.00475797760540957,0.00860544458849583,0.0272567168017013,0.000164857923897322
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6V1F,V-type proton ATPase subunit F,42292,0.0257351469024152,0.00683831847024572,0.0123320427007336,0.0391382511040968,0.000168368025079757
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42679,0.0106859904809203,0.00284141033620697,0.00511682622195467,0.016255154739886,0.000170083347649037
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH6,Cadherin-6,42636,0.0150301196383193,0.00400039551579516,0.00718934442736075,0.0228708948492778,0.000172579888304262
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,42311,0.0162415806025176,0.00432375043508199,0.0077670297497569,0.0247161314552783,0.000173145828477095
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDRG1,Protein NDRG1,42311,0.0252493915442365,0.00672472026244457,0.0120689398298452,0.0384298432586279,0.000174290178166433
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB37,Ras-related protein Rab-37,42370,0.0312582118821795,0.00833401901737922,0.0149235346081162,0.0475928891562427,0.000177113232921012
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40223,0.0110042120208666,0.00293605539740847,0.00524954344194601,0.0167588805997872,0.000179190152678412
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNR,Tenascin-R,42495,-0.0163445229659918,0.00436946417564564,-0.0249086727502573,-0.00778037318172637,0.000184334862059412
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWF,von Willebrand factor,42794,0.0277261370608872,0.00742000912294436,0.0131829191799163,0.0422693549418582,0.000187235140543392
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARF2,Scavenger receptor class F member 2,42711,0.0116398682888015,0.00312273661464025,0.00551930452410663,0.0177604320534964,0.000194209932526992
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,40482,0.0146786630498583,0.00394647403455055,0.00694357394213919,0.0224137521575774,0.000200634534333311
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",40223,0.0327407165732864,0.00881324500316194,0.015466756367089,0.0500146767794838,0.000204251691689191
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCN,Decorin,42357,0.00923278665077686,0.00249135589752453,0.00434972909162877,0.0141158442099249,0.000211480861514577
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42636,-0.0097901133338528,0.00264359101009585,-0.0149715517136407,-0.00460867495406493,0.000213631939693182
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HBQ1,Hemoglobin subunit theta-1,42721,-0.0230079231885127,0.00621414070689851,-0.0351876389740338,-0.0108282074029917,0.000214324538334955
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40302,0.0251200362596495,0.00678855655862376,0.0118144654047469,0.038425607114552,0.000216342054203077
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42794,0.0157079917517316,0.00424960813442474,0.00737875980825908,0.0240372236952041,0.000219590055767769
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42781,0.0226497932797101,0.00613535938576232,0.010624488883616,0.0346750976758043,0.000223647929437877
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SRPX,Sushi repeat-containing protein SRPX,40511,0.0141707238919028,0.00384276279937108,0.00663890880513547,0.0217025389786701,0.000227403192536331
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUCA1,Tissue alpha-L-fucosidase,42721,0.0318658013877566,0.00867248487978987,0.0148677310233685,0.0488638717521447,0.000239370312406885
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOLH1,Glutamate carboxypeptidase 2,40199,0.0388276330658303,0.0105724003485989,0.0181057283825765,0.0595495377490842,0.000241283330122774
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDHR1,Cadherin-related family member 1,42311,0.0162225481556868,0.0044196869432987,0.00755996174682135,0.0248851345645522,0.000243017910611244
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,40302,0.016788707876919,0.00458503780335157,0.00780203378234996,0.0257753819714881,0.000251780011511622
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPNMB,Transmembrane glycoprotein NMB,42315,0.0110017171525554,0.00300560476060022,0.00511073182177895,0.0168927024833318,0.000252809591159126
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,42370,0.0162746050336843,0.00445038125573408,0.0075518577724455,0.0249973522949231,0.000256276688560237
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MANSC1,MANSC domain-containing protein 1,42679,0.0105943816339092,0.00289755379449014,0.00491517619670849,0.0162735870711098,0.000256835596822994
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEZ6L2,Seizure 6-like protein 2,42587,-0.00896415830364723,0.0024528824134271,-0.0137718078339643,-0.0041565087733301,0.000258627519910882
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFAT5,Nuclear factor of activated T-cells 5,40199,0.0327488948138889,0.00897568244767553,0.0151565572164449,0.050341232411333,0.000264867215323964
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NMI,N-myc-interactor,40421,0.0272568754387216,0.00747559006675796,0.012604718907876,0.0419090319695672,0.000267436418656353
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NELL2,Protein kinase C-binding protein NELL2,42676,0.0109064739829995,0.00299337701182981,0.0050394550398131,0.016773492926186,0.000269928449636289
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40182,0.0208126864014395,0.00572330075848984,0.00959501691479937,0.0320303558880796,0.000277649823905592
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKAP12,A-kinase anchor protein 12,40283,-0.00834196569836056,0.00229605749023251,-0.0128422383792163,-0.00384169301750485,0.000281225519771653
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PALM3,Paralemmin-3,40116,0.0269973835485853,0.0074367151537149,0.0124214218473041,0.0415733452498665,0.000284404519431377
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAA10,N-alpha-acetyltransferase 10,40116,0.0193526185284675,0.00533216719665975,0.00890157082301436,0.0298036662339206,0.000285367781059139
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40527,0.0533716094856167,0.0147349589694148,0.0244910899055636,0.0822521290656698,0.000293488887164118
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARFIP1,Arfaptin-1,40482,0.0256260005214131,0.00708000356728447,0.0117491935295355,0.0395028075132906,0.000296475667322238
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C5,Complement C5,40539,0.0056543131852811,0.00156231217537955,0.00259218132153718,0.00871644504902501,0.000296806095496207
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40065,0.0330294689332934,0.00912852364110261,0.0151375625967323,0.0509213752698545,0.00029792361379771
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HLA_A,,40482,0.012473239504031,0.00344768832632482,0.00571577038443438,0.0192307086236277,0.000298350885538875
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42490,0.0376398247765254,0.0104106102037146,0.0172350287772449,0.058044620775806,0.000300847480026214
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PROCR,Endothelial protein C receptor,40116,-0.0130689824416364,0.00363135982988301,-0.0201864477082071,-0.00595151717506566,0.000320952531991821
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RALB,Ras-related protein Ral-B,40199,0.0111685795407047,0.00311940427680429,0.00505454715816826,0.0172826119232411,0.000344603755197741
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MUC16,Mucin-16,42587,0.0709757672880863,0.0198302927523065,0.0321083934935655,0.109843141082607,0.000345920224093223
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42357,0.0324303067286642,0.00906579804483765,0.0146613425607824,0.050199270896546,0.000348521134731369
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,40199,0.0144140229341502,0.00403575177277649,0.00650394945950833,0.0223240964087922,0.00035634440668361
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUGT1,Protein SGT1 homolog,42346,0.0294731521576819,0.00825745361936538,0.0132885430637257,0.045657761251638,0.000359240754392808
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENO2,Gamma-enolase,42711,0.023652358930886,0.00662731104839845,0.0106628292760251,0.036641888585747,0.000359694412889295
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH5,Cadherin-5,42794,-0.0110455091556473,0.00311060230156288,-0.0171422896667106,-0.00494872864458408,0.000385179821337423
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42636,0.00641880445351929,0.00180842564098889,0.00287429019718107,0.00996331870985751,0.000387445400948252
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA13,Carbonic anhydrase 13,42483,0.0375489608423112,0.0106033926945,0.0167663111610912,0.0583316105235311,0.000399642479125683
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRR4,Proline-rich protein 4,40198,0.0255929555283069,0.00724671086903973,0.011389402224989,0.0397965088316248,0.000414642221384839
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRTG,Protogenin,42721,0.00905777738319815,0.00256633863201704,0.00402775366444475,0.0140878011019516,0.000417798982880069
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGA,Fibrinogen alpha chain,40284,0.0113491870945948,0.00321960133282084,0.00503876848226598,0.0176596057069237,0.000425144484584436
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40482,0.0180643308906807,0.00513679567054406,0.00799621137641433,0.028132450404947,0.000438739830287855
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,40451,0.016701700893766,0.00474994572328428,0.0073918072761288,0.0260115945114032,0.000439514288045604
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP9,Caspase-9,40199,0.0228320911370474,0.00649662338876147,0.010098709295075,0.0355654729790199,0.000442427936119947
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRRT3,Proline-rich transmembrane protein 3,40223,0.0146042452531246,0.00415733985514207,0.00645585913704617,0.0227526313692031,0.000445048353166244
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40483,0.0198215257406193,0.00564667755496136,0.00875403773289505,0.0308890137483436,0.00044934894950021
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLMH,Bleomycin hydrolase,42794,0.0113156806473378,0.00322696393004481,0.00499083134445002,0.0176405299502257,0.000455329338660717
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,42448,0.00785443072896674,0.00225443903341143,0.00343573022348034,0.0122731312344532,0.00049560325466482
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ELAVL4,ELAV-like protein 4,40136,0.030804482267201,0.00884822693648196,0.0134619574716964,0.0481470070627056,0.000500690115066699
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCT,Secretin,40182,0.0180595437331213,0.00519211939584625,0.00788298971726266,0.02823609774898,0.000506633381193757
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40199,0.0301121297564313,0.00866446784936959,0.0131297727716669,0.0470944867411957,0.000512137775486094
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPC1,Glypican-1,42721,0.0106777964850346,0.00308223138160105,0.00463662297709656,0.0167189699929727,0.000533245747184512
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,40451,0.0187799057611656,0.00542156550252212,0.00815363737622223,0.0294061741461089,0.000534332677887969
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,40483,0.0135458216533694,0.0039202888302832,0.00586205554601434,0.0212295877607245,0.000551677013457844
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40223,0.0364158118343512,0.0105454432459426,0.0157467430723036,0.0570848805963988,0.000556002212273133
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL28,C-C motif chemokine 28,42538,0.0208849079286437,0.00605163910863379,0.00902369527572144,0.0327461205815659,0.000560002165512129
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UBQLN3,Ubiquilin-3,40116,0.0194175906001527,0.0056393064889625,0.00836454988178623,0.0304706313185192,0.000576905487503084
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLITRK6,SLIT and NTRK-like protein 6,42357,0.0126708178996077,0.00368177333831135,0.00545454215651742,0.0198870936426979,0.000580298279678437
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDNRB,Endothelin receptor type B,40199,0.0159388426490879,0.0046403375563328,0.00684378103867563,0.0250339042595002,0.000595079001264824
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STX1B,Syntaxin-1B,40182,0.014441456124809,0.00422016337769691,0.00616993590452303,0.0227129763450949,0.000623857157182716
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATXN2,Ataxin-2,40136,0.0392766724601465,0.0114962418869499,0.0167440383617248,0.0618093065585683,0.000636672106375787
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42754,0.0231803617614519,0.00679738294867726,0.00985749118204447,0.0365032323408593,0.000651070167958101
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42476,0.0254883320618083,0.00748461497271345,0.01081848671529,0.0401581774083267,0.000662554829221126
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SELL,L-selectin,40539,-0.00839557601726958,0.00247786605813732,-0.0132521934912187,-0.00353895854332044,0.000705849221397116
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIRREL2,Kin of IRRE-like protein 2,42311,0.0141037719740553,0.00417362924021722,0.00592345866322959,0.0222840852848811,0.000728933131200541
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB2B,Ras-related protein Rab-2B,40451,0.0211650732690186,0.00627657809677845,0.00886298019933288,0.0334671663387044,0.000748561586940194
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFP,Properdin,40539,0.00779259793303931,0.00231164298689478,0.00326177767872554,0.0123234181873531,0.000751399747724822
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,40116,0.0350306470512639,0.0104349476861461,0.0145781495864174,0.0554831445161103,0.00079047621953227
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WAS,Wiskott-Aldrich syndrome protein,42370,0.0228455840952468,0.00683098158165661,0.00945686019519985,0.0362343079952938,0.000826886477192442
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD1C,T-cell surface glycoprotein CD1c,42679,-0.00868762109778661,0.00259804249488955,-0.0137797843877701,-0.0035954578078031,0.000828314821145047
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFRA2,GDNF family receptor alpha-2,42587,0.00732795122470093,0.00220049932285915,0.00301497255189698,0.0116409298975049,0.000870395926788176
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42559,0.00743391180072367,0.00223494580395146,0.0030534180249788,0.0118144055764685,0.000882710467080262
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42357,0.00954673330503118,0.00287325437027269,0.00391515473929671,0.0151783118707657,0.000894192717359264
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40302,0.0244490717172209,0.00736675431847076,0.0100102332530182,0.0388879101814236,0.000906832942173351
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DIABLO,"Diablo homolog, mitochondrial",42603,0.0371560875716184,0.0112085155812624,0.0151873970323441,0.0591247781108927,0.000918903956592498
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AOC3,Membrane primary amine oxidase,42689,0.0103341058622858,0.0031205260723612,0.00421787476045782,0.0164503369641137,0.000929894010808993
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENSA,Alpha-endosulfine,40451,0.0182441910895287,0.00551715188666686,0.0074305733916617,0.0290578087873958,0.000946592926628202
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIPC3,PDZ domain-containing protein GIPC3,40449,0.0332833950438578,0.0100756266043412,0.0135351668993491,0.0530316231883665,0.000958326507064425
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHIT1,Chitotriosidase-1,42699,0.0525861871412837,0.0159355002955321,0.0213526065620408,0.0838197677205265,0.00096956133736596
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,40511,0.0101431663328813,0.00307431650199325,0.00411750598897457,0.0161688266767881,0.000972173511692254
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42586,0.0205792033984439,0.00625634162195924,0.00831677381940376,0.032841632977484,0.00100683607864543
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCAM,Basal cell adhesion molecule,42611,0.00833211911442235,0.0025413326763806,0.00335110706871638,0.0133131311601283,0.00104573493707668
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BDNF,Brain-derived neurotrophic factor,40527,0.0284443492565133,0.00867760239872911,0.0114362485550043,0.0454524499580224,0.00104895797025276
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMEM25,Transmembrane protein 25,40482,0.0155362728886794,0.0047400468657051,0.00624578103189739,0.0248267647454614,0.00104986891298719
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPA2,Replication protein A 32 kDa subunit,40199,0.0107992851251578,0.00329671514490486,0.00433772344114429,0.0172608468091713,0.00105699799914008
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX6,Peroxiredoxin-6,42721,-0.0203818363547443,0.00624955156504248,-0.0326309574222275,-0.008132715287261,0.00111166274880517
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,40417,0.0146793897393704,0.00450509942037571,0.00584939487543401,0.0235093846033068,0.00112377906640132
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNNI3,"Troponin I, cardiac muscle",42357,0.0284501673209157,0.00874223144366584,0.0113153936913307,0.0455849409505008,0.00113944224894463
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN4,Contactin-4,42611,-0.00806925413494756,0.00247974993453458,-0.0129295640066353,-0.00320894426325978,0.00114050015886605
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PI16,Peptidase inhibitor 16,40532,-0.00849954089459532,0.00261439452371177,-0.0136237541610704,-0.00337532762812025,0.00115313227705563
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EP300,Histone acetyltransferase p300,40199,0.0104435625881782,0.00322197976905669,0.00412848224082711,0.0167586429355293,0.00119319144772615
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JCHAIN,Immunoglobulin J chain,42370,0.0209185178120484,0.00646223683624014,0.00825253361301774,0.0335845020110791,0.00121075160678273
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP5,Platelet glycoprotein V,40283,0.012151988898271,0.0037570363469969,0.00478819765815706,0.0195157801383849,0.00122229414555667
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPA33,Cell surface A33 antigen,42587,0.0463961769140661,0.0143504173825187,0.0182693588443295,0.0745229949838027,0.00122755899254406
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAP,Prolyl endopeptidase FAP,42794,-0.00910775426131763,0.00281953921489698,-0.0146340511225157,-0.00358145740011955,0.0012398553841322
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,40182,0.0170899557140916,0.00532809657483762,0.0066468864274099,0.0275330250007733,0.00134270319208434
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40451,0.0154905615352029,0.00485772237874923,0.00596942567285438,0.0250116973975514,0.00143229725987659
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRING1,SREBP regulating gene protein,40080,0.0196251066408901,0.00616207606987407,0.00754743754393688,0.0317027757378432,0.00145252020304874
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXNL1,Thioredoxin-like protein 1,40124,0.032676729788587,0.0102719551012781,0.0125436977900818,0.0528097617870921,0.00147096757338035
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,40483,0.0111737285698064,0.00351781065597343,0.00427881968409852,0.0180686374555143,0.00149552414352159
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGS10,Regulator of G-protein signaling 10,40482,0.0194977076902868,0.00614880259317985,0.00744605460765428,0.0315493607729193,0.00152333868062439
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42594,0.0322276272447826,0.0101668031307887,0.0123006931084368,0.0521545613811283,0.00152840831180816
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBX2,Chromobox protein homolog 2,40116,-0.0132032234726261,0.00417283063206723,-0.0213819715114779,-0.00502447543377431,0.0015599379390062
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC11A,C-type lectin domain family 11 member A,42592,0.0159802288157475,0.0050548654963727,0.00607269244285697,0.025887765188638,0.00157386401923729
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,42357,0.0189953512857223,0.00602543599678918,0.00718549673201549,0.0308052058394291,0.00162227042668589
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42357,0.0103092174122059,0.00327943159815002,0.00388153147983183,0.0167369033445799,0.00167254759097557
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42594,0.0116340983849735,0.00370417976103155,0.00437390605335165,0.0188942907165953,0.0016885185628434
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,42297,0.0182939810881573,0.00584534557577703,0.00683710375963433,0.0297508584166803,0.00175389194799183
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOLR3,Folate receptor gamma,42629,0.0595918421502617,0.0191525253433867,0.0220528924772238,0.0971307918232997,0.00186570486769815
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40116,0.0130464845672399,0.00419775317851255,0.00481888833735531,0.0212740807971245,0.00188861855272967
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL36G,Interleukin-36 gamma,40154,0.0222092263205434,0.00716461093543527,0.00816658888709024,0.0362518637539965,0.00194108713274415
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPMT,Thiopurine S-methyltransferase,42346,0.0232781798163325,0.00751814373435364,0.00854261809699939,0.0380137415356657,0.00196385941221549
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APPL2,DCC-interacting protein 13-beta,40283,0.0355927237083507,0.0115118015748321,0.0130295926216797,0.0581558547950217,0.00199409206005616
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUSD5,Sushi domain-containing protein 5,40235,-0.0111974737282746,0.00362506939540477,-0.018302609743268,-0.00409233771328127,0.00201398517209221
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FZD8,Frizzled-8,40136,0.0147182700753326,0.00476749222616771,0.00537398531204388,0.0240625548386213,0.0020254715016862
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBPMS,RNA-binding protein with multiple splicing,40199,0.0204489211988567,0.00664316481030013,0.00742831817066842,0.033469524227045,0.0020877461982968
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANXA4,Annexin A4,42584,0.0226289737017686,0.00736121741919097,0.00820098756015434,0.0370569598433829,0.00211577317356191
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APCS,Serum amyloid P-component,40419,0.0108500164265451,0.00354147396556233,0.00390872745404296,0.0177913053990473,0.00219135654640951
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,40116,0.0107190555828265,0.0034989284879075,0.00386115574652784,0.0175769554191252,0.00219278548201925
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNW1,Interferon omega-1,40116,-0.0117223518980083,0.00383225161218095,-0.0192335650578829,-0.00421113873813363,0.00222713114755842
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP53BP1,TP53-binding protein 1,40199,0.0276329876502759,0.00903578419321235,0.00992285063157969,0.0453431246689721,0.00223226113210041
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOD3,Extracellular superoxide dismutase,40532,-0.0185199248473396,0.00608301401471664,-0.0304426323161842,-0.00659721737849494,0.00233577833217518
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42794,0.00714792816829317,0.00235038953579578,0.00254116467813344,0.0117546916584529,0.00236111412157261
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,40283,0.0115551845370463,0.00380290103723648,0.00410149850406279,0.0190088705700298,0.00238298082687214
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39940,0.0336340254193557,0.011070457762177,0.0119359282054887,0.0553321226332227,0.00238584554981415
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LACRT,Extracellular glycoprotein lacritin,40419,0.0162583894137561,0.00535970954230151,0.00575335871084516,0.0267634201166671,0.00242330611213215
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOP56,Nucleolar protein 56,40116,0.0351644351354278,0.0116335213070869,0.0123627333735375,0.0579661368973182,0.00251126353017637
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FN1,Fibronectin,40539,0.00834572868987411,0.00276165175225618,0.00293289125545199,0.0137585661242962,0.00251665488946794
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VIM,Vimentin,42357,0.036264857516854,0.012008073643364,0.0127290331758604,0.0598006818578475,0.00253226337771286
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,42346,0.0128522419468875,0.00425707555419376,0.00450837386066768,0.0211961100331072,0.00254070903990902
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NINJ1,Ninjurin-1,42346,0.0168507842804226,0.0055869763182915,0.00590031069657126,0.0278012578642739,0.00256552261697639
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPESP1,Sperm equatorial segment protein 1,40511,0.00995726395595147,0.00330135439276536,0.00348660934613137,0.0164279185657716,0.00256604691900049
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,40116,0.0101879674749075,0.00338619925225042,0.00355101694049671,0.0168249180093184,0.00262989237155869
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRTAP,Cartilage-associated protein,40182,0.0149781891666139,0.0049820760654813,0.00521332007827057,0.0247430582549573,0.00264945160752556
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40116,0.0188488605355274,0.00627135503999704,0.00655700465713317,0.0311407164139216,0.00265704552903111
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC13A1,Solute carrier family 13 member 1,40451,0.0195346141467411,0.00650861091533338,0.00677773675268767,0.0322914915407945,0.00269375380077297
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRSS53,Serine protease 53,40483,-0.0115717307739186,0.00387548814986358,-0.0191676875476512,-0.00397577400018598,0.00283372969511549
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40199,0.0146493397364673,0.00491242409372169,0.00502098851277277,0.0242776909601618,0.00286905569801256
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42346,0.014696858621543,0.00493562098004559,0.0050230415006536,0.0243706757424323,0.00290937943095774
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL7,Interleukin-7,42594,0.0193927791552074,0.00652228232072638,0.00660910580658373,0.0321764525038311,0.0029512922821205
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB5,Integrin beta-5,42679,-0.0113649802345313,0.00383823881049132,-0.0188879283030943,-0.00384203216596828,0.00307187674425064
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CX3CL1,Fractalkine,42495,-0.0104857118840634,0.0035493156145394,-0.0174423704885606,-0.00352905327956614,0.00313936971492307
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEPTIN3,Neuronal-specific septin-3,40482,0.0230002014078194,0.00778613434295944,0.00773937809561895,0.0382610247200199,0.00314336294797437
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB2,Integrin beta-2,42569,0.00870997256042443,0.00295445597032056,0.00291923885859613,0.0145007062622527,0.00320306930899921
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEZ6L,Seizure 6-like protein,42679,0.0085395040820209,0.00289718682952645,0.00286101789614906,0.0142179902678927,0.00320887071815539
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FMR1,Synaptic functional regulator FMR1,42346,0.0107492709453089,0.00366760504862362,0.0035607650500066,0.0179377768406112,0.00338596559450826
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYTL1,Cytokine-like protein 1,40527,0.00776741548928816,0.00265311981091272,0.00256730065989923,0.0129675303186771,0.0034220969546205
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HGFAC,Hepatocyte growth factor activator,40428,-0.00843795217710487,0.00288758190596021,-0.0140976127127869,-0.00277829164142286,0.00348314977916858
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENO1,Alpha-enolase,42588,0.0236822548894529,0.00810793042022112,0.00779071126581952,0.0395737985130863,0.0034963176135369
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOA4,Apolipoprotein A-IV,40539,0.0109296224411381,0.00374699090557373,0.00358552026621357,0.0182737246160626,0.00354214672536643
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACRV1,Acrosomal protein SP-10,40199,0.0243285578685265,0.00834393595782711,0.00797444339118532,0.0406826723458676,0.00355588090940947
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNC,Tenascin,42689,-0.01449809627321,0.00498810168653629,-0.0242747755788211,-0.00472141696759886,0.00366049541613002
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTC,Probetacellulin,42346,0.0221822402791828,0.00772312704660048,0.00704491126784584,0.0373195692905197,0.00408297514182836
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42674,0.0211356516341211,0.00739264199319695,0.00664607332745506,0.0356252299407871,0.00425614699589584
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,42311,0.0440439154639862,0.0154182903975212,0.0138240662848446,0.0742637646431278,0.0042887571162289
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOX9,Transcription factor SOX-9,40182,0.00821397278484825,0.00288095776924787,0.00256729555712243,0.0138606500125741,0.00436459166883526
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TEX101,Testis-expressed protein 101,40182,0.0156425959610535,0.00550514899100083,0.00485250393869183,0.0264326879834151,0.00449917968081444
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NTF4,Neurotrophin-4,42346,0.011450788455411,0.00404043084245821,0.00353154400419288,0.0193700329066291,0.00460319536906412
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,42346,0.0152594673268964,0.00540000014694415,0.00467546703888587,0.0258434676149069,0.00472297745863511
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40116,-0.00607853392358915,0.00216005112691579,-0.0103122341323441,-0.00184483371483421,0.00490061199185745
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42618,0.0216209056791041,0.00771700026937706,0.00649558515112509,0.0367462262070832,0.00509030954722855
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTB,Lymphotoxin-beta,40451,0.0104270851563615,0.00372346598179588,0.00312909183204154,0.0177250784806814,0.00511309468167973
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAD51,DNA repair protein RAD51 homolog 1,40302,0.0158066434885703,0.00565854644964908,0.00471589244725812,0.0268973945298825,0.00522447291838879
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOS2,"Nitric oxide synthase, inducible",40116,0.0115316424320887,0.00414159553091563,0.0034141151914941,0.0196491696726834,0.00537277770192916
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FRMD4B,FERM domain-containing protein 4B,40116,0.020234313576927,0.00727194791980694,0.00598129565410536,0.0344873314997486,0.00540317506272134
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,40527,-0.00612233120743366,0.00220293198393358,-0.0104400778959435,-0.00180458451892385,0.0054587099294036
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPTP,Ceramide-1-phosphate transfer protein,40116,0.0115202119584965,0.00415668511976394,0.00337310912375913,0.0196673147932338,0.00558947844059417
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MUC2,Mucin-2,40527,0.0267083976315935,0.00964733756448576,0.00779961600520145,0.0456171792579856,0.00564110681397215
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF5,Eukaryotic translation initiation factor 5,40116,0.0126248129041154,0.00457926947585042,0.0036494447314486,0.0216001810767822,0.00584403091419729
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC10A,C-type lectin domain family 10 member A,42495,-0.0103427767987716,0.00375523087647126,-0.0177030293166552,-0.00298252428088792,0.00589099856540096
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRDX2,Peroxiredoxin-2,40333,0.0178400705366379,0.00650311061328119,0.0050939737346068,0.0305861673386691,0.00609198796265286
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARG1,Arginase-1,42488,0.0146195281221308,0.00533658755703063,0.00415981651035078,0.0250792397339108,0.00616166345638949
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40451,0.0187454638016921,0.00685574262019145,0.00530820826611689,0.0321827193372674,0.00626161832395531
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MORC3,MORC family CW-type zinc finger protein 3,40483,0.00801990988616986,0.00293904737446342,0.00225937703222154,0.0137804427401182,0.00636743313940589
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,42475,0.00962574521268795,0.00353857640739103,0.00269013545420153,0.0165613549711744,0.00653212122183593
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FSHB,Follitropin subunit beta,40223,-0.0153049485824678,0.00562845799201964,-0.0263367262468263,-0.00427317091810932,0.00655408252500707
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42662,0.0138376879873642,0.0050918538602413,0.00385765442129128,0.0238177215534372,0.00658387877617302
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK3,Prostate-specific antigen,40527,-0.0276677076242619,0.0101912298144223,-0.0476425180605296,-0.00769289718799431,0.00664052590115717
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPB41L5,Band 4.1-like protein 5,40182,0.0173058877113951,0.00637556146835967,0.00480978723341019,0.0298019881893801,0.00664975668322257
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MST1,Hepatocyte growth factor-like protein,40370,0.0183921418678324,0.0068145340060192,0.00503565521603472,0.03174862851963,0.00696615013167508
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB39B,Ras-related protein Rab-39B,40116,0.0257497101514907,0.00959722853215493,0.00693914222846707,0.0445602780745144,0.00730670051867646
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSAPL1,Proactivator polypeptide-like 1,40449,-0.0142500244773059,0.0053138254323725,-0.024665122324756,-0.00383492662985584,0.00733585019961835
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYB5A,Cytochrome b5,40080,0.0204140768752304,0.00761340911741831,0.00549179500509055,0.0353363587453703,0.00734402968629281
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK14,Kallikrein-14,42721,-0.013016253509533,0.00486355349355423,-0.0225488183568992,-0.00348368866216666,0.00745330999679742
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UNG,Uracil-DNA glycosylase,40451,0.00949075441513778,0.00354924943429468,0.00253422552392021,0.0164472833063554,0.00750567901098704
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCNE1,G1/S-specific cyclin-E1,40199,0.02463622355412,0.00922547809612587,0.00655428648571327,0.0427181606225267,0.00758598719308878
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,40199,0.0172317258561607,0.00646539657680602,0.00455954856562088,0.0299039031467005,0.00770494984049107
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MATN3,Matrilin-3,42475,-0.00896650299046903,0.00337669133205645,-0.0155848180012997,-0.00234818797963839,0.00793063922340065
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRISP3,Cysteine-rich secretory protein 3,40439,-0.00754966274102514,0.00284462533706234,-0.0131251284016673,-0.00197419708038295,0.00796534944834822
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGB3A1,Secretoglobin family 3A member 1,40283,-0.00737463213497347,0.00278410416118492,-0.0128314762908959,-0.00191778797905103,0.00808842294875702
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PFDN2,Prefoldin subunit 2,42311,0.0151330761602778,0.00571764003819099,0.00392650168542349,0.0263396506351322,0.0081370160222429
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42602,0.0155774101887147,0.00589243897108026,0.00402822980539736,0.027126590572032,0.00821184485160152
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA6,Corticosteroid-binding globulin,40539,-0.00431056410923537,0.00163060983618954,-0.00750655938816686,-0.00111456883030388,0.00821595921953121
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX1,ATP-dependent RNA helicase DDX1,40449,0.0137475667899983,0.00520510396720576,0.00354556301427504,0.0239495705657216,0.00827342874950597
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PODXL2,Podocalyxin-like protein 2,42679,0.00770005540582946,0.00292003992238987,0.00197677715794531,0.0134233336537136,0.00837463272721205
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,40302,0.0237015286342614,0.00899789352884312,0.00606565731772888,0.0413373999507939,0.00844727076965875
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDA1,DET1- and DDB1-associated protein 1,40116,0.0110228956695636,0.0041861202023461,0.00281810007296521,0.0192276912661619,0.00847034194190929
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSTN,Growth/differentiation factor 8,42357,0.0145202214497959,0.00551920178878538,0.00370258594377657,0.0253378569558153,0.00852694959018415
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA6C,Semaphorin-6C,40199,0.00716984365389526,0.00273212519859442,0.00181487826465019,0.0125248090431403,0.00869539512754637
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,42346,0.0143625335022305,0.00547840771599935,0.00362485437887183,0.0251002126255893,0.0087602905283879
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42679,-0.0263127756592258,0.0100502267589064,-0.0460112201066823,-0.00661433121176936,0.00885125551712379
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUSP3,Dual specificity protein phosphatase 3,42311,0.0231142765987354,0.00883610210426178,0.00579551647438231,0.0404330367230885,0.0089096998899355
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42689,-0.00853719072154139,0.00327001514514476,-0.0149464204060251,-0.00212796103705767,0.00904438981657729
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PKLR,Pyruvate kinase PKLR,42636,0.0175154433793874,0.00673905091050551,0.00430690359479666,0.0307239831639782,0.00935716070467557
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,40483,-0.0190192990920259,0.00734366794944844,-0.0334128882729448,-0.00462570991110694,0.00961296566269751
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFHD1,EF-hand domain-containing protein D1,40482,0.00969160276285249,0.00375123678654417,0.00233917866122592,0.0170440268644791,0.00979066356195195
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,42346,0.0104864585204655,0.00409430498635791,0.00246162074720397,0.018511296293727,0.0104412680668314
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LMOD1,Leiomodin-1,40482,0.00950185025950585,0.00371496517045712,0.00222051852540989,0.0167831819936018,0.0105489572772888
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42711,-0.0124113078765377,0.00485694537919694,-0.0219309208197637,-0.00289169493331169,0.0106182498862674
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F3,Tissue factor,42636,-0.00715782731936671,0.00281378891013065,-0.0126728535832228,-0.00164280105551064,0.0109752423909941
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40116,-0.010315809532643,0.00405592541559762,-0.0182654233472144,-0.00236619571807169,0.0109918556141704
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,40287,-0.0132986168154505,0.00522944727344405,-0.0235483334714009,-0.0030489001595002,0.0110031896957862
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,42370,0.0117631421854113,0.00464004963772837,0.00266864489546371,0.0208576394753589,0.0112519353031684
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42611,0.00900161663880925,0.00355306119074277,0.00203761670495342,0.0159656165726651,0.011304840452265
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP30,Rho GTPase-activating protein 30,40302,0.0100653069637938,0.00397309497927284,0.00227804080441902,0.0178525731231685,0.0113109024094517
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL9A2,Collagen alpha-2(IX) chain,40302,0.0117442408285307,0.00466046093036555,0.00260973740501427,0.0208787442520472,0.0117502497697015
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFAP3,Microfibril-associated glycoprotein 3,42357,0.0126211095234983,0.00503383557232701,0.00275479180173739,0.0224874272452593,0.0121792359559991
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAA4,Serum amyloid A-4 protein,40539,0.00837246923910359,0.00336382440142286,0.00177937341231477,0.0149655650658924,0.0128254804284195
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40182,-0.016340397243133,0.00659701462183635,-0.0292705459019322,-0.00341024858433373,0.013266418433175
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,40199,0.0062618446287166,0.00253264427364724,0.00129786185236801,0.0112258274050652,0.013433926946065
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM171B,Protein FAM171B,40451,0.00677444712846241,0.00274793285777852,0.00138849872721651,0.0121603955297083,0.0137051092300065
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLC,Galectin-10,42611,0.0167258324258465,0.00680987835629998,0.00337847084749857,0.0300731940041945,0.0140574700261907
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBM25,RNA-binding protein 25,40080,-0.0121431485487485,0.00494465059456919,-0.0218346637141041,-0.00245163338339285,0.0140720513962564
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,40302,0.0146573099127433,0.00597121812060131,0.00295372239636469,0.0263608974291218,0.0141170182556785
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40182,0.0127116705069487,0.00519105336816533,0.00253720590534461,0.0228861351085527,0.0143502037672219
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PODXL,Podocalyxin,42587,-0.00382399986713797,0.0015778989860327,-0.00691668187976206,-0.00073131785451388,0.0153859429004146
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40116,0.0210082778010383,0.00868950237322078,0.00397685314952561,0.0380397024525511,0.015636850828944
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IMPA1,Inositol monophosphatase 1,42495,0.015019728418204,0.00622134887289712,0.00282588462732569,0.0272135722090824,0.0157821869713032
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARG2,"Arginase-2, mitochondrial",40451,0.0107263272509822,0.0044450423546216,0.00201404423592383,0.0194386102660405,0.0158333945162974
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DOC2B,Double C2-like domain-containing protein beta,40182,0.00907932597215859,0.00376678951664709,0.00169641851953029,0.0164622334247869,0.0159530210076541
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42495,-0.0295963612313898,0.0123341138559546,-0.0537712243890608,-0.00542149807371883,0.0164287661618651
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42638,0.0064039257973557,0.00267385652465927,0.00116316700902354,0.0116446845856879,0.0166332973866868
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYOM3,Myomesin-3,40283,-0.0230896063684553,0.00964553307650762,-0.0419948511984103,-0.00418436153850039,0.0166907435174533
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MORF4L2,Mortality factor 4-like protein 2,40080,0.00909592159683773,0.00382899313626614,0.00159109504975609,0.0166007481439194,0.0175405635329454
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRD2,Bromodomain-containing protein 2,40136,0.00883450538795213,0.00372670594693881,0.00153016173195205,0.0161388490439522,0.0177767733768608
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STAM,Signal transducing adapter molecule 1,40451,0.00920281344524233,0.00388598269299753,0.00158628736696718,0.0168193395235175,0.0178913022529113
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42654,0.0215646568800068,0.00912129900029873,0.00368691083942131,0.0394424029205923,0.0180827329041138
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40482,0.00583141145629299,0.00246759092733551,0.000994933238715392,0.0106678896738706,0.0181347299230889
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSF2RB,Cytokine receptor common subunit beta,40199,0.0106213843371977,0.00453019035646079,0.00174221123853451,0.0195005574358608,0.0190663085927768
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRDT,Bromodomain testis-specific protein,40116,0.00898499007421451,0.00386254854897431,0.00141439491822485,0.0165555852302042,0.0200270607295623
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD200,OX-2 membrane glycoprotein,42594,-0.00658076641520433,0.00282996326177914,-0.0121274944082914,-0.00103403842211721,0.0200660030915164
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40182,0.0258889545681505,0.0111762271243613,0.00398354940440246,0.0477943597318986,0.0205530720863462
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,40080,0.0345343651504653,0.014927685775485,0.0052761010305148,0.0637926292704159,0.0207167782176754
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,40145,0.00921574930472525,0.00398872038671466,0.00139785734676452,0.017033641262686,0.0208816026182563
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40182,0.0130995207585057,0.00567166605466071,0.00198305529137074,0.0242159862256407,0.0209264031058762
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSRP3,Cysteine and glycine-rich protein 3,40116,0.0238504685454864,0.0103925213902626,0.00348112662057177,0.0442198104704011,0.0217540241171545
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OPTC,Opticin,42587,-0.0109327176513806,0.00478798153885553,-0.0203171614675374,-0.00154827383522376,0.0224243656898824
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MZT1,Mitotic-spindle organizing protein 1,42346,0.0121251878297012,0.00532974072671557,0.00167889600533866,0.0225714796540637,0.0229216404403391
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,40449,0.00646647195821665,0.00284307383873708,0.000894047234291967,0.0120388966821413,0.022956776787552
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HRAS,GTPase Hras,40286,0.0236126632641557,0.0103899554401561,0.00324835060144981,0.0439769759268615,0.0230667276787158
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40451,0.0213862846413813,0.00942518163799267,0.00291292863091561,0.0398596406518469,0.0232836353711763
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,40527,0.0149218026293521,0.00658133790541473,0.00202238033473919,0.0278212249239649,0.0233912580696082
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40511,0.00783494825062307,0.00345860661817208,0.00105607927900579,0.0146138172222404,0.0235101385086433
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MELTF,Melanotransferrin,40511,0.00707869008356433,0.00313749381670454,0.000929202202823444,0.0132281779643052,0.0240795770158285
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40451,0.0226554131695404,0.0100528524082452,0.00295182244937979,0.042359003889701,0.0242385912062843
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,40080,0.0137919505089552,0.00615357975428164,0.00173093419056316,0.0258529668273472,0.0250274339006895
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPR1,Atrial natriuretic peptide receptor 1,40116,-0.00955065214316755,0.00426773715438815,-0.0179154169657683,-0.00118588732056678,0.0252494401287087
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTLA,B- and T-lymphocyte attenuator,40080,0.0205182748955202,0.00917410384861546,0.00253703135223389,0.0384995184388065,0.0253364160007954
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,40199,0.00824622018897831,0.0036899414516453,0.00101393494375351,0.0154785054342031,0.0254515573527863
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLASP1,CLIP-associating protein 1,40080,0.0168916930142418,0.00756506571395812,0.00206416421488389,0.0317192218135997,0.0255787729295114
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAGLN3,Transgelin-3,40080,0.0142524895037553,0.00638547431323802,0.0017369598498088,0.0267680191577019,0.0256340827492111
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VEGFD,Vascular endothelial growth factor D,42734,-0.00827771562324627,0.00372148296375725,-0.0155718222322105,-0.000983609014282059,0.0261443103721965
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40223,0.0101818655647502,0.00458821705275557,0.00118896014134925,0.0191747709881511,0.0264979234505735
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MDM1,Nuclear protein MDM1,40182,0.00720681631403165,0.00325423640540764,0.000828512959432677,0.0135851196686306,0.0268083025979841
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42721,-0.00607356434233863,0.00274623246862535,-0.0114561799808443,-0.000690948703832956,0.0270110546553521
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,40199,0.0123335462586554,0.00558559360356264,0.00138578279567263,0.0232813097216382,0.0272578832707508
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40482,0.0264063056069601,0.0119821942456388,0.00292120488550797,0.0498914063284122,0.0275588445187152
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSHB,Thyrotropin subunit beta,42636,0.018026580367665,0.00819456801252892,0.00196522706310832,0.0340879336722217,0.0278365763416366
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GJA8,Gap junction alpha-8 protein,40080,0.0149141356427191,0.00679786781030152,0.0015903147345281,0.0282379565509101,0.028260557199363
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK1,Kallikrein-1,42505,-0.0292867686925454,0.0133738107030434,-0.0554994376705104,-0.00307409971458036,0.0285517091300676
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,40449,0.0126656145628248,0.0057934906488868,0.00131037289100666,0.0240208562346429,0.0288229503722894
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC1A4,Neutral amino acid transporter A,40182,0.0118457393367738,0.00542239991398544,0.00121783550536233,0.0224736431681853,0.0289397261527977
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40116,0.0111390454592404,0.0051040984350403,0.00113501252656139,0.0211430783919193,0.0291032624279272
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD33,Myeloid cell surface antigen CD33,42679,0.0180450431948737,0.00827409022280232,0.00182782635818117,0.0342622600315663,0.0292073192693917
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40080,0.00608585395504257,0.00280199707839332,0.00059393968139166,0.0115777682286935,0.0298794302782341
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GC,Vitamin D-binding protein,40539,0.00583142545700715,0.00268644973514429,0.000565983976124352,0.01109686693789,0.0299759617153364
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40223,-0.00473264126643387,0.00218325388254882,-0.00901181887622956,-0.000453463656638182,0.0302027771867879
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40116,0.0118035354041648,0.0054502950220305,0.00112095716098503,0.0224861136473446,0.0303580550394843
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERC2,ERC protein 2,40182,0.0170064005797399,0.00789340577594264,0.00153532525889228,0.0324774759005874,0.031222074783651
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42653,0.0109393503961179,0.00508433347515312,0.000974056784817828,0.020904644007418,0.0314481825243932
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,INSL3,Insulin-like 3,40483,-0.0173868611991403,0.00812297433018123,-0.0333078908862955,-0.00146583151198507,0.03233937429107
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSCA,Prostate stem cell antigen,40449,0.0591509078336145,0.0276990594627129,0.0048607512866973,0.113441064380532,0.0327429908306333
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCP2,Non-specific lipid-transfer protein,42346,0.0162100344108293,0.00765608172745987,0.00120411422500791,0.0312159545966506,0.0342551893425362
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,42357,-0.00728654725884286,0.0034484295011031,-0.0140454690810049,-0.000527625436680778,0.03461914953213
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZP3,Zona pellucida sperm-binding protein 3,40223,0.0594670805518099,0.0281730927315815,0.00424781879791017,0.11468634230571,0.0348140401648596
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCUN1D1,DCN1-like protein 1,40136,0.0164602906935312,0.00781006242917869,0.00115256833234096,0.0317680130547214,0.0350904744670855
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPN1,Epsin-1,40302,0.00977204588170684,0.00463943666546833,0.000678750017388912,0.0188653417460248,0.0352006670147906
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40199,0.0140138142145873,0.00670445061379675,0.000873091011545719,0.027154537417629,0.0366204321069205
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHP1,Calcineurin B homologous protein 1,40136,0.0161179306167352,0.00772462787446937,0.000977659982775197,0.0312582012506951,0.0369506560586367
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPCAM,Epithelial cell adhesion molecule,42616,0.021305745778806,0.0102130802121342,0.00128810856302305,0.041323382994589,0.0369862785350062
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,40302,0.0117424579643437,0.00563379004239916,0.000700229481241337,0.022784686447446,0.0371564956154448
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HIP1,Huntingtin-interacting protein 1,40116,0.0072340394284591,0.00347442079089852,0.000424174678298001,0.0140439041786202,0.0373579277002422
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAD2,Glutamate decarboxylase 2,40199,-0.0099931513456873,0.00480083843546443,-0.0194027946791976,-0.000583508012177015,0.03740729492708
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYOM1,Myomesin-1,40136,0.0104318688459366,0.00501610967011159,0.000600293892517867,0.0202634437993553,0.0375787430292596
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SUMF1,Formylglycine-generating enzyme,40199,0.0138841429222263,0.00668059651745038,0.000790173748023515,0.026978112096429,0.0377067952036988
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NENF,Neudesin,40451,0.0237691599436553,0.011450890511018,0.00132541454206007,0.0462129053452506,0.0379399367921061
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNF174,Zinc finger protein 174,40199,0.00807540453263661,0.00389773652154253,0.000435840950413243,0.01571496811486,0.0383055651231206
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,40451,0.00864428552506774,0.00417550019001506,0.000460305152638221,0.0168282658974973,0.0384526682018245
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,40136,-0.00733264242534906,0.0035456526636652,-0.0142821216461328,-0.000383163204565272,0.0386572959021701
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANGPTL4,Angiopoietin-related protein 4,42654,0.00956532602104769,0.00462904261746702,0.000492402490812324,0.018638249551283,0.0388124115854897
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42311,0.011249134593339,0.00546687203943013,0.000534065396055943,0.021964203790622,0.0396395019375469
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL9A1,Collagen alpha-1(IX) chain,42594,-0.0102903127446809,0.00501102988178395,-0.0201119313129774,-0.00046869417638434,0.0400403251745575
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYL3,Myosin light chain 3,40223,0.0156141232060081,0.00762743629022437,0.000664348077168331,0.0305638983348479,0.0406719331569246
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDSN,Corneodesmosin,42710,0.00941650956829412,0.00460045349508568,0.000399620717926194,0.018433398418662,0.04069058952232
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RRP15,RRP15-like protein,40136,-0.0195801422558311,0.00957133227812058,-0.0383399535209475,-0.00082033099071481,0.0408090570528063
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SDC4,Syndecan-4,42636,-0.00994099050853642,0.00486462249240195,-0.0194756505936442,-0.000406330423428592,0.0410196880673649
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RELB,Transcription factor RelB,40199,0.010566562517779,0.00517309205454392,0.000427302090872895,0.0207058229446851,0.041115740023268
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POMC,Pro-opiomelanocortin,40223,0.0148200849682455,0.00726131699353356,0.000587903660919752,0.0290522662755713,0.0412781840736468
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40182,0.00846141021106697,0.00415520908323066,0.000317200407934874,0.0166056200141991,0.0417403539953307
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42346,0.00671407092055066,0.00329875441668615,0.000248512263845815,0.0131796295772555,0.0418371650472374
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,40136,-0.00615276202619752,0.00302456801699098,-0.0120809153394998,-0.00022460871289519,0.0419493119005277
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP112,Centrosomal protein of 112 kDa,40116,0.00947439841188905,0.00466501977216417,0.000330959658447268,0.0186178371653308,0.0422847488626808
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BAG3,BAG family molecular chaperone regulator 3,42475,0.00848892793435684,0.00418048891007219,0.000295169670615353,0.0166826861980983,0.042314810823772
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCGB2A2,Mammaglobin-A,40116,-0.00670219348102601,0.00330565831901234,-0.0131812837862902,-0.000223103175761813,0.0426364264324681
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TXK,Tyrosine-protein kinase TXK,40302,0.0158270542027475,0.00782081224614888,0.00049826220029567,0.0311558462051993,0.043023915949865
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TIMP2,Metalloproteinase inhibitor 2,40511,0.00581853394087441,0.00289500323365935,0.000144327602902089,0.0114927402788467,0.0444703287352136
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,40080,-0.00991268934353524,0.0049659815869122,-0.0196460132538832,-0.000179365433187318,0.0459458567286056
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGA2,Integrin alpha-2,40283,-0.00723394607624017,0.0036313558844633,-0.0143514036097882,-0.000116488542692106,0.0463869223348366
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,40080,0.016115330730662,0.00809592883714532,0.000247310209857205,0.0319833512514669,0.0465556216982333
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL17F,Interleukin-17F,42370,0.0155216826560724,0.00780079219361952,0.000232129956578089,0.0308112353555666,0.0466383200209052
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PVALB,Parvalbumin alpha,42654,0.0224855262125389,0.0113120471261509,0.000313913845283238,0.0446571385797946,0.046859528882217
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTNAP4,Contactin-associated protein-like 4,40182,0.0211536972148097,0.0107055641775689,0.000170791426774692,0.0421366030028447,0.0481850171409117
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH3GL3,Endophilin-A3,40250,0.0175748428633117,0.00889483987367483,0.000140956710909038,0.0350087290157144,0.0481969295956259
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIAA2013,Uncharacterized protein KIAA2013,40451,0.0110334308635263,0.00558567374124067,8.55103306946145e-05,0.021981351396358,0.0482574966734521
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AIF1L,Allograft inflammatory factor 1-like,40223,0.0114272219509046,0.00578751954054649,8.36836514334482e-05,0.0227707602503757,0.0483544447714521
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DKK3,Dickkopf-related protein 3,42794,0.00615081077483991,0.00311759800840894,4.03186783583817e-05,0.0122613028713214,0.0485234595907411
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39633,0.0112595217154292,0.00570892773840248,7.00233481603536e-05,0.0224490200826981,0.0486056490383928
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,42370,0.00745134128308451,0.00377998050803615,4.25794873336639e-05,0.0148601030788354,0.0487145252238997
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSG4,Desmoglein-4,42543,-0.0102049050454775,0.00517816172848928,-0.0203541020333164,-5.5708057638465e-05,0.0487721605715249
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GKN1,Gastrokine-1,42017,0.00570657967376903,0.00290524213781942,1.23050836429613e-05,0.0114008542638951,0.0495243566298126
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD109,CD109 antigen,42611,0.00680678776118637,0.00346953355215985,6.50199895306687e-06,0.0136070735234197,0.0497977951464738
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCARB1,Scavenger receptor class B member 1,42311,0.0117743248654554,0.00600808210870868,-1.51606761358662e-06,0.0235501657985244,0.0500464350127249
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42794,0.00556691435808224,0.00284405692765254,-7.43722011673897e-06,0.0111412659362812,0.0503226446678613
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPSD1,Tryptase delta,40482,0.00779710472209536,0.00399271926895898,-2.86250450642336e-05,0.015622834489255,0.0508643385149369
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOS,Proto-oncogene c-Fos,40065,0.00725638534588539,0.00372185562317685,-3.84516755412324e-05,0.014551222367312,0.0512412966890045
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARTN,Artemin,42370,0.00899422326648084,0.00461446720669894,-5.01324586490836e-05,0.0180385789916108,0.0513003989827635
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42311,0.0102182820019278,0.005247688769119,-6.71879855454697e-05,0.020503751989401,0.0515324745036366
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDCL2,Phosducin-like protein 2,40080,0.0107515093902174,0.00552690510357544,-8.12246127905192e-05,0.0215842433932252,0.0517641369145234
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TTN,Titin,40116,0.0132582648202563,0.00682496160353972,-0.000118659922681527,0.0266351895631942,0.0520885014892665
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEB,Nebulin,40116,0.00775225675737839,0.00399315148863321,-7.43201603427019e-05,0.0155788336750995,0.0522369078389632
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42459,-0.00830944907042219,0.00428640987564153,-0.0167108124266796,9.19142858352186e-05,0.0525765124183566
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,40136,0.0100632281579628,0.00520470991240327,-0.000138003270347591,0.0202644595862732,0.0532022509340417
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PYDC1,Pyrin domain-containing protein 1,40223,0.00859169923905726,0.00445012350847141,-0.000130542837546696,0.0173139413156612,0.0535500537084141
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA1,Alpha-1-antitrypsin,40327,0.00163558792420465,0.000850325185881496,-3.10494401230875e-05,0.00330222528853238,0.0544446124378698
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40539,0.00510188590617316,0.00265604910650071,-0.000103970342568222,0.0103077421549145,0.0547749905146397
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40449,-0.0140803775771394,0.00733436630837288,-0.0284557355415503,0.000294980387271406,0.0549108086847759
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TET2,Methylcytosine dioxygenase TET2,40286,0.0204668287653556,0.0106705784837683,-0.000447505062830315,0.0413811625935414,0.0551288237973041
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42705,0.00400106412114416,0.0020874172486506,-9.02736862110239e-05,0.00809240192849934,0.0552903369218549
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL26,C-C motif chemokine 26,42594,0.0183885008451019,0.0096068093538753,-0.000440845488493703,0.0372178471786975,0.0556272326071407
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLB,Beta-klotho,42311,-0.0146450576445718,0.00769938473856237,-0.029735851732154,0.00044573644301045,0.0571789817814767
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,40182,-0.00733925319793752,0.00386129870466189,-0.0149073986590748,0.000228892263199773,0.0573646528039086
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRP1,Neuropilin-1,42705,-0.00543380127794123,0.00286245288468357,-0.011044208931921,0.000176606376038566,0.0576775426717581
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,42425,-0.0337024861394593,0.0177559278010169,-0.0685041046294524,0.00109913235053389,0.0577049520962317
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40482,0.014184752641674,0.00749633585886922,-0.000508065641709705,0.0288775709250577,0.0584866009363611
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SKIV2L,Helicase SKI2W,40116,0.00782107479862673,0.00414026460160427,-0.000293843820517631,0.0159359934177711,0.0589145758904305
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C9orf40,Uncharacterized protein C9orf40,40449,0.0159444166623799,0.00845392575677535,-0.000625277820899755,0.0325141111456596,0.0593156961025032
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTR,Methionine synthase,40116,0.0130110875341769,0.00690078850776915,-0.000514457941050595,0.0265366330094045,0.0593957082627924
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDI2,Protein DDI1 homolog 2,40283,0.0153308095825247,0.00816155969496347,-0.000665847419603722,0.0313274665846531,0.060350404889245
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCG3,Secretogranin-3,42638,0.0066311089341778,0.00353244701551529,-0.00029248721623217,0.0135547050845878,0.0605123470642581
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DOCK9,Dedicator of cytokinesis protein 9,40136,0.023571986351794,0.012579405988676,-0.00108364938601085,0.0482276220895989,0.0609770035410637
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DKKL1,Dickkopf-like protein 1,42587,-0.0169978406033308,0.009086938220614,-0.0348082395157342,0.000812558309072647,0.0614251763051439
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42587,0.00386715590744202,0.00206761601971313,-0.000185371491195719,0.00791968330607976,0.0614576769605605
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCC,Netrin receptor DCC,40182,0.0045016933141576,0.00241097463615772,-0.000223816972711536,0.00922720360102674,0.0619048176066889
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BPIFB2,BPI fold-containing family B member 2,40473,0.013313174675638,0.0071442948050862,-0.000689643142330939,0.027315992493607,0.062422223700341
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINT3,Kunitz-type protease inhibitor 3,40449,-0.0287737533794071,0.0154653299336249,-0.0590858000493119,0.00153829329049763,0.0628362456357791
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFRA3,GDNF family receptor alpha-3,42474,0.00550172673456041,0.00296866943938695,-0.000316865366638008,0.0113203188357588,0.0638667641067026
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,42346,0.0110603542811093,0.00596978984881631,-0.000640433822570674,0.0227611423847893,0.0639447626566458
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THPO,Thrombopoietin,42357,-0.00746103259733089,0.00403175628841556,-0.0153632749226254,0.000441209727963618,0.0642543523496277
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PROS1,Vitamin K-dependent protein S,40539,0.00501073563630824,0.00270979460760795,-0.00030046179460334,0.0103219330672198,0.0644664712647876
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTP1,Glutathione S-transferase P,42237,-0.0133117972720969,0.00725383798555759,-0.0275293197237898,0.000905725179595947,0.0665079307235847
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,40080,0.0165066281357007,0.00901872673877849,-0.00117007627230513,0.0341833325437065,0.0672381757191533
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINF2,Alpha-2-antiplasmin,40317,0.00256412191896594,0.00140189804595852,-0.000183598251112755,0.00531184208904464,0.0674209827260072
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40116,0.0094145466034115,0.00515219785289229,-0.00068376118825738,0.0195128543950804,0.0676838301452239
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SNAP25,Synaptosomal-associated protein 25,40136,0.00893952078237244,0.00492734207337195,-0.000718069681436583,0.0185971112461815,0.0696637962408265
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ALMS1,Alstrom syndrome protein 1,40302,-0.00842940652448046,0.00464864452228641,-0.0175407497881618,0.000681936739200903,0.069811896088192
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYPLA2,Acyl-protein thioesterase 2,40136,0.0211461434252247,0.0116739061494386,-0.00173471262767499,0.0440269994781243,0.0701059681278705
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FST,Follistatin,42654,0.00918320580362482,0.00507359283887369,-0.000761036160567602,0.0191274477678172,0.0703179956571929
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRP2BP,LRP2-binding protein,40182,0.016187033166444,0.0089799740636248,-0.00141371599826061,0.0337877823311486,0.0714831396452922
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB7,Integrin beta-7,42721,0.00854800707277245,0.00475384798359455,-0.000769534975072868,0.0178655491206178,0.0721796843530438
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRG2,Bone marrow proteoglycan,40527,0.00985353220357725,0.00548151217860431,-0.000890231666487206,0.0205972960736417,0.0722680137230657
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLNS1A,Methylosome subunit pICln,40182,0.00621541053283524,0.00347039697869195,-0.000586567545400981,0.0130173886110715,0.073324067828855
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REXO2,"Oligoribonuclease, mitochondrial",40116,-0.00890632220818107,0.00498383759551162,-0.0186746438953838,0.000861999479021699,0.0739585817193194
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40223,-0.00731966823563691,0.00411904351291302,-0.0153929935209464,0.000753657049672616,0.0755906851288032
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GHRHR,Growth hormone-releasing hormone receptor,42311,-0.0103199314027143,0.00581032343364397,-0.0217081653326565,0.00106830252722787,0.0757334872673468
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPS10,40S ribosomal protein S10,40116,-0.00750933635085655,0.00423404486910655,-0.0158080642943054,0.000789391592592277,0.0761636720094207
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGA6,Integrin alpha-6,42594,0.00926633969154069,0.00523476274883935,-0.00099379529618443,0.0195264746792658,0.0767241137116638
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NCLN,Nicalin,42370,0.00946073280122333,0.00535141662197725,-0.00102804377785207,0.0199495093802987,0.0771019067110823
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP164,Centrosomal protein of 164 kDa,42370,0.0120190589298029,0.00681218752912369,-0.00133282862727951,0.0253709464868853,0.0776968339107876
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPM1B,Protein phosphatase 1B,40199,0.011198793152876,0.00635167060358398,-0.0012504812301486,0.0236480675359006,0.077907054289536
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,42346,-0.00560214088363615,0.00317972293376962,-0.0118343978338246,0.00063011606655231,0.0781207416994611
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCL24,C-C motif chemokine 24,42654,0.0150449449760092,0.00854512373276866,-0.00170349754021742,0.0317933874922357,0.0783209043756464
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC2L,C-type lectin domain family 2 member L,40182,0.00901931577197968,0.00512661351597242,-0.00102884671932625,0.0190674782632856,0.0785522542042462
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP290,Centrosomal protein of 290 kDa,40302,0.00996802619237129,0.00568409105198019,-0.00117279226950989,0.0211088446542525,0.079514458140345
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA7,Carbonic anhydrase 7,40302,-0.00643540005048853,0.00367041129950901,-0.0136294061975262,0.000758606096549127,0.0795749314705104
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,40182,0.0153211896036481,0.0087458082859073,-0.00182059463673017,0.0324629738440265,0.0798305403225272
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CFHR5,Complement factor H-related protein 5,40382,-0.00769196047016365,0.00439795682043986,-0.0163119558382258,0.000928034897898481,0.0803210350063115
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42673,0.00585695876781496,0.0033514332555209,-0.000711850413005997,0.0124257679486359,0.0805563953845748
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",40182,0.0152875173448737,0.00874794304633848,-0.00185845102594977,0.0324334857156971,0.0805689324924181
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACTN4,Alpha-actinin-4,42370,0.00588793977530279,0.00337936728191371,-0.00073562009724807,0.0125114996478537,0.0814757680629199
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42311,0.00539880052004413,0.00310783013318972,-0.000692546541007718,0.011490147581096,0.0823822744272276
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAP1A,Ras-related protein Rap-1A,40199,0.0128407606481973,0.00739256212221793,-0.0016486611113498,0.0273301824077445,0.0824180099981936
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRNN,Cornulin,42209,-0.0123655118599505,0.00712918548707087,-0.0263387154146094,0.00160769169470845,0.0828545828092776
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40116,-0.00962369267322887,0.00555095478470441,-0.0205035640512495,0.00125617870479177,0.0829994704518986
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42689,0.00642789217086011,0.00371815647709181,-0.000859694524239846,0.0137154788659601,0.0838705000196432
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42587,-0.00995480422940271,0.00576370039641691,-0.0212516570063799,0.00134204854757444,0.0841628777983643
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEMA4C,Semaphorin-4C,42587,0.0049642194690887,0.00287478408265844,-0.000670357332921839,0.0105987962710992,0.084224002439514
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTA4H,Leukotriene A-4 hydrolase,42721,0.0103967862677111,0.0060335015504594,-0.00142887677118934,0.0222224493066115,0.0848795194576482
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,40116,0.0105969937600451,0.00615640744818733,-0.00146956483840205,0.0226635523584923,0.0852256126635942
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40302,0.00942850856781615,0.00547934231337605,-0.00131100236640091,0.0201680195020332,0.0853263571010107
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXDC2,Plexin domain-containing protein 2,40483,0.00488035682206105,0.00283622816570547,-0.00067865038272167,0.0104393640268438,0.0853289003970988
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX25,ATP-dependent RNA helicase DDX25,40182,-0.00676582581699305,0.00394334459686046,-0.0144947812268396,0.000963129592853456,0.0862344978389805
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NEO1,Neogenin,40482,0.00396026202885332,0.00231000221488301,-0.000567342312317379,0.00848786637002401,0.0864831971318984
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRR1B,Cornifin-B,40302,0.0148161743759149,0.00865791889037015,-0.00215334664921057,0.0317856954010404,0.0870562685614531
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FES,Tyrosine-protein kinase Fes/Fps,42346,0.00841027347195744,0.00491508721976167,-0.00122329747877544,0.0180438444226903,0.0870836906241743
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40136,-0.00563840432882546,0.00329896180371259,-0.0121043694641021,0.000827560806451214,0.0874524358336334
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP350,Centrosome-associated protein 350,40080,0.00674188683953878,0.00396057427165392,-0.00102083873290289,0.0145046124119805,0.0887370980693911
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42357,-0.00541041545531181,0.0031842119943185,-0.0116514709641761,0.000830640053552443,0.0893168230621799
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,YY1,Transcriptional repressor protein YY1,40199,0.00497549874887888,0.0029352053860726,-0.000777503807823417,0.0107285013055812,0.0900826677371981
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,40199,0.00966685590804759,0.00570791091126697,-0.00152064947803567,0.0208543612941308,0.0903716834184865
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40223,-0.00652810640148382,0.00385475868403996,-0.0140834334222021,0.00102722061923449,0.0903849928769511
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,40482,-0.0079706436871695,0.00471210286837947,-0.0172063653091933,0.00126507793485426,0.090764022802529
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40302,0.00920957854079833,0.00545544745225141,-0.00148309846561444,0.0199022555472111,0.091411743522627
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA8,Carbonic anhydrase-related protein,40199,0.0050312943848379,0.00298188829437892,-0.000813206672144792,0.0108757954418206,0.0915769679058712
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP9,Fatty acid-binding protein 9,42594,0.00984946066004827,0.00585467626792543,-0.00162570482508556,0.0213246261451821,0.0925293859940588
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPING1,Plasma protease C1 inhibitor,40516,-0.00319586893002849,0.00190036934534226,-0.00692059284689932,0.000528854986842334,0.0926527891116291
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,42357,0.0135453999305803,0.00806163592057798,-0.00225540647375256,0.0293462063349131,0.0929363656472029
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FOSB,Protein fosB,42311,0.0066347275775025,0.00396135950018736,-0.00112953704286474,0.0143989921978697,0.0939852929858799
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40527,0.00687882431177051,0.00410997555519885,-0.00117672777641924,0.0149343763999602,0.0942191687762138
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TJP3,Tight junction protein ZO-3,40136,-0.00731143051133832,0.00438532597186529,-0.0159066694161943,0.00128380839351764,0.0954935128702475
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEP152,Centrosomal protein of 152 kDa,40080,0.00720279737029152,0.00434189799425952,-0.00130732269845713,0.0157129174390402,0.0971636945218123
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERCC1,DNA excision repair protein ERCC-1,40080,0.00585145053798813,0.00355979187637901,-0.00112574153971472,0.012828642615691,0.100254255218189
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40451,0.00757754155655856,0.00461776698566886,-0.00147328173535242,0.0166283648484695,0.10083497539362
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCIN,Adseverin,40136,0.0124572116606537,0.00760032112478537,-0.00243941774392561,0.027353841065233,0.101234190104267
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MSLNL,Mesothelin-like protein,40182,-0.00670732295006716,0.00409619388583215,-0.0147358629662982,0.00132121706616387,0.101564589462598
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BMP4,Bone morphogenetic protein 4,42475,0.00785726723718081,0.00480457573993442,-0.00155970121309065,0.0172742356874523,0.101994847141961
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,40136,-0.0109638378998357,0.0067074998113134,-0.02411053753001,0.00218286173033856,0.102169240430894
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRD3,Bromodomain-containing protein 3,40116,0.00845216181521641,0.0051715364456776,-0.00168404961831168,0.0185883732487445,0.102211716023008
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPHS1,Nephrin,40199,-0.00571388105974649,0.00349787051317738,-0.0125697072655742,0.00114194514608118,0.10238590338267
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC12A2,Solute carrier family 12 member 2,40116,-0.00461336389208699,0.0028326157138974,-0.0101652906913259,0.000938562907151908,0.103414156142286
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,40182,0.0128817371661258,0.00791171447217642,-0.00262522319933996,0.0283886975315916,0.103514271020127
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTX3,Pentraxin-related protein PTX3,42594,0.00819804045742985,0.00504019501120702,-0.00168074176453591,0.0180768226793956,0.103859961503103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRR5,Proline-rich protein 5,40199,0.00808791620891877,0.0049765361644031,-0.00166609467331132,0.0178419270911489,0.104146461165211
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,42311,-0.00662790201287703,0.00408761693599727,-0.0146396312074317,0.00138382718167761,0.104943336947006
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCDC50,Coiled-coil domain-containing protein 50,40482,0.0127140030023393,0.00784598216404487,-0.00266412203918869,0.0280921280438672,0.105164093227439
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNM1,Dynamin-1,40449,0.0190898960839351,0.0118247615062568,-0.00408663646832815,0.0422664286361984,0.106468703361532
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VIT,Vitrin,40511,0.00645598790996463,0.00400443231467662,-0.00139269942680154,0.0143046752467308,0.106944020857048
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",40116,0.00654250475412794,0.00407412242193934,-0.00144277519287316,0.014527784701129,0.108331721236271
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NECTIN1,Nectin-1,40199,0.00546090028745544,0.00340483637955735,-0.00121257901647696,0.0121343795913878,0.108772354781026
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,40199,0.00667331911037175,0.00417809752178183,-0.00151575203232064,0.0148623902530641,0.110246550354
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIF20B,Kinesin-like protein KIF20B,40136,0.0130213342145483,0.00815486145300475,-0.00296219423334102,0.0290048626624376,0.110348703983311
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL2RB,Interleukin-2 receptor subunit beta,42370,0.00645519044736456,0.00405224958433435,-0.00148721873793075,0.0143975996326599,0.111186566530773
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBLN4,Cerebellin-4,42721,0.00534242294349919,0.00335397857416249,-0.00123137506185929,0.0119162209488577,0.111214656500559
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPTX1,Neuronal pentraxin-1,42611,-0.00658188577591047,0.00413331391145302,-0.0146831810423584,0.00151940949053744,0.111318592556511
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NXPE4,NXPE family member 4,40116,0.005532470649882,0.00350575473785533,-0.00133880863631445,0.0124037499360784,0.114569036494454
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLA2G1B,Phospholipase A2,42782,0.00742859465599251,0.00471206871326496,-0.00180706002200682,0.0166642493339918,0.114933002467484
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40302,0.00772725220975087,0.00493519065117995,-0.00194572146656183,0.0174002258860636,0.117436711629158
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DHODH,Dihydroorotate dehydrogenase,40116,0.00787500700219051,0.00505779010831159,-0.00203826161010022,0.0177882756144812,0.119498154124467
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,42311,-0.00979898082232527,0.00633771995440722,-0.0222209119329634,0.00262295028831288,0.122095704126599
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGSF21,Immunoglobulin superfamily member 21,40223,-0.00635167241071874,0.00411622472834827,-0.0144194728782814,0.00171612805684387,0.122839564417427
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100G,Protein S100-G,40482,-0.00773773091185141,0.00501546539000315,-0.0175680430762576,0.00209258125255477,0.122913588384471
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP15,Matrix metalloproteinase-15,40511,0.0078217762975093,0.00507861416889032,-0.00213230747351572,0.0177758600685343,0.123554215249217
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40511,-0.00514578278931192,0.00334234578966527,-0.0116967805370559,0.00140521495843201,0.123692614928374
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COMMD9,COMM domain-containing protein 9,40451,0.00634093087821108,0.00412957196073648,-0.00175303016483242,0.0144348919212546,0.12469075804527
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SYT1,Synaptotagmin-1,40483,0.00672937064766285,0.0044028596776661,-0.00190023432056271,0.0153589756158884,0.126439022457498
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42311,0.0121967635015536,0.00798274806305171,-0.00344942270202777,0.0278429497051349,0.126563883898097
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL1A,Interleukin-1 alpha,42370,0.00917410637593318,0.00601766039406428,-0.0026205079964328,0.0209687207482992,0.127400262319405
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EVPL,Envoplakin,40302,-0.00558253966519538,0.00366905209227004,-0.0127738817660447,0.0016088024356539,0.128157619586604
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAS6,Growth arrest-specific protein 6,42718,-0.00397905854188108,0.00261572205840955,-0.00910587377636379,0.00114775669260163,0.128230910370918
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42587,0.00532715583475549,0.00350437245644801,-0.00154141417988261,0.0121957258493936,0.128498030789607
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DIPK1C,Divergent protein kinase domain 1C,40182,-0.00663815163642553,0.0043733976100522,-0.0152100109521278,0.00193370767927679,0.129081558491995
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,40136,-0.00846878207460012,0.00558551629288399,-0.0194163940086527,0.00247882985945251,0.129496667315597
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPTX2,Neuronal pentraxin-2,40527,0.0051670006775989,0.00340937402006853,-0.00151537240173542,0.0118493737569332,0.129666716937598
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40116,-0.00749164165055924,0.00494823636476483,-0.0171901849254983,0.00220690162437983,0.130054170920386
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCNA,Proliferating cell nuclear antigen,40080,0.00985799563519135,0.00651617718082631,-0.00291371163922821,0.0226297029096109,0.130346911769255
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40116,-0.00506432425189809,0.00337731572309184,-0.0116838630691581,0.00155521456536192,0.133769853377417
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUOX2,Dual oxidase 2,42357,-0.0110960803840373,0.00741513457670435,-0.0256297441543778,0.00343758338630326,0.134570861015922
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYL6B,Myosin light chain 6B,40182,0.0140697760593293,0.00946569362047937,-0.00448298343681029,0.0326225355554688,0.137202905048261
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSTN,Osteocrin,40182,0.00646156059145522,0.00435353029479145,-0.00207135878633603,0.0149944799692465,0.137781451360389
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GID8,Glucose-induced degradation protein 8 homolog,40482,0.00528312354642126,0.00356149793743921,-0.00169741241095958,0.0122636595038021,0.137996272425449
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,40302,-0.00445404383228201,0.00301940896740285,-0.0103720854083916,0.00146399774382759,0.140203883740563
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPBGL,Trophoblast glycoprotein-like,40182,-0.00644576932055933,0.00437149261751271,-0.0150138948508842,0.00212235620976558,0.140375454340791
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLKB1,Plasma kallikrein,40293,-0.00374678375192796,0.00255474075670868,-0.00875407563507697,0.00126050813122105,0.14251312954798
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPT1,Palmitoyl-protein thioesterase 1,40182,0.0117414881354989,0.00801820326505395,-0.00397419026400689,0.0274571665350046,0.143125854262224
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F11,Coagulation factor XI,40383,-0.00454347501241802,0.00312599416189476,-0.0106704235697318,0.00158347354489572,0.146127004895477
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40302,0.00555532974304446,0.00384038263546333,-0.00197182022246367,0.0130824797085526,0.148049445703792
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLSPN,Claspin,42292,0.00523099949561558,0.00362045362535562,-0.00186508961008144,0.0123270886013126,0.148524948067603
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,40223,-0.00352822312069236,0.00245307721293824,-0.00833625445805131,0.00127980821666658,0.150381700472214
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AFP,Alpha-fetoprotein,42459,-0.00988157296202381,0.00690328502388815,-0.0234120116088446,0.00364886568479696,0.152330421957144
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C4BPB,C4b-binding protein beta chain,42679,-0.0059450188673324,0.00415490446913389,-0.0140886316268348,0.00219859389217002,0.152498188622051
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGR,Progesterone receptor,40199,0.0145424624598163,0.0101845286492659,-0.00541921369274488,0.0345041386123776,0.153349754644438
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPM3,Tropomyosin alpha-3 chain,40116,-0.0064821390168031,0.00455774893970386,-0.0154153269386227,0.00245104890501646,0.154989848252315
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40199,0.00636280286933547,0.00450915983320298,-0.00247515040374237,0.0152007561424133,0.158248143167126
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MANSC4,MANSC domain-containing protein 4,40116,0.0104763992502183,0.00744545679000056,-0.00411669605818282,0.0250694945586194,0.159430294887344
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNMA2,Paraneoplastic antigen Ma2,40136,0.00648926389472954,0.00462881860087955,-0.00258322056299439,0.0155617483524535,0.160965534357629
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OBP2B,Odorant-binding protein 2b,42462,-0.0088766144168599,0.00633395946323811,-0.0212911749648066,0.00353794613108679,0.161108274910385
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40116,0.00869472700175976,0.0062360071154137,-0.0035278469444511,0.0209173009479706,0.163262058159587
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40539,0.0028514304813385,0.00205412293561349,-0.00117465047246394,0.00687751143514094,0.165118671645433
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TLR2,Toll-like receptor 2,40302,0.0033864316379757,0.00244102822971537,-0.00139798369226642,0.00817084696821782,0.165378987674945
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TREML1,Trem-like transcript 1 protein,40532,0.00755036539113952,0.00545313182181748,-0.00313777297962275,0.0182385037619018,0.166204354564465
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK7,Kallikrein-7,40009,0.00565641817673655,0.00408795062117608,-0.00235596504076856,0.0136688013942417,0.166484817615844
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAGEA3,Melanoma-associated antigen 3,40302,0.0125199197803144,0.00905040452402365,-0.00521887308677192,0.0302587126474008,0.166583929420567
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,42311,0.01202261781221,0.00870593191368372,-0.00504100873861011,0.0290862443630301,0.167312170258663
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCND2,G1/S-specific cyclin-D2,40302,-0.00529274482964327,0.00384715227770898,-0.0128331632939529,0.00224767363466633,0.168924765496009
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPR158,Probable G-protein coupled receptor 158,40482,0.00514538281815691,0.00374465499133858,-0.00219414096486672,0.0124849066011805,0.169450157574659
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN2B,Sodium channel subunit beta-2,40182,-0.00415626025348559,0.00303186631087173,-0.0100987182227942,0.001786197715823,0.170447013223083
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PMCH,Pro-MCH,40116,0.0120413821456166,0.00881271273531377,-0.00523153481559841,0.0293142991068316,0.171852560651447
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBP2,Retinol-binding protein 2,42587,0.0108920275660351,0.0079781640661249,-0.00474517400356972,0.0265292291356399,0.17220375659798
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF9,Fibroblast growth factor 9,40065,-0.00585677731300421,0.00429229249926214,-0.014269670611558,0.00255611598554958,0.172442586902601
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPLX2,Complexin-2,40080,-0.00450813281723782,0.00330834365914502,-0.0109924863891621,0.00197622075468643,0.173019283979257
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40080,-0.00435845271528987,0.00320350133089544,-0.0106373153238449,0.0019204098932652,0.17369112069112
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",40482,-0.00631884534992585,0.00465580930706988,-0.0154442315917828,0.00280654089193111,0.17474610531654
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHD,SH2 domain-containing adapter protein D,40083,0.0123885765858931,0.00913993428648724,-0.00552569461562191,0.0303028477874081,0.175307474665477
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HEBP1,Heme-binding protein 1,42357,-0.00739189984630764,0.00546892941874674,-0.0181110015070512,0.00332720181443596,0.176520985688681
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ROBO4,Roundabout homolog 4,40223,0.00255756875772578,0.00189273912826749,-0.0011521999336785,0.00626733744913006,0.176642231596861
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECE1,Endothelin-converting enzyme 1,42311,-0.00495664781100681,0.00367319977495873,-0.0121561193699259,0.0022428237479123,0.177229010848605
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40136,0.00799899171424452,0.00593664709758629,-0.0036368365970246,0.0196348200255137,0.177881865881799
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,40302,0.00893804989002283,0.00663442172630205,-0.00406541669352919,0.0219415164735749,0.177935692298766
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TEX33,Testis-expressed protein 33,40302,-0.00534614037483926,0.00397716347255881,-0.0131413807810545,0.00244910003137601,0.1789081464748
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RASA1,Ras GTPase-activating protein 1,42311,0.00448543678528011,0.00334702346528145,-0.00207472920667153,0.0110456027772317,0.180227246049428
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CXCL12,Stromal cell-derived factor 1,42370,-0.0055564411068089,0.00414841809202356,-0.0136873405671751,0.00257445835355727,0.180459677354901
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESR1,Estrogen receptor,40199,0.0077115575267896,0.00575910478845779,-0.00357628785858768,0.0189994029121669,0.180591760014724
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRXN3,Neurexin-3,40182,0.00493209175317413,0.00369939179297371,-0.00231871616105434,0.0121828996674026,0.182488265883702
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,40182,-0.00515036102836959,0.00386966526453263,-0.0127349049468535,0.00243418289011435,0.183230524443553
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42794,-0.00435467496970788,0.00327486107388696,-0.0107734026745263,0.00206405273511056,0.18363015676856
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,40199,-0.0125344978474123,0.00943073864950997,-0.0310187456004518,0.00594974990562724,0.183838927375001
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP6V1D,V-type proton ATPase subunit D,42587,-0.00357519070491389,0.00270229751413346,-0.00887169383261548,0.0017213124227877,0.18585167736091
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SCN3B,Sodium channel subunit beta-3,40136,-0.00661595183522961,0.00501861616076874,-0.0164524395103363,0.00322053583987711,0.187436826265122
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TCP11,T-complex protein 11 homolog,40302,-0.00808258623491125,0.00617104769923123,-0.0201778397254045,0.00401266725558196,0.190304410930495
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNAR1,Interferon alpha/beta receptor 1,40449,0.00348803256498733,0.00267023542058146,-0.00174562885935232,0.00872169398932699,0.191489468116439
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK12,Kallikrein-12,42346,0.0188837071548057,0.0144578091312448,-0.00945359874243406,0.0472210130520455,0.191532866596596
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PFDN4,Prefoldin subunit 4,40080,-0.00714112297989196,0.00547102362764547,-0.0178643292900771,0.00358208333029316,0.191831003181849
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ROBO2,Roundabout homolog 2,42711,0.00313453261782628,0.00241421757174968,-0.0015973338228031,0.00786639905845566,0.194184515304538
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40302,-0.00953596933544043,0.00734976424397586,-0.0239415072536331,0.00486956858275226,0.194502513581845
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,40136,0.00943757237965926,0.00731381839056678,-0.00489751166585163,0.0237726564251701,0.196947566027788
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DIPK2B,Divergent protein kinase domain 2B,40283,0.00374363969026016,0.00290730207461734,-0.00195467237598983,0.00944195175651016,0.197888448293716
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40116,0.00929692041609036,0.00727039818625556,-0.00495306002897054,0.0235469008611513,0.201017182338368
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40199,0.00592028177877557,0.00464468080705412,-0.00318329260305049,0.0150238561606016,0.202464684689985
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RUVBL1,RuvB-like 1,42346,0.0139235863112454,0.0109443847293745,-0.00752740775832856,0.0353745803808193,0.203320014409052
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNPY2,Protein canopy homolog 2,42357,0.00812478973547168,0.00639572125990542,-0.00441082393394295,0.0206604034048863,0.20398326054192
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40116,0.00538540947283107,0.00424230015249589,-0.00292949882606087,0.013700317771723,0.204305850935141
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,40429,0.00521346553510041,0.00410720319069874,-0.00283665271866912,0.0132635837888699,0.204343668227456
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNPO1,Transportin-1,40302,-0.00467843803234715,0.00369391213997656,-0.0119185058267012,0.00256162976200692,0.205351164651411
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42794,-0.0044933156110665,0.0035723333369796,-0.0114950889515465,0.00250845772941352,0.208482173868343
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ERVV_1,,40116,-0.00570571036439713,0.00453869516221954,-0.0146015528823474,0.00319013215355317,0.208735001436885
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINI1,Neuroserpin,40267,0.00395212374068271,0.00314857094082286,-0.00221907530333009,0.0101233227846955,0.209428332499773
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TG,Thyroglobulin,40451,-0.0150286918077607,0.0119840140628868,-0.0385173593710189,0.00845997575549743,0.209845658110752
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,40302,0.00528118856971218,0.00422406436274686,-0.00299797758127167,0.013560354720696,0.211230070387212
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARHGAP1,Rho GTPase-activating protein 1,42346,0.0058049485005452,0.00466867277664399,-0.00334565014167701,0.0149555471427674,0.213748884123187
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMC3,26S proteasome regulatory subunit 6A,40080,-0.00395659746897634,0.00319085615234928,-0.0102106755275809,0.00229748058962826,0.215009558799248
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A16,Protein S100-A16,42292,0.00770575684528473,0.00627517647862213,-0.00459358905281465,0.0200051027433841,0.219478598115411
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTNNA1,Catenin alpha-1,40136,-0.00447054095999053,0.00366606951351588,-0.0116560372064817,0.00271495528650059,0.222704643254645
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGFL4,Insulin growth factor-like family member 4,40199,0.00934143812925094,0.0076651050768132,-0.00568216782130293,0.0243650440798048,0.22298546085629
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PXDNL,Peroxidasin-like protein,40451,-0.00705676362301095,0.00579997275688189,-0.0184247102264995,0.00431118298047756,0.223748037075518
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40116,0.00427366269178892,0.00352970678449435,-0.00264456260582001,0.0111918879893978,0.226009807466562
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSC1,Hamartin,40199,0.009250888907699,0.00764250262513665,-0.00572841623756883,0.0242301940529668,0.226131178118937
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40136,0.00778350991342416,0.0064439205549999,-0.00484657437437565,0.020413594201224,0.227117908474749
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PCARE,Photoreceptor cilium actin regulator,40136,0.0105719313429376,0.00876156318600155,-0.00660073250162543,0.0277445951875006,0.227602233591863
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HCG22,Protein PBMUCL2,40116,-0.00713408112525626,0.00592822779793865,-0.018753407609216,0.00448524535870349,0.22884427149493
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA3,Alpha-1-antichymotrypsin,40502,-0.00189845964150558,0.00157830553222026,-0.00499193848465728,0.00119501920164613,0.229060823192593
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CORO6,Coronin-6,40136,0.00463263045618308,0.00387846481047177,-0.00296916057234159,0.0122344214847077,0.232328064539876
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAT1,Diamine acetyltransferase 1,40116,-0.00637478551619615,0.00534405514924085,-0.0168491336087082,0.00409956257631592,0.232944557431121
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAMT,Guanidinoacetate N-methyltransferase,40116,0.00469749308329219,0.00394069961554423,-0.00302627816317449,0.0124212643297589,0.233269320276953
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FH,"Fumarate hydratase, mitochondrial",40136,0.0106169485382778,0.00892218957407066,-0.00687054302690069,0.0281044401034563,0.234092344615774
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNF75D,Zinc finger protein 75D,40302,0.00759277834815531,0.00639569221662754,-0.00494277839643466,0.0201283350927453,0.235185686023964
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RYR1,Ryanodine receptor 1,40116,-0.00425224462788181,0.00358710142754316,-0.0112829634258664,0.00277847417010279,0.23587470051046
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC44A4,Choline transporter-like protein 4,40182,-0.00873800745189224,0.00742158803279465,-0.0232843199961698,0.00580830509238528,0.239070545702228
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH23,Cadherin-23,40483,-0.00319056185564134,0.00271390689403998,-0.0085098193679597,0.00212869565667702,0.239765861729842
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF16,Fibroblast growth factor 16,40199,0.00576499894545488,0.00492919530370643,-0.00389622384980971,0.0154262217407195,0.242202653584811
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC123,Cell division cycle protein 123 homolog,40080,0.00766498975928651,0.00657820547861851,-0.00522829297880577,0.0205582724973788,0.243959594429067
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEPTIN7,Septin-7,40302,0.00659040767470572,0.00567185776966034,-0.00452643355382855,0.01770724890324,0.245281275029378
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BGLAP,Osteocalcin,40527,0.0108613151864688,0.009382711545591,-0.0075287994428896,0.0292514298158271,0.247056565651467
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40116,0.00799589840001981,0.00695341560352946,-0.00563279618289793,0.0216245929829376,0.250200417131524
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPR101,Probable G-protein coupled receptor 101,40136,-0.00714660208214203,0.00629552959211355,-0.0194858400826846,0.00519263591840053,0.256321924898292
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,40483,0.00368761857345141,0.00325890979616264,-0.00269984462702736,0.0100750817739302,0.257847811330963
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADRA2A,Alpha-2A adrenergic receptor,40116,0.00816951775852577,0.00723382263864479,-0.006008774613218,0.0223478101302696,0.258775009813419
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40116,-0.0059721682437895,0.00529384218008127,-0.0163480989167488,0.00440376242916979,0.259287722371131
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP3,Stromelysin-1,42611,-0.00580633189278715,0.00520449811026191,-0.0160071481889005,0.00439448440332619,0.264597426937548
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,40136,-0.00849717782191444,0.00764506351338972,-0.0234815023081583,0.00648714666432941,0.266395070743084
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40177,0.00438744834121599,0.0039582425847389,-0.00337070712487225,0.0121456038073042,0.267698952857243
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOH,Beta-2-glycoprotein 1,42611,0.00413754515753354,0.00375669995256878,-0.00322558674950126,0.0115006770645683,0.270752110214853
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLXDC1,Plexin domain-containing protein 1,42346,0.00356823050810712,0.0032651694221459,-0.00283150155929885,0.00996796257551309,0.274494460777519
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LIPF,Gastric triacylglycerol lipase,40223,0.00700982013272313,0.0064718827639763,-0.00567507008467043,0.0196947103501167,0.278779220194112
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDDM3B,Epididymal secretory protein E3-beta,40451,-0.00592951470671723,0.0054830845620348,-0.0166763604483054,0.00481733103487098,0.279533705782149
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,40116,-0.00541489382589547,0.00501506613438071,-0.0152444234492817,0.00441463579749072,0.280288362987234
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40136,0.00605858152018939,0.00561310658912809,-0.00494310739450167,0.0170602704348805,0.280449574768196
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,40302,0.00737828625878915,0.00685990287139015,-0.00606712336913555,0.0208236958867139,0.282144241099491
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RLN1,Prorelaxin H1,40482,0.00541146475680912,0.00503466798967246,-0.0044564845029489,0.0152794140165671,0.282469145420584
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSLP,Thymic stromal lymphopoietin,42357,0.00679633531616684,0.00632942624732205,-0.00560934012858439,0.0192020107609181,0.282946362209414
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42711,0.00789443779849647,0.00735907190787776,-0.00652934314094393,0.0223182187379369,0.28340285316149
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLEC4C,C-type lectin domain family 4 member C,42594,0.00527835869260855,0.00494562402591102,-0.00441506439817705,0.0149717817833942,0.28586527559311
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42346,0.0134166690225397,0.0127144493195899,-0.0115036516438566,0.0383369896889359,0.291339506410971
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGLON5,IgLON family member 5,40080,-0.0104189954806287,0.00987411234072262,-0.029772255668445,0.00893426470718763,0.291365055053461
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CALY,Neuron-specific vesicular protein calcyon,40116,-0.0042948597005387,0.00407318135200018,-0.0122782951504591,0.00368857574938165,0.291712216661827
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,40136,-0.00331351513305165,0.00314582788940629,-0.00947933779628798,0.00285230753018468,0.292224648561953
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40116,-0.00653363905150278,0.00622995772424558,-0.0187443561910241,0.00567707808801855,0.294318552306897
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,40199,0.00316941881437144,0.00302892076145655,-0.0027672658780834,0.00910610350682628,0.295406058736122
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FRMD7,FERM domain-containing protein 7,40182,-0.00364013969693799,0.00348331711539833,-0.0104674412431187,0.00318716184924274,0.296036231026149
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LEG1,Protein LEG1 homolog,39926,0.00758931867754357,0.00728063978911952,-0.0066807353091307,0.0218593726642178,0.29725103536271
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ABO,Histo-blood group ABO system transferase,40532,-0.0157347313078635,0.0151347177398458,-0.0453987780779613,0.0139293154622343,0.298527102626531
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTO1,Protein LTO1 homolog,42370,0.00451731211049894,0.00434550487404863,-0.00399987744263638,0.0130345016636343,0.298574240449685
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LAMA1,Laminin subunit alpha-1,40116,-0.00582219075111906,0.00560747416615175,-0.0168128401167765,0.00516845861453837,0.29915751689803
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMEM132A,Transmembrane protein 132A,40223,-0.00675373116475827,0.00651684179035643,-0.0195267410738569,0.00601927874434033,0.300061453280223
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KCNIP4,Kv channel-interacting protein 4,42311,-0.00528028020549452,0.00509675159960621,-0.0152699133407227,0.00470935292973364,0.300217071775251
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,40182,0.00765505063406515,0.00741761165858894,-0.00688346821676918,0.0221935694848995,0.302090069456726
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NXPH3,Neurexophilin-3,40199,0.00329468431132447,0.00319975488494285,-0.00297683526316352,0.00956620388581245,0.303188643549178
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,40136,-0.00347704477703711,0.00338385702958668,-0.010109404555027,0.00315531500095279,0.304189485211813
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,S100A3,Protein S100-A3,40451,0.00464712353144803,0.00452853104164824,-0.00422879731018252,0.0135230443730786,0.304825097398355
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTRC,Chymotrypsin-C,42626,-0.00701599206036682,0.0068475208066541,-0.0204371328414088,0.0064051487206752,0.305568883000535
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,40136,-0.00836637572126957,0.00817739191030669,-0.0243940638654707,0.00766131242293155,0.306278210066173
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,40302,0.00713516170623357,0.00698795621032352,-0.00656123246600054,0.0208315558784677,0.307245596267863
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40136,-0.00580391980667502,0.00572157425555076,-0.0170182053475545,0.00541036573420447,0.310418114915308
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAD1,Glutamate decarboxylase 1,40080,-0.00276592980197131,0.00272688887450339,-0.00811063199599795,0.00257877239205532,0.310454047445975
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",40080,0.00975348580983933,0.00962685257662267,-0.00911514524034111,0.0286221168600198,0.3110090459973
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPB2,Carboxypeptidase B2,40516,0.00232573057772632,0.0023020699272507,-0.00218632647968505,0.0068377876351377,0.312383713137372
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40136,-0.00648758329808796,0.00642211424777465,-0.0190749272237263,0.00609976062755035,0.312424540527113
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40136,0.00793297067599611,0.00788150005096059,-0.00751476942388664,0.0233807107758789,0.314182675129013
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLGAP5,Disks large-associated protein 5,40482,-0.00531498985315769,0.00528335072580647,-0.0156703572757384,0.00504037756942298,0.314442685525902
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PTTG1,Securin,40302,0.00429130093944604,0.00427003122269908,-0.00407796025704415,0.0126605621359362,0.314927812117098
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40483,0.00271264954715215,0.00271528002212177,-0.00260929929620652,0.00803459839051082,0.317800974645214
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDAC8,Histone deacetylase 8,40199,0.00611492353924295,0.00615461990639086,-0.00594813147728313,0.018177978555769,0.320463767611277
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAG,S-arrestin,40136,-0.0054190752349045,0.00546180300608877,-0.0161242091268385,0.00528605865702948,0.321133137590354
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,VCAN,Versican core protein,42711,-0.00312730878128532,0.00315274000120092,-0.00930667918363912,0.00305206162106849,0.321247666669967
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UGDH,UDP-glucose 6-dehydrogenase,40116,0.0098244908354964,0.00994784725911779,-0.00967328979237447,0.0293222714633673,0.323370617379387
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,40110,0.00353128502540574,0.0035808053308022,-0.00348709342296657,0.0105496634737781,0.324071249713478
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40080,0.00569887170020002,0.00578542105035966,-0.00564055355850491,0.017038296958905,0.324626268999744
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40302,0.00650091719085698,0.0066068762191972,-0.00644856019876952,0.0194503945804835,0.32515547537683
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTF,Ciliary neurotrophic factor,40136,-0.00349981416730783,0.00358248476103336,-0.0105214842989332,0.00352185596431756,0.328628538972673
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLSTN1,Calsyntenin-1,42311,-0.00536430534112181,0.00549152089298562,-0.0161276862913736,0.00539907560913002,0.32866926323191
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F13B,Coagulation factor XIII B chain,40479,0.00262435894230564,0.00268660886532859,-0.0026413944337384,0.00789011231834968,0.328674480585471
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,F2,Prothrombin,40539,-0.00150649407305959,0.00154327301351298,-0.00453130917954503,0.00151832103342584,0.329001922112647
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40080,0.00650695130360172,0.00666947025310476,-0.00656521039248361,0.019579112999687,0.329268339263196
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,40116,0.00483286273569623,0.00499503158877325,-0.00495739917829934,0.0146231246496918,0.333298592233767
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD99,CD99 antigen,42611,0.00200444736613866,0.00208405441253905,-0.00208029928243788,0.00608919401471519,0.336166487159656
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IFNL2,Interferon lambda-2,40136,0.00618497172561681,0.00645307037484813,-0.00646304620908552,0.0188329896603191,0.337855005469636
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40451,0.00635188445343415,0.00663078732575776,-0.00664445870505105,0.0193482276119194,0.338114496730658
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL36A,Interleukin-36 alpha,40199,0.00571269352339658,0.00599465869035578,-0.00603683750970074,0.0174622245564939,0.340629274900721
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KHDC3L,KH domain-containing protein 3,40080,-0.00684522362431243,0.00719145666481836,-0.0209404786873564,0.00725003143873156,0.341191682406159
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRYBB2,Beta-crystallin B2,40483,0.00802445728948056,0.00848607053930767,-0.00860824096756247,0.0246571555465236,0.344371139747353
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40080,0.00507091122597284,0.00536624389569112,-0.00544692680958176,0.0155887492615274,0.344697854366626
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40182,-0.0077335859561563,0.00820285708411791,-0.0238111858410274,0.0083440139287148,0.345808162042746
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDIA2,Protein disulfide-isomerase A2,40080,-0.00413923783714256,0.00439088311938592,-0.012745368751139,0.00446689307685384,0.345860848832076
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRC1,Protein regulator of cytokinesis 1,40451,0.00435780349860601,0.00463334756195214,-0.00472355772282019,0.0134391647200322,0.346965826737702
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CNTN2,Contactin-2,42721,0.0043025754085205,0.00460075661116461,-0.00471490754936213,0.0133200583664031,0.349707775797498
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CENPJ,Centromere protein J,40302,0.00688075982131753,0.00738486482461498,-0.00759357523492784,0.0213550948775629,0.351492148211815
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT17,"Keratin, type I cytoskeletal 17",40116,0.00379011657356192,0.00409992152934374,-0.0042457296239518,0.0118259627710757,0.355279589423662
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,40182,0.00649162726056584,0.00702390441039461,-0.00727522538380759,0.0202584799049393,0.355392500485623
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42370,0.0035263677787028,0.00382685560611719,-0.0039742692092869,0.0110270047666925,0.356817176100814
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOP1,DNA topoisomerase 1,40449,0.0107537006059759,0.0116783016216659,-0.0121357705724894,0.0336431717844411,0.357160261638313
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COPE,Coatomer subunit epsilon,42311,0.00450421084293703,0.00490239552243223,-0.00510448438103014,0.0141129060669042,0.358228842712512
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPAN7,Tetraspanin-7,40136,-0.00902225375355419,0.00982474423571975,-0.0282787524555649,0.0102342449484565,0.3584718873735
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RBM19,Probable RNA-binding protein 19,40116,0.00461127843410762,0.00502160397850021,-0.00523106536375279,0.014453622231968,0.358488410901948
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KDM3A,Lysine-specific demethylase 3A,40199,0.00834093353046648,0.00912517121437128,-0.00954440204970123,0.0262262691106342,0.360706523321316
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLP1R,Glucagon-like peptide 1 receptor,40136,0.00360839682387629,0.00395434630208845,-0.00414212192821706,0.0113589155759696,0.361518245763923
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASQ2,Calsequestrin-2,40116,-0.00464194253943493,0.00510726834524992,-0.0146521884961248,0.00536830341725491,0.363428515065654
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RANGAP1,Ran GTPase-activating protein 1,42346,0.00454481834984758,0.0050017550831589,-0.00525862161314387,0.014348258312839,0.363554342075117
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42113,-0.00349796944459752,0.00389115097212608,-0.0111246253499646,0.0041286864607696,0.368693409015332
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FZD10,Frizzled-10,40182,0.00567270461890572,0.00631502041966304,-0.00670473540363384,0.0180501446414453,0.369051917426325
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,40182,0.00669059753494357,0.00746276627777036,-0.00793642436948633,0.0213176194393735,0.369989142539653
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGB6,Integrin beta-6,42370,0.00284591477976006,0.00322105891159059,-0.00346736068695749,0.0091591902464776,0.37696398887669
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TP73,Tumor protein p73,40182,-0.00315911167697769,0.00359802728773014,-0.0102112451609288,0.0038930218069734,0.379956322490535
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,40449,0.0040001332595987,0.00457216519948852,-0.00496131053139879,0.0129615770505962,0.381653423546897
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,40136,-0.00381837014565789,0.00436956538312217,-0.0123827182965774,0.00474597800526156,0.382215954410183
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42570,0.00776664735182128,0.00892084579845271,-0.00971821041314603,0.0252515051167886,0.383978485437482
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CBLN1,Cerebellin-1,40136,-0.00860566515774535,0.00989189709480115,-0.0279937834635556,0.0107824531480649,0.384335250788096
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAPPA,Pappalysin-1,42370,-0.00417383010108879,0.00482302746432181,-0.0136269639311595,0.00527930372898196,0.386837069602345
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PALLD,Palladin,40199,-0.0035095171167168,0.00405838951195171,-0.0114639605601422,0.00444492632670855,0.38719151567775
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40182,-0.00452277118039585,0.00530166749218479,-0.014914039465078,0.00586849710428635,0.393630955708275
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40116,-0.00382120148932177,0.0045041836785221,-0.0126494014992251,0.00500699852058155,0.396252121012743
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NMRK2,Nicotinamide riboside kinase 2,40080,-0.00373749548990733,0.00442353114161069,-0.0124076165274643,0.00493262554764962,0.398178423101893
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD70,CD70 antigen,42594,0.00372872204726748,0.00446453707172566,-0.0050217706133148,0.0124792147078498,0.403627479224361
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,40182,0.00370907271910158,0.00445565707793312,-0.00502401515364733,0.0124421605918505,0.405178021906918
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,40116,-0.00313389401173786,0.00377068246799065,-0.0105244316489995,0.00425664362552381,0.405923351905495
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPTN,Neuroplastin,42346,-0.00676917783908228,0.00814494839185083,-0.0227332766871099,0.00919492100894535,0.405938383469332
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DENND2B,DENN domain-containing protein 2B,40116,-0.00430520061403115,0.00519502942316236,-0.0144874582834294,0.00587705705536707,0.407283608373673
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,40080,-0.00215887918892326,0.00262734483230085,-0.00730847506023292,0.0029907166823864,0.411267834328463
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40182,0.00442089367539799,0.00539118476553739,-0.0061458284650553,0.0149876158158513,0.412220976411685
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLHL41,Kelch-like protein 41,40482,0.0040754919390639,0.00498271378888088,-0.00569062708714263,0.0138416109652704,0.413416618128927
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40223,0.00216752012149708,0.00266592671346463,-0.00305769623689359,0.00739273647988775,0.416209435256801
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPHA2,Glycoprotein hormone alpha-2,40449,0.00393960696194409,0.00484732348008325,-0.00556114705901909,0.0134403609829073,0.416385128442909
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GH2,Growth hormone variant,42346,0.0139699735488141,0.0172763560235436,-0.0198916842573313,0.0478316313549595,0.418749497906346
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40080,0.00290940896884342,0.00360400616321603,-0.00415444311106001,0.00997326104874685,0.419528115956391
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42311,0.00557146372701162,0.00690896903177588,-0.00797011557526911,0.0191130430292923,0.420020935111256
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HDAC9,Histone deacetylase 9,40136,0.0054788118744664,0.00684058898598996,-0.00792874253807392,0.0188863662870067,0.423191344277122
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD164L2,CD164 sialomucin-like 2 protein,40182,-0.00303812017811367,0.00379328538463047,-0.0104729595319894,0.00439671917576205,0.42319496571639
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MUCL3,Mucin-like protein 3,40080,0.00353200917981883,0.00443554029019337,-0.00516164978896017,0.0122256681485978,0.425876563732906
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMOD4,Tropomodulin-4,40080,0.00341457294310544,0.00429845908648668,-0.00501040686640845,0.0118395527526193,0.426996568072978
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,40539,0.00218115259714411,0.00277370246978231,-0.00325530424362922,0.00761760943791745,0.43166798363571
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40136,0.00474544753147628,0.00609505097990257,-0.00720085238913275,0.0166917474520853,0.436247602523155
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHPK,Sedoheptulokinase,40302,0.00332295756631092,0.00428167399731202,-0.00506912346842064,0.0117150386010425,0.437713309802771
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANPEP,Aminopeptidase N,42666,0.00222295264261495,0.00286651040831206,-0.00339540775767668,0.00784131304290658,0.438063272033027
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TLR4,Toll-like receptor 4,40199,-0.00235341326243153,0.00305128144882456,-0.00833392490212766,0.00362709837726461,0.440553483598261
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40199,-0.0023498503128698,0.00305208792507536,-0.00833194264601751,0.00363224202027792,0.441366445013664
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,40199,-0.00389341505266059,0.00509770846027246,-0.0138849236347946,0.00609809352947343,0.445027909523357
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40136,0.00461853832505056,0.00604938402003483,-0.00723825435421771,0.0164753310043188,0.445198118948445
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",40199,0.00225501882333878,0.00296091145936846,-0.00354836763702339,0.00805840528370096,0.446317382186456
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA4,Carbonic anhydrase 4,42794,0.00189392714176007,0.00249048681382408,-0.00298742701333513,0.00677528129685527,0.446990085135922
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,40116,0.00870864326696683,0.0114646714471456,-0.0137621127694386,0.0311793993033722,0.447506002008664
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40182,-0.00364137181766168,0.00479641880130684,-0.0130423526682231,0.00575960903289973,0.447757857813323
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42570,-0.0143065167079387,0.0189440271007877,-0.0514368098254826,0.0228237764096052,0.450142683384839
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSTM4,Glutathione S-transferase Mu 4,40116,-0.00582373134863676,0.00774713266525342,-0.0210081113725335,0.00936064867525994,0.452231249821244
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYO6,Unconventional myosin-VI,40482,0.00283467299023965,0.00377956397355226,-0.00457327239792277,0.0102426183784021,0.45327033431327
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TBR1,T-box brain protein 1,40182,-0.0037819106703924,0.00504970687958775,-0.0136793361543844,0.00611551481359959,0.45391140672067
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40182,-0.00319317548420858,0.00426572084599871,-0.011553988342366,0.00516763737394889,0.454134585997633
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KLK15,Kallikrein-15,40429,0.00414831278836645,0.00555486367142831,-0.00673922000763304,0.0150358455843659,0.455206378642412
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40451,0.00339205793768517,0.00467207378006798,-0.00576520667124807,0.0125493225466184,0.467836495937958
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD177,CD177 antigen,42595,0.00987164597896475,0.013596936352236,-0.0167783492714178,0.0365216412293473,0.467839268139994
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42370,0.00425109773253261,0.00586538199170027,-0.00724505097119992,0.0157472464362651,0.468601323916853
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZP4,Zona pellucida sperm-binding protein 4,40080,-0.00237369270512078,0.00328658572925436,-0.00881540073445933,0.00406801532421777,0.470164500713464
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DLL4,Delta-like protein 4,40223,0.00641794932888914,0.00891605254475742,-0.0110575136588354,0.0238934123166137,0.471651331920168
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40182,0.0041810755694585,0.00582297129590162,-0.00723194817050867,0.0155940993094257,0.472753262044021
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40136,0.00450830968180686,0.00631181846886926,-0.0078628545171769,0.0168794738807906,0.475078697588475
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PGM2,Phosphoglucomutase-2,40182,-0.00443933653890982,0.00622267744198189,-0.0166357843251943,0.00775711124737469,0.475605625327401
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1R,Complement C1r subcomponent,40539,0.00142456252741384,0.00201734736721509,-0.00252943831232774,0.00537856336715543,0.480105451579272
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DAND5,DAN domain family member 5,40199,0.00406805254646127,0.00577191657887335,-0.0072449039481305,0.015381009041053,0.480949004650306
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DUSP29,Dual specificity phosphatase 29,40182,0.0049217398931809,0.00700875994363756,-0.00881542959634872,0.0186589093827105,0.48255253592337
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH22,Cadherin-22,40302,-0.00203503331595028,0.00292983664335256,-0.00777751313692131,0.00370744650502074,0.487327218549765
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CASP4,Caspase-4,40302,0.0124868223797851,0.01800756449835,-0.0228080040369808,0.0477816487965511,0.488059920844668
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TAP1,Antigen peptide transporter 1,40302,0.00443687723481893,0.00642305890842607,-0.00815231822569616,0.017026072695334,0.489722486671693
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PITHD1,PITH domain-containing protein 1,40065,0.00579381612869341,0.00841041266744638,-0.0106905926995015,0.0222782249568883,0.490909667833391
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42636,0.00235422141197511,0.00341968112401628,-0.0043483535910968,0.00905679641504702,0.491192015121929
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TEF,Thyrotroph embryonic factor,40116,0.00309461749560828,0.0045178648807562,-0.00576039767067386,0.0119496326618904,0.493375210508551
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDAN1,Codanin-1,40483,-0.00159044531163624,0.00235078997535534,-0.0061979936633327,0.00301710304006022,0.4987004181948
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSB,Lupus La protein,42311,0.00407096644221723,0.00601876981754401,-0.00772582240016903,0.0158677552846035,0.498812296254862
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TERF1,Telomeric repeat-binding factor 1,40199,-0.00206473939310924,0.00307917028416732,-0.00809991315007718,0.0039704343638587,0.502520951272697
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42618,-0.00176988117454016,0.00266072292377786,-0.00698489810514477,0.00344513575606445,0.505941631066889
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UPK3A,Uroplakin-3a,40136,-0.00353618453235594,0.00532807152562343,-0.0139792047225779,0.00690683565786599,0.506903115454985
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDH4,Cadherin-4,40136,0.00343350868965813,0.00518536240752467,-0.00672980162909022,0.0135968190084065,0.507886447897305
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,40482,0.00186510464479355,0.00282593451394722,-0.00367372700254301,0.00740393629213011,0.509270050959059
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDKL5,Cyclin-dependent kinase-like 5,40136,0.00370575836110475,0.00563086271492454,-0.00733073256014735,0.0147422492823569,0.510477724556654
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BRD1,Bromodomain-containing protein 1,40302,-0.00209429953718122,0.00318843365030916,-0.00834362949178718,0.00415503041742474,0.511295638595214
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40527,0.00171940129303168,0.00262417446659522,-0.00342398066149494,0.00686278324755831,0.512341945174813
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PSMA1,Proteasome subunit alpha type-1,42346,0.00310930274020991,0.00478756780745801,-0.00627433016240779,0.0124929356428276,0.516056625109769
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,40136,-0.00400826724342251,0.00617233789026442,-0.0161060495083408,0.00808951502149575,0.516098622904632
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CADPS,Calcium-dependent secretion activator 1,40182,-0.00287639114725545,0.00445770022368271,-0.0116134835856736,0.00586070129116267,0.518769929219777
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41948,0.00194147835938032,0.00303198333041114,-0.00400120896822551,0.00788416568698616,0.521967767799038
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RAB6B,Ras-related protein Rab-6B,42311,0.00323859675649032,0.00509215706643522,-0.00674203109372271,0.0132192246067033,0.524789455974611
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZPR1,Zinc finger protein ZPR1,40136,0.00644865928895993,0.0101629549123167,-0.0134707323391808,0.0263680509171007,0.525750860025722
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40136,-0.00420673599646563,0.00664862939340535,-0.0172380496075401,0.00882457761460886,0.526928234843435
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMBN,Ameloblastin,42370,-0.00186270355109068,0.00295737276701423,-0.00765915417443858,0.00393374707225722,0.528803138530663
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,40302,-0.00532081879284747,0.00845737173264926,-0.02189726738884,0.0112556298031451,0.529274372549915
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IKZF2,Zinc finger protein Helios,42346,0.00570913860525274,0.00911013545586437,-0.0121467268882414,0.0235650040987469,0.530879971459516
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,40182,0.00508794203330272,0.00817759600615592,-0.0109401461387629,0.0211160302053683,0.533835995222159
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL25,Interleukin-25,40036,0.00226184965226326,0.00364369802828141,-0.0048797984831683,0.00940349778769482,0.534772821750141
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIAA1549,UPF0606 protein KIAA1549,40302,0.004539116021092,0.00737922354414125,-0.00992416212542484,0.0190023941676088,0.538487356811638
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPP1,Osteopontin,42771,0.00299287237307635,0.00488176644028284,-0.00657538984987803,0.0125611345960307,0.539839265552666
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL20,Interleukin-20,42370,-0.00305831385738284,0.00507591264765267,-0.0130071026467821,0.00689047493201639,0.546841704722703
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINB5,Serpin B5,42357,0.00301230089495814,0.00504776264533792,-0.00688131388990418,0.0129059156798205,0.550678147436626
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,42311,-0.00404553031435884,0.00678303790953231,-0.0173402846170422,0.00924922398832448,0.550905876732935
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MMP13,Collagenase 3,42311,-0.00204206396462341,0.00344614802931578,-0.00879651410208233,0.00471238617283551,0.553483055639398
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42346,-0.00221339592470891,0.00373787111732953,-0.00953962331467479,0.00511283146525697,0.553757542793777
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40199,0.00174836073175114,0.00295850742581027,-0.00405031382283699,0.00754703528633927,0.554559090992268
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,REST,RE1-silencing transcription factor,40080,-0.00210612307490732,0.00357425854690968,-0.00911166982685029,0.00489942367703564,0.555707454613799
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRP2,Neuropilin-2,42611,0.00174153058723926,0.00296088719460283,-0.00406180831418229,0.0075448694886608,0.556422296640005
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLAU,Urokinase-type plasminogen activator,42611,-0.0017554039273907,0.00303984997808313,-0.00771350988443364,0.00420270202965225,0.563635740863322
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TFAP2A,Transcription factor AP-2-alpha,40136,-0.00362903558571276,0.00635858062045758,-0.0160918536018096,0.00883378243038409,0.568194093937086
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40116,-0.00152696890026971,0.00269014231899086,-0.00679964784549179,0.00374571004495237,0.570307135257417
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLINT1,Clathrin interactor 1,40080,0.00272302111928698,0.0048130175492282,-0.00671049327720028,0.0121565355157742,0.571567428552899
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,40080,0.00280644767158818,0.00496971319330131,-0.00693419018728239,0.0125470855304588,0.572282539210134
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42636,-0.00455472915827577,0.0081750649114688,-0.0205778563847546,0.0114683980682031,0.577434914728606
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",40482,0.00214903795323665,0.00385960284651643,-0.00541578362593556,0.00971385953240886,0.577673159468468
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,40080,0.00365534234989101,0.00659832775303836,-0.00927738004606417,0.0165880647458462,0.579603835280791
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL5,Interleukin-5,42370,-0.00785968143702923,0.0143905726776629,-0.0360652038852485,0.0203458410111901,0.584959175860691
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL20RB,Interleukin-20 receptor subunit beta,40199,-0.00233425339884533,0.0042782681058607,-0.0107196588863323,0.00605115208864163,0.585347110104463
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NLGN1,Neuroligin-1,40182,-0.00395913543546467,0.00727262255837436,-0.0182134756498784,0.0102952047789491,0.586184887637791
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LMOD2,Leiomodin-2,40136,0.00341173836532766,0.00650232792447259,-0.00933282436663861,0.0161563010972939,0.599805925837789
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,STEAP4,Metalloreductase STEAP4,40136,-0.003917671232053,0.00759099810158891,-0.0187960275111673,0.0109606850470613,0.605798942333921
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GPC5,Glypican-5,42495,0.00294884138498961,0.00579592108869781,-0.00841116394885809,0.0143088467188373,0.61091576718689
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40116,-0.00355764791303385,0.00703002485947849,-0.0173364966376117,0.010221200811544,0.612821395240466
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40268,0.00328680819530798,0.00662140217880093,-0.00969114007514185,0.0162647564657578,0.619628027038246
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD93,Complement component C1q receptor,42141,0.00165229596486679,0.00333462173281859,-0.00488356263145766,0.00818815456119123,0.620257558410214
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAG,Myelin-associated glycoprotein,40182,-0.00251898189128189,0.00510582798313679,-0.01252640473823,0.00748844095566622,0.621772168441511
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,42357,-0.00305867668554996,0.00621016133390499,-0.0152305929000037,0.00911323952890383,0.622354536202928
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHC1,SHC-transforming protein 1,40080,-0.00606079832576512,0.0123092274426328,-0.0301868841133253,0.0180652874617951,0.622461760562885
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINC1,Antithrombin-III,40516,0.000750017955413469,0.00152699707907552,-0.00224289631957455,0.00374293223040149,0.623314438953241
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCUN1D2,DCN1-like protein 2,40080,-0.00406774766362528,0.00835020695169334,-0.0204341532889442,0.0122986579616937,0.62616656690141
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,40080,-0.00292290077009248,0.00600893828203483,-0.0147004198028807,0.00885461826269579,0.626675311104471
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FRZB,Secreted frizzled-related protein 3,42454,0.00124690604378288,0.00256715345770645,-0.00378471473332177,0.00627852682088753,0.627176968159731
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40116,-0.00195519789602271,0.00404130396499455,-0.00987615366741202,0.0059657578753666,0.628534873611365
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40539,-0.000939393121337377,0.00194633920183301,-0.00475421795693007,0.00287543171425532,0.629356317590688
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL31,Interleukin-31,40199,-0.00282615161447106,0.00586849114732783,-0.0143283942632336,0.0086760910342915,0.630113470770362
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DSG3,Desmoglein-3,42651,0.00173072979015642,0.0036266745223118,-0.0053775522735747,0.00883901185388754,0.633211615920063
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LPA,Apolipoprotein(a),40324,0.0089074154771897,0.018930949301768,-0.0281972451542755,0.0460120761086549,0.637991817547345
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SAP18,Histone deacetylase complex subunit SAP18,40302,-0.00363242421935637,0.00772018328902428,-0.018763983465844,0.0114991350271312,0.637999857416007
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DNLZ,DNL-type zinc finger protein,40136,0.00441236300267946,0.00948955664815585,-0.014187168027706,0.0230118940330649,0.641961902555568
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPSG1,Tryptase gamma,40199,0.00128237328073041,0.00276868084740049,-0.00414424118017454,0.00670898774163536,0.643250803965581
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,40136,0.00271020124262509,0.00585739280682648,-0.00877028865875481,0.014190691144005,0.643590382844834
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMPRSS11B,Transmembrane protease serine 11B,40136,0.00372754722167706,0.00812240780143054,-0.0121923720691268,0.0196474665124809,0.64629968535224
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TSPAN15,Tetraspanin-15,40116,-0.00248283975797259,0.00542006033735707,-0.0131061580191924,0.00814047850324726,0.64690162590246
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42173,-0.00405877854729965,0.00891175878850266,-0.0215258257727649,0.0134082686781656,0.648799767521288
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40223,0.00166973526299228,0.00367062032054026,-0.00552468056526663,0.00886415109125119,0.649196001044099
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ZNF830,Zinc finger protein 830,40451,0.00364588941139271,0.00806927900394079,-0.0121698974363312,0.0194616762591167,0.651404885825775
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,COL4A4,Collagen alpha-4(IV) chain,40284,-0.00251527082159212,0.00558131385094154,-0.0134546459694375,0.0084241043262533,0.65224395269856
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANKRA2,Ankyrin repeat family A protein 2,40080,0.00269492236071827,0.00598153957198799,-0.00902889520037818,0.0144187399218147,0.652330149065917
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC4A1,Band 3 anion transport protein,40527,-0.00217948844032901,0.0048684321418466,-0.0117216154383484,0.00736263855769033,0.654394383992997
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",40080,-0.00227220179804662,0.0051011904060281,-0.0122705349938617,0.00772613139776846,0.656020930855852
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HMMR,Hyaluronan mediated motility receptor,40059,0.00227376029767389,0.0051771950690747,-0.00787354203771251,0.0124210626330603,0.660534284247057
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40116,-0.00221896851796683,0.00505828420074178,-0.0121332055514207,0.00769526851548705,0.660902039809499
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYTH3,Cytohesin-3,40080,0.00340421202408197,0.00778262932586471,-0.0118497414546129,0.0186581655027768,0.661821580226465
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42636,0.00126432129095247,0.00293562799136467,-0.00448950957212228,0.00701815215402723,0.666706722963335
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,40483,0.00178481689066276,0.00414927967943823,-0.00634777128103617,0.00991740506236169,0.667093998846268
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL11,Interleukin-11,42370,-0.00275174522543189,0.00646897482663404,-0.0154309358856346,0.00992744543477084,0.670569704754931
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,42346,0.00245892496675874,0.00586382625036387,-0.00903417448395444,0.0139520244174719,0.674976003058196
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GIPR,Gastric inhibitory polypeptide receptor,40199,0.00213438322273788,0.00509913982116069,-0.00785993082673708,0.0121286972722128,0.67553338760095
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ID4,DNA-binding protein inhibitor ID-4,40302,-0.00189320295654746,0.00452740797132469,-0.0107669225803439,0.00698051666724893,0.675834663732058
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40482,0.00173712370589164,0.00424646614908011,-0.00658594994630538,0.0100601973580887,0.682492285463259
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,APOB,Apolipoprotein B-100,40532,-0.000939427038451054,0.00232408335003112,-0.00549463040451205,0.00361577632760994,0.686062980276806
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40532,-0.0015776622193302,0.0039298210109139,-0.00928011140072144,0.00612478696206104,0.688089745989107
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,H2AP,Huntingtin-interacting protein M,40080,-0.00219719609850634,0.00548801042067261,-0.0129536965230247,0.00855930432601198,0.688897057601237
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPGN,Epigen,40451,0.00187946055831889,0.00473566280772622,-0.0074024385448245,0.0111613596614623,0.691468039104689
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF20,Fibroblast growth factor 20,40199,-0.00186029780175785,0.00469945438180777,-0.0110712283901011,0.00735063278658538,0.692220413454184
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLSTN2,Calsyntenin-2,42754,0.00161518890421628,0.00409412692018237,-0.00640929985934117,0.00963967766777373,0.693208065050762
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL3,Interleukin-3,40080,0.00250196083708943,0.00643858256605902,-0.0101176609923862,0.0151215826665651,0.697587979781724
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD82,CD82 antigen,40302,-0.00165536490799257,0.00427049221035475,-0.0100255296402879,0.00671479982430275,0.69829832953603
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,40136,0.0020722439095246,0.00535432096259634,-0.00842222517716423,0.0125667129962134,0.698746908253092
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL9,Interleukin-9,40302,0.0022567264656107,0.00586383542937885,-0.00923639097597185,0.0137498439071932,0.700352205354946
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLU,Clusterin,40539,-0.00125971802001162,0.00327623544349529,-0.00768113948926239,0.00516170344923914,0.700613860573972
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF7,Fibroblast growth factor 7,40080,-0.00312448692332979,0.00826119487785331,-0.0193164288839223,0.0130674550372627,0.705280136966058
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42311,0.00175511327559987,0.00471249042400491,-0.00748136795544977,0.0109915945066495,0.709572345669897
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GLI2,Zinc finger protein GLI2,40199,0.0012434613064259,0.00334196120960191,-0.00530678266439386,0.00779370527724565,0.709843930775122
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40302,-0.00269413554115333,0.0072816600097887,-0.0169661891603392,0.0115779180780325,0.711397593330206
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL2,Interleukin-2,42370,0.00119026452473377,0.00331196279519482,-0.00530118255384809,0.00768171160331562,0.719314033544896
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40136,0.00166826766868138,0.00464917164304813,-0.00744410875169296,0.0107806440890557,0.719728321470807
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",42311,-0.00151685196199053,0.00422836805070435,-0.00980445334137104,0.00677074941738999,0.719801177560523
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPHS2,Podocin,40199,-0.00391598224315652,0.0109384032104184,-0.0253552525355766,0.0175232880492635,0.720347860833609
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NGF,Beta-nerve growth factor,42495,-0.000442944601341216,0.00123812562181556,-0.00286967082009971,0.00198378161741727,0.720532968892463
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42711,0.00175241954578398,0.00491195219817874,-0.00787500676264635,0.0113798458542143,0.721272254422521
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENOPH1,Enolase-phosphatase E1,40451,-0.00203687233375552,0.00572192673947634,-0.0132518487431291,0.0091781040756181,0.721864719807011
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ICOSLG,ICOS ligand,42587,-0.000707506100171978,0.00200024457745204,-0.00462798547197797,0.00321297327163401,0.723561948601867
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,40136,0.00259567692371184,0.00742204712570951,-0.0119515354426788,0.0171428892901025,0.726551669488348
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,40080,-0.00182204735743284,0.0052674035969965,-0.012146158407546,0.0085020636926803,0.729417069168128
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,C1QL2,Complement C1q-like protein 2,40199,-0.00158188540726054,0.00458885597081328,-0.0105760431100546,0.0074122722955335,0.730309014456077
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CREBZF,CREB/ATF bZIP transcription factor,40080,-0.000938790774045997,0.00272422468304204,-0.00627827115280839,0.0044006896047164,0.730395429065617
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NUP50,Nuclear pore complex protein Nup50,40116,-0.00124125107358953,0.00361048874581809,-0.00831780901539299,0.00583530686821393,0.731010599995043
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ESPL1,Separin,40080,0.00204098287838913,0.00599346739354485,-0.00970621321295878,0.013788178969737,0.733460560049455
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EXOSC10,Exosome component 10,40116,-0.00213648614153468,0.00628172028931368,-0.0144486579085895,0.0101756856255201,0.733779002605842
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AFAP1,Actin filament-associated protein 1,40283,0.00288678182286388,0.00865132531745953,-0.0140698157993568,0.0198433794450845,0.738626690276615
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",40059,0.000919466263265899,0.00275902872459796,-0.00448823003694611,0.0063271625634779,0.738946553759527
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DCLRE1C,Protein artemis,40080,0.00108090647501311,0.00325611243566855,-0.00530107389889724,0.00746288684892346,0.739924140240136
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECM1,Extracellular matrix protein 1,40269,-0.00128744172578251,0.00388207895413616,-0.00889631647588938,0.00632143302432437,0.740169514836019
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42754,0.00122660815343626,0.00377334590164772,-0.00616914981379328,0.00862236612066579,0.745131784563875
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PFDN6,Prefoldin subunit 6,40182,0.00213588362034929,0.00674241960504698,-0.0110792588055428,0.0153510260462414,0.751414315073365
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CSH1,Chorionic somatomammotropin hormone 1,40532,0.000940024360938627,0.00296992237264823,-0.0048810234894519,0.00676107221132916,0.751617626708178
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,40116,-0.00186062605912261,0.00596015310161449,-0.013542526138287,0.00982127402004178,0.754911543552288
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NRN1,Neuritin,40482,-0.0011790474271321,0.00378286615326127,-0.00859346508752418,0.00623537023325999,0.755288740937682
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,40136,-0.0016560038985026,0.00537716847427278,-0.0121952541080772,0.00888324631107205,0.758111400849283
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42572,0.00107416137615351,0.00352861175965211,-0.00584191767276463,0.00799024042507165,0.7608166863196
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,40302,-0.00138831912905533,0.00457578974179945,-0.0103568670229823,0.00758022876487159,0.761586644405564
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CD86,T-lymphocyte activation antigen CD86,40449,0.000958338162937455,0.00315923667755415,-0.00523376572506868,0.00715044205094359,0.761632679929281
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCS,Copper chaperone for superoxide dismutase,42495,-0.00146907050905745,0.00489213944773199,-0.0110576638266122,0.00811952280849726,0.763959101386078
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MORF4L1,Mortality factor 4-like protein 1,40302,-0.00122551481215782,0.00416310117546193,-0.00938519311606321,0.00693416349174757,0.768476519432172
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40136,0.00153262751427211,0.00524325107957989,-0.00874414460170448,0.0118093996302487,0.770059122961379
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OMP,Olfactory marker protein,40136,0.00151049459561659,0.00524575303997645,-0.00877118136273724,0.0117921705539704,0.773393383411813
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,40136,-0.00121182385070487,0.00423493253356059,-0.00951229161648362,0.00708864391507388,0.774769033173561
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMY2B,Alpha-amylase 2B,41779,-0.00147075899397925,0.0051705191507226,-0.0116049765293956,0.00866345854143704,0.776069511756527
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL21R,Interleukin-21 receptor,40199,-0.00165282908238556,0.00582703708656769,-0.0130738217720582,0.00976816360728711,0.776685265077821
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ITGAX,Integrin alpha-X,40302,0.00159989147504155,0.00567411912462353,-0.00952138200922058,0.0127211649593037,0.777977157911735
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40136,0.00096024725950947,0.00346736221470839,-0.00583578268131898,0.00775627720033792,0.78183230191088
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,40182,-0.00106131943860642,0.00383639822103022,-0.00858065995182565,0.00645802107461281,0.782058100669074
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ADAMTSL5,ADAMTS-like protein 5,40511,-0.00111134553512504,0.00410427615964521,-0.00915572680802964,0.00693303573777957,0.786567123400214
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,40182,0.000844178225684039,0.00313028397414421,-0.00529117836363861,0.00697953481500669,0.787410715224845
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MLLT1,Protein ENL,40080,0.0018641382758666,0.00691705380236338,-0.0116932871767656,0.0154215637284988,0.787550909286201
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYH7B,Myosin-7B,40080,-0.00125581859050674,0.00467371110190412,-0.0104162923502388,0.00790465516922534,0.788166892138945
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKCQ,Protein kinase C theta type,42370,-0.0012139534462571,0.00452196377642462,-0.0100770024480494,0.00764909555553516,0.78835166725908
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NLGN2,Neuroligin-2,40136,-0.00134191181192,0.00501003723934529,-0.0111615848010368,0.00847776117719677,0.78882392717278
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENPEP,Glutamyl aminopeptidase,40116,-0.00132651823460156,0.00496121869603528,-0.0110505068788307,0.00839747040962759,0.789183572586488
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SLK,STE20-like serine/threonine-protein kinase,40302,0.00218905845927707,0.00832967269946669,-0.0141371000316776,0.0185152169502318,0.792707714834183
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMC3,Structural maintenance of chromosomes protein 3,40080,0.00151996245384862,0.00578881178207789,-0.00982610863902404,0.0128660335467213,0.792887773796917
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SOX2,Transcription factor SOX-2,40461,-0.00065201768705278,0.00248846070750216,-0.00552940067375701,0.00422536529965145,0.793313535320721
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL13,Interleukin-13,42370,0.00127600539938317,0.00490161914903161,-0.00833116813271878,0.0108831789314851,0.794618512011615
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40116,0.0014003149283158,0.00540551538113768,-0.00919449521871406,0.0119951250753457,0.795599236532381
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40116,0.00237020228908348,0.00915084155957491,-0.0155654471676833,0.0203058517458503,0.79562879591906
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GUCY2C,Heat-stable enterotoxin receptor,40302,-0.00215873937386689,0.00840006194851612,-0.0186228607929585,0.0143053820452247,0.797190567557866
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42346,0.00336743361357861,0.0131391853124359,-0.0223853695987958,0.029120236825953,0.797731408066485
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,40199,-0.00161375799585672,0.00640532834703068,-0.0141682015560369,0.0109406855643234,0.801092197304915
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,METAP1,Methionine aminopeptidase 1,42311,-0.000753942403570044,0.00301714789027326,-0.00666755226850564,0.00515966746136555,0.802679580810868
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GSAP,Gamma-secretase-activating protein,42346,-0.00220052094740922,0.00886461301720268,-0.0195751624611265,0.015174120566308,0.803955264400753
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAPS,Calcyphosin,40483,0.0026502421624395,0.0107593704368412,-0.0184381238937693,0.0237386082186483,0.805439436497909
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40065,0.00132823720297575,0.0054215344761529,-0.00929797037028394,0.0119544447762354,0.806466588902389
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40116,0.00154472568806004,0.00637459428707815,-0.0109494791146131,0.0140389304907332,0.80853263507065
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EPHA10,Ephrin type-A receptor 10,42311,-0.00166878742600342,0.00692135177923465,-0.0152346369133033,0.0118970620612965,0.809475837098784
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40116,-0.000945585635661895,0.00392465283957304,-0.00863790520122505,0.00674673392990126,0.80961013515186
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,40136,0.00102558948084866,0.00450750166621951,-0.00780911378494159,0.0098602927466389,0.82001630466449
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGS8,Regulator of G-protein signaling 8,42370,-0.00150528728880128,0.00665631178643879,-0.0145516583902213,0.0115410838126188,0.821092660987179
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42611,0.00053655670157478,0.00244828544318258,-0.00426208276706309,0.00533519617021265,0.826531781070125
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40116,0.00109136754282517,0.00503396999986066,-0.00877521365690173,0.0109579487425521,0.828367820461578
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40080,0.0010067456752438,0.00471212805009252,-0.00822902530293754,0.0102425166534251,0.830824086168462
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42794,-0.000704302189862882,0.00340086839571023,-0.00737000424545494,0.00596139986572918,0.835938916761324
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,40281,0.0011633732084655,0.00567874045586573,-0.00996695808503134,0.0122937045019623,0.837681630855447
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40182,-0.000665190227610842,0.00329965015168821,-0.00713250452491973,0.00580212406969804,0.840237736475083
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FAM171A2,Protein FAM171A2,40482,-0.00330579745654734,0.0166303043085427,-0.035901193901291,0.0292895989881963,0.842437218875232
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF3,Fibroblast growth factor 3,40199,-0.000597404979449957,0.00302992229148066,-0.00653605267075204,0.00534124271185213,0.843699386848469
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RTKN2,Rhotekin-2,40116,-0.00104642291488884,0.00536711015757625,-0.0115659588237383,0.00947311299396061,0.845420432254545
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GUK1,Guanylate kinase,40116,-0.000776791270294756,0.00399598339833092,-0.00860891873102337,0.00705533619043386,0.845871772346975
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PPM1A,Protein phosphatase 1A,42346,-0.000639251075965921,0.00329498051152944,-0.00709741287856362,0.00581891072663177,0.846172971254712
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYH4,Myosin-4,40116,-0.000905853658597366,0.00471631939938877,-0.0101498396813994,0.00833813236420463,0.84769257359725
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CLIC5,Chloride intracellular channel protein 5,40182,0.000628532986207666,0.00329182865694575,-0.00582345118140601,0.00708051715382134,0.848578217909619
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,40527,0.000592026452575155,0.00312005183623477,-0.00552327514644499,0.0067073280515953,0.849509286178964
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGFR4,Fibroblast growth factor receptor 4,40283,0.0010252887848259,0.00553711707696783,-0.00982746068603105,0.0118780382556829,0.85310180253711
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BTNL10,Butyrophilin-like protein 10,40080,-0.000813999039262833,0.0044437242152877,-0.00952369850122673,0.00789570042270106,0.854660615052833
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIRREL1,Kin of IRRE-like protein 1,40136,-0.00106953841910575,0.00599834607368516,-0.0128262967235287,0.0106872198853172,0.858486318229251
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40451,0.00141750818628412,0.00797406553495681,-0.0142116602622312,0.0170466766347995,0.858910888945323
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EVI2B,Protein EVI2B,40080,0.000747760302976497,0.00426608131619001,-0.00761375907675592,0.00910927968270892,0.860862596981735
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40080,-0.00153736151825064,0.00881270886498781,-0.0188102708936267,0.0157355478571255,0.861516452400977
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42495,0.00121195376780584,0.00711130505016847,-0.0127262041305244,0.015150111666136,0.8646774425976
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DBH,Dopamine beta-hydroxylase,40515,0.0018927232932585,0.011421952548226,-0.0204943037012645,0.0242797502877815,0.868388718123158
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OTOA,Otoancorin,40136,0.000939904529117612,0.0056959702616869,-0.0102241971837887,0.0121040062420239,0.868937435307315
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40449,0.00299148066403264,0.0182325584372401,-0.032744333872958,0.0387272952010233,0.869676186569549
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CA11,Carbonic anhydrase-related protein 11,42346,0.000543729788443283,0.00336332060659331,-0.0060483786004796,0.00713583817736617,0.871572487735596
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,UNC5D,Netrin receptor UNC5D,40199,-0.00043590753495857,0.00272436146140744,-0.00577565599931716,0.00490384092940002,0.872881205705861
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DPEP2,Dipeptidase 2,42587,-0.000487247274684715,0.00305068240474992,-0.00646658478799456,0.00549209023862513,0.873106047224829
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB118,Beta-defensin 118,40136,0.000944359637750816,0.00594339192045223,-0.0107046885263356,0.0125934078018372,0.873756603331259
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,40116,-0.000783225846601544,0.0050573834859319,-0.0106956974790281,0.00912924578582498,0.876928402064357
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MTPN,Myotrophin,42357,-0.000527538714068488,0.00344128061256649,-0.00727244871469881,0.00621737128656183,0.878166251229423
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MN1,Transcriptional activator MN1,40182,-0.000934842853760682,0.0061708673528623,-0.0130297428653708,0.0111600571578494,0.879589658687641
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42370,-0.0017752967566393,0.0117631476409143,-0.0248310661328314,0.0212804726195528,0.880040965170681
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40199,0.000541786167669976,0.00367504078998735,-0.00666129378070523,0.00774486611604518,0.882800717994258
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ODAM,Odontogenic ameloblast-associated protein,42292,-0.000808693399460593,0.00581340957789613,-0.012202976172137,0.0105855893732158,0.8893667250986
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SULT1A1,Sulfotransferase 1A1,42711,0.00178304102444962,0.0131429842312754,-0.0239772080688501,0.0275432901177494,0.892088254141395
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ENG,Endoglin,42794,-0.000240934697259848,0.00179688596975095,-0.00376283119797171,0.00328096180345201,0.893337678401351
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RGMA,Repulsive guidance molecule A,42711,0.000431396487814878,0.00330437455848675,-0.00604517764681914,0.0069079706224489,0.896130753755038
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMIGO1,Amphoterin-induced protein 1,40182,0.000686536323811275,0.00526252185816076,-0.00962800651818381,0.0110010791658064,0.896206732879103
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ATP1B4,Protein ATP1B4,40080,-0.000572166917548484,0.00440537433036523,-0.00920670060506433,0.00806236676996737,0.896664324416059
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TUBB3,Tubulin beta-3 chain,40136,-0.000378295354773718,0.00293216599363,-0.00612534070228853,0.00536874999274109,0.897347622299546
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPT1,Translationally-controlled tumor protein,42370,-0.00086632446826703,0.00674696071357039,-0.014090367466865,0.0123577185303309,0.897832665233587
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HBZ,Hemoglobin subunit zeta,40511,0.00136684373537494,0.0110588891987343,-0.0203085790941443,0.0230422665648942,0.901636691217471
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,42370,-0.000374431435284246,0.00307170851024966,-0.00639498011537359,0.0056461172448051,0.902982609575301
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AGBL2,Cytosolic carboxypeptidase 2,40136,0.00114715749301357,0.00946947903117297,-0.0174130214080854,0.0197073363941126,0.903580296851722
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,40182,-0.000440724657519148,0.00377561054809211,-0.00784092133177969,0.00695947201674139,0.907076645251758
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ACTN2,Alpha-actinin-2,40116,0.000720449112230476,0.00618555262168618,-0.0114032340262744,0.0128441322507354,0.907279921897379
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SHH,Sonic hedgehog protein,40199,-0.000490219830133119,0.00439891478736091,-0.00911209281336051,0.00813165315309427,0.911268615342528
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40199,-0.000479515697988803,0.00442136649664208,-0.00914539403140729,0.00818636263542968,0.913637398731496
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ISM2,Isthmin-2,40527,0.000477023459028186,0.0044991907189163,-0.00834139035004777,0.00929543726810414,0.915564964172933
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NPTXR,Neuronal pentraxin receptor,42636,0.000371392067110411,0.00351383169052689,-0.0065157180463223,0.00725850218054312,0.915826460594587
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,40136,0.000665637477391887,0.00652550815630774,-0.0121243585089713,0.0134556334637551,0.918754208395425
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SEZ6,Seizure protein 6 homolog,40182,-0.00033032536426977,0.00326524757496889,-0.00673021061120879,0.00606955988266925,0.919422154070334
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HK2,Hexokinase-2,42357,-0.000278864062547543,0.00286189216760353,-0.00588817271105047,0.00533044458595538,0.922378106118561
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42594,-0.000880533339004183,0.00930431833885218,-0.0191169972831545,0.0173559306051461,0.924604526792529
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40080,-0.000571797656079293,0.00611735037793312,-0.0125618043968282,0.0114182090846696,0.925530744139666
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,EXTL1,Exostosin-like 1,40116,-0.000452195405540511,0.00492271596586401,-0.010100718698634,0.00919632788755294,0.926811809760074
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CRX,Cone-rod homeobox protein,42357,-0.00101167229796675,0.0110231944346506,-0.0226171333898819,0.0205937887939484,0.926876861187646
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,NME1,Nucleoside diphosphate kinase A,40199,0.000208694095819482,0.00229207582337505,-0.00428377451799563,0.00470116270963459,0.927454313610219
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,40080,-0.000272229943157382,0.00301376733893477,-0.00617921392746952,0.00563475404115476,0.928027608061181
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CGA,Glycoprotein hormones alpha chain,42611,-0.00058702593166409,0.00649948847303379,-0.0133260233388103,0.0121519714754821,0.928035237465433
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40302,-0.000568705591578291,0.00656063529754277,-0.0134275507747621,0.0122901395916055,0.930923835304072
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GBP6,Guanylate-binding protein 6,40116,-0.000400806550920372,0.00479851513849082,-0.00980589622236239,0.00900428312052164,0.933433878380117
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LHB,Lutropin subunit beta,42346,-0.000717660497871968,0.00872345748070138,-0.0178156371600467,0.0163803161643027,0.934434934587854
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYOM2,Myomesin-2,40116,0.000418295365047731,0.00524161458172733,-0.00985526921513783,0.0106918599452333,0.936395582944247
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42794,0.000568888496790271,0.00726125341454209,-0.0136631681957122,0.0148009451892928,0.937554161974463
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,40080,-0.000755665980495661,0.0100315575617959,-0.0204175188016156,0.0189061868406242,0.939954429233645
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL4,Interleukin-4,42370,-0.000713679214055374,0.00966925972346741,-0.0196654282720515,0.0182380698439407,0.941163418273861
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF6,Fibroblast growth factor 6,40199,0.000294980574964125,0.00431883915057167,-0.00816994416015634,0.00875990531008459,0.945547353346452
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MORN4,MORN repeat-containing protein 4,40080,0.000532159220618543,0.00801148541000632,-0.0151703521829938,0.0162346706242309,0.947041054289207
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SERPINA11,Serpin A11,42794,0.000270977406199356,0.00422385174530829,-0.0080077720146049,0.00854972682700361,0.948848468024604
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CDC25A,M-phase inducer phosphatase 1,40080,-0.000193847332708469,0.0040619429863092,-0.00815525558587449,0.00776756092045755,0.961938030629262
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,CAPN3,Calpain-3,40451,0.000171932711608575,0.00397863890955678,-0.00762619955112272,0.00797006497433987,0.965531749687009
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BSND,Barttin,40080,-0.000151520067863297,0.00355724556039642,-0.00712372136624027,0.00682068123051368,0.96602534328178
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL24,Interleukin-24,42370,0.000220155122753621,0.00521746410515682,-0.0100060745233537,0.010446384768861,0.966343242286169
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,GAGE2A,G antigen 2A,40080,-0.000278687073767921,0.00694599983092158,-0.0138928467423742,0.0133354725948384,0.967996636263352
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MAPT,Microtubule-associated protein tau,42311,0.000181733275927318,0.00550125763684413,-0.0106007316922872,0.0109641982441418,0.973647291165842
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40116,0.000241721661065674,0.00745407738980643,-0.0143682700229549,0.0148517133450863,0.974131236192166
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,ANK2,Ankyrin-2,40116,-0.000215539529387151,0.00765780814999227,-0.015224843503372,0.0147937644445977,0.977545922141048
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,40116,0.000100956446196802,0.00393184319178274,-0.00760545620969737,0.00780736910209097,0.979515740792625
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,40199,0.000106818048578894,0.00434188494110148,-0.00840327643598,0.00861691253313779,0.980373054643634
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,HSP90B1,Endoplasmin,42247,-0.000146838285332274,0.00689435695510896,-0.0136597779173458,0.0133661013466813,0.983008002038896
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,40080,0.000134882707563063,0.00687647797811509,-0.0133430141295425,0.0136127795446686,0.984350788671017
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,FGF12,Fibroblast growth factor 12,40199,9.03284146421263e-05,0.00487604334104841,-0.00946671653381275,0.00964737336309701,0.985220416857026
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,DEFB116,Beta-defensin 116,40136,0.000148408579683324,0.00802676259485555,-0.0155840461062336,0.0158808632656002,0.985248914382738
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39845,7.63074024252319e-05,0.00537424230417048,-0.0104572075137489,0.0106098223185994,0.988671701065715
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,MYOC,Myocilin,42611,-6.05685283679143e-05,0.00461030736969123,-0.00909677097296273,0.0089756339162269,0.989518181957323
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40080,-2.99058832647677e-05,0.00603357001068046,-0.0118557031041985,0.0117958913376689,0.996045326928549
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,BEX3,Protein BEX3,40080,-1.88833716220713e-05,0.00498139645787206,-0.0097824204290513,0.00974465368580716,0.99697547290099
NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,AMY2A,Pancreatic alpha-amylase,42114,6.89718229554372e-07,0.00504807993988468,-0.00989354696394443,0.00989492640040353,0.999890987289605
